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ABSTRACT
Parasite-derived variant surface antigens (VSA) expressed on the infected erythrocyte 
surface are important targets of naturally acquired protective immune responses against 
malaria. The three major VSA-encoding multigene families of Plasmodium falciparum, 
var, r if  and stevor, exhibit high inter- and intra-strain genomic variability. The VSA 
component encoded by the var gene family, PfEM Pl, comprises the major cytoadhesive 
ligand and the major antigenic target o f protective antibodies. However, other VSA 
families, including those encoded by the r i f  and stevor multigene families, may also play 
important roles in malaria pathogenesis and immunity. However, the biological relevance 
of non-PfEMPl VSA remains largely unknown.
This thesis represents the first extensive analysis o f sequence diversity and expression 
patterns of r if  and stevor variant gene families in African field isolates of P. falciparum. 
The work details the characterization o f r i f  and stevor gene repertoires of P. falciparum  
parasites from diverse geographical locations and identification o f conserved genes in 
both P. falciparum  and the related chimpanzee malaria parasite P. reichenowi.
Both capillary sequencing and clone-free, 454 deep sequencing methods have been used 
to study changes in variant gene expression during asexual development of wild and 
culture-adapted isolates. Isolate- and stage-specific transcription patterns o f r i f  and stevor 
genes were observed, and the major sets o f transcripts in multiple isolates, including 
parasites that have been selected for different cytoadhesive phenotypes (resetting and 
adhesion to human brain endothelial cell lines) identified.
2
The role o f RIFIN antigens in the natural acquisition o f antibodies to malaria was tested 
using a strain transcendent variant PF3D7_1253700 (PFL2585c). The hypervariable 
region o f this RIFIN, expressed as a recombinant protein was used to purify naturally 
acquired human antibodies from sera from malaria-immune African adults. These 
antibodies recognized native RIFIN antigen on the surface o f intact trophozoites showing 
that RIFINs for additional targets o f naturally acquired antibodies that recognize the 
surface o f parasite-infected red blood cells.
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CHAPTER 1
1 LITERATURE REVIEW
1.1 Malaria -  an overview
Although malaria is a preventable and curable disease, it still remains a major public 
health problem causing significant morbidity and mortality. In the year 2013, an 
estimated 198 million malaria cases were reported, of which 584,000 resulted in death.
Of these deaths, 90% occurred in sub-Saharan Africa (SSA) (WHO report, 2014).
Malaria is a vector-borne disease caused by Apicomplexan parasites o f the genus 
Plasmodium, which have been found to infect mammals, reptiles and birds, and are 
transmitted by a variety o f insect vectors. Anopheles mosquito vectors transmit 
Plasmodium species that infect humans and other mammals, whereas culicine mosquitoes 
(Aedes and Culex sp.) are primarily responsible for the transmission o f avian plasmodia. 
All Plasmodium species show two distinct types o f division, asexual division and sexual 
division. There are two forms of asexual division, schizogony within the vertebrate host 
and sporogony in the insect vector. Sexual division occurs solely in the definitive insect 
host. Four species of Plasmodium naturally cause malaria in humans, P. falciparum, P. 
vivax, P. malariae and P. ovale. Recently a fifth species P. knowlesi has been shown to 
be a cause o f malaria in humans (Singh et al., 2004). The infection is zoonotic in nature 
and it is not known whether human-to-human transmission occurs. The most lethal form 
of malaria is caused by P. falciparum, which is the basis o f this thesis.
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1.2 P. falciparum  m alaria
P. falciparum  malaria remains a major public health problem in tropical countries 
especially in SSA where the burden o f disease is borne by young children and pregnant 
women. Currently, there are no licensed vaccines. The need for effective malaria 
vaccines is justified by the high cost of early childhood mortality as well as the 
epidemiological transition o f some areas o f high transmission to low transmission (Okiro 
et al., 2007, Ceesay et al., 2008, Kleinschmidt et al., 2009, O'Meara et al., 2008) leading 
to large populations o f less immune individuals. In addition widespread resistance of 
parasites to drugs and vectors to insecticides complicates alternative malaria control 
efforts.
1.2.1 Life cycle o f Plasmodium falciparum
P. falciparum  has a complex life cycle involving two hosts (Figure 1.1). The parasite life 
cycle begins when a female Anopheles mosquito takes a blood meal from an infected 
individual containing intra-erythrocytic sexual forms termed gametocytes (Figure 1.1. 8, 
9, and 10). Gametocytes, the precursors o f male and female gametes are crescent-shaped 
forms containing a single nucleus that persist within erythrocytes in the periphery as 
mature forms arrested in Go. In the mosquito gut, changes in the environment including a 
drop in temperature, an increase in carbon dioxide and other mosquito factors trigger 
differentiation o f gametocytes to gametes. The gametocytes escape the host cell by lysing 
the infected erythrocyte. The male gametocytes simultaneously go through three mitotic 
divisions resulting in 8 male gametes, a process known as exflagellation (Figure 1.1. 11). 
The male and female gametes fuse to form a diploid zygote. Within 20-24 hours, the
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zygote elongates and differentiates to a highly motile, invasive form known as an 
ookinete (Figure 1.1. 12). The ookinete escapes from the blood meal, and invades the 
midgut epithelial wall, lodging underneath the basal lamina, where it differentiates into a 
spherical oocyst (Figure 1.1.13). Within 8 to 15 days the oocyst matures as multiple 
mitotic nuclear divisions occur, producing thousands o f haploid sporozoites. When the 
process o f sporozoite budding (sporogony) is complete, the oocyst ruptures releasing the 
sporozoites (Figure 1.1.1 and 14) into the hemolymph, a fluid that bathes all the organs 
in the mosquito’s body cavity. Sporozoites are passively carried to the salivary glands, 
where they bind to and penetrate the basal lamina, invade the salivary gland epithelial 
cells, exit into secretory cavities and only a minor proportion eventually enter the salivary 
ducts to await transmission (Pimenta et al., 1994, Frischknecht et al., 2004). During 
feeding about 1-100 sporozoites are injected into the subcutaneous tissue of an individual 
together with the mosquito’s saliva (Medica and Sinnis, 2005, Jin et al., 2007). Some 
sporozoites remain in the skin or invade lymphatic vessels and are subsequently degraded 
(Amino et al., 2006). Some sporozoites enter blood vessels and flow into the liver where 
they traverse through several hepatocytes and Kupffer cells (Vanderberg et al., 1990, 
Mota et al., 2001, Mota et al., 2002, Mota and Rodriguez, 2004, Menard, 2001) before 
invading a hepatocyte and differentiating into a clinically silent liver stage schizont 
(Figure 1.1.2 and 3). After 5 to 7 days, merozoite filled vesicles termed merosomes 
(Figure 1.1.4) bud off from the mature schizont into the blood stream (Sturm et al., 2006, 
Graewe et al., 2011). Thousands of merozoites are liberated into the blood stream by the 
breakdown of the host cell plasma membrane and parasitophorous vacuole membrane 
(PVM) that enclose the merosomes (Graewe et al., 2011). The newly released merozoites
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invade red blood cells (RBCs) (Figure 1.1. 5) and establish the clinically relevant, 
pathogenic, intraerythrocytic developmental cycle (IDC), where multiple cycles of 
erythrocytic schizogony occur. Some merozoites that invade erythrocytes do not go 
through asexual erythrocytic schizogony but develop into the sexual blood stages, male 
or female gametocytes (Dyer and Day, 2000, Smith et al., 2002, Drakeley et al., 2006, 
Bousema and Drakeley, 2011). These transmissible forms are taken up by the mosquito 
to complete the parasite life cycle.
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Figure 1.1. Life cycle o f  P. falciparum. Image from adapted from Menard R. (Menard,
2005)
1: P. falciparum sporozoite, air-dried, and labeled with hyperimmune Kenyan adult sera, 
followed by secondary fluorescent antibody (AlexaFluor488 goat anti-human IgG). The 
sporozoite’s surface coat and the trail produced as it glides are shown in green. Photo by 
Offeddu, V. and Thathy V, unpublished.
2: Sporozoites migrating to hepatocytes to initiate liver stage infection. Parasites in 
green, tubulin in red and DNA in blue; Photo by Charo Armas (Preiser, 2002)
3: A multinucleated liver stage schizont developing within a vacuole in the hepatocytes; 
Photo by Charo Armas (Preiser, 2002).
4: Scanning electron micrograph o f  a budding merosome (Sturm et al., 2006).
5: Transmission electron micrograph o f  merozoite invading an erythrocyte (Srinivasan et 
al, 2011).
6: Colourized electron micrograph o f  an infected erythrocyte (blue), which has altered 
morphology and permeability pathways as compared to the uninfected erythrocytes (red): 
Photo by A. Mora (Sanchez, 2011).
7: Live immunofluorescence assay showing an IE surface stained with anti-stevor serum 
(Niang et al., 2009).
8: Scanning electron micrograph o f  a mature gametocyte (Pradel, 2007).
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9: Stage IVgametocyte showing surface-associated Pfs230 expression (shown in green) 
(Pradel, 2007).
10: Stage Vgametocyte surface showing gametocyte-specific multi-domain adhesion 
protein PfCCpl (in green, erythrocyte shown in red) (Pradel, 2007).
11: Exflagellating microgametocyte with 8 microgametes expressing alpha-tubulin II 
(alpha-tubulin II  labeling shown in green, erythrocytes shown in red) (Pradel, 2007).
12: A cluster o f  3 zygotes, one o f  which is transforming into an ookinete, expressing 
Pfs25 on the surface (Pfs25 labeling shown in green, erythrocytes shown in red) (Pradel, 
2007)
13: Electron micrograph o f  an oocyst packed with sporozoites (sp) budding o ff  the 
sporoblast (spr) (Thathy et al., 2002).
14: Scanning electron micrograph o f  midgut sporozoites isolated from infected 
mosquitoes on day 14post infection. Bar: 2 um. (Thathy et al., 2002).
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1.2.2 Intraerythrocytic developmental cycle (IDC)
Invasion o f host erythrocytes as well as other cells is possible mainly due to an apical 
complex (anterior pole) found in infective forms, the “zoites” of members o f the 
Apicomplexan phylum (Baum et al., 2008, Sinnis and Sim, 1997). In the case of 
Plasmodium, the merozoite invades erythrocytes to initiate the IDC, a clinically important 
phase of the parasite’s life cycle where the symptoms associated with malaria morbidity 
and mortality are manifested (Figure 1.1. 5, 6 and 7). Erythrocyte invasion is a complex 
receptor-mediated process involving an array o f factors, including proteins from the 
apical secretory organelles, micronemes, rhoptries, and dense granules. Invasion involves 
binding of a merozoite to the erythrocyte, reorientation, formation o f a tight junction 
(Figure 1.1. Image 5), and entry into the erythrocyte (Riglar et al., 2011). After invasion, 
the parasite goes through a period of intracellular growth, followed by asexual replication 
by schizogony, erythrocyte rupture and release o f multiple daughter merozoites 24-72 
hours later, depending on the species. P. falciparum  undergoes a 48-hour growth cycle 
from the initial ring form, to trophozoite and finally the schizont stage, which ruptures to 
release up to 32 daughter merozoites (Figure 1.1). The newly released merozoites invade 
other erythrocytes perpetuating the growth and asexual division cycle until either the host 
dies or the parasite is controlled by the host’s immunity or drug therapy.
Inside the erythrocyte the parasite exists inside a membrane bound vacuole, the 
parasitophorous vacuole (PV). The parasites ingest the erythrocyte cytosol and digests 
hemoglobin in the food vacuole to obtain amino acids. Free heme is detoxified by 
converting into the malaria pigment hemozoin. Erythrocytes are metabolically inert host
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cells. Thus, after invasion, the parasite modifies the infected erythrocyte (IE) by 
formation of new permeability pathways (Ginsburg and Stein, 2004, Ginsburg and Stein, 
1987, Ginsburg et al., 1983) to allow influx of low molecular weight metabolites as well 
as set up elaborate tubular structures, the tubulovesicular network (TVN) and Maurer’s 
clefts (MC) (Tilley et al., 2008) for protein export to the IE surface to interface with the 
host (Spielmann et al., 2006). Parasites dramatically remodel the IE by exporting 
hundreds o f proteins, the exportome to enable survival and proliferation in the 
bloodstream (Maier et al., 2009). The exported proteins alter cellular properties of the 
host cell making them less deformable, and enables expression of parasite antigens on the 
surface o f IE (Maier et al., 2009). The surface proteins alter the antigenic properties o f 
the IE and undergo clonal antigenic variation to evade host immunity. In addition surface 
antigens mediate adhesion o f the late-stage-IE to a variety o f cell receptors leading to 
sequestration o f the IE in the microvasculature o f different organs. It is likely that tissue 
specific sequestration o f IE plays a role in the pathogenesis o f different clinical 
phenotypes, such as cerebral malaria associated with parasitized red cells binding to brain 
endothelial cells (Turner et al., 2013, Moxon et al., 2013) and pregnancy malaria, 
associated with parasites sequestering in the placenta (Duffy and Fried, 2003b, Beeson et 
al., 2001). Late-stage IE can also adhere to uninfected erythrocytes forming “rosettes”. 
Rosetting is believed to contribute to sequestration o f IE through mechanical obstruction 
of the capillaries (Mercereau-Puijalon et al., 2008)
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1.3 M alaria pathogenesis
P. falciparum  infection in a non-immune individual is most likely to result in clinical 
disease. During clinical disease, symptoms including fever spasms, muscle aches and 
headaches, are manifested during the asexual erythrocytic cycle. In P. falciparum  the 
spasms of fever occur every 48 hours, which coincides with the rupture of schizont IE 
and release o f merozoites, parasite antigens, and pigment into the bloodstream. Clinical 
outcomes range from asymptomatic infections to severe malaria and death depending on 
age at infection and transmission levels (which modify host immune status). In high 
transmission areas incidence o f clinical disease is highest in the first year of life, but as 
children are constantly challenged they acquire immunity to clinical malaria within the 
first four years o f life, and thus experience fewer cases and less severe disease. In areas 
with low transmission the peak in disease incidence occurs at a later age (Snow et al., 
1997).
Severe malaria in African children presents as a single syndrome or a combination of 
three overlapping syndromes, impaired consciousness, respiratory distress and severe 
anemia (Marsh et al., 1995). Severe malaria with respiratory distress poses the highest 
risk of death in African children followed by impaired consciousness. Impaired 
consciousness presents as deep coma and inability to make verbal or motor responses. 
The depth o f coma is assessed based on Blantyre coma score (BCS) with a score o f 4 or 
less classified as impaired consciousness (Molyneux et al., 1989, Newton et al., 1997, 
Marsh et al., 1995). A BCS of less than 3 is classified as cerebral malaria (Newton et al., 
1997, Molyneux et al., 1989). Respiratory distress is characterized by recession or 
abnormally deep breathing with metabolic acidosis (Marsh et al., 1995). Severe malarial
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anemia is defined as venous hemoglobin concentration of 5g/dl or less on admission 
(Marsh et al., 1995).
1.4 Immunity to malaria
Attempts to develop a malaria vaccine are based on the fact that people can acquire some 
degree of immunity to malaria through natural exposure or experimental vaccination. It is 
therefore important to understand the mechanisms of acquisition and molecular targets of 
natural immunity to malaria to help guide rational vaccine design. Some studies have 
suggested that people living in high malaria transmission areas acquire immunity to 
severe malaria after relatively few clinical episodes (Gupta et al., 1999). This immunity is 
usually acquired by the age o f five years and is evidenced by decline in prevalence of 
clinical episodes in the immune individual. Immunity to mild febrile malaria is acquired 
more slowly and immunity to infection is hardly ever achieved (reviewed in (Marsh, 
1992).
Naturally acquired immunity to malaria has stage, strain and variant specific elements 
(Bull and Marsh, 2002, Langhome et al., 2008, Doolan et al., 2009) but eventually the 
individual may develop more cross protective responses (Marsh and Howard, 1986, 
Langreth and Reese, 1979, Hommel et al., 1983). Antibody responses to blood stage 
parasites play an important role in the development o f protective immunity to malaria 
(Cohen et al., 1961, Marsh et al., 1989, Bull et al., 1998, Duffy and Fried, 2003a, Staalsoe 
et al., 2004). Studies on passive transfer o f gamma globulin from malaria immune adults 
to infected children showed that P. falciparum-induced antibodies rapidly reduced
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parasitemia (Cohen et al., 1961). In addition maternal transfer of antibodies has been 
shown to protect infants against malaria (Edozien, 1962).
Antibodies can be targeted to the free merozoites or IE. Immune responses to the IE are 
targeted to parasite derived variant surface antigens (VSA) expressed on the IE (Marsh et 
al., 1989, Newbold et al., 1992). A number of studies have suggested that antibodies 
against these VSA confer protection against malaria (Marsh et al., 1989, Fried and Duffy, 
1998, Bull et al., 1998, Giha et al., 2000, Dodoo et al., 2001).
1.5 Variant Surface Antigens (VSA).
During the asexual growth cycle malaria parasites reside inside erythrocytes, cells that 
lack surface major histocompatibility complex (MHC) molecules and hence have no 
capacity for antigen presentation. Thus the parasites would stay hidden from the host 
immune responses. The hypothesis that the parasites were “invisible” to host immune 
system was challenged with the advent of the schizont-infected cell agglutination assay 
(SICA) (Eaton, 1938). Using the SICA test in a monkey malaria model, Eaton 
demonstrated that serum from an infected monkey agglutinated P. knowlesi IE (Eaton, 
1938). This agglutination was species specific and was observed when erythrocytes 
infected with mature stage parasites were incubated with serum. Uninfected erythrocytes 
as well as early-stage-IE were not agglutinated. Sera from monkeys that had not been 
infected with malaria or infected with a different species, or were acutely ill with malaria 
did not agglutinate IE. This suggested that species-specific antigens were present on the 
surface of mature stage IE and these were targets of host immune responses. Later studies 
by Brown et a l,  further explored antigenic variation in P. knowlesi. By infecting
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monkeys with P. knowlesi and subjecting them to sub-curative chemotherapy, the 
investigators were able to induce chronic infections with each successive peak in 
parasitemia being lower than the previous. Each peak in parasitemia represented distinct 
antigenic variants expressed on IE that induced a protective immune response (Brown 
and Brown, 1965, Brown et al., 1968). Variants from each recrudescence were infective 
to naive monkeys and induced antibodies that were able to agglutinate homologous 
schizont-infected erythrocytes. Sera from monkeys infected with heterologous parasites 
or serum collected from the same monkey before the infection did not induce 
agglutination. These antibodies conferred protection against homologous antigenic 
variants but not against heterologous variants (Brown and Brown, 1965, Brown et al., 
1968), suggesting that variant antigens on mature stage IE (SICA antigens) are targets of 
protective immune responses. Because these studies were looking at parasite populations 
it was not clear whether an individual parasite was able to switch to expressing a new 
variant antigen within an infection. The switch could alternatively result from immune 
selection o f the dominant variant within the population. Definitive evidence o f the former 
came from an experiment using cloned parasites (Barnwell et al., 1983). Barnwell et al., 
showed that multiple passages o f P. knowlesi SICA[+] parasites through splenectomized 
monkeys lead to a change in phenotype to SICA[-] variants that were not agglutinatable 
by immune serum (Barnwell et al., 1982). They later cloned both SICA[+] and SICA[-] 
by micromanipulation. The cloned SICA[+] parasites switched to SICA[-] after multiple 
passages in splenectomized monkeys and the SICA[-] to SICA[+] when passaged through 
intact monkeys (Barnwell et al., 1983). This conclusively showed an individual parasite 
had the capacity to switch between different antigenic variants.
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Following these studies the major P. knowlesi surface antigen was identified by 
immunoprecipitating radiolabelled antigens from schizont-IE from cloned parasites of 
distinct SICA phenotypes using immune sera. These antigens were characterized as high 
molecular weight parasite proteins that were expressed on schizont-IE in a variant 
specific manner (Howard et al., 1983). Similarly experiments using in vitro cultures of P. 
falciparum  identified a high molecular weight protein as the major VSA on the surface of 
trophozoite-IE (Leech et al., 1984, McBride et al., 1985) and later termed P. falciparum  
erythrocyte membrane protein 1 (PfEMPl) (Baruch et al., 1995).
Clonal antigenic variation in VS As in P. falciparum  was demonstrated in vitro using 
cloned parasites from the isolate IT (Biggs et al., 1991, Roberts et al., 1992).
These studies suggest that targets of naturally acquired antibodies to malaria are highly 
diverse and undergo switching between variants, suggesting that immunity to malaria 
may involve acquisition o f a wide repertoire of antibodies against multiple polymorphic 
antigens. This might be the reason why immunity to mild malaria is acquired over many 
years and immunity to infection hardly ever achieved (Marsh, 1992). On the other hand 
immunity to severe malaria is acquired relatively quickly after a few symptomatic 
episodes (Gupta et al., 1999). In addition, epidemiological studies have shown that people 
living in malaria endemic areas develop immunity to severe malaria early in life with 
older children and adults being resistant to severe malaria (Marsh and Kinyanjui, 2006). 
This suggests that there exist immune targets with restricted heterogeneity.
The importance o f VSA as targets o f naturally acquired immunity to malaria was 
suggested in a longitudinal study o f children living in a malaria endemic area in The 
Gambia, which showed that the level preexisting antibodies to the IE surface was the best
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predictor of protection from subsequent clinical episodes (Marsh et al., 1989). Later 
studies showed that children develop anti-VSA antibodies to the variants that caused an 
acute episode (Marsh and Howard, 1986, Newbold et al., 1992, Bull et al., 1999), and 
acquisition o f antibodies to a specific antigenic variant protected the children from 
clinical episodes caused by infection with that variant type (Bull et al., 1998, Giha et al., 
2000).
Three major multigene families present in the P. falciparum  genome (Gardner, 2002) 
encode VSA: var genes, which encode P. falciparum  erythrocyte membrane protein 1 
(PfEMPl), the repetitive interspersed family (rif) encoding RIFIN proteins, and the 
subtelomeric variant open reading frame (stevor) family, encoding STEVOR proteins 
(Table 1.1).
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Table 1.1. Number o f  genes in the multigene families encoding VSA in whole genome 
sequenced laboratory isolates.
3D7 IT HB3 Dd2
var No. o f intact genes 63 49 38 39
No. o f pseudogenes 40 7 12 11
Total 103 56 50 50
r if No. o f intact genes 157 121 161 99
No. o f pseudogenes 27 19 27 34
Total 184 140 188 132
stevor No. o f intact genes 31 34 32 24
No. o f pseudogenes 9 5 11 7
Total 40 39 43 31
pfmc-2tm No. o f intact genes 10 5 13 2
No. o f pseudogenes 3 3 1 1
Total 13 8 14 3
3D7 v3 (completely sequenced repertoire) and IT  v3 sequences obtained from  GeneDB 
(Gardner et al., 2002).
HB3 sequences obtained from HB3 genome sequenced by the Sanger Wellcome Trust 
Institute (unpublished).
Dd2 sequences obtained from the Broad Institute (http://www.broad.mit.edu).
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1.5.1 var encoded PfE M Pl
The major VSA expressed on IE is the extensively characterized PfEMPl family, 
encoded by the polymorphic var multigene family made of about 60 members (Su et al., 
1995, Baruch et al., 1995, Smith et al., 1995, Gardner et al., 2002). These genes are 
expressed in a mutually exclusive manner (Chen et al., 1998, Scherf et al., 1998) and 
undergo transcription switching during intraerythrocytic growth, thus orchestrating clonal 
antigenic variation of the IE surface (Roberts et al., 1992, Horrocks et al., 2004). All 
members o f this gene family share a similar structure consisting of a large 5’ exon 
encoding a short amino-terminal segment preceding a highly variable extracellular 
domain, and a short 3 ’ exon encoding the conserved intracellular acidic terminal segment 
(Su et al., 1995, Smith et al., 1998). The extracellular segment is made up of different 
combinations of Duffy Binding Like (DBL) domains and Cysteine rich Inter-Domain 
Regions (CIDR), which are thought to mediate cytoadhesion. Despite high sequence 
diversity var genes share key sequence features enabling classification into biologically 
important groups. Based on the 5’ flanking, or upstream (Ups), region, most var genes 
have been classified into UpsA (group A), UpsB (group B) and UpsC (group C) (Gardner 
et al., 2002, Lavstsen et al., 2003). Recently, a sequence classification system based on 
the modular domain architecture at the 5’ end of var genes from seven different P. 
falciparum  genomes has been used to classify var genes into different sub-types, termed 
domain cassettes (DC1-DC24) (Rask et al., 2010). Importantly expression o f var genes 
belonging to specific sub-types has been associated with severe malaria showing the 
biological significance o f the classifications (Bull et al., 2000, Nielsen et al., 2002,
Salanti et al., 2003, Jensen et al., 2004, Warimwe et al., 2009, Moxon et al., 2013, Turner
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et al., 2013, Abdi et al., 2014). More recent work has shown that DC8 and DC 13 mediate 
binding to brain endothelial cell lines in culture, and expression of these var genes is 
associated with severe malaria (Avril et al., 2012, Claessens et al., 2012, Lavstsen et al., 
2012, Turner et al., 2013). DC4 PfEMPl proteins have been shown to bind intracellular 
adhesion molecule 1 (ICAM) expressed on transformed Chinese hamster ovary cells 
while DC5 PfEMPl bind platelet/ endothelial cell adhesion molecule 1 (PECAM1) 
expressed on transformed human bone marrow endothelial cells (Berger et al., 2013). 
var gene expression is highly controlled to ensure expression of a single PfEMPl on the 
IE surface (Gardner et al., 1996). The Ups region, var promoter and epigenetic 
mechanisms are involved in var expression regulation (Voss et al., 2006, Voss et al.,
2007, Dzikowski et al., 2006a, Frank et al., 2006, Dzikowski et al., 2007, Chookajorn et 
al., 2007, Gannoun-Zaki et al., 2005). The three main var promoters alternate between a 
silenced and activated state. Activation of one promoter results in silencing o f all the 
other promoters thus silencing all other vars. Upregulation of an episomal var promoter 
driving expression o f a drug selectable marker, led to down regulation o f all 
endogenously expressed var genes, showing that these promoters act as important 
regulators for mutually exclusive var gene expression (Witmer et al., 2012).
PfEMPl proteins are believed to play a central role in malaria pathogenesis because they 
can mediate adherence of the IE to various receptors on host cells (Urban et al., 1999, 
Rowe et al., 1997, Reeder et al., 1999, Smith et al., 1995). Further evidence of a direct 
link between IE adhesion and pathogenesis was provided by Moxon et al, when they 
observed decreased EPCR expression and increased fibrin deposition at the cytoadhesion 
sites
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between IE and brain endothelium in post-mortem specimens from children who died 
from cerebral malaria (Moxon et al., 2013). PfEMPls are also the major candidate targets 
of protective antibody responses directed against the surface of IE (Chan et al., 2012). 
However it is likely that other VSA families in P. falciparum, such as RIFIN and 
STEVOR, that may be co-expressed with PfEMPl on the IE surface also play important 
roles in host-parasite interactions (Voss et al., 2006, Abdel-Latif et al., 2004, Newbold et 
al., 1999, Cheng et al., 1998, Kyes et al., 1999, Fernandez et al., 1999, Niang et al., 2009, 
Sanyal et al., 2012, Tiburcio et al., 2012, Niang et al., 2014, Goel et al., 2015). PfEMPl 
is only found in P. falciparum  and the related non-human malaria parasite P. reichenowi. 
Other Plasmodium species lack PfEM Pl, yet they evade host immune responses and can 
exhibit cytoadherence phenotypes like sequestration and rosetting, suggesting that these 
functions are likely to be mediated by other VSA (Jemmely et al., 2010).
1.5.2 Small variant surface antigens.
RIFIN (Cheng et al., 1998, Fernandez et al., 1999, Kyes et al., 1999, Petter et al., 2007) 
STEVOR (Blythe et al., 2004, Limpaiboon et al., 1990, Cheng et al., 1998, Lavazec et al., 
2006, Niang et al., 2009), PfMC-2TM (Sam-Yellowe et al., 2004) and SURFIN (Winter 
et al., 2005) have been identified as potential VSA in P. falciparum. They are encoded by 
the r if  stevor, P. falciparum  Maurer’s cleft 2- transmembrane (Pfmc-2tm) and surf 
multigene families respectively. The r if  stevor and pfmc-2tm  genes belong to the two- 
transmembrane (2TM) variant gene superfamily, which share a number of structural 
characteristics (Figure 1.2) (Cheng et al., 1998, Lavazec et al., 2006, Sam-Yellowe et al., 
2004). The rif, stevor, and Pfmc-2tm genes share a similar two-exon architecture. The
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short first exon encodes a signal peptide and the longer second encodes a semi-conserved 
amino-terminal region, separated from a highly polymorphic region by a putative 
transmembrane domain, with a second predicted transmembrane domain occurring before 
the semi-conserved, positively charged, short carboxyl-terminal region (Figure 1.2). All 
members have the Plasmodium export element (PEXEL)/vacuolar transport signal (VTS) 
motif (Hiller et al., 2004, Marti et al., 2004) near the start of exon 2, targeting them for 
translocation into the host cell. The hypervariable regions of each gene family exhibit 
extensive sequence diversity across paralogs and between parasite isolates (Kyes et al., 
1999, Lavazec et al., 2006, Joannin et al., 2008). Different topologies for the 2TM 
proteins on the IE surface have been proposed (Templeton, 2009b, Niang et al., 2009, 
Przyborski et al., 2005, Kyes et al., 1999, Bultrini et al., 2009, Goel et al., 2015, 
Bachmann et al., 2015). Until recently, the prevailing model was that the protein products 
of the 2TM superfamily possess two transmembrane (TM) domains flanking the 
hypervariable region, which forms a surface-exposed loop (Lavazec et al., 2006, Joannin 
et al., 2008) (Figure 1.3). Recent data challenge the existence o f the first N-terminal 
putative transmembrane domain (TM1), at least for some RIFIN and STEVOR family 
members, and instead support a topology where both the semi-conserved N-terminal 
region and the hypervariable region are exposed on the IE surface and anchored to the 
membrane only by the C-terminal transmembrane domain (TM2) (Bultrini et al., 2009, 
Niang et al., 2009, Goel et al., 2015, Bachmann et al., 2015). Regardless of the exact 
membrane topology of the 2TM proteins, the available data suggests that the 
hypervariable region flanking the 2TM domains is extracellular and exposed at the host- 
parasite interface. The profound sequence diversity confined largely to this region, in
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addition to the conserved PEXEL/VTS trafficking motif as a signature o f export into the 
IE, has led to the hypothesis that the hypervariable region defines a surface-exposed loop 
that is diversifying as a result o f  immune selection (Sam-Yellowe et al., 2004, Dzikowski 
et al., 2006b, Przyborski et al., 2005, Lavazec et al., 2006, Templeton, 2009b, Kyes et al., 
1999).
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Figure 1.2. Schematic showing the architecture o f  the P. falciparum 2TM variant gene 
superfamily. The r if  stevor, and Pfmc-2TM genes share a common two-exon structure in 
which a short first exon encodes a predicted signal peptide (SP) (red) and a longer exon 
2 (~lkh) encodes a PEXEL/VTS export m otif (black), a semi-conserved (SC) predicted 
globular domain (orange), two predicted transmembrane domains, a weakly predicted 
TMl (shaded blue) and a strongly predicted TM2 (solid blue) which flank a 
hypervariable region (grey), and a short semi-conserved positively-charged carboxyl 
terminal region (C) (yellow). The black solid line indicates the intron. The lengths o f  the 
hypervariable regions o f  each protein family differ, being 170, 60 and <20 amino acids 
in RIFIN, STEVOR and PfMC-2TMproteins respectively
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1.5.3 The pir  multigene family.
Unlike var, which is unique to P. falciparum  and P. reichenowi (Otto et al., 2014b) r if  
and stevor belong to the larger Plasmodium interspersed repeat (pir) gene superfamily, 
which is found in human, monkey and rodent malarias (Janssen et al., 2004, 
http://www.genedb.org/genedb/malaria/, http://www.plasmodb.org/plasmo/home.jsp). Pir 
gene families are the largest in each parasite genome, and encode proteins that are 
expressed at the host parasite interface (Florens et al., 2002, Niang et al., 2009, 
Mwakalinga et al., 2012, Khattab and Meri, 2011). The pir  multigene family has ancient 
evolutionary origins (Janssen et al., 2004), but the definitive function is still unknown.
There is emerging evidence o f the role o f PIR proteins in cytoadhesion and immune 
evasion (Niang et al., 2009, Bemabeu et al., 2012, Goel et al., 2015, Niang et al., 2014).
In the closely related chimpanzee malaria parasite, P. reichenowi, the pir  family is highly 
expanded in comparison to P . falciparum. Interestingly, the P. reichenowi genome 
contains the same three variant multi-gene families as P. falciparum, var, rif, and stevor. 
There are 568 r if  and 66 stevor in the P. reichenowi genome, as compared to 184 r i f  and 
42 stevor in P. falciparum  genome (Otto et a l, 2014b). The pir  genes have also been 
identified in the human malaria parasite, P. vivax (vir) (del Portillo et al., 2001, Lopez et 
al., 2013), the human and simian malaria parasite P. knowlesi (kir) (Pain et al., 2008), and 
in rodent malaria parasites, P. berghei (bir), P. chabaudi (cir) and P. yoelii (yir) (Carlton 
et al., 2002, Otto et al., 2014a, Lawton et al., 2012). Members o f the pir  multigene family 
encode proteins with similar features suggesting that they might have shared functions 
(Janssen et al., 2004, Jemmely et al., 2010). In P. vivax the vir gene family encode VIR
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proteins that are translocated to the surface of infected reticulocytes and have been 
associated with cytoadhesion (Carvalho et al., 2010, Bernabeu et ah, 2012). A recent 
study on diversity o f cir revealed similarities between cir and r i f  multigene families 
(Lawton et ah, 2012). cir can be subdivided into two functionally divergent groups, a 
more diverse A subfamily and the more conserved B subfamily based on an insertion of 
18 amino acids in the A subfamily. The insertion in cir A bears some sequence similarities 
to the insertion that is present in the P. falciparum rifA group, which is also larger and 
more diverse than the rifB sub-family (see section 1.5.3.1 and Figure 1.4 below) (Lawton 
et ah, 2012). Importantly, and for the first time, the cir genes have been implicated in 
virulence (Spence et ah, 2013). In this study, serially blood passaged (SBP) P. chabaudi 
were more virulent than mosquito transmitted (MT) parasites because of a modified 
immune response to the blood stage parasite. The difference in virulence between the MT 
and SBP parasites dependent on the presence of an intact immune system and attributed 
to a change in the pattern of expression of cir genes, with the SBP parasites expressing 
few cirs, and reaching higher parasitemias, while the MT parasites expressed many more 
cir genes and were associated with lower, more chronic parasitemias (Spence et ah,
2013). This study suggests for the first time a link between pir  gene expression, parasite 
multiplication rate and host immunity.
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Figure 1.3. Proposed model o f  the 2TM protein topology in infected erythrocytes. Figure 
adapted from (Scherf et al., 2008). The central hyper variable regions flanked by the two 
predicted transmembrane domains o f  RIFIN, STEVOR and P/MC-2TM proteins harbor 
extensive sequence polymorphism both within and across parasite isolates. For this 
reason, it has been proposed that the hyper- variable regions may form surface-exposed 
loops in parasitized erythrocytes (Cheng et al., 1998, Kyes et al., 1999, Templeton, 
2009a). Recent experimental data suggest that STEVOR and at least a subset o f  A-type 
RIElNs have only one TM segment near the C-terminus with the N-terminus (including 
the hypervariable loop region) exposed on the surface o f  the infected erythrocyte 
(Bultrini et a l, 2009, Niang et al., 2009, Bachmann et al., 2015, Goel et al., 2015)
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1.5.3.1 The /v/’multigene family
Although repetitive sequence elements interspersed in the P. falciparum genome had 
been reported as early as 1988 (Weber, 1988), it was only in 1999 with the early releases 
of whole genome sequencing data from chromosome 3 that Kyes et a l, identified r if  
{repetitive interspersed repeat) as a large multigene family that potentially encoded 
hypervariable membrane proteins (Kyes et al., 1999). The r if  genes form the largest 
multigene family in P. falciparum with 157 intact copies in the 3D7 laboratory isolate 
genome (Gardner et al., 2002, Joannin et al., 2008).
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Figure 1.4. Schematic diagrams o f  the predicted secondary structures ofRIFINs. 
Diagram adapted from (Bultrini et al., 2009).
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The r if  genes have been subdivided into two major groups rifA and rifB based on 
different sequence features (Figure 1.4.), most notable an insertion of a 25 amino acid 
consensus peptide, located about 66 amino acids downstream of the PEXEL m otif in A- 
type RIFINs (Gardner et al., 2002, Joannin et al., 2008). The B-type RIFINs exhibit a 
greater degree o f conservation than A-types and can be further sub-divided into at least 3 
groups (Joannin et al., 2008, Wang et al., 2009) (Figure 1.5). Sequence analyses have 
shown that rifB genes have unique untranslated regions (UTRs) (Bultrini et al., 2009, 
Joannin et al., 2008), suggesting a functional significance of this sub-grouping. 
Importantly, despite the hypervariability observed within these multigene families, there 
are conserved groups and individual subsets o f genes that are conserved across the 
sequenced laboratory isolate genomes (3D7, Dd2, IT and HB3) (Joannin et al., 2008, 
Wang et al., 2009, Bultrini et al., 2009, Claessens et al., 2011). A study by Claessens et 
al., described a group o f r if  and stevor that are conserved across 4 laboratory isolates and 
Brazilian field isolates (Claessens et al., 2011). 13 r i f  and 5 stevor were shared in at least 
3 o f the 4 isolates with an overall amino acid similarity above 90% in a pair. In some 
instances the conserved r i f  and stevor occur next to each other on the chromosome. The 
intergenic region between such pairs is also conserved (Claessens et al., 2011). This 
observation suggests that there are conserved chromosomal regions in the genome that 
encode genes important for parasite survival. The strain-transcendent r i f  and stevor genes 
may themselves be functionally important or may be physically linked to genes important 
for parasite survival. It is therefore important to analyse r i f  and stevor diversity across 
phenotypically distinct field isolates. Some of the strain-transcendent r i f  and stevor are 
pseudogenes and it is possible that pseudogenes are more likely to be conserved because
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they are not evolving under selection pressure from host immunity. These conserved 
pseudogenes might shed light on molecular evolution of these genes. Interestingly, the 
3D7 genome also contains a distinct subset of 8 conserved rifA genes whose promoters 
are oriented head-to-head (i.e. share a common upstream (5’) intervening region) with a 
Group A var gene (Lavstsen et al., 2003). Six o f these group A var-linked rz/have been 
classified into 2 different conserved sub-groups, named rifAl and those neighbouring the 
short Type 3 var genes, named r i f  A3 (PFA0020w/PF3D7_0100400, 
PFD0025w/PF3D7_0400500, PFI1815c/PF3D7_0937500, PF11_0009/PF3D7_1100300, 
PF11_0520/PF3D7_1150300, PF13_0004/PF3D7_1300400) (Wang et al., 2009).
Another unique rifA sequence, classified as rifA2 (PF3D7_ 040600. l/PFD0070c), which 
has a unique 5’ UTR, was also found to be conserved across parasite genomes (Wang et 
al., 2009).
1.5.3.2 The stevor multigene family.
The stevor gene family was first described as an expressed sequence, 7H8 detected by a 
monoclonal antibody (Limpaiboon et al., 1990). stevor is related to r i f  (Figure 1.5) in 
that they share some sequence homology at the 5’ end and in the region encoding the 
cytoplasmic tail (Gardner et al., 1998), as well as having a similar gene architecture as 
shown in Figure 1.2. stevor forms a much smaller multigene family than the r i f  gene 
family, consisting of 31 intact genes in the 3D7 genome (Table 1.1). In comparison to r i f  
stevor also form a much more conserved gene family (Gardner et al., 1998, Cheng et al., 
1998, Newbold, 1999). Phylogenetic analyses have classified stevor into two distinct 
groups per genome, a major group, which contains the majority o f the sequences and a 
more diverse minor group (Blythe et al., 2009, Schreiber et al., 2008).
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Conserved stevor genes have been observed across laboratory and field isolates (Albrecht 
et al., 2006, Lavazec et al., 2006, Blythe et al., 2009, Claessens et al., 2011)
There have been a limited number o f studies that describe sequence diversity o f r if  
(Joannin et al., 2008, Bultrini et al., 2009, Wang et al., 2009) and stevor (Lavazec et al.,
2006) from several laboratory isolates with broad geographical origins and a few field 
isolates from Brazil (r if  and stevor) (Albrecht et al., 2006), Gabon (rif) (Abdel-Latif et al., 
2004), Kenya (stevor) (Blythe et al., 2009) and 5 isolates from West Africa sampled from 
traveller malaria patients (Bachmann et al., 2012). All studies describe a high divergence 
within the hypervariable loop regions o f these proteins further supporting the hypothesis 
that host immune pressure drives antigenic diversification within this region (Lavazec et 
al., 2006, Templeton, 2009a). Full repertoires of r if  and stevor repertoires from global 
collections of field isolates will enable detailed functional studies to establish whether 
they are targets o f immune selection. Although whole genome sequence data is now 
available for hundreds o f field isolates (http://www.broad.mit.edu, 
http://www.genedb.org/genedb/malaria/, http://www.sanger.ac.uk/Projects/P_falciparum) 
the data is fragmentary and inadequately annotated (Joannin et al., 2008, Wang et al., 
2009, Lawton et al., 2012). Furthermore, optimized algorithms that allow automated 
assembly o f the full P. falciparum pir  gene repertoires are currently lacking and have thus 
far been based on algorithms that work best for var gene assembly (Newbold C., Otto, T, 
unpublished).
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Figure 1.5. Maximum likelihood tree o f  the pir multigene family from the 3D7 isolate 
showing clustering o f  stevor (blue) and r if  genes into separate, but related, groups. The 
r if  genes are divided into two major groups, A (green) and B. with B clustering further 
into B1 (pink), B2 (brown) and B3 (orange) subgroups (green). Three rifB  sequences did 
not fall into either o f  the B subgroups (black). The tree was based on MUSCLE- 
alignments o f224 r i f  (n=184) and stevor (n=40) coding sequences, including 
pseudogenes or truncated genes in the 3D7 genome (version 2). These highly diverse and 
potentially recombining sequences resulted in trees with low statistical support and long 
branch lengths (Log-likelihood: - 140966). Tree constructed using PhyML 
(http://www. atgc-monlpellier. fr), GTR model, viewed and edited using FigTree v 1.4.0.
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1.5.4 Transcription of r if  and stevor genes.
Microarray studies observed that gene expression in P. falciparum  occurs in a tightly 
regulated cascade such that a gene is expressed just in time when the protein is required 
in the life cycle o f the parasite (Bozdech et al., 2003). Early studies suggested VSA- 
encoding genes also followed a similar stage-specific expression profile, where each 
family is expressed sequentially, in overlapping windows, during the parasite’s asexual 
intraerythrocytic developmental cycle, var transcription occurs in rings (Kyes et al., 2000, 
Llinas et al., 2006), followed by rif'm  late rings to early trophozoites (Kyes et al., 1999, 
Kyes et al., 2000, Llinas et al., 2006) and stevor in trophozoites (Kaviratne et al., 2002, 
Lavazec et al., 2007, Niang et al., 2009). However, subsequent studies showed within the 
P. falciparum pir  gene family, different r i f  and stevor genes are expressed at multiple life 
cycle stages (Florens et al., 2002, Petter et al., 2008, Wang et al., 2010, Khattab et al., 
2008, Mwakalinga et al., 2012, Tiburcio et al., 2012, Bachmann et al., 2012) as well as 
multiple stages during the 1DC. r if  transcripts have been observed throughout the intra­
erythrocytic cycle (Bachmann et al., 2012, Wang et al., 2009), although peak expression 
of some members occurs at the late-ring to early-trophozoite (Kyes et al., 1999, Kyes et 
al., 2000), and o f others in schizonts, merozoites, gametocytes, gametes and sporozoites 
(Petter et al., 2008, Mwakalinga et al., 2012, Wang et al., 2010). stevor transcripts have 
been observed in the ring stage (Bachmann et al., 2012), mid-trophozoite to late schizont 
stage (Niang et al., 2009, Kaviratne et al., 2002, Sanyal et al., 2012), merozoites (Khattab 
et al., 2008, Bachmann et al., 2012, Khattab and Meri, 2011) and in gametocytes 
(Sutherland, 2001, McRobert et al., 2004, Sharp et al., 2006, Tiburcio et al., 2012). 
Bachmann et al., looking at expression o f VS A in laboratory isolates and five field
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isolates from patients with traveller’s malaria showed two distinct peaks in r if  and stevor 
transcription in the field isolates, at ring and trophozoite stages, disputing the proposed 
cascade-like expression pattern for the expressed repertoires of r i f  and stevor genes as 
initially described (Bachmann et al., 2012). Collectively, these data suggest that the 
diverse sub-groupings or clades of the r if  and stevor gene families (Janssen et al., 2004, 
Joannin et al., 2008, Wang et al., 2009, Bultrini et al., 2009, Blythe et al., 2009) might 
reflect the evolution o f specialized functions for different sub-groups in different life 
cycle stages o f the parasite (Otto et al., 2014a), in addition to their postulated roles in 
evading host immune responses. Laboratory isolates show low level o f expression o f r if  
and stevor compared with that o f field isolates (Blythe et al., 2008, Bachmann et al., 
2012, Daily et al., 2005), again hinting at important biological role(s) in host-parasite 
interactions.
There is evidence of transcriptional switching in the r i f  and stevor genes, though not in a 
mutually exclusive manner like the var genes (Lavazec et al., 2006, Lavazec et al., 2007, 
Cabral and Wunderlich, 2009). The strictly mutually exclusive expression o f var genes 
(Scherf et al., 1998) is not observed for other multigene families. Multiple r i f  and stevor 
transcripts have been detected in bulk parasite populations as well as in populations o f 
cloned lines in vitro (Bachmann et al., 2012, Kaviratne et al., 2002, Niang et al., 2009, 
Petter et al., 2008, Petter et al., 2007, Rovira-Graells et al., 2012). Transcription of 
multiple stevor in a single IE was clearly illustrated by Kaviratne and group where 
different stevor sequences were obtained from cloning and sequencing reverse 
transcription (RT) PCR products from individual trophozoites (Kaviratne et al., 2002). 
Although the processes involved in transcription regulation of VS A families may appear
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to be very different, the factors controlling these processes may be shared. Evidence 
suggesting that transcription of VS A might be under shared control came from a study by 
Howitt et al., (Howitt et al., 2009), where parasites were transfected to carry a var 
promoter-driven blasticidin-S-deaminase (bsd) selectable gene cassette. By growing the 
parasites in increasing doses o f blasticidin the investigators were able to increase the 
numbers o f episomally replicating plasmids containing the respective promoters. High 
expression of the episomal var promoter not only led to repression of the endogenous 
expressed var gene, but additionally resulted in reduced expression of other VSA, rif, 
stevor and to a lesser extentpfmc-2tm. In the reciprocal experiments, transgenic parasites 
carrying rif, stevor o rpfmc-2tm  promoter-driven drug selectable constructs were used to 
examine the effects on endogenous var expression. Parasites expressing high copy 
numbers o f r if  or stevor promoters episomally had decreased var expression, while 
parasites overexpressingpfmc-2tm  promoter-driven selectable markers showed no 
difference in var expression. Using this promoter titration strategy the authors 
demonstrated that VSA transcription requires a shared transcription factor. The overlap 
between transcriptional regulation o f the individual variant gene families is still unclear, 
although the authors suggested that var and r if  expression might be linked due to the 
overlap in expression timing o f both gene families. The notable upregulation in pfmc-2tm  
genes in transfected parasites where stevor had been downregulated suggested potentially 
complementary roles for these two gene families in parasite survival.
Interestingly an earlier study observed co-regulation o f var genes with upsA promoters 
(Group A var) and their neighbouring r i f  genes linked in a head-to-head direction (rifA l) 
(Tham et al., 2007, Wang et al., 2009). More recent work showed similar temporally
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linked expression profiles between group ri/Al genes and their linked upsA-var genes. In 
addition, activation of ri/Al promoter resulted in knock down of endogenous var, a 
similar effect to that of var promoter (Witmer et al., 2012). This study demonstrated that 
the r if  promoter had a direct effect on var gene expression levels. Additional evidence for 
linked transcription between upsA var genes and ri/A l genes comes from analysis o f var 
expression in parasites selected on human brain endothelial cells (HBEC) (Claessens et 
al., 2012). HBEC-selected parasites showed up-regulation o f Group A var genes as well 
as the head-to-head-linked r i f  gene.
60
1.5.5 Localisation
P. falciparum  parasites exist within a membrane-bound parasitophorous vacuole (PV) 
inside the IE. Blood stage P. falciparum  extensively remodels its relatively inert host cell 
using a complex process o f parasite-driven protein export involving translocation through 
several membranes (Maier et al., 2009). Exported proteins are trafficked through the 
endoplasmic reticulum, cross the parasite plasma membrane, through the PV membrane 
(PVM) and into the IE cytosol. Additionally membrane proteins including VSA have to 
cross through the IE cytosol to the IE membrane (Figure 1.6). Most exported proteins 
contain signal sequences that direct them into the secretory pathway. The signal peptide 
mediates entry into the endoplasmic reticulum and translocation across the parasite 
plasma membrane to the PV (Wickham et al., 2001). To cross the PVM and enter the IE, 
an additional signal, Plasmodium export element (PEXEL/VTS), consisting o f a 
pentameric motif RxLxE/Q/D is required (Hiller et al., 2004, Marti et al., 2004). An 
aspartyl protease, plasmepsin V mediates cleavage o f the PEXEL at the leucine residue 
(Boddey et al., 2013). Exported proteins which contain a PEXEL/VTS motif are 
translocated through the PVM into the IE via the translocon complex, PTEX 
(Plasmodium translocon o f exported proteins) (de Koning-Ward et al., 2009, Riglar et al., 
2013, Elsworth et al., 2014, Beck et al., 2014). Parasites also export a number o f proteins 
that lack a PEXEL/VTS motif (PEXEL-negative exported proteins or PNEPs) using 
transport pathways that have not yet been fully characterized (Spielmann and Gilberger, 
2010, Gruring et al., 2012).
Both RIFIN and STEVOR have a signal peptide as well as the PEXEL/VTS motif for 
export to the IE surface. PfEMPl lacks a signal peptide and a classical PEXEL m otif but
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contains conserved motifs that function as PEXEL/VTS motif (Hiller et al., 2004, Marti 
et al., 2004). RIFIN, STEVOR and PfEMPl are targeted for transport via the Maurer’s 
clefts (MC), a network of parasite-derived membranous structures that first appear in the 
early ring stages o f parasite development within the IE (Haeggstrom et al., 2004, Hiller et 
al., 2004, Marti et al., 2004, Haeggstrom et al., 2007, Gruring et al., 2012). Trafficking of 
STEVOR and PfEMPl to the IE membrane via the MC are both dependent upon a 
protein called P. falciparum  PfEMPl trafficking protein one (PfPTPl) (Maier et al.,
2008, Rug etal., 2014).
The A- and B-RIFIN sub-groups are reported to have distinct subcellular localizations 
within the IE. A-RIFINs are translocated into the MC and are associated with the IE cell 
surface while B-RIFINs reside within the parasitophorous vacuole (Petter et al., 2007, 
Petter et al., 2008, Bachmann et al., 2012). Surface iodination and immunoprecipitation 
experiments suggested localization o f RIFIN at the IE surface (Fernandez et al., 1999, 
Kyes et al., 1999). In merozoites, the A-RIFINs are localized at the apical tips while the 
B-RIFINs are found inside the merozoite cytosol (Petter et al., 2007). More recently a B- 
RIFIN was found to be preferentially expressed in merozoites, gametocytes and gametes, 
and localized to the surface of merozoites, gametes and sporozoites (Florens et al., 2002, 
Petter et al., 2008, Wang et al., 2010, Mwakalinga et al., 2012).
Studies based on immunofluorescence assays have located STEVOR within the MC in 
trophozoites and closely apposed to the IE surface in late trophozoites (Lavazec et al., 
2006, Blythe et al., 2008, Kaviratne et al., 2002). Later a study using a live 
immunofluorescence assay showed that STEVOR are located on the surface o f IE (Niang 
et al., 2009). STEVOR have also been shown to translocate to the apical ends of
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merozoites (Blythe et al., 2008), and to the surface of invading merozoites (Khattab et al., 
2008, Khattab and Meri, 201 1). STEVOR proteins have also been detected in 
gametocytes (McRobert et al.. 2004, Tiburcio et al., 2012) and in sporozoites (Florens et 
al., 2002).
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Figure 1.6. Many-exportedproteins in P. falciparum infected erythrocytes (IE) contain a 
PEXEL/VTS m otif that is cleaved in the ER and targets the protein into the red blood cell 
Some IE surface membrane-associated parasite proteins are thought to be transported by 
the translocon complex PTEXacross the PVM into MC which carries the protein to the 
IE surf ace. Adapted from Maier et al 2009.
63
1.5.6 RIFIN and STEVOR function.
RIFINs were initially thought to be involved in rosetting and were termed rosettins 
(Helmby et al., 1993). Subsequent studies showed that PfEMPl mediated this phenotype 
(Rowe et al., 1997), though whether or not RIFINs play a complementary role in rosetting 
remained unclear. A structural analysis has suggested different architectures o f the 
different RIFIN sub-groups, where B-RIFINs are predicted to have a signal peptide and 
two TM domains, while a majority of the A-RIFINs do not have a conventional signal 
peptide and in silico and experimental data suggest the presence o f only one TM domain 
(Bultrini et al., 2009, Niang et al., 2009, Goel et al., 2015). A similar topology is 
predicted for stevor genes (Niang et al., 2009). Additionally a study on a splenectomized 
malaria patient revealed lack of expression of rifA as well as var and stevor while rifB 
and Pfmc-2TM  were expressed in the infecting parasite that also lacked cytoadherent 
properties (Bachmann et al., 2009) suggesting different functional properties of the two 
major r if  groups. A recent study that showed A-RIFINs mediate rosetting of blood group 
A erythrocytes (Goel et al., 2015). The study first demonstrated the ability of RIFINs to 
bind RBC using A-RIFIN-transfected Chinese hamster ovary (CHO) cells. The 
transfected CHO cells expressed RIFIN on the surface and preferentially bound blood 
group A RBCs via blood group A antigens to form large rosettes. Treatment o f blood 
group A RBCs with neuraminidase to convert them into group O RBCs by cleaving off 
the a3 N-acetylgalactosamine residue, reduced binding to the RIFIN-expressing CHO 
cells. The authors then showed that a specific r if  together with a var gene were highly 
expressed in the rosetting parasite line FCR3S1.2 when the parasite was enriched for 
rosetting. Anti-RIFIN IgG disrupted rosettes in this parasite when cultured in blood group
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A but did not affect rosetting when cultured in blood group O. This supported the role of 
the specific FCR3S1.2 RIFIN in rosetting of FCR3S1.2-IE with group A RBCs. 
Transfecting a low-rosetting parasite line with this specific RIFIN increased the ability of 
the parasite to form rosettes, and more so with blood group A RBCs. These results 
demonstrated that A-RIFINs could play a complementary role to PfEMPl in rosetting. 
STEVOR have been shown to undergo clonal variation at the IE surface (Lavazec et al., 
2007, Blythe et al., 2008, Niang et al., 2009) and thus may play a role in immune evasion 
of the IE along with simultaneously expressed RIFIN and PfEM Pl. However, besides a 
potential role in immune evasion, STEVOR, like RIFIN, may serve specialized roles in 
the life cycle o f the parasite. Recent studies imply a role for STEVOR in malaria 
pathogenesis. In a study looking at changes in IE deformability, STEVOR overexpression 
increased the rigidity o f the trophozoite-IE (Sanyal et al., 2012) and gametocyte-IE 
(Tiburcio et al., 2012). Infected and uninfected erythrocytes were perfused through a 
defined matrix of microspheres with flow and retention rates determined. Deformability 
of IE was also measured using ektacytometry via Laser-assisted optical rotational cell 
analyzer (LORCA). Increased deformability index as measured by ektacytometry 
analysis as well as increased retention rates were observed in parasites that overexpressed 
stevor compared to parasites that did not (Sanyal et al., 2012, Tiburcio et al., 2012). 
Synthetic STEVOR peptides can bind to human erythrocytes (Garcia et al., 2005), which 
supports a possible role in rosetting. Localization o f STEVOR at the apical ends of 
merozoites (Blythe et al., 2008), and on the surface o f invading merozoites (Khattab et 
al., 2008, Khattab and Meri, 2011), suggests a role in invasion, or immune evasion by the 
merozoites. More recent data has confirmed that STEVOR antigens can also mediate
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PfEMPl-independent rosetting of IE and may play a role in invasion via the glycophorin 
C pathway (Niang et al., 2014). This study first demonstrated that STEVOR proteins 
were co-localised on live merozoite surface with the merozoite surface protein 1 (MSP1), 
the well characterised merozoite surface antigen key in the invasion process. Anti- 
STEVOR sera raised against the semiconserved regions o f 2 STEVOR antigens were able 
to inhibit invasion. The study then demonstrated that STEVOR mediated binding to 
RBCs via Glycophorin C, and that this rosetting in turn enhanced invasion.
VSA are non-essential for parasite survival in vitro. VSA gene knock out experiments 
(Dzikowski and Deitsch, 2008, Howitt et al., 2009) and a study looking at stevor 
expression in laboratory and field isolates (Blythe et al., 2008) showed that parasite 
growth was not affected by downregulation of these genes. A different study looking at 
malaria in a splenectomized individual showed that the parasites causing the infection did 
not express var, rifA and stevor (Bachmann et al., 2009). As mentioned above, different 
groups of RIFIN and STEVOR are expressed at the host-parasite interface, i.e. the IE 
surface, merozoite surface, mature gametocytes, sporozoites and gametes, suggesting 
they have important functions in parasite biology (Florens et al., 2004, McRobert et al., 
2004, Petter et al., 2008, Niang et al., 2009, Khattab and Meri, 2011, Mwakalinga et al., 
2012, Tiburcio et al., 2012, Goel et al., 2015, Niang et al., 2014). In the rodent malaria 
parasite P chabandi, a difference in cir gene expression was observed between mosquito- 
transmitted parasites and serially blood-passaged parasites. The switch in cir expression 
was linked to a change in virulence (as measured by parasite multiplication rates), with 
fewer cir genes expressed and increased virulence in the serially blood passaged parasites 
(Spence et al., 2013). Taken together, these studies suggest important roles for pir  genes
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during host-parasite interactions, specifically immune evasion strategies and/or functional 
roles in infection and virulence.
1.5.7 Immune responses to RIFIN and STEVOR.
Few studies have described immune responses to RIFIN and STEVOR. A cross sectional 
study in a hyperendemic area in Gabon reported higher recognition o f recombinant 
RIFIN in exposed immune adults as compared to children, although antibodies were also 
detected in the children (Abdel-Latif et al., 2002). A second study showed that high levels 
of antibodies to RIFIN were associated with rapid clearance of parasites in children 
(Abdel-Latif et al., 2003). There is evidence that responses to RIFIN, in addition to 
PfEM Pl, can contribute to the overall anti-VSA antibody response formed against the IE 
surface (Abdel-Latif et al., 2004). In this study immune sera from Gambian adults was 
preadsorbed with recombinant RIFIN, which resulted in a reduction in the reactivity to 
the IE surface. In another study, patients with severe malaria in Ghana had higher 
antibody levels to RIFIN than asymptomatic controls suggesting that antibodies to RIFIN 
are boosted by current infections (Schreiber et al., 2006).
Even fewer studies have looked at the role o f STEVOR as targets o f immune responses. 
Sera from immune adults recognized recombinant STEVOR proteins (Schreiber 2008). In 
addition a longitudinal study in 9-month old infants showed that although there was no 
correlation with protection, antibody levels to a recombinant STEVOR were higher in 
children that experienced a higher frequency o f malaria episodes (Schreiber et al., 2008). 
Recently, Chan et al., have shown that PfEMPl is the major target o f anti-VSA 
antibodies targeted to IE. Genetically modified parasites with reduced expression o f
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PfEMPl were produced by transfecting parasites with a construct containing var 
promoter without the downstream var gene. Drug driven expression o f the var promoter 
resulted in silencing o f endogenous var genes. Sera from immune Kenyan adults showed 
decreased surface binding to PfEMPl knockdown parasites in comparison to wild type 
parasites suggesting that PfEMP l forms the major target of IE surface antibody response 
(Chan et al., 2012). However residual reactivity to the PfEMPl knockdown parasites was 
observed suggesting that RIFIN and STEVOR might still serve as immune targets on the 
IE surface (Voss et al., 2006, Chan et al., 2012).
More comprehensive studies are required to establish the functional role of these PIR 
antigens in development o f protective immunity against malaria, as well as in parasite 
biology and disease pathogenesis, and how they interact with the most well characterized 
virulence factors in P. falciparum, PfEMPl.
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1.6 Thesis objectives.
1.6.1 General objective
To assess whether the variant antigens encoded by the r i f  and stevor multigene families 
contribute to the pathogenic and antigenic properties of P. falciparum-’m fected red cells.
1.6.2 Specific objectives
1) To characterise the sequence diversity of r i f  and stevor in culture-adapted and 
clinical isolates of P. falciparum  from different geographical locations.
2) To profile r i f  and stevor gene expression patterns during asexual blood stage 
development of parasite isolates exposed to different selection pressures.
3) To investigate whether the hypervariable loop region of RIFIN antigens are 
targets of naturally acquired antibodies.
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CHAPTER 2
2. Materials and Methods
2.1. Study area and study participants
The work discussed in this thesis was carried out at the KEMRI-Wellcome Trust 
Research Programme located in Kilifi County along the Kenyan coast, north of 
Mombasa. The Programme works in partnership with the Kilifi County Hospital. The 
hospital serves the entire Kilifi population o f about 544,000. Kilifi is a malaria endemic 
area, typically experiencing two seasons o f high malaria transmission, May to June and 
December to January following the long and short rains respectively. Malaria 
transmission has been on the decline from 1999 (Okiro et al., 2007, Ceesay et al., 2008, 
Kleinschmidt et al., 2009, O'Meara et al., 2008) but hotspots of both febrile and 
asymptomatic malaria still exist (Bejon et al., 2010, Bejon et al., 2014). The major vector 
has been Anopheles gambiae sensu lato (s.l.) with Anopheles funestus playing a minor 
role (Mbogo et al., 2003), but recent studies have observed vector replacement along the 
Kenyan coast with Anopheles arabiensis and Anopheles merus becoming major vectors 
(Mwangangi et al., 2013). Chloroquine was used as the first-line treatment for non­
complicated malaria until 1998 when the switch was made to sulphadoxine- 
pyrimethamine (Shretta et al., 2000). Artemether-lumefantrine replaced sulphadoxine- 
pyrimethamine in 2006 (Amin et al., 2007).
2.2. Sample collection and processing
Isolates used in this study were sampled from children admitted at the Kilifi County 
hospital with either severe malaria (part of an ongoing var study led by Dr. P. Bull) or ex
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vivo samples collected from children with non-severe malaria (part o f an ongoing 
microarray study led by Dr. M. Mackinnon). Additional isolates were collected from 
children with asymptomatic malaria during annual cross-sectional surveys for malaria in 
2 field cohorts, RTS,S cohort (2007-2012) (Bejon et al., 2006) and Junju cohort (2006- 
2015) (Mwangi et al., 2005) in Kilifi County. 2-5 ml of blood was collected from each 
child and 2-4.4 ml transferred into heparinized vacutainers containing 50units o f heparin. 
The samples were transported to the laboratory on ice.
In the laboratory, the samples were centrifuged at 2000 revolutions per minute (rpm) for 
5 minutes to separate plasma from the pellet. Plasma was harvested into 2ml cryotubes 
and stored at -80°C. The remaining pellet was resuspended in 5ml “yellow RPMI”
(RPMI medium pH 7.2 containing ImM L-Glutamine, 25ug/ml Gentamicin and 200mg D- 
glucose/ml). To separate the buffy coat and peripheral blood mononuclear cells (PBMCs) 
from the RBC pellet, the resuspended pellet was layered onto an equal volume of 
Lymphoprep ® (Axis-shield poc AS cat. No. 1114545, Norway), and centrifuged at 2000 
rpm for 20 minutes, without brakes. The PBMCs were harvested and stored at -80°C.
The remaining pellet was resuspended in equal volume yellow RPMI. To remove 
granulocytes from the resuspended pellet, a suspension o f the pellet and 0.6 x volume 
Plasmion ® (Bellon France cat. No. 00-13-6676) was made and incubated at 37°C for 10 
minutes. The supernatant containing granulocytes was harvested, washed in yellow RPMI 
and stored at -80°C. The RBC pellet was resuspended in yellow RPMI to a final volume 
of 5ml and split into 3 aliquots for storage o f ring-infected RBCs in glycerolyte (parasite 
stabilate), in Trizol™ (Life Technologies, Invitrogen) for RNA extraction, (ring RNA, 
acute stage) and the rest for culturing to trophozoite stage (approximately 24 hours). The
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pellet for culturing was resuspended in 5ml “blue RPMI” (yellow RPMI with 10% AB 
serum from adult non-immune European donors) and cultured for 24 hours or until the 
parasites matured to pigmented trophozoite stage as determined by Giemsa staining. The 
cultures were split into two aliquots for storage of trophozoite-infected RBCs in 
glycerolyte, and in Trizol™ (trophozoite RNA, acute stage). All the aliquots for RNA 
preparation were frozen in Trizol™ at -80°C. The ring and trophozoite parasite stocks in 
glycerolyte were stored in liquid nitrogen at -180°C.
2.3. Parasite culture methods
2.3.1. Thawing cryopreserved P. falciparum  and culture establishment
Ciyopreserved ring-infected erythrocytes were thawed through gradual addition of 
decreasing concentrations o f saline solution to restore parasites to isotonic condition. The 
frozen stocks were retrieved from liquid nitrogen and rapidly thawed in 37°C water bath 
for 1 minute. The IE were transferred to a 50ml falcon tube (Greiner Bio-One). While 
gently shaking the falcon tube, sodium chloride (NaCl) was added drop-wise to the IE in 
order o f decreasing concentration. First 200pl of 12% NaCl was added followed by 10ml 
of 1.8% NaCl and 10ml of 0.9% NaCl. The IE suspension was centrifuged at 1800rpm for 5 
minutes and the supernatant removed by aspiration. The IE pellet was then washed twice by 
adding 10ml yellow RPMI and centrifuging at 1800rpm for 5 minutes. After the final 
wash the pellet was resuspended in 5ml blue RPMI (yellow RPMI with 10% pooled 
serum from malaria non-exposed non-immune Kenyan donors or 10% AB serum from 
non-immune European adults) and transferred to a 50ml flask for continuous culture.
Two aliquots o f approximately 1 OOpl were taken for parasite assessment by Giemsa 
staining o f blood films, and for mycoplasma testing.
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Established parasite cultures were grown in complete medium (RPMI medium pH 7.2 
containing ImM L-Glutamine, 25pg/ml Gentamicin and 200mg D-glucose/ml and 10% 
pooled serum), and in a gas mixture of 3% O2 , 5% CO2 and 92% N2 at 37°C. The cultures 
were maintained at 10% RBC hematocrit and below 10% parasitemia.
2.3.2. Assessing parasite growth using Giemsa-stained blood films
Thin blood films were prepared from cultures by applying a drop o f the culture pellet 
onto glass slides (Thermo Fisher Scientific Inc.) and spreading the blood very thinly 
using a slide. The smears were air dried and fixed using methanol (Analar ® VWR 
International). The smears were stained with 10% Giemsa stain (Sigma Aldrich) for 10 
minutes after which they were rinsed in water. The slides were left to air dry and 
examined under a light microscope (Leica Microsystems) at lOOOx magnification in oil 
immersion.
Parasitemia was determined by calculating the percent o f IE per 1000 intact erythrocytes 
at random fields on the slide. Cultures with parasitemia of 10% and above were diluted 
by adding 0 + uninfected erythrocytes.
2.3.3. P. falciparum  synchronisation
Parasites were regularly synchronized using 5% D-sorbitol (Sigma Aldrich), which 
causes selective lysis o f late-stage parasite-IE. Cultures with predominantly ring-IE were 
transferred to 15ml falcon tubes (Greiner Bio-one), centrifuged at 2000 rpm for 5 minutes 
and the supernatant aspirated. lOx pellet volume of pre-warmed 5% D-sorbitol was added 
and the mixture incubated in a water bath at 37°C for 10 minutes. The cultures were then 
washed three times with yellow RPMI and centrifuged at 1800 rpm. Assessment of 
synchronization success was done by examination o f Giemsa-stained slides prepared
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immediately after synchronization, with a successful synchronization resulting in cultures 
with predominantly ring stage parasites.
2.3.4. Mycoplasma testing and treatment
Parasite cultures were regularly tested for mycoplasma contamination and immediately 
treated or discarded if found to be infected (Rowe et al., 1998). Parasite DNA was 
extracted from lOOpl of culture by freeze-thaw method or using the QIAamp DNA Blood 
Mini Kit (Qiagen). A nested polymerase chain reaction (PCR) targeting 16s and 23s 
rRNA spacer regions on Mycoplasma and Acholeplasma was used to detect mycoplasma 
contamination (Tang et al., 2000).
Freshly thawed parasites from frozen stocks and new 0 + uninfected erythrocytes from 
donors were tested for mycoplasma after one overnight culture. Cultures that tested 
positive for Mycoplasma or Acholeplasma were put through a 7-day treatment regime 
using Mycoplasma Removal Agent (AbD Serotec, Bio-Rad), and re-tested to ensure the 
contamination had been eliminated.
2.4. Time course experiments
Time course experiments were conducted to analyse r if  and stevor expression patterns at 
different stages o f asexual parasite development within red blood cells and to establish 
the peak expression points for the two gene families (see Appendix Table 9.5 and 9.6). 
For the laboratory isolates 3D7, IT and HB3, RNA was extracted from synchronized 
cultures at specific time points: 0 hours post invasion (hpi), 12 hpi, 18hpi, 24hpi, 30hpi 
and 40hpi corresponding to early ring, late ring/ early trophozoite, mid trophozoite, late 
trophozoite and schizont stages, respectively. For the culture adapted field isolates RNA
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was extracted at four time points across the I DC, early to mid ring, late ring to early 
trophozoite, mid to late trophozoites and schizont stages as determined by examining 
Giemsa-stained blood films. For the ex v/vocultured, wild (non-culture-adapted) Kilifi 
isolates, RNA was extracted at 7 time points every 10 hours across a single IDC. For the 
culture adapted laboratory and field isolates, to ensure that synchrony was maintained 
throughout the time course, two sorbitol synchronizations, eight hours apart were done at 
beginning of each time course experiment (see Figure 5.1. and Appendix Tables 9.5 and 
4.6). Parasites were harvested from culture into Trizol™ for RNA extraction (Kyes et al., 
2000).
2.5. Extraction of P. falciparum  RNA and genomic DNA (gDNA)
2.5.1. RNA extraction from P. falciparum  parasites
To harvest RNA lOOpl parasite pellets were prepared by spinning the appropriate volume 
of cultures at 2000 rpm for 5 minutes and aspirating the supernatant. To cultures 
containing predominantly ring-IE lOx pellet volume of Trizol™ was added and to 
cultures containing mainly trophozoite-IE, 20x pellet volume Trizol™ was added. The 
Trizol™ suspensions were stored at -80°C or immediately used for RNA extraction. RNA 
was extracted according to standard protocol (Kyes et al., 2000). 200(4.1 o f chloroform 
(Sigma- Aldrich) was added to lOOOjil o f Trizol™ sample, mixed vigorously and 
centrifuged at 4200 rpm at 4°C for 35 minutes. The aqueous phase containing total RNA 
was harvested and mixed with Isopropanol (Sigma-Aldrich) and incubated overnight at 
4°C to precipitate the RNA. The RNA pellet was washed in ice cold 75% ethanol and
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resuspended in 20pl RNA Secure™ (Life Technologies, Invitrogen) by heating at 60°C 
for 10 minutes.
2.5.2. gDNA extraction from P. falciparum  parasites
To obtain parasite gDNA, infected erythrocytes were lysed by adding 0.2% Saponin 
(Sigma-Aldrich) in lx  PBS to culture pellets and vortexing briefly. The parasite DNA 
pellet was harvested by spinning the culture-saponin mixture at 5000 rpm for 10 minutes. 
The DNA pellets were washed twice in lx  PBS and resuspended in 200pl PBS. Samples 
in PBS were used for DNA extraction using the QTAamp DNA mini blood kit (Qiagen) 
according to manufacturer’s instructions.
2.6. Generating gDNA and cDNA libraries
2.6.1. cDNA preparation
Prior to cDNA preparation, gDNA was removed from the total RNA preparation (Section
2.5.1.) by treatment with DNase. 1-2 units o f DNase (Anibion) and 20pi finai volume 
DNase buffer was added to total RNA and the mixture incubated at 37°C for 1 hour. First 
strand cDNA was synthesized using the Superscript® III kit (Invitrogen) and random 
hexamers following manufacturer’s instructions. For every RNA sample, two reactions 
were set up. In one reaction 1 unit o f SuperScript®III, the reverse transcriptase enzyme, 
was added (RT+), while in the control reaction the enzyme was omitted (RT-). The 
cDNA was stored in aliquots at -20°C.
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2.6.2. Reverse transcriptase PCR (RT-PCR)
RT-PCR was used to analyse r if  and stevor expression patterns in the laboratory and wild 
isolates. The different primer combinations used to amplify r i f  and stevor fragments are 
listed in Table 2.1.
For r if  expression analysis a set of published primers (Kyes et al., 1999) with slight 
modifications were used. For the two different amplicon sequencing approaches, 
capillary and 454 sequencing, different r i f  reverse primers were used. The original 
reverse primer was used (Kyes et al., 1999) for most isolates where amplicons were first 
cloned and then sequenced using the capillary method, whereas a modified version was 
used for all the amplicons sequenced using clone-free 454 (Table 2.1).
For stevor gene sequencing, different sets o f primers were used in the different 
sequencing approaches. For amplicon cloning followed by capillary sequencing, primers . 
published by Lavazec et al. were used (Lavazec et al., 2006), while for 454 amplicon 
sequencing a combination of a new stevor degenerate forward primer designed using 
Primer3 (http://primer3.sourceforge.net) (Stevor-primer3_F_72), and a published reverse 
primer (Albrecht et al., 2006) was used. For each PCR, the component volumes and 
concentrations were optimized by titrating dNTPs (0.2-0.4mM), primers (0.4- ImM) and 
Taq polymerase (0.5-1 units).
Cycling conditions were optimized by setting up different PCR reactions to run in parallel 
on a gradient thermocyler at different annealing temperatures. A gradient PCR was set up 
for every new primer pair and and/or polymerase. For most amplicons for cloning and/or 
sequencing the high fidelity Platinum Taq Polymerase High Fidelity enzyme was used.
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For a subset of amplicons for 454 sequencing the regular Platinum Taq Polymerase, with 
6 X less fidelity was used.
For each rif/stevor PCR, gDNA was included, (1) as a positive control to ensure the PCR 
conditions and primers were optimal for amplification from cDNA, (2) to sample the 
genomic repertoire matched for every isolate used to assay rif/stevor expression, and (3) 
to determine whether there was any bias in the sampling of transcripts from cDNA.
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Table 2.1. Degenerate primer sets used to generate r if and stevor amplicons for 
sequencing.
Primer Name Sequence (space after each set of 3)
Length
(bases)
rif
aK yes-rifFl C[A/G]T CAC GA[G/T] TGT TAA GCG 18
aKyes-rifF2 CGA [A/G][C/T]G TGA ATT GTA TGC 18
aKyes-rifF3 C[C/T]A C[C/T]A G[A/G]TTAT TAT GCG 18
aKyes-rifRev # CTT CA[A/T] ATT [A/G]TT [A/T]TT T[C/T] [G/T] [A/G/T]CG ATA ACG
aKyes-rifRl-VT@ CTT CA[A/T] TTT [C/T]TT [A/T]TT T[C/T][G/T] [G/A/T]C[G/T] ATA ACG 27
stevor
bLavazec_L CAA AAG GAA GAG ATA AGT AT 20
bLavazec_R GTT TCT TGC ATT CAT GTT TCC 21
cS tev o r-p rim er3 _ F _ 7 2 [A/T][A/G/T] [A/C/T] AGA ACC [A/C/T/G]AT GTC AAC G 19
dA lbrecht_R CAT AAA TGT TTC TTG CA[C/T] TCA TG 23
a: Complex r if  primer set with 3 forward and 1 reverse primer ((Kyes et al., 1999), with 
the original and modified reverse primer. Changes highlighted in red text.
#: Original r if  reverse primer from publication.
Modified r if  reverse primer
b: stevor primers set 1 (Lavazec et al., 2006) used fo r  cloning/capillary sequencing
c: Newly designed (using Primer 3) stevor forward primer fo r  stevor primer set 2 (Thathy 
et al., unpublished)
d: Published stevor reverse primer fo r stevor primer set 2 (Albrecht, et al., 2006). Primer 
set 2 used to amplify stevor fo r  454 sequencing
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2.6.3. Gel electrophoresis of amplicons
Agarose gel electrophoresis was used to analyse amplicons and to purify amplicons for 
cloning and sequencing, as needed. 1% - 2% agarose gels were prepared by dissolving 
appropriate volumes o f UltraPure™ Agarose (Invitrogen) in lx  Tris Acetate 
ethylenediaminetetraaceticacid (EDTA) (TAE) Buffer (Sigma-Aldrich) with 0.5mg/ml 
ethidium bromide (EtBr). Each sample was mixed with 5x (Qiagen) or 6x (Fermentas) 
loading dye before electrophoresis. 1 Kb Plus DNA Ladder™ (Invitrogen) was used as 
the DNA size marker in each gel for estimation o f amplicon size. Gels were run in IX 
TAE at 100-200 V depending the size o f the fragments, agarose concentration and on the 
size of the gel tank used. A gel imaging system (Biorad) was used to visualize gels under 
UV light and image and analyze separated nucleic acids.
2.6.4. Amplicon purification and quantification
PCR fragments were purified using the QIAquick PCR Purification Kit (QIAgen) 
following the manufacturer’s instructions with slight modifications, including elution 
with IX TE in place o f elution buffer and reduced volume of elution solution, (using 
between 6 to 35pl IX TE). An additional wash with 35% guanidine hydrochrolide 
aqueous solution prior to elution was included to remove primer dimers. For a subset of 
amplicons with large amounts o f primer dimers a prior purification through sephacryl 
columns was done prior to purification using the QIAquick PCR Purification Kit. In 
addition a subset o f r i f  amplicons were purified by gel extraction of bands using the 
QIAquick Gel Extraction Kit (QIAgen).
Purified amplicons were quantified using either the NanoDrop (1000 or 8000, Thermo 
Scientific) or Qubit® 2.0 Fluorometer (Life Technologies, Invitrogen).
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2.6.5. TOPO-cIoning
Purified amplicons were cloned into pcr2.1TOPO vector (Life Technologies, Invitrogen) 
following manufacturer’s instructions. Briefly 2ml of amplicon was mixed with 1 pi 
pcr2.1TOPO vector, lp l salt solution (1.2 M NaCl and 0.06 M M gCf) and 2 pi of water. 
The reaction was incubated at room temperature for 15-30 minutes and then placed on 
ice. 2pl o f the reaction was added to 50pl o f One Shot® Top 10 competent Escherichia 
coli cells (Life Technologies, Invitrogen) and incubated on ice for 30 minutes. 
Transformation of E. coli was achieved by heat shock treatment by incubating the 
plasmid - E. coli mixture in a water bath at 42°C for 30 seconds and immediately placing 
the tube on ice for 3 minutes. 250pl o f SOC medium was added to the cells and incubated 
at 37°C for 1 hour with agitation (200rpm). 50-200pl o f the culture was plated on LB agar 
plates containing 50mg/ml ampicillin and 40mg/ml X-gal for blue white colony 
screening. Plates were incubated at 37°C overnight. White colonies (i.e. transformed E. 
coli harboring plasmid vectors containing inserts) were picked for sub-culturing and 
plasmid DNA preparation. 20 clones from cDNA (per timepoint, and in certain cases for 
r i f  amplicons per upper and lower band per timepoint per sample) and 50 clones from 
gDNA were picked for screening and sequencing.
2.6.6. Plasmid DNA preparation
White colonies were picked and incubated in LB broth containing 50mg/ml ampicillin at 
37°C overnight with agitation (250rpm). Plasmid DNA was harvested using QIAprep 
Miniprep kit (Qiagen) following manufacturer’s instructions. Briefly 1.5ml o f the 
cultures were pelleted by centrifugation at maximum speed for 2 minutes. The bacterial 
pellet was dissolved in resuspension buffer (PI) containing RNase A. The cells were
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lysed using alkaline lysis buffer (P2) and subsequently neutralized and adjusted to high- 
salt binding conditions for purification using silica membrane filters on microspin tubes. 
Plasmid DNA was analysed by agarose gel electrophoresis and screened for presence of 
intact inserts using restriction digestion.
2.7. Capillary sequencing
TOPO clones containing inserts {rif or stevor amplicon) as per restriction digestion 
results were sequenced using the BigDye terminator kit version 3.1 (Life Technologies, 
Invitrogen) and resolved with a 3130x1 ABI (Applied Biosystems) capillary sequencer. 
Some of the plasmids were sent either to the Sequencing, Genotyping, OligoSynthesis 
and Proteomics (SEGOLIP) Unit at BecA-ILRI Hub (Nairobi, Kenya), or to Beijing 
Genomics Institute (BGI), Hong Kong, for capillary sequencing. For each plasmid, the 
insert was sequenced in both the forward and reverse directions using M l 3 forward and 
reverse primers (Appendix Table 9.7).
2.8. 454 sequencing
454 library preparation and sequencing o f r if  and stevor amplicons was performed at the 
Wellcome Trust Sanger Institute, Cambridge, UK. Purified amplicons were quantified 
using Qubit® 2.0 Fluorometer or PicoGreen® dsDNA quantitation assay (Life 
Technologies, Invitrogen). A starting concentration o f lOOng of amplicon was used. For 
amplicons with concentrations less than lOOng, carrier amplicon o f the same length but 
from an unrelated species (bovine) was added to make up a final concentration of 1 OOng. 
Amplicons were mixed with lx  TE to a final volume of 16pl.
Library preparation was done using the GS FLX Titanium Rapid Library Preparation Kit 
(Roche) using the Ligated Adaptors design following manufacturer’s instructions. In
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summary, the amplicons (bearing TA overhangs) were blunt ended by adding the 
fragment end repair mix containing polynucleotide kinase (PNK), PNK buffer, ATP, 
dNTPs, T4 polymerase and Taq polymerase and incubating at 25°C for 20 minutes, 72°C 
for 20 minutes and 4°C hold. Rapid Library (RL) Multiplex Identifiers (MID) Adaptors 
from the GS FLX Titanium Rapid Library MID Adaptors Kit were ligated to the blunt 
ends o f the amplicons by adding the RL MID adapters and RL ligase to the amplicons 
and incubating at 25°C for 10 minutes. For our experiment, 48 RL MID adapters were 
used to allow multiplexing 48 different amplicons in a single sequencing pool. Small 
fragments were removed from the libraries by carrying out two rounds of solid phase 
reversible immobilization (SPRI) using Agencourt AMPure beads (Beckman Coulter) 
purification, as follows. The libraries were mixed with the SPRI beads to a 1:1.8 
volumetric ratio in 1.5ml DNA LoBind tubes (Eppendorf) and incubated for 5 minutes at 
room temperature. The tubes were placed on a magnetic particle concentrator (MPC) till 
the beads were fully pelleted on the walls of the tubes. The supernatant was removed and 
discarded and the beads washed with 70% ethanol and resuspended in lx  TE. After the 
second round of purification the libraries were eluted in 50pl o f lx  TE and quantified 
using PicoGreen®. The libraries were further quantified using quantitative real time PCR 
(QRT-PCR). Starting with the quantities obtained by PicoGreen® assay, the libraries 
were diluted to a starting concentration o f 108 molecules in 1ml o f lx  TE. Equimolar 
concentrations o f 48 libraries were pooled based on QRT-PCR results.
Amplification o f libraries was carried out through emulsion PCR using Lib-L emPCR 
Kit. Sequencing was done on the GS FLX+ (Roche).
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2.9. Sequence assembly and analysis
2.9.1. Capillary sequence analysis.
For reads obtained by capillary sequencing, assembly and analysis were done using 
BioEdit Sequence Alignment editor (v 7.0.5.3) and Geneious Pro (5.3.4-6.1.5). For each 
plasmid the forward and reverse reads were assembled into a single contiguous sequences 
(contig) using the CAP3 sequence assembly program (Huang and Madan, 1999) 
preinstalled on BioEdit and Geneious Pro. Multiple sequence alignments were done using 
the ClustalW sequence alignment program (Larkin et al., 2007) in BioEdit or using the 
Multiple Sequence Alignment (MUSCLE) program (Edgar, 2004a, Edgar, 2004b) in 
Geneious Pro. The r i f  sequences were classified into A and B groups based on the 
presence o f a distinguishing insert in the N-terminal semi-conserved region o f ri/A genes 
(Figure 1.4) (Joannin et al., 2008), and assigned a sequence label made up o f a number 
followed by A or B depending on which r i f  group they fell into. A sequence identity 
matrix was computed in BioEdit to identify similar sequences. Sequences that had a score 
of 99% and above were considered identical and given the same sequence label. For each 
sample, proportions o f unique sequences were computed and plotted on pie chart.
2.9.2. 454 sequence analysis
Analysis o f 454 sequence reads was done in collaboration with Thomas Otto and Martin 
Hunt o f WTSI and Etienne De Villiers o f KWTRP. The raw reads were extracted from 
the 454 SFF (Standard flowgram format) files. A Perl script was used to group the reads 
by their barcode (MID). Two approaches were used to analyse the 454 reads: (1) mapping 
reads to homologous genomes sequenced using Illumina done by T. Otto (Appendix 
method 9.1) and (2) de novo assembly o f 454 reads into contigs using done by E. de
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Villiers (Appendix Script 6.1: Parameters for Newbler assembly of 454 amplicon 
sequence reads into contigs).
2.9.2.1. Analysis by mapping reads to homologous genomes
For a subset o f isolates with whole genome sequence data (Appendix Table 9.6), reads of 
each bar code were mapped against their reference genome, using SMALT 
(ftp://ftp.sanger.ac.uk/pub/resources/software/smalt/) with the following parameters: 
index -k 13 -s 3 (k-mer length o f 13 and a step size of 3), mapping -r 0 (random placing 
of reads) -y 0.5 (identity o f complete read must be at least 50%). The resulting output 
(sam file) was transformed with samtools (Li et al., 2009) to a bam file. In Artemis 
(Rutherford et al., 2000) BAM view (Carver et al., 2013), RPKM (reads per kilo base pair 
per million) and read counts were calculated for all the annotated r if  and stevor genes. 
Read counts were used for analysis of expression because the amplicon lengths were 
similar hence there was no need to normalize for gene lengths by using RPKM.
Read counts were tabulated in Excel and pie charts generated based on the proportion of 
read counts for each gene across all time points for each isolate. Genes with less than 5X 
coverage (less than an average o f 5 reads across time points) were removed from the list 
before further analysis in R Studio. Read count data normalization for library size and 
differential expression analysis was carried out using DESeq (Anders and Huber, 2010) 
in R Studio. Heat maps were generated in R Studio.
2.9.2.2. De novo contig assembly
For the subset of Kilifi isolates that had no whole genome sequence data, 454 reads were 
assembled into contigs using the Newbler assembler (Margulies et al., 2005). Newbler 
was run with default parameters, minimum input read length o f 20 base pairs (bp),
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minimum overlap length of 40 bp and minimum overlap identity of 90%. The contig 
length cutoff was set at 100 bp (Appendix Script 6.1: Parameters for Newbler assembly 
of 454 amplicon sequence reads into contigs).
The contigs were reoriented to all be in the same direction (5’-3’) and primer sequences 
tagging the ends o f each amplicon were removed. Non-target amplicons were removed by 
running MegaBLAST against all r i f  / all stevor databases on Geneious Pro. These 
databases were compiled in house and consisted o f 2450 rif and 735 stevor sequences 
from a collection o f laboratory (3D7, HB3, Dd2, IT) and wild isolate genomes (from 
Brazil (Albrecht et al., 2006), Gabon (Abdel-Latif et al., 2002), and Kenya ((Blythe et al., 
2009), WTSI, Otto et al, unpublished, www.sanger.ac.uk). The results were binned into 
hit or no hit. The hit bins were further evaluated using alignments and trees, to remove 
any non-target sequences.
The cleaned r i f  and stevor target contig sets were then clustered to obtain a list o f unique 
r if  and stevor variants from each isolate. A combination of CD-HIT (Huang et al., 2010, 
Li and Godzik, 2006) and BLAST were used. R if  and stevor sequences were clustered at 
97% and 95.3% identity respectively. The number o f reads per contig was computed to 
give the expression value. Pie charts were generated from the reads data in Excel. DESeq 
analysis and heat maps were done in R Studio.
2.10. Northern blotting
Northern blotting o f RNA from laboratory and field isolates was carried out in order to 
confirm whether r i f  messenger RNA was intact and full-length, and to estimate 
expression levels. A non-radioactive method based on digoxygenin (DIG) labeling 
(Roche) was employed. 1-2% agarose gels containing 2% formaldehyde (Sigma Aldrich)
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were prepared by dissolving the appropriate amount of agarose in 141.9ml 1 x MOPS 
(200mM MOPS, 50mM NaAC, 20mM EDTA) and boiling the mixture. The agarose 
solution was let to cool to about 55°C before 8.1ml of 37% formaldehyde was added and 
the gel let to set. 5pg total RNA was resolved on formaldehyde gels, transferred to 
positively charged membranes by capillary transfer and fixed by UV crosslinking. 
Previously published primers were used to generate the probes; r i f  varC (exon2), mspl, 
calmodulin and var (exonl DBLa) fragments (Kyes et ah, 2000) for DIG-labelling, from 
genomic DNA and cDNA. DIG-labeled sense and anti-sense RNA probes were generated 
by in vitro transcription using T7 RNA polymerase using the DIG RNA Labeling Kit 
(SP6/T7) (Roche), var and mspl were included to check the stage of the parasite while 
calmodulin which is a housekeeping gene was used to check mRNA level across the IDC. 
The probes were hybridized to the membrane overnight after which high stringency 
washes were performed. DIG-labeled hybrids were detected with anti-DIG-alkaline 
phosphatase conjugate and the substrates CSPD or CPD (Roche). Visualization was done 
under white light on a gel imaging system (Biorad) at increasing exposures to a 
maximum exposure o f 1 hour.
2.11. Sequence diversity analysis
2.11.1. Collection o f r if  and stevor sequences from sequence databases
We have obtained the full repertoire of r i f  and stevor sequences from 3D7 and IT genome 
(www.plasmodb.org; www.genedb.org), HB3 genome from the Wellcome Trust Sanger 
Institute (unpublished), partial r if  and stevor repertoires from the Dd2, HB3 genome 
sequences (www.broad.mit.edu, Broad Institute o f Harvard and MIT), as well as several
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r if  sequences from a limited number of Brazilian (Albrecht et al., 2006), Gabonese 
(Abdel-Latif et al., 2002) and Kenyan isolates (Blythe et al., 2009) (Table 3.1).
2.11.2. Multiple sequence alignments
Multiple sequence alignments were carried out using MUSCLE (Edgar, 2004b) or 
ClustalW in Geneious, or directly on the European bioinformatics web server 
(http://www.ebi.ac.uk/Tools).
2.11.3. Phylogenetic tree construction and visualization
Maximum likelihood phylogenetic trees constructed from MUSCLE-aligned sequences 
using PHYML (http://www.atgc-montpellier.fr/phyml) (Guindon et al., 2005, Guindon 
and Gascuel, 2003). PhyML was run with either o f the two substitution models, 
Generalized Time Reversible (GTR) for nucleotide sequences and LG model for amino 
acid sequences. Bootstrap analysis was performed with 100 to 500 replicates.
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2.12. Live immunofluorescence assays (IFA) to show RIFIN surface 
localization
2.12.1. Protein expression and antibody purification
The hypervariable region (HVR) of the strain transcendent RIFIN PFL2585c 
(PF3D7_1253700) was expressed as a FLAG-tagged protein (Kibwana E., Kadasia K. 
et al., manuscript in preparation) using the cell free wheat germ system (Takeo et al., 
2009). The purified antigen was used to identity highly reactive sera from immune 
adults using enzyme-linked immunosorbent assay (ELISA). The identified highly 
reactive serum was used for anti-RIFIN HVR antibody purification. The recombinant 
RIFIN HVR was coupled to Aminolink® beads and incubated with the highly reactive 
serum overnight to bind anti-RIFIN IgG. The antibodies were eluted from the antigen- 
beads complexes using IgG elution buffer.
2.12.2. Immunofluorescence assay
Parasites for use in the IFA assay were first assessed for PFL2585c gene expression by 
RT-PCR. Parasites that were positive for expression were cultured as described above 
(section 2.3). Cultures were synchronized and grown to above 5% parasitemia before IFA 
was performed. Early to mid trophozoite parasite stages were targeted for IFA. 500pl of 
cultures were spun down and the pellets washed three times in incomplete media. 5pi of 
iRBC pellet was mixed with 5 pi of the purified human anti-RIFIN HVR antibody (or 
total immune serum as positive control) and 5pl 1% BSA solution. The mixture was 
incubated at 37°C for 30 minutes to an hour. The pellets were then washed three times in 
1000ml cold PBS with 1% BSA. The pellets were incubated with secondary goat anti­
human IgG Alexa 488 F(ab)’ antibody conjugate at 37°C for 30 minutes in the dark.
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During the last 5 to 10 minutes of incubation with secondary antibody the nuclei stain 
Hoechst at a final concentration 0.5pg/ml was added. The pellets were then washed three 
times in lOOOpl o f cold 1% BSA in PBS and resuspended in 50pl o f 1% BSA in PBS. 
20pl of the pellets were placed on a glass slide and sealed with a coverslip. The slides 
were examined using 40x or lOOx (oil) objective, and incident light of 450-495nm for 
FITC fluorescence, 390-440nm for DAPI /Hoechst.
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CHAPTER 3
3. Characterising the sequence diversity of r if  and stevor multigene families.
3.1. Introduction.
Plasmodium species contain several large multigene families located in the subtelomeric 
regions that encode variant surface antigens. One large multigene family called 
Plasmodium interspersed repeat (pir) gene family is found in both human and simian 
malaria parasites as well as rodent malaria parasites (del Portillo et al.5 2001, Fischer et 
al., 2003, del Portillo et al., 2004, Janssen et al., 2004, Pain et al., 2008, Otto et al., 2014a, 
Otto et al., 2014b). These genes code for proteins that are potentially expressed on the 
surface o f infected erythrocytes and may play important roles in immune evasion o f the 
IE and pathogenesis (Cunningham et al., 2010, Jemmely et al., 2010, Bernabeu et al., 
2012, Niang et al., 2014, Niang et al., 2009, Goel et al., 2015). In P. falciparum, the pir  
multigene family is made up of two related superfamilies rz/(Fernandez et al., 1999,
Kyes et al., 1999, Cheng et al., 1998) and stevor (Limpaiboon et al., 1990, Cheng et al., 
1998). The pir genes, together with the well-known var genes (Su et al., 1995, Baruch et 
al., 1995, Smith et al., 1995, Gardner et al., 2002), encode the major variant surface 
antigen (VSA) that modify the antigenic and immunogenic properties o f infected 
erythrocytes (IE).
The var encoded PfEMPl is the most well studied VSA. The var gene family is highly 
diverse partly due to recombination and this diversity complicated approaches to classify 
these genes into meaningful groups. The completion o f the first P. falciparum  genome 
revealed genetic structuring o f var genes (Gardner et al., 2002). Based on the 5’ flanking
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region (upstream) and chromosomal location var genes could be classified into 3 major 
groups, upsA (group A), upsB (group B), upsC (group C), and a minor group upsE var 1-3 
(Gardner et al., 2002, Lavstsen et al., 2003). These groups are functionally important 
(Robinson et al., 2003, Kraemer and Smith, 2003). The semiconserved DBL alpha 
(DBLa) domain provides a region that can be used to design universal primers to amplify 
all var genes, the DBLa tag (Taylor et al., 2000). Approaches to classify var genes based 
on the DBLa tag region have been developed, (1) based on number o f cysteine residues 
and the presence or absence o f mutually exclusive motifs, REY and MEK (Bull et al.,
2005) and (2) based on recombining blocks (Bull et al., 2008). The DBLa tag 
classification is able to provide clinically important information about the full length 
PfEMPl molecule. Expression o f groupA like var tags has been associated with the 
severe malaria (Warimwe et al., 2009). Because the DBLa tag only covers a very small 
region of the var gene, a classification approach based on full length var genes was 
recently developed (Rask et al., 2010). In this approach, DBL and CIDR domains were 
classified using homology blocks, and the sequence in which the domains occurred 
enabled subgrouping of var into domain cassette (DC) groups (Rask et al., 2010). 
Subsequent studies have associated expression o f certain DC types with binding 
phenotypes and severe malaria (Avril et al., 2013, Turner et al., 2013, Claessens et al., 
2012). The many approaches developed to classify var genes are a reflection o f the 
difficulties with classification o f highly variable multigene families, such as the var and 
pir  multigene families.
92
The pir multigene family encodes VSA that are coexpressed on the surface of IE together 
with PfEM Pl. The pir  genes are related in that they share similar gene architecture 
composed o f two transmembrane domains flanking a hypervariable region. This is 
suggestive of shared ancestry. A previous study suggested that pir  genes from human and 
rodent malaria parasites share distant but common ancestry based on sequence homology 
within the intron as well as shared predicted secondary structure of the proteins they 
encode (Janssen et al., 2004, Jemmely et al., 2010). P. falciparum pirs, r if  and stevor, 
share similar architecture and share some sequence homology at the 5’ end of the coding 
sequence and in the 3 ’ region encoding the cytoplasmic tail (Gardner et al., 1998).
The highly diverse r i f  family forms the largest multigene family with 184 copies in the 
3D7 genome (http://www.genedb.org/genedb/malaria/). The rz/family is made up o f two 
major groups rifA and rifB based on a 25 amino acid insertion in rifA (Joannin et al.,
2008, Petter et al., 2007, Joannin et al., 2011). This subgrouping was shown to be 
conserved across laboratory isolates and a few (n=9) wild isolates from Brazil (Albrecht 
et al., 2006) and Gabon (Abdel-Latif et al., 2002). The rifA subgroup is more diverse than 
rifB and contains a majority of the sequences (129/184 in 3 D7). The conserved rifA that 
are oriented head-to-head with a neighbouring Group A var (Lavstsen et al., 2003) have 
been named rifA l and those oriented head-to-head with UpsA-linked Type 3 var genes 
are named rifA3 (Wang et al., 2009). The Type 3 var genes are also highly conserved 
across parasite isolates (Kraemer and Smith, current opinion micro 2006). Another 
conserved rifA group is the rifA2 which occurs as a single copy gene in all P. falciparum  
genomes (Wang et al., 2009).The relatively conserved rifB subgroup can be further sub-
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divided into at least 3 groups, B l, B2 and B3, with the B3 group being more diverse 
(Joannin et al., 2008, Joannin et al., 2011).
The more conserved stevor multigene family has 40 gene copies in the 3D7 genome 
(Gardner et al., 2002, http://www.genedb.org/genedb/malaria/). Phylogenetic analyses 
have classified stevor into two main groups, a major group, which contains a majority of 
the sequences and a more diverse minor group (Blythe et al., 2009, Schreiber et al., 2008, 
Joannin et al., 2011). An even more divergent group within the minor group was 
observed in a stevor phylogenetic tree derived from multiple alignments o f stevor from 
3D7, DD2 and IT (Joannin et al., 2011). This group o f stevor sequences that did not 
cluster with the rest o f the sequences was termed stevor-like. This grouping is observed 
across laboratory isolates and a few isolates from Kilifi on the Kenyan coast (Blythe et 
al., 2009). The 5’ untranslated regions (UTRs) have not been characterized.
With the advent of high throughput sequencing technology more laboratory and wild 
isolates have subsequently been sequenced. In addition previously sequenced genomes 
have been resequenced and reannotated to correct gene models. Phylogenetic analysis 
with the additional cleaner sequence data is necessary in order to validate previous r i f  and 
stevor subgrouping and to determine whether these groups are conserved in wild isolates.
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3.2. Objectives
i.) Utilize phylogenetic trees to cluster pir  genes from P. falciparum  parasites from 
different geographical locations into groups.
ii.) Identity conserved pir  groups in P. falciparum  isolates.
iii.) Conduct phylogenetic analysis o f pir  upstream non-coding regions.
iv.) Analyze length distribution o f r if  and stevor genes and determine whether genes 
cluster by length.
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3.3. Methods.
Some of the methods used in this chapter have been described in the Methods chapter 
(2 .11).
3.3.1. Retrieval of pir  repertoires from laboratory and wild isolates.
Publicly available r if  and stevor sequence were retrieved from sequence databases (Table 
3.1); 3D7 and IT pir  sequences was obtained from GeneDB
(http://www.genedb.org/genedb/malaria/). Dd2 and a partial list o f HB3 pir sequences 
were downloaded from the Broad Institute (http://www.broad.mit.edu). With the 
completion of the HB3 genome sequencing by the Sanger Institute more complete and 
updated HB3 pir  sequences were obtained from the Sanger HB3 genome 
(http://www.sanger.ac.uk/Projects/P_falciparum). Incomplete pir  repertoires from wild 
isolates were obtained from published data: pir  from Brazilian isolates (Albrecht et al.,
2006), rz/from a Gabon isolate (Abdel-Latif et al., 2002), and stevor from Kenyan 
isolates as well as a few sequences from laboratory isolates (Blythe et al., 2009). Later in 
the study, genomes o f 12 Kilifi (Kenya) patient isolates were sequenced by the Sanger 
Institute. Partial pir  repertoires were extracted from these genomes. The data set from the 
12 Kilifi genomes was only used for identification o f pir  orthologs in wild isolates, and 
not included in the phylogenetic analysis.
The non-coding upstream regions of 3D7 and IT parasite isolates were obtained from 
GeneDB by downloading lkb upstream from the start codons o f pir  genes.
96
Table 3.1. Complete and incomplete pir repertoires from different geographical 
locations.
Parasite isolate Geographical location
Whole
genom e
sequence
Complete or partial pir  full length 
and amplicon sequences
No. of rif No. of stevo r
3D71 Africa (West Africa) Y 184 (complete) 42 (complete)
IT1 South America (Brazil) /  Africa Y 138 43
HB32 America (Honduras) Y 142 35
HB33 America (Honduras) Y 103 31
Dd23 SE Asia (Laos/Thailand) Y 114 31
Brazilian isolates4 South America (Brazil) N 106a 75a
Gabonesse Isolates5 Africa (Gabon) N 13a n
Kilifi isolates6 Africa (Kenya) N n 57a
68167 Africa (Kenya) Y 177 45
83837 Africa (Kenya) Y 17* 3*
91067 Africa (Kenya) Y 155 42
92157 Africa (Kenya) Y 168 39
96057 Africa (Kenya) Y 177 41
96267 Africa (Kenya) Y 19* 2*
97757 Africa (Kenya) Y 35* 9*
106687 Africa (Kenya) Y 179 40
109367 Africa (Kenya) Y 181 41
109757 Africa (Kenya) Y 27* 9*
110147 Africa (Kenya) Y 17* 2*
110197 Africa (Kenya) Y 197 48
SA0757 Africa (Kenya) Y 95#* 31#*
1: PlasmoDB (http://www.plasmodb.org/plasmo/home.jsp)
2: HB3 sequenced at the Sanger Institute
(http://www.sanger.ac.Uk/Projects/P Jalciparum) (Unpublished)
3: Dd2 and HB3 sequenced at the Broad Institute (http://www.broad.mit.edu)  
4: p ir amplicon sequence data (Albrecht et al., 2006)
5: stevor amplicon sequence data (Abdel-Latif et al., 2002)
6: stevor amplicon sequence data (Blythe et al., 2009)
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7: Kenyan patient isolates (12 from Kilifi and 1, SA075,from Kisumn) sequenced at 
the Sanger Institute (http://www.sanger.ac.nk/Projects/P Jalciparum) (Unpublished)
* - Noticeably incomplete pir repertoire due to insufficient sequence data leading to 
partial whole genome assembly
# - Additional 55 rifs and 9 stevors annotated manually 
a - amplicon sequences
n — none
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3.3.2. Phylogenetic sequence analysis
Multiple sequence alignments were carried out using the program Multiple Sequence 
Comparison by Log-Expectation (MUSCLE) (Edgar, 2004a) both online on the European 
Bioinformatics Institute server (http://www.ebi.ac.uk/Tools/msa/muscle/) and within 
Geneious® (Biomatters, Inc) software (http://www.geneious.com, Kearse et al., 2012), 
using default settings. Alignments were visualized and edited in Geneious. Phylogenetic 
analyses were carried out either on the online ATGC bioinformatics platform (South of 
France bio informatics platforms) (http://www.atgc-montpellier.fr) or in house within the 
Kilifi Bioinformatics server. Maximum likelihood phylogenetic trees were constructed 
from aligned sequences using PhyML (Guindon et al., 2009) with the Generalized Time 
Reversible (GTR) substitution model for nucleotide sequences and LG model for amino 
acid sequences. For branch support statistics the aLRT statistic was computed or a 
Bootstrap analysis performed with 100 to 500 replicates.
3.3.3. Genomic locations of p ir  genes.
Centromere locations, chromosome sizes and chromosomal locations o f pir  genes were 
obtained for 3D7, IT and the chimpanzee malaria parasite P. reichenowi from GeneDB 
and PlasmoDB. Whole genome sequence data files for the 3 isolates were downloaded 
from PlasmoDB. The chromosomal annotations o f pir  genes and chromosome lengths 
were extracted in Geneious as csv files. Centromere locations were obtained from 
GeneDB. The centromere locations were based on GC-content and have not been 
experimentally verified. Chromosomal maps were drawn using R studio.
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3.4. Results.
3.4.1. Multiple sequence alignments of r if  and stevor genes showing key
sequence features.
Multiple alignments were performed on the complete repertoire of r i f  and stevor amino 
acid coding sequences (CDS) from 3D7 for initial characterization of the gene families 
and to identify key gene features. As has been shown previously the two gene families 
share similar architecture, a semiconserved N-terminal, two predicted transmembrane 
(TM) domains flanking a hypervariable region (HVR) that is thought to form a loop on 
the IE surface, and a conserved intracellular C-terminus (Figures 1.2, 3.1 and 3.2). The r i f  
genes have two variable regions, an N-terminal (or 5') variable domain (VI) between the 
signal sequence and the PEXEL motif and a second hypervariable region (V2/ HVR) 
between the two predicted transmembrane domains (Figure 3.1) (Joannin et al., 2011).
The two subgroups rifA and rifB were distinguished mainly by the insert within the first 
conserved region in the N-terminus in rifA (Figure 3.1). The rifA exhibit higher sequence 
diversity with 37% overall amino acid pairwise identity as compared to 40% for rifB 
(Table 3.2). Conserved cysteine residues were observed as previously described (Joannin 
et al., 2008), 10 in rifA, and 6 in rifB with 5 of them overlapping between rifA and rifB 
(Figure 3.1).
Alignments of the more conserved stevor gene family showed a slightly different 
architecture, with one variable region, and the HVR between the two putative 
transmembrane domains (Figure 1.2 and 3.2). Two residues, a tyrosine and leucine that 
lie within the conserved region were perfectly conserved in IT and 3D7. One o f the
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tyrosine residues was conserved in both rifA and rifB. 7 conserved cysteine residues were 
observed with 3 being specific to the major stevor A group.
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3.4.2. C haracterising r i f  and stevor sequences relationships using 
phylogenetic trees.
To explore r i f  and stevor repertoire diversity phylogenetic trees were constructed from 
available genome sequence data. A maximum likelihood tree from 224 MUSCLE-aligned 
r if  and stevor coding sequences (CDS) from 3D7 was constructed to show the 
phylogenetic relationships between members of the two multigene families (Figure 3.3). 
The tree showed clustering o f the two families into separate but related groups.
Previously described r i f  and stevor major subgroups, A and B were observed and rifB 
subgroups rifB l, rifB2 and rifB3 (Joannin et al., 2008). The rifA group was further 
clustered into 10 subgroups, Al to A 10. The rifA l, rifA2 and rifA3 groups have been 
previously described (Wang et al., 2009), although in our case the Al and A3 naming is 
not strictly applied to the UpsA r i f  sequences as previously described. In our case the 
naming was given to clusters containing these special r i f  genes from the phylogenetic 
tree. A few other non-UpsA r if  sequences clustered with the previously defined A l and 
A3 UpsA var-linked r i f  genes thus making these groups bigger in our classification 
(Figure 3.3). The previously described strain-transcendent r i f  (PFD0070c, previously 
named rifA2 (Wang 2009), together with its orthologs in Dd2 (PFDG_04771) and HB3 
(PFHG_03700) and the related 3D7 pseudogene PFL2580w formed a divergent but 
extremely well-conserved group named A2. A few rifA sequences did not fall into any 
group and one rifA clustered with rifB. The rifB further clustered into three groups B l, B2 
and B3 as previously described.
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The stevor gene family subdivided into two types, the major group with a majority of the 
sequences (named stevorA), and a more divergent minor group (stevorB) (Figure 3.3). 
The stevorB subdivided into four divergent groups while stevorA formed four groups.
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Figure 3.3. Maximum likelihood tree o f  the 3D7 pir gene family from showing clustering 
o f  stevor (blue) and r if  genes into separate groups, r if  further clustered into two major 
groups, A (green) and B. Previously describedB subgroups (Joannin et a l, 2008) are 
shown, B1 (pink), B2 (brown) and B3 (orange) subgroups (green). r ifB  that did not fa ll 
into either o f  the B subgroups are shown in black. rifA was further classified into 10 
subgroups, with three previously described groups, A l, A2 and A3 (Wang et al., 2009). 
Previously described stevorA (major) and B (minor) subgroups (Schreiber et al., 2008) 
are in blue and purple respectively. Branch support indicated is the log likelihood value, 
the higher the number the more likely the clade. The tree was constructed from  
MUSCLE-alignments o f224 r if  (n=184) and stevor (n=40) coding sequences, 
constructed using PhyML (run on the ATGC bioinformatics platform South o f  France: 
http://www. atsc-montpellier. fr), GTR model, viewed and edited using FigTree v 1.4.0. 
Log-likelihood: - 140966. Scale: nucleotide substitutions per site.
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3.4.2.1. Phylogenetic analysis of r if  sequences from laboratory and wild 
isolates.
Generally r i f  and stevor repertoires are similar across different isolates. To analyse 
whether the subgroups were maintained in other laboratory and wild isolates, 
phylogenetic trees were constructed using r if  and stevor sequences from additional 
laboratory and wild isolates. The sequences were extracted from genome sequence 
databases and published literature.
519 r i f  CDS sequences were obtained from publicly available resources, 181 r if  
sequences from 3D7 (PlasmoDB), 113 from Dd2 and 106 from HB3 (Broad Institute of 
MIT and Harvard), 106 r i f  sequences from nine Brazilian isolate (Albrecht et al., 2006) 
and 13 sequences from a Gabonese clinical isolate (Abdel-Latif et al., 2002). A 
phylogenetic analysis o f multiple alignments o f the 519 r i f  nucleotide sequences resulted 
in a tree with long branches and very low statistical support (log likelihood o f -305,956) 
because o f the high diversity o f the recombining r i f  sequences (Figure 3.4). The branch 
support was low for most o f the clades (bootstrap values below 100 out o f 500 
replicates). Despite the low statistical support an overall tree structure similar to that o f 
the 3D7 only r i f t  ree was observed, with rifA separating from rifB and further subdividing 
into rifA and rifB subgroups previously observed (Figure 3.4) with a few cluster shifts. 
This phylogenetic tree revealed that the major r i f  subgrouping was conserved across 
genomes (Figure 3.4). The rifA grouped into 12 subgroups, with smaller subgroups 
splitting off previously observed subgroups A2, A5 and A6. The previously described 
rifA l and r i f  A3 sequences clustered together with other non-upsA r i f  sequences in this 
tree (labeled A l and A3 respectively). The ancient strain-transcendent rifA2 PFD0070c
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and orthologs from DD2 and HB3 were maintained in their own cluster together with the 
related pseudogene PFL2580w forming an out-group labeled A2a on the tree. This r if  
was not recovered in the field isolates most likely because of lack o f coverage by primers. 
This r if  is divergent and would not be captured by universal r i f  primers. The rifB 
subdivided into the previously described groups B l, B2 and B3. B3 further subdivided 
into 3 smaller groups B3a, B3b and B3c (Figure 3.4).
Ill
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Figure 3.4. Maximum likelihood tree o f  r if  nucleotide sequences from laboratory isolates 
3D7 (red), DD2 (blue), HB3 (green) and partial repertoires from wild two isolates from  
Gabon (yellow) and Brazil (black), showing clustering o f  r i f  from  distinct geographical 
locations into previously described groups (Figure 3.3) with some sequences falling o ff  
larger groups and form ing smaller clusters. rifA  — green, B1 - pink, B2 - brown and B3 — 
orange branches. The clades are labeled with the bootstrap values (out o f  500 
replicates). The tree was based on MUSCLE-alignments o f  519 r i f  CDS nucleotide 
sequences (3D7=181, DD2=113, HB3=106, Brazilian=106 and Gabonese^ 13). The tree 
was constructed using PhyML (in house), GTR model, with 500 bootstrap replicates. The 
tree was viewed and edited using FigTree v 1.4.0. Log-likelihood: -305,956.
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3.4.2.2. Phylogenetic analysis of the hypervariable regions of r if  
sequences from laboratory isolates.
The hypervariability o f r if  genes is concentrated within the HVRs, with the N and C 
terminal regions being relatively conserved (Figure 3.1 and Table 3.2). The HVRs are 
potentially exposed to host immune responses and are likely to have diversified under 
immune selection pressure. In addition these regions may be undergoing recombination 
or gene conversion processes creating sequence mosaics that would further increase the 
sequence diversity in order to evade the host immune responses. Phylogenetic analysis 
was carried on rz/HVRs to determine whether there is any structuring o f sequences based 
on these highly variable region, and to identify putative recombining groups o f r i f  genes. 
For this analysis the HVRs regions were extracted starting from the first transmembrane 
domain (TM1) up to the second transmembrane domain (TM2), starting and ending with 
conserved codons encoding cysteine and arginine respectively. Only sequences with long 
enough sequences running from TM1 up to TM2 were used (3D7=179, DD2=113, 
HB3=105 and Gabon=13). Sequences from the wild isolates from Brazil were excluded 
because of missing TM2 sequences.
Pir genes, like any other genes with hypervariable region, present several challenges for 
clustering using alignment-based traditional phylogenetic approaches. One is the 
nonuniform rate of evolution, with a higher rate in the hypervariable regions as compared 
to the conserved regions. In addition, recombination may be occurring in the 
hypervariable region that is not typically accounted for during phylogenetic
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reconstruction. The resulting trees are therefore to be interpreted with caution, and are 
useful for describing the bigger groups. Nonetheless, there were interesting results 
obtained from this analysis.
The resultant phylogenetic tree showed clustering o f r if  HVR sequences into 16 groups 
labeled HI to H I6, 10 rifA groups, 2 rifB groups B1 and B2, and 4 groups made up o f 
rifA and rifB sequences (Figure 3.5). The unique ancient rifA2 PFD0070c with its 
ortho logs from DD2 and HB3 together with the related pseudogene PFL2580w formed a 
unique cluster in the tree named H I. Most rifA HVRs clustered together with only a few 
grouping with rifB. The group HI 2 contained a majority o f rifA HVR sequences with 
others being distributed into the other rifA and the mixed rifAlrifB groups. HI 6 contained 
the r i f  A3 HVR sequences together with other non-Ups A r i f  sequences. For rifB the two 
groups B1 and B2 clusters were maintained in the HVR tree (H I4 and H I3 respectively) 
while the more diverse B3 group fell into different HVR groups, a majority o f the 
sequences falling into H7 together with a few rifA. Other rifB3 HVRs were observed in 
H5, a cluster that contained the other UpsA rifs, the rifA l. H3 and H I3 contained the 
remaining rifB3 sequences together with rifA sequences. The extensive mixing o f rifB3 
and rifA HVRs was striking and implied that between-group recombination was 
occurring. In fact in four instances the rifA and rifB HVRs were in adjacent branches 
within the same clades. For these four groups a pairwise alignment was done for each 
pair and pairwise identities were indeed much higher than would be expected for non- 
orthologous sequences within the HVR, ranging between 71% and 86% (Table 3.4.1). 
Some level o f clustering o f rifA and rifB HVRs was not entirely unexpected because the
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most apparent difference between the A and B groups is the 75 nucleotide insertion in 
rifA that is upstream of the HVR and was not included in the sequences for the HVR tree. 
Although there are distinguishable sequence motifs unique to rifA or rifB, without the 
most prominent differentiating feature, the insertion in As, it is expected that some rifA 
and rifB would group together. The fact that group mixing was only observed for rifB3 
and not rifBl and rifB2 implies that rifB3 forms a special group that might represent a 
transition group between A and B types, generated by recombination. The rifB l and rifB2 
groups are well conserved in both full length sequences and in the most diverse HVR 
regions suggesting restricted recombination that occurs only within group. These groups 
might be evolutionarily constrained to maintain specific functions. The UpsA var-linked 
rifs also formed stable groups in both the full-length and HVR tree suggesting limited 
recombination outside o f the group probably to conserve their function.
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Figure 3.5. Phylogenetic tree based on the hypervariable region o f  r if  sequences from  3 
laboratory isolates 3D7 (red), Dd2 (blue) and HB3 (green) and a wild isolate from  
Gabon (yellow). The sequences cluster into clades (HI to H I6). The rifA branches are 
coloured in green and B in pink (Bl), brown (B2) and orange (B3). Previously described 
clusters from the fidl-length tree indicated in brackets in the cluster labels, with rifA in 
green and rifB in red numbers. Branch support indicated is the log likelihood value (blue 
numbers). The tree was based on MUSCLE-alignments o f  411 r if  HVR sequences 
(3D7=181, DD2=z112, HB3=105 and Gabonese=13). The tree was constructed using 
PhyML (run on the ATGC bioinformatics platform South o f  France: http: 7/www. atgc- 
montpellier.fr), GTR model, viewed and edited using FigTree v 1.4.0. Log-likelihood: - 
159,763.
Table 3.4.1. Table showing pairwise percent identities o f  related rifA and rifB3 HVR 
sequences clustered in the same clades in the HVR tree.
ID Type
Vo pairw ise la e n m y  (iden tica l su e s  
o v er fu ll length )
1
PFDG _00193  
PDHG 0 2 0 7 3
A”
B
81% (4 4 5 /5 4 6 )
2
P F10_0394
PFB0015C
B3
A
76% (3 9 9 /5 2 3 )
3
PFH G_05051  
PFDG 0 0 1 9 5
A
B*
86% (4 6 8 /5 3 9 )
4
PFL2630W
PFD G _01035
B
A
71% (3 9 3 /5 5 1 )
118
3.4.2.3. Phylogenetic analysis of the semiconserved N term inal regions 
of r i f  sequences from laboratory isolates.
The phylogenetic tree resulting from full-length r if  sequences above had long branches 
and low statistical support because of the hypervariability o f the genes. The variability of 
r if  and stevor genes is concentrated in the HVR with the N and C terminals being 
semiconserved (Table 3.2 and 3.3). Therefore the trees that result from alignments o f full- 
length sequences have low statistical support and long branch lengths, as observed above 
(Figure 3.3 and 3.4). To construct phylogenetic trees with better statistical support the N 
terminal regions o f 377 rif genes from 3D7, Dd2, HB3, and a Gabonese isolate were 
aligned and phylogenetic trees constructed based on this semiconserved region. The 
resultant tree was structurally different with short branches and laddering o f the branches 
(Figure 3.6). The sequences clustered into 20 groups labeled N1 to N20. The rifA and rifB 
groups were resolved into separate clades with rifA clustering into 14 groups and rifB 
subgrouping into 6 groups. The rifA subgroups were restructured, with sequences from 
the subgroups identified in the full-length tree shifting into new groups. The rifA2 
divergent group was maintained as an out-group, N20. The rifA l and r i f  A3, the UpsA r if  
clustered into one group, N15, together with a few other non-upsArifA genes. The B l, B2 
and B3 subgroups were observed. B3 genes were distributed in 5 different subgroups, 
N10, N 11, N12 unique to B3, and N6 and N14 containing rifA and rifB3 sequences. B l 
further subdividing into B la  and B ib  (N7 and N8). Two small subgroups were made up 
o f rifA and rifB N terminal sequences (N6 and N 14), but besides these there was no 
mixing o f rifA and rifB. The mixing o f rifA and rifB N terminal sequences was 
unexpected because one definitive feature that differentiates the two groups is the
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presence o f a 75 nucleotide insert within the rifA N terminal region upstream of the first 
transmembrane domain, as discussed earlier (Figure 3.1). The observation of closely 
related rifA and rifB sequences suggest that some recombination or gene conversion 
between groups does occur, but at low frequency because only two such groups were 
observed.
From the analysis it was clear that the N terminal regions formed a different tree structure 
from the full-length sequences, with the subgrouping becoming distorted as a result of the 
missing information from the FTVR and C terminal regions. Sequence sharing was also 
observed for rifA and rifB3 in the N terminal regions, despite rifB missing the 75 
nucleotide insert. As expected the statistical support for the tree was higher for the N 
terminal tree (Log-likelihood -  34501) than for the full-length tree but the overall tree 
structure was significantly different. These results give support for using full-length 
sequences for r i f  sequence classification.
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Figure 3.6. Phylogenetic tree based on the semiconserved N  terminal region o f  r if  
sequences from 3 laboratory isolates 3D7 (red), DD2 (blue) and HB3 (green) and a wild 
isolate from  Gabon (yellow). The sequences cluster into clades within the A and B groups 
and are marked with a grey circle, rifA green branches, rifB l pink, rifB2 brown and 
rifB3 orange branches. Previously described clusters from the full-length tree (Figure 
3.4) are indicated in brackets in the cluster labels, with rifA in green and rifB in red 
numbers. Branch support indicated is the log likelihood value (blue numbers). The tree 
was based on MUSCLE-alignments o f 377 r ifN  terminal amino acid sequences 
(3D7=158, DD2=103, HB3=103 and Gabonese=13). The tree was constructed using 
PhyML (run on the ATGC bioinformatics platform South o f  France: http: 7/www. atgc- 
montpellier.fr), GTR model, viewed and edited using FigTree v 1.4.0. Log-likelihood: - 
34501.
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3.4.2.4. Phylogenetic analysis of stevor sequences from laboratory and 
wild isolates.
To explore phylogenetic relationships o f the stevor multigene family 102 stevor 
sequences from laboratory isolates were retrieved from genome databases: 40 sequences 
from 3D7 (PlasmoDB), 31 sequences from Dd2 and 31 sequences from HB3 (Broad 
Institute). The sequences clustered into the two main groups (Figure 3.7), the major group 
stevorA and a minor group stevorB, as previously observed (Abdel-Latif et al., 2002, 
Joannin et al., 2011) and in the 3D7 rif/stevor tree above (Figure 3.3). The stevorA major 
group was further classified into 13 subgroups A l to A13 (Figure 3.7). The stevorA 
clusters were characterized by short branches, which is indicative of the sequence 
conservation of this group. With exception o f one group, stevor A l ,  all stevorA clusters 
contained sequences from all the laboratory isolates. A l did not have any sequences from 
3D7. The stevorB group was further subdivided into 5 subgroups, B l to B5 (Figure 3.7). 
All clusters contained stevor sequences from the different isolates with no isolate-specific 
cluster, suggesting that stevor repertoire was conserved across isolates from different 
geographical locations. The previously described stevor-like divergent cluster (Joannin et 
al., 2011) was observed with the members from the three genomes (Cluster B l in Figure
3.7).
The branch support, log likelihood ratio, for most o f the clades was lower than 0.9 but 
above 0.6.
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Figure 3.7. Maximum likelihood tree o f  102 stevor nucleotide sequences from laboratory 
isolates 3D7 (red), DD2 (blue) and HB3 (green) showing the two larger stevor groups 
the major group stevor A (red branches) and the minor group stevorB (green branches). 
The larger groups further split into smaller groups. The clades are marked with a black 
open circle. The stevorA splits into 13 subgroups (A1-A13) and the stevorB into 5 
subgroups (B1-B5). Nodes with high branch support (log likelihood >0.9) were labeled. 
The tree was constructed from  MUSCLE-alignments o f  102 stevor CDS nucleotide 
sequences (3D7-40, DD2=31 andHB3=31), usingPhyML (run on the ATGC  
bioinformatics platform South o f  France: http://www. atgc-montpellier. fr), GTR model. 
The tree was viewed and edited using FigTree v 1.4.0. Log-likelihood: -33,625.
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Analysis of full length stevor coding nucleotide sequences (CDS) from laboratory 
isolates and amplicon sequences from laboratory and Kilifi isolates from published data 
(Blythe et al., 2009) showed similar clustering as with the laboratory isolates (Figure
3.7), with the subgroups maintained and only minor shifting o f clades on the tree (Figure
3.8). The major groups stevorA and stevorB as well as their subgroups were observed.
The stevorA further split into 14 subgroups (Al to A 14). None o f the amplicon sequences 
from Blythe, et al. (Blythe et al., 2009) were from the stevorB group. This is a divergent 
group and unlikely to be captured by universal primers. A new clade was observed that 
was made up o f sequences from a Kilifi isolate and the laboratory isolate T9/96 (clade 
A14 in Figure 3.8). This clade was not previously observed in 3D7, Dd2 or HB3.
126
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Figure 3.8. Maximum likelihood tree o f 308 stevor fu ll length nucleotide sequences from  
laboratory isolates 3D7 (red), DD2 (blue) and HB3 (green), and a wild isolate from  
Brazil (orange) and amplicon length sequences from laboratory (light coloured tip 
labels) and Kilifi isolates (black) from published data (Blythe et al., 2009). The sequences 
clustered into the two main stevor groups the major group stevorA (red branches) and 
the minor group stevorB (green branches). The two groups further split into smaller 
groups (clades are marked with a black open circle), stevorA into 14 subgroups (A1-A14) 
and stevorB into 5 subgroups (B1-B5). The asterisks (*) indicated a new clade not 
observed in the tree o f  stevor sequences from laboratory isolates (Figure 3.7). The tree 
was constructed from MUSCLE-alignments o f308 stevor CDS nucleotide sequences (full 
length stevor; 3D7=40, DD2=30, HB3=30, Brazilian isolate-75. Amplicon sequences; 
3D7=6, A4=24, C10=5, D10=l, FCB1=17, T9/69= 23 and Kilifi isolates=57), using 
PhyML (in house), GTR model. The tree was viewed and edited using FigTree v 1.4.0. 
Log-likelihood: -52,415.
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3.4.2.5. Phylogenetic analysis of the hypervariable region of stevor 
sequences from laboratory isolates.
As with the r if  multigene family stevor sequence diversity is concentrated in the HVR. 
Phylogenetic analysis was carried out based on these regions to identify recombining 
stevor groups. The HVRs including the two transmembrane domains were extracted from 
stevor sequences for laboratory isolates (3D7, DD2 and HB3). The sequences were 
between 117 and 228 nucleotides long. Multiple sequence alignments were done and a 
phylogenetic tree constructed. The resultant tree was characterized by long branches 
suggestive o f the high variability and poor resulting alignments o f the sequences (Figure
3.9). The branch support for most nodes was low (below 80 out of 100 bootstrap values). 
The stevor HVRs clustered into 12 groups (HI to H I2), 6 stevorA only groups and 6 
stevorB only groups. No A and B mixed groups were observed, indicating lack of 
between-group recombination stevorA and stevorB HVR sequence. The stevorB HVR 
clusters were more similar to the full-length clusters with only two exceptions, B1 splits 
into two H2 and H12, while B3 splits into HI and H5 groups (Figure 3.9). The stevorB 
groups showed higher bootstrap support than the stevorA groups. The stevorA HVR 
showed high within group mixing. All the stevorA HVR groups were made up o f a 
combination o f sequences from different groups from the full-length tree. This 
observation suggests that stevorA sequences undergo recombination with other members 
within the group. Overall the grouping observed in the HVR tree was significantly 
different from the full length tree and this is telling of the different evolutionary pressures 
working on the different gene regions. The HVR are under diversifying selection pressure 
hence the high diversity, which may be important for a role in immune evasion o f 
infected erythrocytes.
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Figure 3.9. Maximum likelihood tree o f  97 HVR and the two transmembrane domains o f  
stevor nucleotide sequences from laboratory isolates 3D7 (red), Dd2 (blue) and HB3 
(green). The HVR sequences clustered into 12 groups (HI to H I2) with no mixing 
between the two main groups, stevorA (red branches) stevorB (green branches) 
separated out. The larger stevorA further split into 6 large clusters (H6 to H I 1) and the 
stevorB into 6 smaller groups (HI to H5 and H I2). The clades are marked with a black 
open circle. Nodes are labeled with the bootstrap value (out o f  100 bootstrap 
replications). The tree was constructed from  MUSCLE-alignments o f  97 stevor HVR plus 
TMs nucleotide sequences (3D7=39, DD2=29 and HB3=29), using PhyML (run in 
house). Substitution model: GTR. Log-likelihood: - 14,468. The tree was viewed and 
edited using FigTree v 1.4.0.
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3.4.2.6. Phylogenetic analysis of the semiconserved region of stevor 
sequences from laboratory isolates.
The N terminal region of stevor genes is highly conserved with overall sequence identity 
of over 50% for sequences from different parasite isolates (Figure 3.2 and Table 3.3). The 
full length trees had low likelihood because o f the poorly aligned FIVRs. Trees based on 
the more conserved N terminal regions would be less computationally intense and 
generate trees with better statistical support. This analysis sought to determine whether 
these regions are phylogenetically informative enough for sequence classification, and 
whether a similar structure to the full-length tree would be observed. Analysis o f stevor 
semiconserved N terminal regions based on sequences obtained from laboratory isolates 
3D7, Dd2 and HB3 revealed a different tree structure with short branch lengths (Figure
3.10), better branch support and overall better statistical likelihood (log likelihood o f - 
19,464) than the full length tree. The subgrouping especially for stevorA was significantly 
different to what was observed in the full-length (Figure 3.7) or HVR (Figure 3.9) trees. 
The stevorA sequences were reordered into different groups resulting in new 
combinations of subgroups. The stevorB groups were maintained suggesting that the 
stevorB are evolutionary constrained. This tree structure was more similar to the full- 
length tree (Figure 3.7) especially for stevorB groups with the major changes observed 
with stevorA groups.
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Figure 3.10. Maximum likelihood tree o f  102 N  terminal stevor nucleotide sequences 
from laboratory isolates 3D7 (red), Dd2 (blue) and HB3 (green) showing the two larger 
stevor groups the major group A (red branches) and the minor group B (green branches). 
The larger groups further split into smaller groups. The clades are marked with a black 
open circle. The stevorA splits into 12 subgroups with most sequences reordered into 
different groups from the groups observed in the full-length tree resulting into new 
combination o f  groups while stevorB maintains the same 5 subgroups. The tree was 
constructed from MUSCLE-alignments o f  102 stevor CDS nucleotide sequences 
(3D7=40, DD2=31 andHB3=31), using PhyML (in house), GTR model. The tree was 
viewed and edited using FigTree v 1.4.0. Log-likelihood: - 19,464.
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3.4.3. Phylogenetic analysis of r if  upstream regions in laboratory isolates.
As previously discussed, certain var genes are associated with specific upstream (ups) 
sequences. Phylogenetic analysis was carried on pir  5’ UTRs to explore whether these 
ups groups are associated with specific pir  groups. R if  UTRs, 1000 nucleotides upstream 
of the start codons, for 3D7 (184) and IT (138) r if  genes were downloaded from GeneDB 
(http://www.genedb.org/genedb/malaria/). The IT genome still has gaps and a few rz/Ups 
sequences had stretches of missing sequence data and were excluded from the analysis 
ending up with 120 IT rz/Ups sequences.
The r i f  upstream regions clustered into 13 groups, 9 groups predominantly made up of 
rifA and 4 with mostly rifB sequences, although the separation between rifA and rifB 
groups was not as apparent as in the CDS region (Figure 3.11). The rifB grouped together 
with rifBl and rifB2 mostly clustered in the same clades. A few rifB3 did cluster with 
rifA in the same clades in adjacent branches. The conserved rifA groups rifAl and rifA3 
clustered on the ups tree together with other rifA ups sequences. rifA l grouped together 
with other rifA in the ups clade U9 while r if  A3 fell into U 1. Most o f the other rifA groups 
previously seen in the full-length tree were not maintained in the ups tree.
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Figure 3.11. Maximum likelihood tree o f3D 7 (red) and IT  (blue) r if  upstream regions 
showing clustering into 13 Ups groups (U1 to U13), 9 predominantly rifA (green 
branches) and 4 predominantly B groups (Bl pink, B2 brown and B3 orange branches). 
The branch support fo r the 13 groups are indicated (bootstrap values out o f  100 
replicates). The tree was based on MUSCLE-alignments o f 304 r if  upstream sequences 
(307=184 and IT= 120) coding sequences, constructed using PhyML (run in house). 
Model: GTR. . Log-likelihood: -180837. The tree was edited using FigTree v 1.4.0.
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3.4.4. Analysis of stevor upstream regions in laboratory lines 3D7 and IT.
Similarly, stevor Ups regions consisting o f 1000 nucleotides upstream of the start codons 
were downloaded from GeneDB (http://www.genedb.org/genedb/malaria/) for 3D7 (42) 
and IT (39).
The stevor ups sequences grouped into 3 large clusters, U l, U2 and U9 that contained a 
majority o f the sequences, and 7 smaller clusters with between 2 and 7 sequences.
In the stevor ups tree stevorA and stevorB groups did not segregate but instead grouped 
together and in some cases in adjacent branches (Figure 3.12). With the exception o f U8 
and U10 that contained only stevorB ups sequences most other stevorB mixed in with 
stevorA ups sequences on the tree.
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Figure 3.12. Maximum likelihood tree o f 3D7 (red) and IT  (blue) stevor upstream 
regions showing 10 stevor Ups groups, 5 predominantly stevorA groups (red branches) 
and 5 predominantly stevorB groups (green branches). The branch support fo r  groups 
are indicated (bootstrap values out o f  100 replicates). The tree was based on MUSCLE- 
alignments o f  81 r if  (n=42) and stevor (n=39) coding sequences, constructed using 
PhyML (run in house). Model: GTR. . Log-likelihood: -39719. The tree was edited using 
FigTree v 1.4.0.
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3.4.5. Conserved chromosomal locations of pir  genes across parasite isolates 
and species.
Large multigene families in Plasmodium including pir  genes are mainly located in the 
subtelomeric regions, but a few are found within the centromeric regions (Gardner et al., 
2002, Pain et al., 2008, Carlton et al., 2008, Otto et al., 2014a, Otto et al., 2014b). The pir  
genes are found interspersed between the var genes, with the vars on the most 
subtelomeric regions, followed by a r if  or a number o f rifs and then stevors (Figure 3.13). 
In some chromosomes var genes appear singly or in a cluster in the centromeric regions. 
Some central var genes neighbor central r i f  and stevor genes (Figure 3.13). In the 
centromeric regions r i f  and stevor genes always appear next to a var gene. In 3D7 only 5 
of the 14 chromosomes contain centrally located vars and rifs, chromosomes 4, 6, 7, 8 
and 12. O f the 184 r i f  genes, 12 are centrally positioned. 6 o f these are pseudogenes. 
Chromosome 7 has a cluster o f central var genes and interspersed between them are 4 
rifs, three of which are pseudogenes located on the reverse strand. All central r if  genes in 
3D7 belong to the rifA subgroup. Only one stevor gene (PF3D7_0617600) is centrally 
located on chromosome 6 next to a var gene and a r i f  pseudogene (Figure 3.13. A).
A similar overall chromosomal location is conserved in the genome of another laboratory 
isolate IT (Figure 3.13. B). Although not all genes have been assigned chromosome 
locations (43 r i f  and 9 stevor are currently in the bin, that is not assigned to any 
chromosome region), a majority o f pir  genes are located in the subtelomeric regions, with 
7 r i f  genes centrally located. The central rifs are found in chromosomes 4, 6, 7, 8 and 12, 
as observed in 3D7. The central r i f  genes always appear next to var genes. Centrally 
located stevor genes were not observed in IT (Figure 3.13. B).
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With the availability of high quality P. reichenowi genome, a close relative of P. 
falciparum, it was possible to analyse chromosomal locations of pir  genes. P. reichenowi 
contains many more pir genes in comparison to P . falciparum, with 462 r if  and 66 stevor 
compared to 184 r if  and 42 stevor in 3D7. A good number of these genes have not been 
assigned to any chromosome (about 418 r i f  and 53 stevor), but the available 
chromosomal location data was used. The non-assigned pir  genes were placed on an 
artificial chromosome zero (0) in descending order based on their gene IDs (Figure 3.13).
A comparison between the chimpanzee malaria parasite P. reichenowi and P. falciparum  
revealed that the chromosomal positioning of VS A coding genes was generally 
conserved. Most were located in the subtelomeric regions with a few found in the central 
regions o f the chromosomes (Figure 3.13. C). Central var genes were observed in 
chromosomes 4, 6, 7, 8 and 12 as observed in 3D7 and IT. There were 9 central r i f  genes 
found in chromosomes 4, 7 and 12. O f these 4 were pseudogenes, one each in 
chromosome 4 and 12 and two in chromosome 7. All but one o f the central r i f  were from 
the rifA group. The exception was the central rz/PRCDC_0410600 on chromosome 4 that 
was from the rifBl subgroup. The central r i f  pseudogene on chromosome 12 
(PRCDC_1218500) is a conserved gene with syntenic orthologs in 3D7 and IT (Figure 
3.14 and Appendix table 9.3). Only one P. reichenowi stevor (PRCDC_0410700) was 
centrally located in chromosome 4. This stevor had no ortholog in P. falciparum  but was 
closely related to the 3D7 stevor PF3D7_1372800 (MAL13P1.505) with a percent 
pairwise identity o f 83% in 759 o f 906 nucleotides.
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Figure 3.13. Chromosomal organization o f  VSA-encoding genes, var (red), r i f  (blue) and 
stevor (green) in two P. falciparum parasite isolates 3D7 (A) and IT  (B) (PF3D7 and 
PFIT) and the chimpanzee malaria P. reichenowi isolate PRCDC (version dated 2014- 
09-03 from PlasmoDB) (C). The 14 chromosomes are labeled on the Y-axis and the 
genomic coordinates on the X-axis in megabase pairs (Mbp). Chromosomes labeled 0 
(zero) fo r  IT  and P. reichenowi contain VSAs that have not been assigned chromosomal 
locations and are still in the bin. The genes on chromosome 0 are ordered by name, in 
ascending order, along the chromosomes. The predicted centro meres are indicated in 
black bars.
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3.4.6. Centrally located r if  genes are conserved in laboratory and wild 
isolates.
The P. falciparum  central chromosomal regions are considered less “recombinogenic” as 
compared to the telomeric regions, thus centrally positioned genes are in turn expected to 
be more conserved. A group of var genes, UpsC var located near the centromeres are 
proposed to be conserved because o f the reduced recombination events. As previously 
discussed, there are r i f  genes located next to the central vars. To analyse whether central 
rifs formed a conserved group, 28 central r i f  sequences from 3D7 (n=12), IT (n=7) and P. 
reichenowi (n=9) were extracted, aligned, and a phylogenetic tree constructed from the 
alignment. With the exception o f a divergent 3D7 r if  pseudogene (PF3D7 0617500/ 
PFF0847w) all the other r i f  genes fell into clusters with one or more closely related r if  
within and across isolates (Figure 3.14). The high branch support and high log likelihood 
suggest that these centrally located rifs formed a conserved group. Six pairs o f rifs from 
3D7 and IT fell in the same clades (Figure 3.14) suggesting that these were closely 
related. A one-to-one pairwise comparison between the 3D7 and IT r i f  genes that fell in 
the same clades revealed that they were indeed orthologs (between 95% to 100% 
pairwise identity) (Appendix Table 9.3). In fact, four o f these are syntenic orthologs 
(Table 3.4 and Appendix Table 9.3) (PlasmoDB
(http://www.plasmodb.org/plasmo/home.jsp). Three clades with long branches but high 
bootstrap values were composed o f pairs o f sequences from 3D7 and P. reichenowi 
(Figure 3.14). The rifs in these clades were not orthologs based on results from pairwise 
sequence comparisons (below 70% pairwise identity). These P. reichenowi and P. 
falciparum r if  genes might have shared ancestry but have diverged further after 
speciation o f the parasites to different hosts. One clade with high branch support was
made up of /"//'sequences from chromosome 12 of 3D7, IT and P. reichenowi. The three 
central n/pseudogenes PF3D7_1219200, PFIT_1218900 and PRCDC_1218500 were 
positionally conserved in the three parasite genomes and had an overall pairwise identity 
of 97% (Table 3.4, Appendix Table 9.3 and Figure 3.15). The upstream regions o f all the 
syntenic orthologs of centrally located rifs were conserved with identities between 90% 
and 98% over the full length of the sequences (Appendix table 9.3). This region in 
chromosome 12 is conserved in the 2 P. falciparum  genomes 3D7 and IT and in P. 
reichenowi and contains a var gene, a r i f  pseudogene and
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Figure 3.14. Phylogenetic tree o f  the centrally located r if  genes in P. falciparum isolates 
3D7 (red), IT  (blue) and the chimpanzee malaria parasite P. reichenowi (version dated 
2014-09-03 from PlasmoDB) (black). The pseudogenes are on the gray branches with 
lighter shades o f  colour on the tip labels. The brown branch indicates the one centrally 
located rifB in P. reichenowi. The branches labeled indicate bootstrap values out o f  100 
replicates. The tree was based on MUSCLE alignments o f  28 CDS r if  sequences 
(3D7=12, IT  =7 and PRCDC=9, constructed using PhyML with GTR model. 100 
bootstrap replicates were performed. Log likelihood: -18408.
146
The centrally located rifs formed a conserved group as discussed previously. To find out 
if these rifs were conserved in other parasite isolates BLAST searches were carried out 
using the 3D7 or IT representative as the query. Highly conserved orthologs were 
identified in the laboratory isolates DD2 and HB3 and in patient isolates from Kenya 
(Table 3.4). All central rifs had at least two orthologs from wild isolates and most had 
orthologs from other laboratory isolates, forming 12 groups o f orthologous r i f  genes.
Four of these groups had syntenic orthologs in 3D7 and IT, and in one case, 
PF3D7_1219200, the synteny was also conserved in P. reichenowi. Five of these 
orthologous groups were pseudogenes and they showed higher within group sequence 
identity on average as compared to the intact coding genes (Table 3.4).
The central 3D7 stevor P F 3 D 7 0 6 17600/ PFF0850c was used to search for orthologs in 
other laboratory isolates as well as wild isolates. There were no orthologs identified in the 
other three laboratory isolates DD3, HB3 and IT. Orthologs were found in three wild 
isolates, with an overall sequence identity o f 98.3% (Figure 3.16).
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Table 3.4. Conserved centrally located r if  genes and their orthologs from laboratory and 
patient isolates.
Group Lab Isolate Gene ID Old ID (3D7) Pseudogene
Idnetitlcal 
nucleotides (% 
pairwise identity)
Patient
isolate Gene ID
% mean pairwise 
identity
Group % pairwise 
identity
1 3D7 PF3D7_0412600 (s) PFD0620C Y Query 6816 PF8443_8_1_U561100 980/1023 (95%) 93.4
IT FIT_0411200 (s) 975/1023 (95%) 10936 PF8443_8_10_U489500 986/1023 (96%)
3D7 PF3D7_0711900 MAL7pl.43 1013/1074(94%) 10936 PF8443_8_10_U489700 985/1073 (91%)
IT PFIT_0811700 851/934 (91%) 10936 PF8443_8_10_U489800 959/1036 (92%)
HB3 PfHB3_BroadWashl44100 N/A 1019/1074 (94%) 9626 PF8443_8_2_U283400 885/939 (94%)
HB3 PfHB3_BroadWash054500 971/1053 (92%) 11019
11019
9215
9215
9775
10668
11014
SA075
SA075
PF8443_8_3_U116300
PF8443_8_3_U546400
PF8443_8_4_U515500
PF8443_8_4_U515600
PF8443_8_5_U058900
PF8443_8_8_U508400
PF8443_8_9_U052000
PFSA075_071600
PFSA075_137600
970/1023 (94%) 
787/816 (96%) 
909/959 (94%) 
853/905 (94%) 
825/859 (96%) 
828/870 (95%) 
928/970 (95%) 
978/1074 (91%) 
951/1023 (92%)
2 3D7 PF3D7_0808900 PF08_0104 N Query 6816 PF8443_8_1_U073300 916/1000 (91%) 91.3
HB3 PfHB3_BroadWashl72400 912/999 (91%) 6816 PF8443_8_1_U 547100 916/999 (91%)
IT PFIT_1240200 921/999 (92%) 10936 PF8443_8_10_U548000 939/999 (93%)
IT PFIT_bin08400 916/1005 (91%) 9626 PF8443_8_2_U143100 917/999 (91%)
DD2 PFDG_04323 928/999 (92%) 9626
11019
11019
9215
9215
9775
9605
9106
10668
11014
11014
PF8443_8_2_U513000 
PF8443_8_3_U164800 
PF8443_8_3_U477700 
PF8443_8_4_U071400 
PF8443_8_4_U195200 
PF8443_8_5_U165400 
PF8443_8_6_U548500 
PF8443_8_7_U513600 
PF8443_8_8_U293700 
PF8443_8_9_U142300 
PF8443_8_9_U162600
918/1002 (91%) 
965/1020 (94%) 
923/999 (92%) 
876/961 (91%) 
911/1001 (91%) 
884/950 (93%) 
923/1002 (92%) 
908/999 (90%) 
952/999 (95%) 
951/999 (95%) 
916/999 (91%)
3 3D7 PF3D7_0713000 (s) MAL7P1.57 N Query 10936 PF8443_8_10_U132900 508/525 (96%) 97.4
HB3 PfHB3_BroadWashl44500 512/525 (97%) 10975 PF8443_8_12_U137000 924/963 (95%)
IT PFIT_0711100 (s) 1021/1041(98%) 9626 PF8443_8_2_U127100 1026/1041(98%)
11019 PF8443_8_3_U123700 1010/1041 (97%)
9215 PF8443_8_4_U144300 1025/1041 (98%)
9775 PF8443_8_5_U139700 1009/1041 (96%)
9605 PF8443_8_6_U140200 1027/1041 (98%)
9106 PF8443_8_7_U060200 994/1041 (95%)
10668 PF8443_8_8_U135200 1022/1024 (99%)
11014 PF8443_8_9_U121800 1010/1041 (97%)
SA075 PFSA075 137800 508/525 (96%)
4 3D7 PF3D7_1219200 (s) PFL0933W Y Query 10936 PF8443_8_10_U495100 625/629 (99%) 99.4
IT PFIT_1218900 (s) 704/704(100%) 10975 PF8443_8_12_U312700 701/704 (99%)
PRCDC PRCDC_1218S00 (s) 688/704 (97%) 9626 PF8443_8_2_U300600 700/704 (99%)
11019 PF8443_8_3_U279800 640/644 (99%)
9215 PF8443_8_4_U327700 626/629 (99%)
9775 PF8443_8_5JJ324600 701/704 (99%)
9106 PF8443_8_7_U 276900 626/629 (99%)
10668 PF8443_8_8_U 309400 625/629 (99%)
11014 PF8443_8_9_U278200 701/704 (99%)
SA075 PFSA075_318800 701/704 (99%)
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Lab Isolate Gene ID Old ID (3D7) Pseudogene
% m ean pairwise 
identity
’atient isolat Gene ID % m ean pairwise 
identity
Group % pairwise 
identity
5 3D7
IT
DD2
PRCDC
PF3D7_0413300 (s) 
PFIT_0411800 (s) 
PFDG_03424 
PRCDC_0410800*
PFD0645W N Query
1017/1041(97%) 
1037/1041 (99%) 
765/1049 (72%)*
6816
10975
9626
11019
9215
9775
10668
11014
SA075
PF8443_8_1_U061600 
PF8443_8_12_U07020 
PF8443_8_2_U053400 
PF8443_8_3_U052600 
PF8443_8_4_U059600 
PF8443_8_5_U059100 
PF8443_8_8_U 056700 
PF8443_8_9_U052300 
PFSA07S 061500
1031/1041 (99%) 
846/860 (98%) 
1029/1041 (98%) 
1015/1041 (97%) 
945/1041 (90%) 
1037/1041 (99%) 
945/1041(90%) 
1037/1041 (99%) 
1016/1041 (97%)
96
6 BD7 PF3D7_0413200 PFD0640C N Query 6816
9626
11019
9775
9605
10668
SA075
PF8443_8_1_U061500 
PF8443_8_2_U053300 
PF8443_8_3_U052500 
PF8443_8_5_U059000 
PF8443_8_6_U059100 
PF8443_8_8_U056600 
PFSA075 061400
1050/1134(92%) 
1131/1131(100%) 
1103/1131 (97%) 
889/939 (94%) 
1102/1131 (97% 
1105/1131 (97%) 
1021/1131 (90%)
94.1
7 3D7
DD2
PF 3D7_0808800 
PFDG_04322
PF08_0105 N Query
1008/1114(90%)
9215
10668
6816
9626
11014
6816
11019
PF8443_8_4_U171000 
PF8443_8_8_U293600 
PF8443_8_1_U 560100 
PF8443_8_2_U143200 
PF8443_8_9_U502600 
PF8443_8_1_U 547200 
PF8443 8 3 U568200
998/1070 (93%) 
1022/1113 (91%) 
1020/1113 (91%) 
879/891 (98%) 
1014/1116 (90%) 
964/1038 (92%) 
923/976 (94%)
91.4
8 IT
DD2
PFIT_0616600
PFDG_02423
N Query
663/725 (91%)
10936
9215
9775
9106
SA075
PF8443_8_10_U110500 
P F8443_8_4_U134400 
PF8443_8_5_U130900 
PF8443_8_7_U112500 
PFSA075 PN18
1048/1148 (91%) 
1137/1147 (99%) 
1137/1147 (99%) 
1049/1148 (91%) 
1059/1069 (99%
94
9 3D7
IT
DD2
PF3D7_0712500 
PFIT_0411700 
PFDG 00027
MAL7P1.52 Y Query
995/997 (99%) 
1106/1139 (97%)
9775
9626
6816
PF8443_8_5_U139500 
PF8443_8_2_U126900 
PF8443 8 1 U141200
1107/1137 (97%) 
1089/1137 (95%) 
1043/1065 (97%)
98.4
10 3D7 PF3D7_0617500 PFF0847W Y Query 9106
SA075
9775
PF8443_8_7_U 100400 
PFSA075_071100 
PF8443 8 5 U530200
886/892 (99%) 
582/586 (99%) 
582/586 (99%)
99.5
11 3D7 PF3D7_0617700 PFF0855C N Query 9106
SA075
PF8443_8_7_U 100500 
PFSA075 071300
906/1003 (90%) 
717/752 (95%)
92.6
12 3D7 PF3D7_0712200 MAL7P1.47 Y Query 9775
11014
PF8443_8_5_U 139300 
PF8443 8 9 U435200
1014/1017 (99%) 
944/1018(92%)
94.9
Yellow highlights indicate the centrally located rifs.
The reference gene was used to search fo r  orthologs using BLAST search in Geneious 
(version 6.1.5). 
s indicates syntenic orthologs
* non-orthologs because o f  the low pairwise sequence identity
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Figure 3.15. Nucleotide sequence alignment o f  a conserved central rifpseudogene (exon 
2 only) in P. falciparum isolates 3D7 and IT and in P. reichenowi isolate PRCDC. Above 
the sequences is the identity score, the mean pairwise identity o f  all the pairs in the 
column: green: 100% identity, brown-green: 30-99%, and red: less than 30% identity. 
The overall pairwise identity o f  the four sequences was 97%).
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Figure 3.16. Nucleotide sequence alignment o f  a conserved central stevor gene in P. 
falciparum laboratory isolate 3D7 and three wild isolates. Above the sequences is the 
identity score, the mean pairwise identity o f  all the pairs in the column; green: 100% 
identity, brown-green: 30-99%, and red: less than 30% identity. The overall pairwise 
identity o f  the three sequences was 98.3%.
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3.4.7. R if  and stevor sequence length analysis.
On average, rifA are longer than rifB, 1227 and 1115 basepairs (bp) for ri/A and rifB 
respectively from 3D7 genome. This is mainly due to the 25 amino acid insertion in rifA 
(Figure 3.1). Distribution of all the r i f  CDS lengths appears to follow a normal 
distribution, a few very short or very long sequences with a majority o f the sequences 
longer than 900 nucleotides and shorter than 1150 nucleotides. When separated by type, 
sequences separate by length with rifA having 3 length groups, short (less than 1000 
nulceotides), medium long (1000 to 1100 nucleotides) and long (longer than 1100 
nucleotides). Two length groups were observed for rifB, short (less than 1000 nucleotides 
long) and long (longer than 1000 nucleotides) (Figure 3.17). From phylogenetic analysis 
of CDS from 3D7 it was evident that r if  sequences clustered by length, especially the 
longer rifs that were mostly found to form their own clusters (Figure 3.18). Multiple 
alignments o f the different groups by length revealed that the longer sequences were 
more conserved than the shorter sequences, albeit only slightly. For rifA the mean 
pairwise identity o f the sequences longer than 1100 nucleotides was 62.9% (n=53) as 
compared to 57.5% for the sequences between 1000-1100 nucleotides (n=44) or 55.9% 
for the sequences shorter than 1000 nucleotides (n=33). The overall pairwise identity for 
rifA from 3D7 genome was 54%. Similary for rifB, the longer sequences were more 
conserved than the short ones. The short rifB were all from rifB3 subgroup and had an 
overall pairwise identity o f 60.3 (n=16) as compared to 69.9% in the longer rifB. The 
overall pairwise identity for all rifB from 3D7 genome was 61.6%.
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Figure 3.17. Length distribution o f  129 rifA (A) and 48 rifB (B) intact fu ll length CDS 
sequences from 3D7 genome showing the three length groups fo r rifA, short, medium and 
long (below 1000, 1000 to 1100, and above 1100 nucleotides respectively) and two 
length groups fo r  rifB, short and long (below 1000 and above 1000 nucleotides 
repsectively).
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Figure 3.18. Maximum likelihood tree o f  the 3D7 r if  CDS gene family from showing 
clustering o f  r if  genes by length. Tip labels are coloured by length, black fo r long 
sequences (rifA >1100, and rifB >1000 nucleotides), darker gray fo r medium long r if  
(> 1000<1100 nucleotides only rifA) and light gray fo r  short r if  (<1000 nucleotides). 
Branches are coloured based on r if  major groups, A (green) and B subgroups, B l (pink), 
B2 (brown) and B3 (orange) subgroups (green). The tree was constructed from  
MUSCLE-alignments o f  184 r if  CDS, using PhyML (run on the ATGC bioinformatics 
platform South o f  France: http://www.atyc-montpellier.fr), GTR model, viewed and 
edited using FigTree v 1.4.0. Log-likelihood: - 112112.
Two sequence length groups were observed for stevor sequences from 3D7, short 
sequences less than 900 nucleotides and long sequences longer than 900 nucleotides 
(Figure 3 .19 .1). Similar to the observation in r if  sequences, longer stevor sequences were 
slightly more conserved with 69.5% mean pairwise identity (n=28) than the shorter 
sequences with 62.3% mean pairwise identity (n=12). Overall stevor pairwise identity 
was 65.5% (n=42). Phylogenetic analysis did not show any clustering of stevor sequences 
by length (Figure 3.19. II).
155
CDS seq u e n c e  length
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Figure 3.19. Analysis o f  stevor sequences by length (I) Length distribution o f  40 intact 
fu ll length stevor CDS sequences from 3D7 genome showing distribution o f  stevor into 
two length groups (short and long, <900 and >900 nucleotides respectively. (II) A 
maximum likelihood tree o f  40 intact fu ll length stevor CDS sequences showing the main 
groups stevorA (blue branches) and stevorB (purple branches).
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3.4.8. Conserved r i f  and stevor genes 
Despite the high diversity in pir  genes especially the r if  genes, there are highly conserved 
groups and individual genes. The major r if  groups A and B, and B l, B2 and B3 
subgroups have been described (Joannin et al., 2008) while for stevor, the major and 
minor groups were described in laboratory isolates (Schreiber et al., 2008). Some o f the 
highly conserved rifs have been described in literature, including the ancient r i f  found as 
a single copy in all genomes rifA2 (PF3D7_0401600/PFD0070c), the UpsA var-linked 
r if  (Wang et al., 2009), and the strain transcendent r if  and stevor observed in laboratory 
and field isolates (Claessens et al., 2011).
With the availability o f more pir  repertoires from whole genome sequencing projects it 
was possible to identity orthologs from more laboratory and wild isolates from different 
geographical locations. In addition, the availability o f the P. reichenowi whole genome 
sequence data enabled identification of ancient conserved pir  genes.
To identify conserved pir  genes in other laboratory and wild isolates 3D7 pirs were used 
as queries in BLAST searches (run within Geneious) against a database of pir  sequences. 
The databases contained pir repertoires from P. falciparum  and P. reichenowi. The P. 
falciparum pir  genes were obtained from 4 laboratory isolates (3D7, IT, DD2 and HB3) 
and 13 wild isolates from Kenya (12 Kilifi and 1 Kisumu isolate). Additional incomplete 
r i f  repertoires were obtained from published data, field isolates from Brazil (Albrecht et 
al., 2006) and Gabon (Abdel-Latif et al.j-2002). P reichenowi pir  repertoires were 
obtained from the recently published PRCDC genome sequenced by the Sanger Institute 
(Otto et al., 2014b). Genes were considered to be orthologs if the nucleotide pairwise 
identities were above 90% over greater than half the length of the query and hit. A pir
gene was considered to be strain-transcendent if it had orthologs in two different isolates, 
that is, the gene was found in at least three different isolates (Claessens et al., 2011).
Using this approach highly conserved pir  genes were identified. 35 r if  and 29 stevor 
genes from 3D7 had at least two orthologs, either from two different laboratory or wild 
isolate, or one each from a laboratory and wild isolate (Table 3.5 below and Appendix 
Table 9.3 and 9.4). This threshold was intentionally lowered because many isolates, 
especially the wild isolates have incomplete genome annotations. The implication is that 
there may be more conserved pir  genes that have not been annotated in some genomes 
and increasing the threshold would result in identification o f only a few conserved pir  
genes. Certain chromosomal regions of the P. falciparum  genome are highly conserved. 
Some of the conserved pirs  were found within these highly conserved regions.
O f the 35 conserved r i f  genes, 23 were A type and 12 B type. O f these 13 were 
pseudogenes, 12 rifA pseudogenes and 3 rifB pseudogenes. 10 conserved r i f  genes were 
syntenic orthologs in 3D7 and IT genomes. O f the 35 conserved r i f  2 had orthologs in P 
reichenowi including a highly conserved syntenic orthologous pseudogene on 
chromosome 12 (PF3D7_1219200). 3 other conserved r i f  had close relatives in P  
reichenowi (above 80% sequence identity).
Many 3D7 stevor genes had at least two orthologs either from laboratory or wild isolates. 
29 of the 42 stevors were conserved in at least one other isolate (Appendix Table 9.4). O f 
these 21 were from the major group stevor A and 9 were pseudogenes. 9 of the conserved 
stevor shared synteny with orthologs from IT. 10 strain transcendent stevor genes,
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conserved in at least 2 laboratory and 2 wild isolates, were observed (Table 3.5). 7 of the 
strain transcendent stevor had syntenic orthologs in IT. 2 of the conserved stevor A 
pseudogenes had orthologs in P. reichenowi.
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Strain transcendent pirs defined as genes with orthologs (at above 90% pairwise identity 
over half the sequence length) in at least three different parasite isolates.
Yellow highlights indicate the centrally located rifs.
The reference gene was used to search fo r  orthologs using BLAST search in Geneious
(version 6.1.5).
s: syntenic orthologs
Y: Ortholog identified in wild isolates
N: No ortholog identified
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3.5. Discussion.
A characteristic feature of Plasmodium parasites is the presence of large multigene 
families that encode VSA. These VSA are thought to play a role in host-parasite 
interactions, specifically immune evasion. In P. falciparum  the major VSA, PfEMPl 
encoded by var genes has been ascribed this role. The var genes are a more recent gene 
family and are only found in Laverania parasites with a homologous family sicavar in P. 
knowlesi. Therefore other genes encoding VS As are probably key in mediating antigenic 
variation o f the IE and may also play a role in cytoadherence. The pir  multigene family 
one o f the largest multigene families found in all Plasmodium species is a likely 
candidate. The P. falciparum pir  gene families, r i f  and stevor encode VSAs that are 
coexpressed with PfEMPl on the surface of IE. Preexisting data on repertoire diversity 
was limited to the WGS data available. With the availability o f more high quality WGS 
data we sought to characterize sequence diversity in the pir  gene families of P. 
falciparum.
Generally rifA and rifB are mainly differentiated by the presence of a 75 nucleotide 
insertion in the rifA but additional key sequence features differ between the two r if  
groups. It was interesting to observe certain genes from rifA clustering with rifB in the N 
terminal tree. The N terminal region contains the insert in rifA and therefore it was 
unexpected to observe mixing of rifA and rifB clusters based on the N terminal region. 
This observation indicates that some rifA and rifB are recombining more freely, and 
generate sequences that share both rifA and rifB features as a means of sequence 
diversification. The high sequence diversity accumulated in the HVR is suggestive of
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immune diversifying selection pressure as well as higher rates of recombination within 
these regions. Although a lot more group mixing was observed in the tree based on HVRs 
it was surprising to see conserved groups maintaining cluster structures in the trees based 
only on the HVR. The r if  subgroups that were structurally maintained in the HVR tree 
included rifBl and rifB2, the Ups A r if  genes rifAl and r if  A3, and the conserved ancient 
rifA2 that always formed a separated cluster from all other r i f  in all trees. These groups 
formed conserved clades in the HVR tree suggesting restricted recombination that occurs 
only within group. On the other hand the diverse rifB3 sequences mixed freely with some 
rifA on the tree. Many rifA groups were reorganized suggesting that there is little 
restriction to recombine among the non-UpsA rifA and rifB3 groups in the HVRs.
Overall, phylogenetic trees obtained from the more conserved N terminal regions or the 
highly variable regions (HVR) had different fine structures from those observed in the 
full-length trees. The larger groups were generally maintained but smaller clades were 
shifted around the tree with certain genes moving from one subgroup to another. This is 
probably due to the different selection pressures that are imposed on the different regions 
of the sequences resulting in different evolutionary rates. For this reason it is difficult to 
obtain a clear picture o f overall diversity in these genes without considering the full- 
length sequences. The limitation of clustering full length sequences is the inability to 
distinguish between the effects o f diversifying selection pressure acting on the 
hypervariable regions and stabilizing selection pressure acting on the conserved and 
probably functional regions of the genes. It is therefore important for future analysis to
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use a two-step approach initially clustering full length genes then clustering the different 
regions separately.
Phylogenetic analysis o f pir  upstream regions in two laboratory isolates revealed 
subgrouping o fpirs that was different from the groupings observed with the coding 
sequences. The ups regions of the conserved r i f  groups rifA l, A2 and A3, were also 
conserved and clustered together. The ups regions o f rifBl and rifB2 were also mostly 
conserved and clustered together. A major limitation of the analysis on pir  upstream 
regions was that it was done for only two laboratory isolates, 3D7 and IT, of which IT 
was missing sequence data because o f incomplete WGS data. (O f the 120 r i f  ups 
sequences retrieved 26 had long stretches of missing sequence data.) For stevor 4 of the 
39 ups sequences retrieved 4 had missing segments and one was truncated. A more 
comprehensive analysis of the pir  upstream regions from laboratory and wild isolates will 
be useful to elucidate sequence clustering based on these regions.
A major limitation with this analysis is the inherent difficulty of clustering hypervariable 
regions or regions filled with sequence mosaics using traditional phylogenetic methods.
In addition, these hypervariable regions may be undergoing recombination with small 
sequence blocks shuffling between sequences resulting in mosaics in the sequences.
These traditional phylogenetic tree construction approaches generally assume lack of 
recombination between sequences and evolution via accumulation o f point mutations. 
Thus functional groupings that may be dependent on smaller blocks o f sequences or 
particular motifs within the HYRs may be lost using multiple alignments and tree
164
building. This limitation is evidenced by the long branches and low statistical support 
seen in the HVR trees (Figure 3.5 and 3.9) The preferred approach using non-alignment 
based network analysis was not possible within the scope of this PhD, but should be 
utilised in future to derive sequence subgroups.
Many r i f  and stevor sequences from 3D7 had orthologs and very closely related sequences 
from patient isolates from Kenya. In addition orthologs of 3D7 r i f  and stevor were more 
readily identified in genomes o f patient isolates from Kenya than from other laboratory 
isolates IT, HB3 and DD2. This was despite the fact that the genomes from wild isolates 
were mostly incomplete with only partial pir  repertoires; therefore many more orthologs 
are likely to be identified once the complete genomes are available. This observation of 
close orthologs is in line with the fact that parental line NF54 from which 3D7 originated 
is from Africa and therefore is more closely related to patient isolates from Kenya than 
from the other laboratory isolates from different parts o f the world.
There are stretches o f conserved chromosomal regions in 3D7 and IT genomes that 
contained conserved pir  genes. The centromeric regions as expected did contain a number 
of r if  and one stevor that made up a conserved group. This group was made up o f both 
coding and pseudogenic sequences. Highly conserved orthologs o f these central pirs were 
identified from other laboratory isolates (DD2 and HB3) and wild isolates as well as the 
related non-human malaria parasite P. reichenowi. Although having common ancestry the 
P. falciparum  and P. reichenowi central r i f  genes appear to have undergone divergent 
evolution after speciation o f the two parasites as could be seen by low sequence identity 
scores (below 90% pairwise identity). One exception is the highly conserved strain-
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transcendent central r if  pseudogene PF3D7_1219200/ PFL0933w with syntenic orthologs 
in IT and P. reichenowi, and also found in patient isolates from different geographical 
locations in Kenya (Kilifi and Kisumu). This r if  pseudogene together with a conserved 
central var (PF3D7_1219300) are located in a highly stable region of chromosome 12 
that is conserved in 3D7, IT and P reichenowi. In chromosome 1 and 5 several conserved 
pirs and a conserved var (PF3D7_0114400 in chromosome 1 and PF3D7_0533100 in 
chromosome 5) were observed. These regions are not centromeric, but are located in 
subtelomeric regions, which are thought to be highly recombinogenic, making the 
conservation even more peculiar. Another curious observation was the syntenic pir  genes 
in two different chromosomes, chromosome 13 of 3D7 and right arm of chromosome 7 in 
IT. These two chromosomes contained the conserved syntenic n /(PF3D 7_l 372600 and 
PFIT_0733200) and stevor pseudogene (PF3D7_1372500 and PFIT 0733100) orthologs. 
Despite the high diversity of pir  genes there appears to be conservation o f repertoires in 
isolates from different geographical locations. For both gene families the subgrouping 
into A and B groups is conserved in all isolates. Recently, analysis o f pir  genes from the 
rodent malaria parasite P. chabaudi cir revealed a similar structure with A and B 
subfamilies. The CIR A family was larger and more diverse and was characterized by an 
insertion with similarities to the RIFIN-A insertion (Lawton et al., 2012). This gene 
structure conservation observed in a distantly related parasite might suggest that the rifA 
and rifB split occurred very early in evolution o f these gene families, and might have 
been due to functional divergence.
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Closely related pirs that are positionally conserved have been observed in P. falciparum  
and P. reichenowi suggesting that there are constraints to maintain sequence homology in 
certain regions of the chromosome. This could be either due to presence of important 
genes for parasite survival that are under stabilizing selection pressure or these regions 
function as homology blocks to facilitate recombination.
Strain transcending r if  and stevor genes have been identified in laboratory and patient 
parasite isolates, and in the related non-human malaria parasite P reichenowi. These 
groups o f pirs might be functionally constrained and more directed experiments might 
help elucidate their role in host parasite interactions.
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CHAPTER 4
4. Analysing r if  and stevor transcription profiles by amplicon cloning and
capillary sequencing.
4.1. Introduction.
There is limited data on r if  and stevor transcription in wild isolates. Studies based on 
laboratory isolates show VSA transcription to occur sequentially in overlapping windows 
during the parasite’s IDC, with var transcription occurring at the early ring stage, 
followed by r if  during the late ring early trophozoite stage, followed by stevor during the 
trophozoite stage (Kyes et al., 2000) (Kaviratne et al., 2002). Using northern blotting, 
Kyes and group showed n/transcription started as var transcription trailed off at about 12 
hours post invasion (hpi) and peaking at 18hpi in the early pigmented trophozoite stage 
(Kyes et al., 2000). Stevor expression was shown to peak in trophozoites (Kaviratne et al., 
2002). More recent studies involving whole transcriptome analysis by RNAseq (Otto et 
al., 2010) and microarrays (Le Roch et al., 2003, Rovira-Graells et al., 2012, Llinas et al., 
2006) have detected r i f  and stevor transcripts in multiple IDC stages. Bachmann and 
group using quantitative real-time PCR reported that there were 2 peaks of the 2TM gene 
family expression in wild and laboratory isolates. In ex vivo parasites var, rif, stevor and 
pfmc2tm  transcripts were detected in early rings. Var transcripts were maintained at high 
level until about 20hpi while 2TM transcription decreased to a minimum at 12-16hpi 
before rising in a second peak at the mid trophozoite stage (24-32hpi) (Bachmann et al., 
2012). They observed the same 2TM gene variants in the two peaks o f expression, the 
ring and trophozoite stages. In the same study wild isolates showed higher levels o f VSA
168
expression than the laboratory isolate 3D7. This chapter will focus on r if  and stevor 
transcript detection across IDC in laboratory and wild isolates by reverse transcriptase 
PCR (RT-PCR), and cloning and sequencing.
4.2. Objectives.
i.) To analyse r if  and stevor expression profiles in wild and laboratory 
isolates in order to identity peak expression points as well as identity dominant 
transcripts.
ii.) Utilize Northern blotting analysis to determine whether transcripts 
detected by RT-PCR were properly spliced.
4.3. Method.
The methods in this chapter have been detailed in Chapter 2 (materials and methods). R if  
and stevor transcription was analysed in P. falciparum  laboratory and wild isolates 
(Table 4.1). Laboratory isolates (3D7 and IT) and culture-adapted Kisumu isolates, 
rosetting clone (SA075R+) and non-rosetting fraction (SA075R-) were thawed from 
frozen glycerolyte stocks and maintained in culture to bulk up IE. RNA was extracted 
from at least lOOul o f RBC pellet per time point o f synchronous cultures at 5% 
parasitemia. Double sorbitol synchronization was carried out before commencing the 
time course experiment. For 3D7 and IT, RNA was extracted at 6 time points, 
corresponding to early ring (ER), late ring (LR), early pigmented trophozoite (ET), mid
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trophozoite (MT), late trophozoite (LT) and schizont (S) stages. For the Kisumu isolate 
SA075 RNA was extracted at 4 time points, ring (R), late ring to early pigmented 
trophozoite (LRET), mid to late trophozoite (T) and schizont (S) (Appendix table 9.5 and 
9.6). For the Kilifi ex vivo isolates the time course experiment was carried out by 
culturing the ex vivo isolates for a single IDC. RNA was extracted at 7 time points (T1 to 
T7) every 10 hours across the IDC and certain time points were selected for expression 
profiling of pir  genes (Appendix table 9.5). For some parasite isolates the sampling 
extended to the next IDC, with last time point (T7) coinciding with the-second-generation 
rings. The time points were selected to represent the developmental stages; ring, late ring/ 
early trophozoite, mid/ late trophozoite and schizont stages, depending on availability o f 
good quality RNA. Genomic DNA (gDNA) was extracted from asynchronous cultures at 
trophozoite stage.
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Table 4.1. Isolates used fo r r if  and stevor expression profiling by cloning and capillary 
sequencing.
Isolate ID Isolates for rif/stevor expression during asexual blood stage growth
cDNAtime 
points analysed ri/sequences
stevor
sequences
307 Laboratory isolates (48hr cycle RNA 
time series)
6 / -
IT 4 / -
SA075c_R+ Culture-adapted Kisumu isolate; 
Rosetting positive (R+) or negative 
(R-)
4 / /
SA075c„R- 4 / /
10594"
Kilifi isolates from non-severe 
malaria (acute/ex vivo 48hr cycle 
RNA time series; M. Mackinnon/M. 
Rono collaboration)
3 / -
10595" 4 / -
10735 N/A / -
10739 4 / /
10761 2 / /
10814 2 / /
#: Isolates fo r  which cDNA was prepared without DNase digestion to remove gDNA 
contamination. For complete parasite metadata in appendix table 9.6 and detailed 
parasite staging in appendix table 9.5.
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RNA harvested at the different time points was treated with DNase to remove any gDNA 
contamination prior to cDNA synthesis. Two cDNA samples were prepared per RNA 
sample, one sample with (RT+) and one without (RT-) the reverse transcriptase. The RT- 
cDNA sample was set up to check for gDNA contamination in the RNA. For two Kilifi 
ex vivo isolates (10594 and 10595) already prepared cDNA without DNase treatment was 
obtained. Reverse transcription PCR (RT-PCR) was done using gene family specific 
primers (Figure 5.2 and Appendix Table 9.7). A complex set of degenerate primers, 3 
forward and 1 reverse (Kyes et al., 1999), were used to sample r if  repertoires and 
transcription, and a set of published forward and reverse primers were used for stevor 
(Lavazec et al., 2006). For each isolate the two cDNA amplicons, RT+ and RT- were run 
in parallel on an Agarose gel, in adjacent wells.
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Table 4.2. r if  and stevor primer sets. A complex set o f  4 primers, 3 forward (rifFl, ri/F2 
and rifF3) and 1 reverse (rifR) were used to generate r if  amplicons. Lavazec L and R 
primers were used to generate stevor amplicons.
Prim er Sequence
rifFl fwd 5’ -  C(AG)T CAC GA(GT) TGT TAA GCG
rifF2 fwd 55 -  CGA (AG) (CT)G TGA ATT GTA TGC
rifF3 fwd 5’ -  C(CT)A C(CT)A G(AG)T TAT TAT GCG
rifR rev 5’ -  CTT CA (AT) ATT (AG)TT (AT)TT T(CT) (GT) (AGT)CG ATA ACG
LavazecJL 5' - CAA AAG GAA GAG ATA AGT AT
L avazecR 5' - GTT TCT TGC ATT CAT GTT TCC
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Prior to cloning r if  and stevor amplicons were purified as described in Chapter 2. For r if  
two approaches were used for purification, total amplicon or gel extraction of specific 
bands. For stevor total amplicon purification using the QIAquick PCR Purification Kit 
was carried out. Cloning and screening o f positive pcr2.1TOPO vectors into pcr2.1TOPO 
was carried out by restriction digestion using ECOR1 as described in Chapter 2.6.5 to 
2 .6 .6 .
Capillary Sanger sequencing of insert-positive vectors was done using M13 forward and 
reverse primers. Sequencing was carried out in-house on the ABI 3130 sequencer. 
Sequence assembly and analysis was carried our as described in Chapter 2. Briefly 
forward and reverse sequence reads were assembled into contigs using CAP3 in BioEdit 
and Geneious pro. Multiple alignments of the contigs were done on Geneious pro using 
MUSCLE. Vector and primer sequences were trimmed off. Contigs that met a 99% 
sequence identity threshold were clustered using CD-HIT. BLAST analysis was run on 
clusters representatives on Geneious pro. Proportions o f clusters per sample were 
analysed for each isolate and expressed as pie charts.
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4.4. Results
4.4.1. R if  and stevor transcripts detection by RT-PCR
R if  and stevor transcripts were sampled by reverse transcriptase PCR (RT-PCR) using 
sets of primers described in the methods and table above and detected by gel 
electrophoresis. R if  and stevor amplicons were detected at all time points across the IDC 
in all parasite isolates (examples Figure 4.1 and 4.2). This contrasts with previous work 
that suggested r if  and stevor transcription occurred within a narrow window (Kaviratne et 
al., 2002, Kyes et ah, 2000). Amplicons of the expected size ranges were observed, 800- 
980 base pairs (bp) for r i f  and 400bp for stevor (Figure 4.1 and 4.2). No amplicon was 
detected in the RT- sample confirming that there was no gDNA contamination in the 
cDNA prep.
A striking observation was the difference in band patterns and intensities for r i f  in 
different time points and in different isolates (Figure 4.1). IT cDNA amplicons appeared 
as a single band (Figure 4.1. A) while 3D7 had 2 distinct bands (Figure 4.1. B). Wild 
isolates had complex banding patterns with up to 3 distinct bands in some stages (Figure
4.1. C and D). The observation o f multiple bands indicates transcription o f multiple rifs at 
a single time point. The upper and lower bands most likely corresponded to transcripts 
from the 2 r i f  subgroups, longer rifA and shorter rifB (discussed in Chapter 3). This 
would suggest that in some isolates members of the two r i f  groups are co-expressed 
during the IDC. gDNA amplicons appeared as a smear on Agarose gel indicating that 
multiple r i f  variants were amplified by our primers.
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850bp
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850bp
SA075R+ SA075R-
Figure 4.1: r if  amplicons detected on 1% agarose gels. Top panel: laboratory isolates IT  
and 3D7 (A and B) amplicons at 6 different time points and gDNA. Lower panel (C) wild 
isolate 10735 amplicons at 7 different time points and gDNA. (D) Culture-adapted wild 
isolates, rosetting clone SA075R+ and non-rosettingfraction SA075R- amplicons at 4 
different time points and gDNA from SA075R+. (+) and (-) indicate samples with (RT+) 
and without (RT-) the reverse transcriptase enzyme. The product size in base pairs (bp) is 
indicated.
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Stevor amplicons of the expected (400bp) were observed across all timepoints. Unlike r if  
a single band was observed in all isolates at all time points and in gDNA (Figure 4.2) 
stevor sequence lenghts are under normal distribution therefore the amplicons are likely 
to be of similar lengths as observed on the gel images. Non-specific bands o f about 200bp 
and 300bp were observed in cDNA in some isolates (Figure 4.2. B and C), while upper 
non-specific bands were detceted in gDNA (Figure 4.2).
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SA075 R+ SA075 R-
10739 10761 10814
Figure 4.2. 1% agarose gel electrophoresis images o f  stevor amplicons in culture- 
adapted and wild isolates. (A) Amplicons from culture adapted isolate SA075; rosetting 
clone R+ (1-4) and non-rosetting uncloned fraction R- (5-8) cDNA and gDNA (gl and g2 
respectively). Lower panel: amplicons from wild isolates 10739, 10761 (B) and 10814 
(C) cDNA at four time points across the IDC and gDNA (C) g3, g4 and g5. The '+ ' or - ’ 
signs indicate samples with and without the reverse transcriptase enzyme respectively.
The product size in base pairs (bp) is indicated.
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4.4.2. Cloning and sequencing r if  and stevor amplicons.
R if  and stevor amplicons were cloned and sequenced as previously described in the 
methods chapter. 1595 r if  and 498 stevor contigs were successfully assembled. These 
were clustered into 537 r i f  and 58 stevor clusters. Sequence searches using BLAST were 
carried out on cluster representatives.
4.4.2.1. r i f  cloning bias.
From an initial analysis of r i f  sequences obtained from cloning total PCR from a wild 
isolate a significant bias towards recovery o f rifB sequences was observed (Figure 4.3). 
On average r i f  A are longer thar rifB, 1227 and 1115 basepairs (bp) for rifA and rifB 
respectively from 3D7 genome (see Chapter 3 section 3.3). It is therefore likely that the 
shorter rifB amplicons were preferentially cloned into the TOPO.
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Figure 4.3. Proportions ofrif'A and rifB recovered in cDNA (top panel) and gDNA 
(bottom panel) from cultured and wild isolates by r if  amplicon cloning and sequencing. 
Significant bias towards recovering rifB sequences (red) in gDNA fo r all isolates and in 
cDNA o f  wild isolates was observed. rifA (blue) was predominantly recovered in cDNA 
from laboratory isolates.
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To further explore the extent of this bias comparison was made between cloning total 
amplicon and cloning gel extracted upper and lower bands separately (see Figure 4.1. B,
C and D). Total amplicon as well as gel extracted upper and lower bands from 3D7 
(Figure 4.1. B lane 5+) and 10735 (Figure 4.1. C lane 4+) trophozoites were cloned and 
sequenced. These two samples were selected on the basis that the upper and lower bands 
appeared to be of similar intensities (Figure 4.1. B and C). Length analysis gave some 
indication that there might be a bias was towards shorter sequences when total amplicon 
was cloned (Table 4.3). In 3D7 the average length o f r if  sequences from total amplicon 
cloning was 865bp as compared to 896bp in the upper band, and in the wild isolate 891 bp 
and 909bp from total amplicon and upper band respectively. On average mostly ri/A 
sequences were rcovered from cloning the upper band and total PCR product, while the 
lower band gave mostly rifB sequences (Table 4.3).
Table 4.3 summary o f  the lenght and type o f  r i f  recovered from cloning total amplicon 
versus seperately cloning gel extracted upper and lower bands.
3D7 late trophozoites 10735 early trophozoites
Upper band Lower band Total Upper band Lower band Total
Total r if 896bp (15) 823 (15) 865 (15) 909(16) 830(18) 891 (17)
rifA 912(12) 814(6) 865 (15) 924(14) 820(13) 897 (14)
rifB 832 (3) 830 (9) 0 833 (2) 850 (5) 961 (3)
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Although the results above suggested cloning bias the analysis is based on sequences 
obtained from cDNA and may be confounded by expression bias. Analysis based on 
sequences from gDNA sequences was not possible as bands from gDNA did not separate 
well on the gel and appeared as a smear (Table 4.4).
To confirm that indeed shorter rifs were preferentially recovered from cloning total 
amplicon, a comparison of lengths was done between r i f  recovered by cloning total 3D7 
gDNA amplicons and the expected length o f r i f  amplicon in 3D7 genome. We observed a 
bias towards recovery o f shorter r i f  when total amplicon was cloned than would be 
expected (Table 4.4). We observed no specific bias towards recovering A or B type r i f  
To overcome the length bias during cloning we gel purified the upper and lower bands 
separately in subsequent cloning and sequencing experiments.
Table 4.4. Table comparing sequence lengths o f  total riffrom 3D7 genome, expected r if  
amplicons based on primer coverage and observed coverage from  3D7 gDNA cloned 
amplicon.
No. of sequences mean length shortest longest
Total r if 184 847.3 645 968
r if  amplicon # expected 163 844.5 728 953
r if  amplicon® observed 35 829.2 742 939
#: expected r i f  coverage by the complex set o f  rifprimers obtained by running primer test 
(Primer3 application on Geneious Pro).
@: r i f  sequences obtained from cloning total 3D7 gDNA amplicon
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4.4.3. Primer coverage from cloning and capillary sequencing data.
r if  primer coverage was determined by computing the number of unique sequences 
obtained from cloning and sequencing rz/’amplicons from 3D7 gDNA. Stevor primer 
coverage was analysed from SA075 gDNA amplicons. The expected coverage was based 
on the 3D7 genome repertoire o f 184 r i f  copies and 40 stevor copies. For the r if  primers, 
the expected coverage was 17% due to the limited number o f clones analysed (35 clones). 
To obtain 80% coverage analysis of at least 400 clones from gDNA per experiment was 
required, but this was not feasible at the time. Despite limited sampling the there was no 
significant difference between expected and observed coverage for rifB (Figure 4.4). 
There was a large difference between expected and observed rifA mainly because very 
few rifA were recovered from cloning and sequencing total gDNA amplicon (Figure 4.4). 
It was therefore difficult to establish primer bias for rifA. For stevor primers (Lavazec, 
2006) the expected coverage in 61 clones sequenced (78%) was much greater than the 
observed, (38%) pointing to primer bias (Figure 4.4).
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Figure 4.4. Primer coverage for rif/stevor expression analysis by cloning and sequencing 
3D7 gDNA (rif) and SA075 gDNA (stevor). Blue bars: expected coverage (%), red bars: 
observed coverage (%>).
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4.4.4. R if  transcription profiling in laboratory isolates.
There was high diversity of n/transcripts expressed throughout the intra-erythrocytic 
developmental cycle (IDC) in both the field and laboratory isolates. In 3D7 there were 
different dominant transcripts at rings, trophozoites and schizonts (Figure 4.5 and Table 
4.5). In rings the dominant rz/PF3D7_1300400 (PF13_0004) belongs to the conserved 
UpsA r i f  group that are in a head-to-head orientation with UpsA var genes. There was a 
switch to different r i f  transcripts at the middle stages, with a single dominant r i f  
PF3D7 0425900 (PFD1240w) at the early pigmented trophozoite stage, the stage o f peak 
r if  expression. At the schizont stage there was a switch to different n /PF3D 7_l 000300 
(PF10_0003) and PF3D7 1373400 (MAL13P1.535) but the number o f sequences 
recovered was too small to confidently identify dominant transcripts. Two minor 
transcripts were over represented in gDNA suggesting some level o f bias to certain 
variants.
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Figure 4.5. 3D7 r if  genomic repertoire from 35 sequences (G), and transcription (cDNA) 
profile across IDC; early ring (ER), late ring (LT), early trophozoite (ET), mid 
trophozoite (MT), late trophozoite (LT) and schizont (S). Coloured regions o f  the cDNA 
pies represent sequences that were recovered more than once from cDNA while in the 
genomic pie coloured regions represent sequences that came up at least once in cDNA. 
Numbered regions represent the dominant transcripts in the specific stage (sequence 
labels in Table 4.5).
Table 4.5. Dominant r if  transcripts in 3D7 cDNA.
Label C lu ster I D
Frequency % (p rop ortion )  
at peak exp ression  point
Peak  expression  point
A /B B L A ST  top hit
1 50%  (6/12) Early ring A PF13 0004
2 RIF K038* 17% (2/12) Late ring A P F D I020c |p s
3 RIF K048 17% (2 /12) and 29%  (2/7) Late ring  and schizont A M A L 13P I.535
4 RIF K 065 17% (2/12) and 9%  (2 /23) Late ring  and early  trophozoite A P FA 0760w
5 RIF K084 17%  (2/12) Late ring A PF3D 7 0701100
6 RIF K O I5 39%  (9 /23) Early trophozoite A P FD 1240w
7 R I F  K099 13% (3 /23) Early trophozoite A PFI1825w
8 RIF K079 13% (2/15) M id trophozo ite B PF14 0003
9 RIF K I0 3 13%  (2/15) M id trophozo ite B PF14 0770
10 RIF K022 23%  (10/45) Late trophozoite B P F 1 3 0 0 0 6
11 RIF K034 25%  (11/45) Late trophozo ite A PFL 0025c
12 RIF K151 29%  (2/7) S chizont B PF10 0003
*/ | ps: pseudo gene.
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^//transcription profiles were analysed for four time points across the IDC in IT and at 
an additional 2 time points in a biological replicate that was passaged in culture for over 
40 cycles (ITp). IT showed much more focused r i f  expression profile with a single 
dominant transcript at the later stages (Figure 4.6. A). PFIT_bin02300 (1), PFIT_0835500 
(2) and PFIT0424300 (3) were the dominant ring transcripts with PFIT_0835500 
dominating trophozoite and schizont stages. IT n/PFIT_0835500, PFIT_bin02300 and 
PFIT_0734200 are 99% identical to r if  that were previously identified in Palo Alto by 
Kyes and group (Kyes et al., 1999). PFIT0835500 is identical to rifl that was expressed 
in Palo Alto clones in both the rosetting and non-rosetting fractions, PAR+ and PAR- 
respectively while PFIT_0734200 and PFIT_bin02300 are identical to rif2 and rif3 
respectively expressed in the non-rosetting fraction PAR-. None o f the transcribed r if  
were recovered from gDNA (Figure 4.6. A. G) but this could be due to under sampling 
the genomic repertoire (only 24 sequences were recovered from cloning and sequencing 
IT gDNA amplicon). A different set o f r i f  emerged in IT after continuous passage in 
culture (Figure 4.6. B). This could have been caused by slight modification in the reverse 
primer used to amplify r i f  from the passaged IT (see discussion below). The reverse 
primer was modified to make it more degenerate, and therefore able to capture more rifs. 
A pseudogenic transcript PFIT_0536700 (5) was predominantly recovered in ITp rings 
and trophozoites. This pseudogene is closely related to a conserved 3D7 pseudogene 
(PF3D7_0533000/PFE1635w) that lies tail-to-head with the varlcsa  pseudogene 
(PF3D7_0533100) on the chromosome. The n/PFIT_0424300 (3) was recovered in rings 
and trophozoites o f both IT and ITp while PFIT_0900150 (4) was mainly found in 
trophozoites.
187
BMR
V
* 5
ET MT
/ >
Figure 4.6. r if  genomic repertoire from 24 sequences (G) and transcription fcDNA) 
profile in (A) Original IT line at 4 IDC stages; mid ring (MR), early trophozoite (ET), 
mid trophozoite (MT) and schizont (S), and in (B) ITp passaged continuously in culture 
fo r  2 months. Coloured regions o f  the cDNA pies represent sequences that were 
recovered more than once from cDNA while in the genomic pie coloured regions 
represent sequences that came up at least once in cDNA. Numbered regions represent the 
dominant transcripts in the specific stage (sequence labels in Table 4.6).
Table 4.6. Dominant r if  transcripts in IT  cDNA.
Label Cluster ID
Frequency % (proportion) at peak 
expression point
Peak expression point A/B BLAST top hit
1 RIF K021 40%  (10/25) Ringu A PFIT_bin02300
2 R IF K 0 0 4 89% (8/9), 68%  (13/19) and 80% (8/10) Late ring to Schizont" A PFIT_0835500
3 RIF K050 31% (11/35) Ring1’ A PFIT 0424300
4 RJt 21% (4/19) and 24% (11/45) Trophozoites “ a n d 1 A PFIT 0900150
5 RIF K.532 43% ( 15/35) and 40% (18/45) Ring1’ and trophozoite1’ A PFIT0536700*
a: Original IT
ft: ITp after 2 months o f  continuous passage in culture. 
* • pseudogene
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4.4.5. R if  transcription profiling in wild isolates.
There was high diversity of rz/transcripts in wild isolates across the IDC with little 
sharing between isolates (4.7). It was not possible to determine dominant transcripts in 
some time points. A few conserved transcripts were commonly expressed in wild isolates. 
A conserved rifB RJF_K006 (1) was expressed in 4 of the 6 Kilifi isolates and recovered 
from gDNA in the Kisumu isolate. This gene is 96% identical to 3D7 PFE1630w, one of 
the conserved r i f  with orthologs identified in HB3, DD2 and a Brazilian field isolate 
(Claessens et al., 2011). Another rifB RIF K037 was expressed in 2 Kilifi isolates at the 
trophozoite stage and found in the genomic DNA of the same 2 Kilifi isolates and in 3D7. 
This r i f  is related to 3D7 rz/PFF1570w/PF3D7_0632300 (94% identity). A conserved 
rifB pseudogene RIF K014 (2) was recovered from 10594 rings and schizonts and 10814 
gDNA. This pseudogene is highly conserved with 100% identity to a 3D7 pseudogene 
PFE0015c/PF3D7_0500300. A late stage rifB RIF_K025 (4) dominated expression in 
10595 schizonts and 10793 trophozoites. This r i f  is closely related to a Brazilian r if  
DQ265287 and a 3D7 rz/PFD0045c.
In one isolate 10761 a single rifA RIF K011 (10) dominated ring and schizont 
transcription. This rif, PFL2585c is strain transcendent (Claessens et al., 2011). In a 
previous study PFL2585c was upregulated in clinical isolates as compared to laboratory 
isolates (Lemieux et al., 2009). In this isolate different sets o f transcripts were expressed 
in the mid stages o f the IDC (Figure 4.7 panel 5). In the isolate 10814 a clearer pattern of 
stage-specific rz/transcription emerged. This was probably because o f better sampling 
depth. Different r i f  transcripts were upregulated in the different IDC stages (Figure 4.7
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panel 6). Two rifA dominated at the ring stage, a different rifA came up in the ring to 
trophozoite transition stage, a rifB dominated in trophozoites and a second rifB in 
schizonts.
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Figure 4.7. r if  genomic repertoire (G) from 43, 44, 44, 26, 47 and 96 sequences from 
10594, 10595, 10735, 10739, 10761 and 10814 respectively, and transcription (cDNA) 
profile at 4 IDC stages; ring (R), late ring- early trophozoite (LR-ET), trophozoite (T) 
and schizont (S), in wild isolates. The coloured regions represent sequences that were 
recovered more than once in cDNA. Numbered regions represent the dominant 
transcripts and the time points or gDNA from which they were recovered. (Sequence 
labels and frequencies in Table 4.7).
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Table 4 .7. Dominant r if  transcripts in wild isolates.
Label Cluster II)
Frequency % (proportion) at 
peak expression point
Peak expression time point A/B BLAST top hit
1 RIF K006 23% (3/13) R ing1 B PFEI630w
2 RIF K 0I4 54% (7/13) Schizont1 Bps PFE0015c|ps
3 M F  K M 9 15% (4/26) Trophozoite1 B PFB 1005w
4 RIF K025 40%  (6/15) Schizont2 B PFD0045C
5 RIF KOI9 16% (4/25) Ring'' B PFF1570w
6 RIF K049 16% (4/25) Ring" A PFI0030cb
7 RIF K030 20%  (4/16) Ring4 B PFC0030c
8 RIF K070 24%  (4/17) Trophozoite4 A M AL13P1,535b
9 RIF K057 18% (3/17) Trophozoite4 A PFB0015c
10 RIF K011 85% (11/13) 31%  and (8/26) Ring5 and schizont" A PFL2585C
11 RIF K069 21%  (3/14) L.ate ring/ early trophozoite5 A PFD1240wb
12 RIF K126 14% (2/13) Late ring/ early trophozoite5 A PF10010cb
13 RIF K043 22%  (4/17) Trophozoite" B PF10 0397
14 RIF K032 18% (3/17) Trophozoite" B PFF0045c|ps
15 R IF K 0 1 6 30% (12/40) Ring" A PF11 0021b
16 RIF KOI8 25% (10/40) Ring" A PI7L2625wb
17 RIF K058 22% (4/18) Late ring/ early trophozoite6 A PFB 1035 w
18 RIF K009 47%  (9/19) Trophozoite6 B PFB0055cb
19 RIF K027 26%  (5/19) Trophozoite6 A PFA0760vvb
20 RIF K013 28%  (11/40) Schizont6 B PFC0030cb
1: 10594, 2: 10595, 3: 10735, 4: 10739, 5: 10761, 6: 10814
h: Top BLAST with low sequence similarity.
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4.4.6. R if  transcription profiling in a rosetting laboratory-adapted Kisumu 
isolate.
Results from r if  and stevor expression analysis in the rosetting wild isolate SA075 
revealed differential expression of r if  and stevor in the rosetting clone and the non- 
rosetting fraction. At ring and schizont stage both parasites shared some r if  and stevor 
transcripts but at late ring and trophozoite stages we observed different dominant 
transcripts in the rosetting and non-rosetting parasites (Figure 4.8).
A single rifA RIF_K001 (1) clearly dominated ring and schizont transcription in both R+ 
and R- lines (Figure 4.8. A). In the R+ clone two dominant transcripts emerged in the 
trophozoites a rifA RIF K003 (3) and a rifB RIF_K005 (4). The rifA has no closely 
related ortholog but shares a small region o f homology with MAL7P1.217 and a 
Brazilian rz/rDQ265279. The dominant trophozoite rifB is a conserved r i f  with orthologs 
in 3D7 (92% in 758/818bp), HB3 (93% in 762/818bp) and a Kilifi isolate 10595 (99% in 
814/821bp). In our 3D7 line this r i f  was expressed predominantly in late trophozoites 
(Figure 4.5 and Table 4.5).
A stevor pseudogene STE K 002 (1) was predominantly transcribed in rings and 
schizonts in both rosetting and non-rosetting parasites (Figure 4.8). This stevor was 98% 
identical to 3D7 stevor pseudogene PF3D7_0102100 In the R+ trophozoites a major 
stevor transcript STE_K003 (2) was detected. This stevor has closely related orthologs in 
3D7 PFF1550w and IT PFIT_0100600 (97% pairwise identity over 356/367bp). A 
pseudogene STE_K005 (3) was predominantly transcribed in the late ring/ early 
trophozoites and trophozoites. This pseudogene has no orthologs but is closely related to
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a stevor from a Kilifi isolate. A transcript S T E K 0 0 5  (4) orthologous to PFL2635w a 
3D7 stevor was detected at high levels in the late ring/ early trophozoite stage.
Figure 4.8. pie charts showing genomic repertoires (G) o f  r i f  (A) and stevor (B) and 
expression profiles in a culture-adapted highly rosetting wild isolate across the IDC (R: 
rings, LRJET: Late ring to early trophozoites, T: mid to late trophozoites and S: 
schizonts) in (R+) SA075 rosetting clone and (R-) non-rosetting fraction. For r if  the 
genomic repertoires are based on 56 sequences (R+) and 50 sequences (R-) while fo r  
stevor 11 sequences (R+) and 12 sequences (R-■). *: pseudogene.
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Table 4.8. Dominant r if  and stevor transcripts in a culture-adapted wild SA075.
Gene Label Cluster ID
Frequency % (proportion) at peak 
expression point
Peak expression point A/B BLAST top hit
rif 1 RIFJCOOl
54% (19/35), 33% (14/43), 63% 
(26/41), 76% (31/42)
R+ and R- Ring and schizont A MAL.I3P 1.500
rif 2 RIF K0I2 22% (12/55) R+ late ring/early trophozoite A PF3D7 0700200
rif 3 Rtf K003 44% (18/41) R+ trophozoite A MAL7P1.2171’
rif 4 \ RIF K005 39% (16/41) R+ trophozoite B PFIO 0006
r f 5 RIF K007 22% (9/42) and 20% (8/42) R- ring and schizont A PF08 0138
n f 6 RIF K.QQ2 34% (22/66) and 38% (24/42) R- Late ring to trophozoite B PFB1005w
r f 7 RIF K010 20% (13/55) R- late ring/early trophozoite A RIF K123
stevor I STEK002
86% (19/22), 67% (8/12), 71% 
(12/17) and 88% (15/17)
R+ and R- ring and schizont na PFA0105vv
stevor 2 89% (17/19) and 92% (23/25) R+ Late ring to trophozoites na PFF1550w
stevor 3 STE K006 42% (11/25) R- Trophozoite na PF8443 8 3 U4466001’
stevor 4 STE K005 27% (7/19) R- Late ring/early trophozoites na PFL2635w
h: Top BLAST with low sequence similarity, 306/342 identical sites with 89% pairwise 
identity for the r if  gene RIFK003,  and 302/380 identical sites with 79% pairwise identity 
for the stevor gene STE_K006.
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4.4.7. Stevor transcription in wild isolates.
Analysis of stevor sequences from wild isolates revealed a conserved and commonly 
expressed stevor pseudogene STE_K001 (1) that was recovered from all 3 Kilifi isolates 
at high frequency (Figure 4.9 and Table 4.9). The pseudogene was predominantly 
expressed in ring and schizont stages but was detected in late rings/ early trophozoites 
and in mature trophozoites. This stevor was 99% identical to a 3D7 stevor pseudogene 
PFA0105w (PF3D7 0102100); with two inframe stop codons occurring at the same 
location in the sequences from wild isolates and 3D7.
A second dominantly expressed stevor pseudogene STE_K015 (3) was detected at the 
ring to trophozoite transition stage in 10739. This stevor is closely related to an IT 
pseudogene PFIT 0100600 (98.5% identity across 837/850 nucleotides).
Other minor transcripts were detected at low frequency across the different isolates at 
different IDC stages. There was a significant primer bias for stevor, which can be seen in 
the gDNA pies (Figure 4.9. G).
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Figure 4.9. stevor genomic repertoire (G) from 20, 42 and 40 stevor sequences from 
10739, 10761 and 10814 respectively, and, transcription (cDNA) profiles at 4 IDC 
stages; ring (R), late ring- early trophozoite (LR-ET), trophozoite (T) and schizont (S), in 
10739 and 10814, and 3 stages in 10761. *: Pseudogene.
Table 4.9. Dominant stevor transcripts in wild Kilifi isolates.
Label Cluster ID
Frequency % (proportion) 
at peak expression point
Peak expression point BLAST top hit
1 STE K001 64%  (9/14) to 90%  (18/20) Ring and schizont 1.2.3 PF3D7 0 102100|ps
2 STE K004 14% (2/14) and 18% (3/17) Ring and schizont 1 PF3D7 0400800
3 STE KOI5 75% (6/8) Late ring/ early trophozoite 1 PFIT 0100600|ps
4 STE K009 31%  (4/13) Trophozoite 1 PFIT bin00600
5 STE KOI 2 20%  (4/21) Late ring/ early trophozoite2 PFD0035c
6 STE KOI4 15% (4/21) Late ring/ early trophozoite2 PFIT 1100300
7 STE K021 20%  (3/15) Trophozoite2 PFIT bin05300b
8 STE K023 25%  (3/12) Late ring/ early trophozoite3 PFIT 0800600
9 STE K013 17% (2/12) Late ring/ early trophozoite3 PF3D7 1254300
h: Top BLAST with low sequence similarity (192/216 (88%) 
ps: pseudogene
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4.4.8. Diversity of r if  transcripts obtained from capillary sequencing.
The Simpson diversity index is a measure of homogeneity where a high SDI corresponds 
to more homogenous transcription. An analysis of the diversity of 77/transcripts was 
carried out to determine whether the laboratory parasite isolates exhibited decreased 
transcription diversity than wild isolates due to the absence o f immune selection pressure 
in culture. There was no significant difference in r if  transcription diversity between 
laboratory and wild isolates, but this could be due to our low sampling depths as well as 
primer and cloning biases. IT and SA075 non-rosetting fraction showed the least diversity 
(0.284 and 0.289 respectively) while field isolates 10595 and 10735 showed the most 
diversity (0.030 and 0.031 respectively) with 3D7 showing moderate diversity (Figure
4.10). Interestingly rosette selected isolates IT, SA075 R- and SA075 R+ expressed 
markedly less diverse sets o f rz/transcripts. The IT clone used in our study obtained from 
the Sanger Institute had been put through rosette selection. Similarly the SA075 R+ was 
constantly kept under rosette selection. The R- fraction was however not put through 
negative rosette selection process, suggesting that the observed reduction in diversity was 
due to selection o f a sub population o f parasites that predominantly expressed a few 
subsets of r i f  genes. Overall most isolates showed higher diversity in r i f  recovered from 
gDNA as compared to cDNA, indicating overall good primer coverage. In one isolate 
10735 there was higher transcript diversity than the recovered gDNA repertoire (Figure
4.10). This was probably due to under-sampling o f the genomic repertoire (44 clones 
analysed for gDNA amplicon vs. 123 clones analysed for cDNA).
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Figure 4.10. r if  transcript and genomic diversity from cloning and sequencing amplicons 
from cDNA (blue circles) and gDNA (red squares).
4.4.9. Determining clone composition of Kilifi isolates using merozoites 
surface antigens 1 and 2 (MSP1 and MSP2).
Many isolates sampled from P. falciparum  natural infections are composed o f  multiple 
distinct parasite clones. This multiplicity o f  clones in wild isolates could in part explain 
the higher diversity of transcripts observed in wild isolates as compared to laboratory 
isolates. To determine clonal composition o f isolates MSP1 and MSP2 genotyping by 
capillary electrophoresis was carried out as described earlier (Liljander, 2009). As 
expected, the wild isolates were composed o f  multiple genotypes while the laboratory 
isolates had single clones each (Table 4.10). The number o f  clones in an isolate however 
did not completely explain the difference in the diversity o f  rz/transcripts observed. (In 
this case high transcript diversity was defined by low SDI) (Table 4.10 and Figure 4.11). 
For instance two wild isolates 10595 and 10735 with different clonal diversity (4 and 2 
respectively) showed similar SDI, 0.030 and 0.031 respectively. The laboratory line
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composed o f single clones showed moderate (3D7) and low heterogeneity (IT) in r if  
transcription (SDI of 0.56). This indicated that other factors besides clonal diversity may 
play a role in regulating rz/transcription diversity.
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Table 4.10. Number o f  clones in isolates by MSP 2 genotyping using capillary 
electrophoresis
Label Isolate No. o f  c lo n es  by MSP2 g e n o ty p in g Diversity
(SDI)FC27 1C Total
1 3D7 0 1 1 0.056
2 IT 0 1 1 0.285
3 SA075c_R+ 0 2 2 0.130
4 SA075c_R- 0 2 2 0.289
5 10594 1 2 3 0.074
6 10595 3 1 4 0.030
7 10735 0 2 2 0.031
8 10739 4 0 4 0.034
9 10761 1 1 2 0.102
10 10814 1 1 2 0.057
SDI: Simpson's diversity index.
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0.200
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Figure 4.11. Comparing number o f  clones and r if  transcript diversity across isolates 1: 
3D7, 2: IT, 3:SA075R+, 4:SA075R~, 5:10594, 6:10595, 7:10735, 8:10739, 9:10761 and 
10:10814. Bar graph shows the number o f  clones by MSP 1 genotyping (axis on the left) 
while the line graph shows the SDI o f  each isolate (axis on the right). High SDI 
corresponds to high homogeneity in transcription.
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4.5. Analysis of r if  transcription by northern blotting.
The excessive diversity of /^/transcript detected by the highly sensitive RT-PCR raised 
the question as to whether all the transcripts detected were full length and correctly 
spliced, between 1.8-2.1 kb range (Kyes et al., 2000). For this reason Northern blotting of 
RNA from laboratory isolates was carried out. A non-radioactive technique based on 
digoxygenin (DIG) labelling was applied because o f the regulation against the use of 
radioactive isotopes in our laboratory.
RNA probes were gerenated by in vitro transcription using T7 RNA polymerase. RNA 
probes were preferred over DNA probes as they are better in detecting rare mRNA 
species in total RNA. RNA probes were generated by amplifying r i f  MSP1, varC (var 
exon 2) and calmodulin genes using gene specific primers (Kyes et ah, 2000), modified to 
include a T7 RNA polymerase sequence for in vitro transcription (Methods chapter 
section 2.10). MSP1 and var probes were included to analyse stage-specific gene 
expression while calmodulin, a constitutively expressed gene was include to control for 
RNA amounts across the different parasites and IDC stages. In vitro transcription by T7 
RNA polymerase was carried out using the DIG RNA Labelling Kit (SP6/T7) (Roche). 
Two sets o f probes were generated, sense probes to detect antisense mRNA and antisense 
probes to detect sense mRNA, althoguh for the experiment only the anitsense probes 
were used. For sense probes the T7 RNA polymerase sequence was added to the fro ward 
primers while for the antisense probes the polyemares sequence was added to the reverse 
primers. Amplicons for probe transcription were generated from IT gDNA (Figure 4.12. 
A). Additional probes for r if  and calmodulin were generated from cDNA from IT and
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Kilifi isolates. For r if  cDNA amplicons were used to improve sesnitivity as only a small 
subset of r if  are transcribed from the genomic repertiore. For calmodulin the transcript 
was much shorter than the genomic sequence (450bp and 982bp respectively) and 
therefore the shorter cDNA amplicon would be better labelled than the longer gDNA 
amplicon (Figure 4.12. A). Good labelling efficiency was obtained with intensities 
similar to those of the DIG-labelled RNA control included in the labelling kit (Figure 
4.12. B).
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Figure 4.12: A: PCR products for probe generation. R if MSP1, var and calmodulin 
amplicons generated with primers containing T7 RNA polymerase sequence on the 
forward primer for sense (s) probes or the reverse primer for the antisense (a) probes. 
For r if  and calmodulin (CAM) probes were generated from gDNA (g) and cDNA (c) 
amplicons. For r if  a control PCR without the T7 promoter sequence in the primers (-T7) 
was carried out. B: Determination o f  labelling efficiency. Spot blots o f  dilutions ofDIG- 
labeled probes, MSP1, r if  (from gDNA), var and calmodulin (from gDNA) and the DIG- 
labeled RNA control. Only the first two dilutions o f  probes and control were detectable 
after 1200 seconds o f  exposure.
MSP1 var CAM
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lug of total RNA was resolved on a 0.8% agarose gel (Figure 4.13. A) and successfully 
transferred to a nylon membrane, as shown by the DIG-labelled RNA marker (Figure 
4.13 B and C). The 2.1 kb 18S and 4.1 kb 2.8S rRNA were clearly visible in the agarose 
gel (Figure 4.13. A) implying that RNA was intact with little degradation detected. When 
the DIG-labelled complex r i f  probe from IT gDNA was hybridized to the blot no signal 
was detected even after prolonged exposure upto one hour. A low intensity signal o f the 
18S and 28S rRNA was detected with the r i f  probe (Figure 4.13. B). No signal was 
detected when the blot was stripped and reprobed with the MSP1 (Figure 4.13. C). In 
addition the signal from the RNA ladder was much weaker suggesting that signal 
intensity was significantly reduced by stripping (Figure 4.13. C).
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Figure 4.13: Images o f  RNA lug o f  3D7 and IT  RNA from 6 time points o f  the IDC and 
an additional pooled RNA sample from IT (IT*) on a 0.8% agarose gel (A) and northern 
blots o f  the same RNA transferred onto a nylon membrane and probed with DIG-labbeled 
r if  (B) and MSP1 (C) probes. L: single stranded RNA ladder (NEB). L 1: DIG-labbeled 
RNA marker I  (Roche). *: non-specific 18s and 28s rRNA signale detected with r if  probe.
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Failure to detect r i f  or MSP1 transcripts in the initial blot could have been as a results of 
low mRNA levels in the total RNA. To remedy this, two concentrations of total RNA 
from IT, a high concentration (5ug) and a low concentration (lug) were assayed. The two 
high and low concentration RNA samples were loaded in quadruplicates together with the 
RNA ladders (Figure 4.14. A) to enable parrallel probing with the four different probes, 
complex r i f  var, MSP1 and calmodulin without the need for stripping and reprobing. In 
addition, the parallel blots would reveal whether all probes gave the 18S and 28S non­
specific rRNA signal.
A 6kb MSP1 mRNA signal was clearly detected in the 5ug RNA sample even after 5 
minutes exposure. After 20 minutes exposure the signal from the lug RNA sample was 
visible (Figure 4.14. B MSP1 lane). A 1.3kb calmodulin mRNA band was decteted after 
1 hour long exposure (Figure 4.14. C) thus the resulting image had excessive background 
signal. No signal was detected with r if  and var probes even after prolonged exposure 
(Figure 4.14. B). The probes did label the amplicons that were used to generate them 
except the var PCR product (Figure 4.14. B). All probes labelled the 2.1 kb and 4.1 kb 
non-specific rRNA even in the low concentration (lug) RNA sample suggesting that the 
signal was not probe specific.
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Figure 4.14: Northern blotting o f  total IT  RNA from 6 pooled timepoints o f  the IDC. (A) 
0.8% ethidium bromide stained agarose gel with dug (5) and lug  (1) o f  RNA, and 2ul o f  
PCR product used to generate the four probes, rif(R), var (V), MSP1 (M) and calmodulin 
(C). (B) Blot o f  the RNA transferred onto a nylon membrane short exposure (20 
minutes). The membrane was cut into 4 strips on the single stranded RNA ladder (L) lane 
and each strip probed with one o f  the four DIG-labelled probes. The asterisks (*) in 
figure B point to the MSP 1 mRNA signal detected using the MSP 1 probe in the high and 
low RNA concentrations. (C) A strip o f  the blot probed with calmodulin probe after long 
exposure (1 hour). The asterisks (*) in figure C point to a diffused signal from 
calmodulin mRNA. L: single stranded RNA ladder (NEB). L 1: DIG-labbeled RNA marker 
I  (Roche).
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To rule out that the I 8s and 28s rRNA band was as a result o f  non-specific binding o f 
anti-DIG AP conjugate antibody to rRNA, a fresh blot was incubated with antibody 
before probibg with any o f the four probes. No rRNA signal was detected in the 6ug, 4ug 
and 2ug o f total RNA lanes (Figure 4.15). When the MSP1 probe was hybridised 
transcript was detected even in the 2ug RNA sample (Figure 4.15). No signal was 
detecetd with the r i f  and var probes even at high total RNA concentrations (Figure 4.14). 
Increasing probe concentraion, varying the amount o f  probe and antiDIG antobody, and 
exposure time had no effect on rif and var blotting results.
a-DIG MSP1
L 6 4 2 L 6 4 2
6 .9 kb
4 .7 k b
2 .7 kb
1 .8kb
Figure 4.15: Northern blotting o f  total RNA from pooled IT timepoints at 3 different 
concentrations 6ug (6), 4ug (4) and 2ug (2). In the first lane no probe was hybridiese to 
check specificity o f  the anti-DIG antibody. The second, third and fourth lanes is the blot 
sequentially probed with MSP I, r if  and var respectively without stripping. L: DIG- 
labbeled RNA marker I (Roche).
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The r if  multigene family is highly diverse and probes generated from gDNA amplicons 
might not be specific enough to detect transcripts. To make the assay more specific r i f  
complex probes were generated from cDNA instead of gDNA. cDNA probes were 
generated from RNA from asynchronous cultures containing mixed stages for IT and 3 
culture-adapted Kilifl patient isolates, 10668, 9106 and 8383. 5ug o f the same RNA 
sample used to generate cDNA for the probes was resolved on a 1.5% agarose gel and 
transferred to a nylon membrane. The specific probes were hybridised sequentially 
starting with the IT cDNA probe, then followed with the wild isolates probes 10668, 9106 
and 8383. Using the specific probes, a band slighlty under 2kb, corresponding to r i f  
transcript was detected in homologous RNA (figure 4.16). For IT an intense band was 
observed just below the 18s rRNA band (Figure 4.16. A). For 10668 a faint band was 
detected just below the 18s rRNA band (Figure 4.16. B, lane 2). The faint band was 
masked by the rRNA band and was only clearly visible after a long exposure (Figure 
4.16. B (II) lane 2). No n/transcript signal was detected in 9106 and 8383 using 
homologous cDNA probes (Figure 4.16. C and D), but this was probably due to masking 
by the rRNA signal. Non-specific bands were observed below the 28s rRNA band at 
about 3kb and 2.7kb and below the n /b an d  at about 1.5kb, especially after probing with 
10668 cDNA probe.
210
AD
4 . 7 k b  — >
2 .7 k b  _ >  
rif — >
B  4 .7 k b
4 .7 k b
2 .7 k b
1 .8kb
I II
1 2 3 4  1 2 3 4
2 .7 k b  — > 
rif — ->
4 .7k b
2 .7 k b
1.8kb
i
, IT rif probe
10668 rif probe
9106 rif probe
8383 rif probe
Figure 4 .16: Northern blots o f  5ug total RNA from pooled timepoints from IT (1), 10668 
(2), 8383 (3) and 9106 (4) hybridised with probes generated from IT  (A), 10668 (B), 9106 
(C) and 8383 (D) rifRT-PCR products sequentially, after 20 minutes exposure (A) and 60 
minutes exposure (B). Red arrow points to the ~~2kb r if  band in IT RNA (lane 1) o f  the 
blot probed with r if  IT  cDNA probe (A) and in 10668 RNA (lane 2) probed with 10668 r if  
cDNA probe (B). No clear signal was detected fo r 9106 and 8383 using homologous 
cDNA probes. L: DIG-labbeled RNA marker I  (Roche).
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4.6. Discussion.
The high sensitivity of RT-PCR in detecting transcripts as compared to northern blotting 
enabled detection o f multiple r if  and stevor transcripts throughout the IDC of laboratory 
and wild isolates. Despite inherent limitations of our approach, which include primer and 
cloning bias, we were able to observe high intra- and inter-isolate rj/transcript diversity. 
Previous studies have reported transcription of multiple r if  and stevor at different IDC 
stages (Otto et al., 2010, Daily et al., 2005, Rovira-Graells et al., 2012).
The lack o f clear dominant rz/transcripts at certain time points especially in 3D7 and the 
field isolates could point to limited sampling o f transcripts. In order to clearly define 
transcription profiles much more sampling depth using high throughput sequencing 
technologies will be required. Despite this shortcoming our study was able to reveal 
patterns of r if  and stevor transcription through the asexual blood stage cycle. Clear stage- 
specific patterns o f r i f  expression emerged in laboratory and culture-adapted wild 
isolates. In some wild isolates dominant r i f  were observed at certain stages, especially in 
the schizont stage.
It was interesting to recover an UpsA var-linked r//PF13_0004 in our 3D7 line at ring 
stage (RIF_K0044). Previous published expression data in 3D7 parasites showed that in 
3D7 parasites selected on immune sera or for HBEC-binding group A var were 
preferentially expressed and so were the r if  neighbouring them (Wang et al., 2009, 
Claessens et al., 2012).
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In a previous study, Bachmann et al observed the same genes in the two peaks o f r if  
expression, at ring and trophozoite (Bachmann et al., 2012) but this could be due primer 
bias and/or sequence homology in the target region they analysed. In our study most 
isolates transcribed different rifs at the different IDC stages. However we did observe 
similar rifs coming up in rings and schizonts. This was observed in IT, SA075 R+/ R-, 
10594, 10761 and 10814, although in 10814 the shared transcript was observed in late 
ring/ early trophozoites and schizonts. In addition we observed less transcript diversity 
with a clear dominant r i f  transcripts in schizonts in most isolates. Although we did 
observe dominant schizont r i f  in 10594 and 10595, interpretation o f expression profiles in 
the 2 isolates was complicated by suspected gDNA contamination o f cDNA. This 
schizont-associated transcript could be the merozoites transcript, and hence carried over 
to the rings after invasion. A previous study reported two r if  that were expressed at the 
beginning and end o f the 48 hour IDC in 3D7 (Wang et al., 2009) suggesting that these 
rifs played a role in the early and late stages o f the IDC. We detected one o f the two rifs 
PF13_0006 in late trophozoites in our 3D7. We did not detect it in schizonts probably due 
to under-sampling.
Interesting rif/stevor expression profiles were observed in the rosetting culture-adapted 
wild isolate SA075. There was a clear difference in r i f  and stevor transcripts at 
trophozoite stages in the rosetting clone and the non-rosetting fraction. A previous study 
showed two rifs upregulated in rosette-selected IT (Claessens et al., 2011). One o f the 
upregulated rifs termed IT4rifA_054 was head-to-head with the most upregulated var, the 
rosette associated ITvar9. This r i f  was mostly expressed in the mature pigmented
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trophozoites (28hpi). The other upregulated r i f  IT4rifA_042 was predominantly 
expressed in rings (12hpi). Our IT line that underwent rosette-selection had a very 
restricted profile, similar to the Kisumu rosette-selected lines. This might suggests that 
selection pressure does play a role in r i f  and stevor expression. Further analysis is needed 
to link specific r i f  and stevor with rosetting phenotype.
Stevor expression profiling was significantly limited by primer bias. Our primers were 
only able to pick up 59 stevor variants out o f a possible 160 variants from all four wild 
isolates. The observed high level o f sequence sharing in Kilifi isolates could be a true 
phenomenon or could be due to primer bias. For a clearer picture o f stevor transcription 
different primers sets with better repertoire coverage will be required. Despite the 
substantial bias, we observed very little sharing o f stevor transcripts in Kilifi and Kisumu 
isolates. In fact only two stevor were shared between Kilifi and Kisumu isolates. A study 
looking at repertoire diversity in Kilifi and laboratory isolates detected shared stevor in 
wild and laboratory parasites (Blythe et al., 2009).
One major limitation was the inability to capture all r i f  and stevor variants using the 
primer sets. Due to the high variability o f these multigene families, it is impossible to 
design universal primers that will capture the entire repertoire in wild isolates. The 
primers used were designed on laboratory and
In conclusion, r i f  and stevor expression profiling was evaluated in laboratory and wild 
isolates across the IDC. Clear stage specific and isolate specific expression patterns were 
revealed. Dominant transcripts were observed in specific stages in certain parasites.
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Conserved r if  and stevor genes were observed in Kilifi isolates, with little sharing 
between laboratory and wild isolates. Most interesting was identification of rosette- 
associated r if  and stevor transcripts in a patient isolate.
In the northern blotting analysis all probes labelled the 2.1 kb and 4.1 kb non-specific 
rRNA even in the low concentration (lug) RNA sample, suggesting that the signal was 
not probe specific therefore migh be from the anti-DIG antibody, from non-specific 
products amplified during PCR for probe preperation, from the gene-specific primers or 
the T7 promoter sequence. This signal was very high, and changing the stringency of 
washes and hybridisation at higher temperatures did not reduce the intensity. These 
highly abundant RNA species gave intense bands at 2kb (18s) and 4kb (28s) that 
interfered with correctly spliced r if  transcript signal which is o f about the same size as the 
18s rRNA, and a previously detected unspliced product o f about the same size as the 28s 
rRNA (4kb, [Kyes, unpublished]). BLAST analysis o f the complex r if  probe against 
NCBI nucleotide database identified the T7 polymerase anchor sequence included in all 
the primer sets as a region likely to hybridise to rRNA. In addition, the complex primers 
used to amplify r if  for probe generation did non-specifically amplify non-target genes in 
P. falciparum  including rRNA and ring-infected erythrocyte surface antigen (RESA). The 
non-specific band at about 3kb is most likely RESA (transcript length 3.2kb).
Overall full-length, sense r i f  transcripts were detected in IT and in a culture-adapted 
Kilifi isolate, 10668. This implies that o f the many transcripts detected by RT-PCR some 
are correctly spilced and in the correct orientation. This is in line with literature showing
215
multiple r if  variants transcribed in an isolate or cloned parasite. Post transcription 
regulation may play an importatnt role in regulating r if  expression. The observation that 
only homologous probe from cDNA was able to detect n/transcript suggests that r if  
expression is isolate specific, at least in IT and the three Kilifi isolates, as no signal was 
detected using probes from heterologous isolates. This would also suggest that a small 
fraction o f the genomic repertoire is expressed since the gDNA probes were not able to 
detect transcripts.
An important and missing piece o f information is whether all the detected transcripts are 
made into protein during the parasite’s IDC. Reagents to analyse protein localisation for 
r if  and stevor in wild isolates were not available at the time of our study and that was a 
major limitation. Earlier studies have detected RIFIN and STEVOR proteins in multiple 
stages in laboratory isolates. It is unclear whether all the upregulated transcripts detected 
were properly spliced and made into protein. This could be addressed in future work 
using recombinant proteins and RIFIN/STEVOR-specific antisera.
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CHAPTER 5
5. Analysing r if  and stevor expression profiles by 454 amplicon sequencing.
5.1. Introduction.
During its life cycle P. falciparum  undergoes different selection pressures as it matures 
through different morphological stages and in different hosts and host environments. 
Switching between different variant types o f VS A was linked to switches in adhesive 
phenotypes in earlier studies (Roberts et al., 1992). This function has been well described 
for var genes, where a switch in var gene expression correlated with a change in binding 
phenotype o f the parasite to ICAM1 (Smith et al., 1995) and HBEC 5i cell line 
(Claessens et al., 2012). Expression switching under different selection pressures has not 
been well documented for pir  genes. Members of the pir  multigene families have been 
observed in all Plasmodium species, unlike var genes that are only found in P. 
falciparum  and P. rechenowi. It is therefore likely that the antigens encoded by pir  genes 
may play a role in cytoadhesion and in disease pathogenesis in other Plasmodium species. 
Recently a link between parasite virulence and expression o f subsets o f the pir  gene 
family has been shown in P. chabaudi (Spence et al., 2013). In the study it was observed 
that mosquito transmitted
(MT) P. c. chabaudi AS parasites were less virulent than serially blood passaged (SBP) 
parasites, because of a modified immune response to the blood stage parasite. The main 
difference between the MT and SBP parasites was in cir (pir genes in P. chabaudi) gene 
expression, with the SBP parasites expressing a dominant cir, while the MT had 
increased but diverse cir expression (Spence et al., 2013). This study revealed mosquito 
transmission directly modified blood stage parasites, by modifying expression of
virulence determinants, cir genes, and thus modifying the host immune response, which 
in turn regulates virulence.
Although many studies have looked at var expression and regulation there is poor 
understanding o f the expression patterns and mechanisms that regulate r if  and stevor gene 
expression, r i f  and stevor are expressed in multiple stages of the parasite life cycle and in 
many stages o f the IDC. In addition, these genes undergo switching thus the antigens are 
clonally variant (Fernandez et al., 1999, Lavazec et al., 2007, Niang et al., 2009). These 
data suggest that r if  and stevor are under strict transcriptional control and are upregulated 
in stages in which they need to functional. Studies on temporal expression o f r i f  and 
stevor have been limited to laboratory isolates (Otto et al., 2010, Bozdech et al., 2003, 
Bachmann et al., 2012, Claessens et al., 2011, Llinas et al., 2006) with limited data on 
expression in field isolates. One recent study looking at VS A transcription in a limited 
number of wild isolates by realtime PCR and amplicon cloning and sequencing 
(Bachmann et al., 2012) showed two peaks of r i f  and stevor expression, in the early and 
late IDC stages, with multiple r i f  and stevor variants being transcribed. Other studies 
looking at r i f  and stevor transcription revealed upregulation in wild isolates as compared 
to laboratory adapted lines (Lemieux et al., 2009, Blythe et al., 2008).
Even more limited is data on the effect of selection pressure on r i f  and stevor expression. 
In a study looking at the effect of rosette-selection on VS A expression in IT one var 
ITvar9 was highly upregulated in the rosetting line (Claessens et al., 2011). Although 
many r if  and stevor were expressed above background only one specific UpsA r if
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neighbouring the dominant var, ITvar9 was significantly upregulated in the rosetting line. 
This suggested transcription co-regulation of UpsA var and their neighbouring r if  A. 
Stevor were not differentially expressed in the rosette-selected parasites. Another study 
by the same group looked at effect o f selection for binding to HBEC-5i cells on VSA 
expression (Claessens et al., 2012). Group A var genes were upregulated in the selected 
lines in 3D7, IT and HB3. The UpsA var-linked r i f  neighbouring the upregulated var 
were also upregulated in 3D7 and HB3 suggesting an association in transcription between 
the two VSA gene families. The link in expression between var and r i f  has previously 
been reported in a study showing that parasites selected to express PfEMPl associated 
with severe malaria upregulated UpsA var as well as the neighbouring rifAl (Wang et al., 
2009).
Elucidation of the role of RIFIN and STEVOR will require better characterisation o f 
expression patterns through the different parasite stages and under different selection 
pressures. Our previous attempt to analyse r i f  and stevor expression profiles by cloning 
and capillary sequencing described in Chapter 4 was hampered by limitation in repertoire 
coverage due to the few numbers o f clones analysed as well as cloning bias. Significant 
primer bias was noted for stevor. The results therefore did not represent an accurate 
depiction o f expression patterns across the parasite IDC. Clone-free 454 amplicon 
sequencing was carried out to overcome cloning bias, increase r i f  and stevor repertoire 
coverage and to validate the results previously obtained from cloning and sequencing r i f  
and stevor amplicons. Additional wild isolates put under different selection pressures
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were analysed to understand whether selection had an effect on r if  and stevor 
transcription.
454 sequencing from Roche 454 Life Sciences™ is a pyrosequencing system where a 
single strand of a DNA fragment is immobilized on a micron-sized bead, amplified in an 
emulsion and sequenced via sequencing-by-synthesis chemistry. 454 sequencing 
technology allows for massively parallel sequencing of amplicons therefore help to 
resolve diversity of the complex patterns o f pir  expression seen with capillary Sanger 
sequencing, just by increasing the depth of sequencing. Massively parallel sequencing o f 
the targeted regions (rif/stevor) would permit better quantification of reads o f different 
variant types and thus enable quantification o f transcripts and identify dominant 
transcripts, more reliably than Sanger sequencing. Important advances in 454 technology 
allowed longer read lengths than other next generation sequencing platforms, and 
therefore might permit sequencing o f the 850-900 bp r i f  amplicons and -550-650 bp 
stevor amplicons (Figure 5.2), which are necessarily long in order to encompass semi­
conserved regions where the degenerate primers can be designed and the hypervariable 
central regions to characterize variant-specific expression profiles. The GS FLX Titanium 
XL+ that can achieve read length o f up to lkb was used. With the ability to multiplex 
samples, over two hundred r i f  and stevor amplicons were sequenced in parallel.
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5.2. Objectives
Deep sampling of r if  and stevor genomic repertoires and expression profiles by 454
amplicon sequencing to:
i.) Optimise 454 sequencing and data analysis protocol for r if  and stevor amplicon 
sequencing.
ii.) Analyse r if  and stevor expression across IDC stages in laboratory isolates.
iii.) Analyse r i f  and stevor expression across the IDC in patient isolates under 
different selection pressures.
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5.3. Method.
The methods in this chapter have been detailed in Chapter 2 (materials and methods) and 
Chapter 4 (methods). R if  and stevor expression analysis was carried out in laboratory and 
wild isolates. Expression profiles were analysed at 6 time points in laboratory isolates, 
and 4 to 7 time points in wild isolates. There was a total of 16 isolates, 3 laboratory 
isolates (3D7, IT and HB3), 12 Kilifi isolates, 3 from patients with severe malaria and 9 
from patients with non-severe malaria, and 1 Kisumu isolate from a patient with severe 
malarial anemia. Effects of selection pressure on r if  and stevor expression was analysed 
by comparing rif/stevor transcripts obtained from different lines of wild isolates that had 
been exposed to different selection pressures; host immune pressure, culture-adaptation, 
and binding phenotypes (Table 5.1 and Figure 5.1). To analyse the effect of host immune 
pressure r if  and stevor expression profiling was done on fresh-from-the-arm and ex vivo 
parasites. Culture-adapted wild isolates, as well as isolates selected for different binding 
phenotypes were obtained from an on-going var study (Dr. Pete Bull). Two Kilifi 
isolates, 9106 and 10668 had been selected for binding to human brain endothelial cell 
line and one Kisumu isolate, SA075 had been selected for rosetting. The rosetting 
fraction of SA075 was cloned by limiting dilution. The culture-adapted unselected and 
selected lines were analysed to determine whether there was an effect o f selection on r i f  
and stevor expression (Appendix Table 9.6).
As previously described in Chapter 4 RNA was extracted from the different parasite lines 
at different time points. For the laboratory isolates 3D7, IT and HB3, RNA was extracted 
at 6 time points, corresponding to early ring (ER), late ring (LR), early pigmented
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trophozoite (ET), mid trophozoite (MT), late trophozoite (LT) and schizont (S) stages. 
For patient isolates, RNA was extracted from fresh-from-the-arm ring samples (R) and 
from ex vivo 24 hour cultured trophozoite samples (T). For the culture-adapted Kisumu 
and Kilifi lines RNA was extracted at 4 time points, ring (R), late ring to early pigmented 
trophozoite (LRET), mid to late trophozoite (T) and schizont (S) (Appendix table 9.5). 
For the Kilifi ex vivo isolates the time course experiment was carried out by culturing the 
ex vivo isolates for a single IDC. RNA was extracted at 7 time points every 10 hours 
across the IDC (Appendix table 9.5). Genomic DNA (gDNA) was extracted from 
asynchronous cultures at trophozoite stage.
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3D7 HB3 IT
HBEC-selection^
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X  9106A 10668A 9215A 8383A
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Figure 5.1. Isolates used fo r  r if  and stevor expression profiling. Laboratory lines: 3D7, 
HB3 and IT. Wild isolates: 9106, 10668, 9215, 8383, SA075, 10594, 10595, 10735, 
10739, 10727, 10761, 10747 and 10814. A subset o f  the wild isolates were culture 
adapted: 9106, 10668, 9215, 8383 and SA075. A subset o f  the wild-adapted parasites 
were selected for binding to HBEC (9106J I B  and 10668J IB )  and rosetting (SA075_R+ 
and SA075JR.-). The rosetting fraction ofSA075 was cloned by limiting dilution to give 
SA075_R+_C2. Parasite lines that were used in this experiment are enclosed in boxes.
10735
10739
10727
10761
10747
10814
->
r *  10594  
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PCR amplification of r if  and stevor was carried out using gene family-specific degenerate 
primers (Figure 5.2 and Table 2.1). For r if  previously published complex primer sets with 
3 forward and one reverse primer were used (Kyes et al., 1999). The reverse primer was 
modified to correct an error in the published primer sequence and to make it more 
degenerate. For stevor a newly designed forward primer was used together with a 
previously published reverse primer (Albrecht et al., 2006). The amplicons were between 
850 and 950 base pairs (bp) for r if  and 550 to 650bp for stevor (Figure 5.2).
Amplicons were purified and shipped to the Sanger institute for 454 sequencing. Library 
preparation was carried out according to the GS FLX Titanium Rapid Library Preparation 
Kit (Roche) protocol and sequencing done on the GS FLX+ (Roche) (chapter 2 section 
2.8). Prior to sequencing amplicons were multiplexed and pooled into 6 pools o f 48 
amplicons per pool. A total of 246 amplicons were sequenced, 136 r i f  and 110 stevor 
amplicons.
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>
Signal (?) PEXEL TM1 (?) HVL T M 2«
M M U X )  sPS
850-950 bp
3 0  1 3 3  1 4 0  3 6 0
SP PEXEL V I  TM? HVL TM < [
550-650 bp
Figure 5.2. Schematic diagram o f r if  and stevor genes showing the gene features and 
primer positions (purple arrow heads), and the length o f  amplicons, 850-950bp for r if  
and 550-650for stevor. TM: transmembrane domain, HVL: hypervariable loop, SP: 
signal peptide, VI: variable region 1.
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5.3.1. Sequence analysis.
For the 3 laboratory lines (3D7, IT and HB3) and 4 wild isolates (9106, 9215, 10668 and 
SA075) whole genome sequence was available (Table 5.1). For one Kilifi isolate the 
genome sequence data was very poor and could not be used for further analysis (Table
5.1). Genome annotation for the wild isolates was done automatically with no manual 
curation. Previously identified motifs unique to pir  gene family (discussed in chapter 3) 
were used to annotate pir  genes in the Kilifi parasites genomes (work done By Dr.
Thomas Otto). This annotation was automated therefore a few pir  genes were missing 
annotations or incorrectly annotated, and some had incorrect gene models requiring a lot 
of manual curation before further analysis.
Reads generated by 454 sequencing were mapped against the homologous genome where 
available. Raw reads were extracted from the 454 SFF files and a Perl script was used to 
group the reads by their barcode (multiplex identifiers). Reads o f each bar code were 
mapped against their reference genome, using SMALT
(ftp://ftp.sanger.ac.uk/pub/resources/software/smalt/), with the following parameters; k- 
mer length of 13 and a step size of 3 (index -k 13 -s 3), random placing of reads (mapping 
-r 0), 50% minimum identity o f complete read and region in the genome (-y 0.5). The 
resulting output (sam file) was transformed with samtools (Li et al., 2009) to a bam file. 
The bam file was loaded onto Artemis (release 15.0.11) (Rutherford et al., 2000). In 
Artemis BAM view (Carver et al., 2013) RPKM (reads per kilo base pair per million) and 
read counts were calculated for all the annotated r i f  and stevor genes. For transcript 
abundance read counts were used because the amplicon lengths were similar hence there 
was no need to normalise for gene lengths by using RPKM.
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The wild isolates were collectedfrom children with either non-severe malaria (NS) or 
severe malaria with respiratory distress (RD), respiratory distress with impaired 
consciousness (IC&RD) or severe malaria anaemia (SMA). For the time series expression 
profiling RNA was sampled at 6 IDC stages in laboratory isolates; early ring (ER), late 
ring (LR), early trophozoite (ET), m id trophozoite (MT), late trophozoite (LT) and  
schizont (S), 2 stages, ex vivo ring (R) and trophozoite (T), 4 stages in cultured and  
selected lines; ring (R), late ring to early pigmented trophozoite (P), m id and late 
trophozoite (T) and schizont (S). For laboratory isolates and 5 o f  the culture-adapted wild  
isolates whole genome sequencing data was available (Y). Y l: poor quality whole genome 
sequence data fo r  Kilifi isolate 8383. For some isolates p ir  expression profiling was done 
using both capillary and 454 amplicon sequencing; Y: sequence data available, no 
sequencing data, r: rif, s: stevor. Complete description o f  isolates used in this study in 
Appendix table 9.6.
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5.4. Results
5.4.1. Optimising 454 sequencing runs.
The first two 454 sequencing runs (4 lanes each with 48 multiplexed amplicons) 
resulted in very short mean read lengths, about 100 base pairs (bp), much shorter than 
the expected amplicon length o f 850-950bp for r i f  and 550-650bp for stevor (Figure
5.2). Sequence analysis revealed that the short reads were primer-primer concatemers. 
This was as a result o f amplicon contamination with primer dimers. The amplicons 
had passed quality control checks and the contaminating primer dimers were not 
visible on Agarose gels (Figure5.4.1) or on the Agilent Bioanalyser traces (Figure 5.4. 
II), but they were in sufficient quantities to significantly interfere with sequencing 
resulting in suboptimal read lengths (Figure 5.3). The short fragments (primer dimers) 
were preferentially amplified in the emulsion PCR (Figure 5.5) and therefore 
preferentially sequenced. This resulted to recovery of short reads from the sequencing 
runs.
To overcome this problem the pools o f amplicon were taken through high stringency 
solid phase reversible immobilization (SPRI) beads clean up, using a ratio o f 0.7 SPRI 
beads to DNA solution instead o f the normal ratio o f 1.8 and resequencing o f the 
libraries in a third 454 sequencing run. Much longer reads were recovered in the third 
sequencing attempt with the r i f  pools still containing a significant number o f  short 
reads (Figure 5.3).
Because o f limited resources and samples it was not possible to repeat sequencing for 
all the pools. Therefore only r i f  pools 1 and 2 and stevor pools 5 and 6 were repeated. 
Stevor pool 4 had succeeded in the first run (Figure 5.3). Low quality data was 
obtained from the “failed” sequenced r i f  pool 3. Because the aggressive cleanup was
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done on the pools and not individual samples there was sample-to-sample variation in 
reads even within the same pool.
Run 1
rif pooll rif poo!2
Mean read length 114.2bp Mean read length 102.9bp
Run 2 ----------------------
stevor poo!4
1
Mean read length 586.6bp
stevor pool5
Hy-wr -y vfcrry _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
rif pooll
L
»  tas <» sb w  a ;  j a  «
Mean read length 129.7bp
rif pool3
M ean read length 302.2bp
stevor pool5
Mean read length 114.2bp 
stevor pool6
M ean read length 91.7bp Mean read length 99.8bp
/'Run 3
rif pooll rif pool2 stevor pool5 stevor pool6
3 X S 3 3 9 B « 8 ! C B a a ! l « ! : B J f 8 i S
Mean read length 493.2bp Mean read length 455.0bp Mean read length 456.3bp Mean read length 471.6bp
Jl_
Figure 5.3. Read lengths distributed in the 2 fa iled  454 runs (1 and 2) and the 3'd and 
successful run. Graphs show the number o f  reads (Y axis) plotted against the length in 
base pairs (X axis) fo r  all the four pools per run in 3 sequencing runs. The mean read  
length in base pairs fo r  each pool is indicated below each graph. Red boxes are 
drawn around pools that had longer reads (mean read length >100bp) that were used 
fo r  subsequent analysis.
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5.4.2. Optim ising 454 sequence data analysing protocol.
Due to the suboptimal 454 sequencing results, many reads did not span the entire 
amplicon, more so for the longer r i f  amplicon (Figure 5.1). This fact compounded by 
the large number o f reads (raw reads mapping data on tables 9.8-9.12) required 
approaches to analyse the data. Two analysis approaches were taken, analysis by 
mapping reads on to corresponding genomes and de novo assembly of reads into 
contigs. The mapping approach was used for parasite isolates with whole genome 
sequence data available (Table 5.1) that is 3 laboratory isolates 3D7, IT and HB3, and 
four wild isolates 9106, 9215, 10668 and SA075. Reads were mapped onto 
corresponding genomes as described in the methods above and the number o f reads 
that map to features annotated as r i f  or stevor was visualised and computed in 
Artemis. De novo assembly o f reads into contigs was used to assemble reads where 
mapping to a reference genome was not possible due to unavailable or poor whole 
genome sequence data (Table 5.1). The results o f the de novo assembly approach are 
discussed in chapter 6.
5.4.3. Confirmation and correction of genome annotation by mapping 
reads to genomes.
Whole genome sequence data from laboratory isolates has undergone extensively 
manual curation, and it was possible to extract complete p ir  repertoires (from 3D7) 
and correct annotations for the annotated partial pir  repertoire in IT and HB3. The 
wild isolates on the other hand had undergone automated curation and for some the 
pir  repertoire was incomplete (Table 5.2). For some genomes failed sequencing in
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long tracts of the genome resulted in very few pirs annotated, with some genomes 
having as few as 17 annotated rifs out of an expected 180, and 2 annotated stevors out 
of an expected 40 (Table 5.2). For some genomes misannotations were observed 
where non -pir sequences were annotated as pir, and a few incorrectly spliced pir 
genes. Manual correction was done for isolates used in the 454 amplicon sequencing 
study. The pir  genes with missing annotations were identified by mapping all 454 
sequence reads to the genome, and scanning by eye for reads mapping on regions with 
no annotations. This way most missing annotations were corrected for pir  genes 
amplified by the degenerate primer sets. Some pirs  mostly those not recovered in the 
454 sequencing data. For one wild isolate genome, SA075 where many r i f  and stevor 
were not annotated, by mapping all reads from SA075 sequenced amplicons an 
additional 55 rifs and 9 stevors were annotated For IT version 2 o f the genome, the 
available version for mapping at the time of this analysis, had many annotation errors. 
The revised version IT version 3 had fewer pirs  annotated, 132 rifs and 39 stevors (as 
compared to 138 rifs and 43 stevors in IT v2). The version 3 was used to correct 
version 2 for misannotations and improper splicing.
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Table 5.2. Number o f  pirs from  whole genome sequences from  laboratory and field  
isolates.
Parasite isolate
Whole genome 
sequence
Complete or partial pir counts pir expression 
dataNo. of rif No. of stevor
3D7 Y 184 (complete) 42 (complete) Y
IT Y 138 43 Y
HB3 Y 142 35 Y
6816 Y 177 45 N
8383 Ya 17 3 Y
9106 Y 155 42 Y
9215 Y 168 39 Y
9605 Y 177 41 N
9626 Ya 19 2 N
9775 Ya 35 9 N
10668 Y 179 40 Y
10936 Y 181 41 N
10975 Ya 27 9 N
11014 Ya 17 2 N
11019 Y 197 48 N
SA075 Ya 95# 31# Y
a - noticeably incomplete p ir repertoire 
# - additional 55 rifs and 9 stevors annotated
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5.4.4. P rim er coverage 
R if  and stevor primer coverage was estimated using reads from gDNA for all the 
isolates that have whole genome sequence data (Table 9.6). In view of the incomplete 
annotation for some of the Kilifi genomes (see Table 5.2) an assumption was made 
that the repertoires were similar to the 3D7 reference with 184 r i f  and 42 stevor copies 
per genome. Using these estimates a normal distribution was computed based on the 
total number o f reads from gDNA that mapped to r i f  or stevor on corresponding 
genomes, n /p rim er coverage varied from 50% in HB3 to 72% in 10668 (Figure 5.6. 
A). In 3D7 r i f  primer coverage was 67% based on reads from gDNA and 81% based 
on reads from both gDNA and cDNA. stevor primer coverage varied from 47% in 
HB3 to 72% in 3D7 and IT (Figure 5.6. B). O f importance was the inability o f stevor 
primers to capture any members o f the more divergent minor group (discussed in 
Chapter 3) (Blythe et al., 2009, Schreiber et al., 2008). Overall the observed primer 
coverage was significantly less than the expected coverage for all the isolates, an 
inherent problem in trying to capture all members o f highly variable multigene 
families using degenerate primers. Thus the resulting expression profiles presented 
are for a subset o f pir  genes as it was not possible to design primers to capture the 
complete repertoire. An ideal strategy that was not feasible at the time of this study 
would be whole transcriptome sequencing.
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Figure 5.6. r if  (A) and stevor (B) primer coverage based on reads from  gDNA 
obtained by 454 amplicon sequencing. Y-cixis shows rif/ stevor percent expected or 
observed coverage computed from  number o f  reads recovered from  sequencing gDNA 
amplicons fo r  the different isolates. X-axis represents isolates analysed by mapping 
reads to homologous genomes.
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5.4.5. Differential pir  expression analysis.
A closer look at reads from gDNA data revealed uneven coverage of genomic 
repertoires in the different parasite isolates and uneven coverage o f genes within a 
genome (Figure 5.7). This was tested by comparing the expected vs the observed 
coverage o f variants per isolate using reads from gDNA amplicons. The expected 
coverage was calculated in excel using BINOMDIST, using the total number o f reads 
from gDNA as the number o f trials, and the probability o f getting x number o f genes 
from the annotated r i f  stevor genes in a genome. The proportions were then plotted 
against the observed read counts o f each gene from gDNA. There was a difference in 
the expected and observed frequency distributions for both r i f  (Figure 5 .7 .1) and 
stevor (Figure 5.7. II), with the primers preferentially amplifying certain pir  members 
o f the parasite genomes. Genomes from patient isolates have not been manually 
curated and annotated, and the IT and HB3 genomes are still undergoing editing and 
correcting, therefore pir  repertoires for all isolates except 3D7 are incomplete. In 
order to accurately test for significance between the expected and observed frequency 
distributions the 3D7 reads data was used. There was a significant difference between 
the expected and observed coverage for both r i f  and stevor repertoires (Pearson’s chi 
squared/>=<0.0001) suggesting primer bias. The difference in coverage was required 
to be taken into account before analysing r i f  stevor expression across time points. For 
this reason, the DESeq normalisation approach was used to normalise read data 
(Anders and Huber, 2010). DESeq was used to normalise for differential sequence 
coverage by normalising the number o f reads from different libraries. After correcting 
for sequence coverage within an isolate, uneven gene coverage within a genome was 
accounted for by computing a corrected transcript upregulation by dividing reads 
from cDNA by reads from gDNA for each gene captured by the primers.
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Normalised cDNA reads
Transcript upregulation = -------------------------------
Normalised gDNA reads
Therefore for each isolate both raw read proportions representing raw transcript 
abundance, and corrected transcript upregulation were computed. Transcript 
abundance proportions are represented in piecharts, colouring regions of the pie where 
the transcript took up at least 10% of the total transcription at any cDNA timepoint. 
Transcript upregulation is represented as heatmaps, with the darker shades o f purple 
indicating increased upregulation. Next to each upregulation heatmap smaller 
heatmap (orange coloured) was drawn to represent transcript abundance. In this 
heatmap the reads proportions were grouped into quartiles, with the highest quartile 
(darker shades o f orange) representing high transcript abundance (for example see 
Figure 5.10 for 3D7 transcript upregulation and abundance).
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5.4.6. A switch in relative proportions of r i f  A  to rifB  transcrip ts in 
laboratory  isolates and culture-adapted wild isolates.
There are more rifA than rifB genes in the genome, at about 70% rifA to 30% rifB , as 
previously described in chapter 3 (129 rifA and 55 rifB in 3D7) and this is reflected by 
the fact that there were generally more rifA transcripts than rifB transcripts. In 
laboratory isolates and in three out o f the four culture-adapted wild isolates, there was 
significantly more rifA transcripts than rifB, than would be expected, at about 90% 
rifA to 10% rifB transcripts (Figure 5.8). This difference could not be completely 
explained by the genomic proportions o f rifA and rifB. In addition, because o f better 
coverage o f rifB than rifA by the primers the proportion rifA and rifB reads from 
gDNA amplicons in all isolates was not drastically different (Figure 5.8). This shift in 
relative transcript proportions in favour of rifA was observed in the laboratory 
isolates, and in 3 o f the four culture-adapted wild isolates, with IT and culture-adapted 
10668 isolates showing highest rifA transcript proportions (Figure 5.8). In two wild 
isolates, 9106 and 10668, the culture-adapted lines had markedly preferential rifA 
transcription as compared to ex vivo parasites and HBEC-selected lines (Figure 5.8 E 
and F), while in the rosetting wild isolate SA075 the bias towards rifA transcription 
was stronger in the rosetting clone than in the non-rosetting fraction. A previous study 
on VSA expression in laboratory and wild isolates using realtime PCR reported low 
levels o f rifB expression (Bachmann et al., 2012). This finding was likely due to poor 
coverage o f rifB  by the primers used as explained by the authors. In our case primer 
coverage did not explain the bias. For subsequent r i f  expression profiling the two 
groups, rifA and rifB were analysed separately because o f this observed bias towards 
rifA transcription.
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Figure 5.8. Comparison between rifA and rifB transcript abundance in laboratory 
and wild isolates. Bar graphs represent proportions o f  rifA and rifB reads (left Y-axis) 
number o f  unique rifA and rifB (right Y-axis) from  cDNA and gDNA in 3D7 (A), HB3 
(B), IT  (C), 9215 (D), 9106 (E), 10668 (F) and SA075 (G) parasites, and selected 
lines. The X-axis shows the IDC stages, early ring (ER), late ring (LR), early 
trophozoite (ET), mid trophozoite (MT), late trophozoite (LT) and schizont (S) fo r  the 
laboratory isolates and rings (R), Late ring to early trophozoites (P), trophozoites (T) 
and schizonts (S) fo r  the wild isolates. G: proportion o f  reads from  gDNA amplicons. 
For the Kilifi isolates two to three parasite analysed are shown in the X-axis; Acute 
parasites (°), culture-adapted parasites (l) and culture-adapted and HBEC-selected 
(2). For the Kisumu isolate the two lines analysed, the rosette-selected clone (+) and 
the non-rosetting uncloned fraction (-) are shown in the X-axis. The gray graphs show 
the expected rifA to rifB ratios from  gDNA o f  the respective isolates.
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5.5. Distinct and dynamic r if  and stevor transcrip tion patterns in
laboratory  isolates.
Similar to results obtained by cloning and capillary sequencing there was high 
diversity o f r i f  and stevor transcripts across the IDC in the laboratory isolates, 3D7 
and HB3 having higher diversity than IT. Despite this apparent diversity, more 
sequencing depth revealed clear stage-specific dominant transcripts, more clearly for 
rifB and stevor.
5.5.1. Pir expression in 3D7
In 3D7 rifA had a high diversity o f transcripts while a single transcript dominated rifB 
expression (Figure 5.9). In rings three o f the four most abundant rifA transcripts were 
UpsA var-linked-r//genes that share a promoter region with UpsA var, PF13_0004, 
PF11_009 and PF11_0520. These have been shown to be upregulated in a 3D7 line 
that expressed Group A var (Wang, 2009) (Figure 5.9). Only one o f the UpsA r i f  
genes, PF13_0004 was recovered in rings in the capillary data (Figure 4.5 Chapter 4) 
probably due to reduced coverage from sampling a small number o f cloned 
amplicons. The UpsA var linked-n/w ere not expressed in trophozoites and a new set 
of transcripts PFD1240w, PF10_0006 and a pseudogene, PFD 1020c, were most 
abundant. At schizont stage PFL0025c and PFD1240w were the dominant r i f  
transcripts.
rifB had more restricted transcription. In early rings multiple dominant rifB transcripts 
were observed, PF14_0003, PF10_0003, PF10_0006 and a pseudogene 
PF3D7_0701200. In late rings to trophozoites PF10_0006 dominated rifB
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transcription. This r if  has been shown to be expressed in 3D7 early and late IDC 
stages, sporozoites, mature gametocytes and gametes (Wang et al., 2010, Mwakalinga 
et al., 2012, Wang et al., 2009). M AL13pl.495 was on in mid trophozoites but was 
undetectable in late trophozoites. PF10_0006, PF13_0006 and PFI0025c dominated 
rifB expression in schizonts. PF13_0006 and PFI0025c are B1 r i f  that were reported 
to dominate early and late stage transcription in 3D7 (Wang et al., 2009).
Analysis o f stevor expression profile showed a difference in expression at early and 
late stages. There was a switch from the dominant ring transcripts to different ones 
that stayed on across the later stages o f the IDC (Figure 5.8). PFF0850c and 
PFD0065w transcripts were predominant in rings. There was a switch at the ring- 
trophozoite transition stage with PF10_0395 being the dominant stevor transcript in 
late rings and trophozoite stages, but this decreased in schizonts. PFF0850c was 
maintained at moderate transcription levels all through the IDC. Multiple transcripts 
were in dominantly transcribed in schizonts with the ring stevor PFF0850c and 
PFD0065w also coming up. PFI0080w was the only stevor transcript that was 
uniquely transcribed in the late stages. The three dominant stevor genes in rings and 
trophozoites PF10_0395, PFF0850c and PFI0080w had previously been shown to be 
expressed in 3D7 clones (Niang et al., 2009, Sharp et al., 2006) and gametocytes 
(Sharp et al., 2006).
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Figure 5.9. (A) 3D7 r if  and stevor repertoires and proportion o f  transcripts in 6 IDC  
stages, early ring (ER), late ring (LR), early trophozoite (ET), mid trophozoite (MT), 
late trophozoite (LT) and schizont (S). The pies represent proportions o f  reads that 
mapped to rifA (top panel), rifB (middle panel) or stevor (lower panel). Coloured 
regions o f  the cDNA pies represent transcripts that accountedfor 10% and above o f  
the total expression in at least one time point, while in gDNA pies, coloured regions 
indicate genes whose read counts represent >10% o f  the total reads obtainedfrom  
amplification o f  matched cDNA. The numbers indicate the gene labels fo r  transcripts 
that represent 10% and above o f  the total expression within a time point (see table 
below), a: UpsA var-linked-rif. *: pseudogene. (B) Table listing transcripts that 
made up at least 10%> o f  the expression at any stage.
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Due to differential primer coverage of the r if  repertoire, corrected transcript values 
were determined by first normalising read counts across time points and gDNA, then 
dividing normalised read counts from cDNA by normalised gDNA read counts. There 
was a clear stage-specific upregulation o f r i f  (Figure 5.10). Certain genes clustered 
together by transcription patterns. For instance rifs in cluster 1 and 2 were upregulated 
through most o f the IDC with slight changes while those in cluster 10 were mostly 
switched off through the IDC.
Clusters 4 and 5 and some members o f clusters 6 and 7 were upregulated in the early 
and late stages. They were switched on in rings, off in mid and late trophozoites, then 
back on in schizonts. Cluster 4 contained three members o f the conserved UpsA-var- 
linked r i f  group, PF11 0520, PF13 004 and PFD1230c. Previous literature reported 
this r i f  group to be upregulated in parasites that express the associated var. PFD1230c 
was the most upregulated r i f  in rings with over 100 fold change over gDNA. 
Interestingly the associated var PFD1235w was the second most abundant var 
transcript in 3D7 rings, from the same RNA sample as used to generate thiis data. This 
gene r i f  was swiftly switched off in the late ring and stayed at low transcription levels 
through the rest o f the IDC. This profile was strikingly similar to var transcription 
profile.
Cluster 8 and 9 were upregulated in mid and late trophozoites and cluster 3 was kept 
at low levels throughout the IDC but peaks at the mid trophozoite stage.
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Figure 5.10. Heat maps showing upregulated r i f  in 3D7 at 6 IDC stages, early ring 
(ER), late ring (LR), early trophozoite (ET), mid trophozoite (MT), late trophozoite 
(LT) and schizont (S) (left panel) and transcripts abundance in the same stage (right 
panel). The panel on the left (purple) shows log 10 fo ld  change o f  the upregulated r if  
across the IDC. The right panel (orange) represents transcript abundance 
categorised into quartiles. Dendogram generated by hierarchical clustering in R 
based on transcript upregulation patterns.
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For stevor it was observed that transcript abundance was correlated with transcript 
upregulation (Figure 5.11). Cluster 1 stevor PF10_0395 and PFF0850c, dominant 
transcripts in mid IDC were the most upregulated transcripts in the same mid IDC 
stage. Cluster 2 stevor were upregulated in early to mid trophozoites and cluster 3 in 
the late ring early trophozoite transition stage. Cluster 4 and 5 came up in the early 
and late stages while cluster 6 was stevor that mostly stayed at low transcription 
levels.
Overall the transcript abundance and upregulation o f 3D7 r i f  and stevor genes showed 
good correlation (mean correlation coefficient = 0.82 and 0.9 for r i f  and stevor 
respectively).
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Figure 5.11. Heal maps showing stevor transcript upregulation (left panel) and 
transcript abundance (right panel) in 3D7 at 6 IDC stages, early ring (ER), late ring 
(LR), early trophozoite (ET), mid trophozoite (MT), late trophozoite (LT) and schizont 
(S). The panel on the left (purple) shows log 10fo ld  change o f  the upregulated r if  
across the IDC. The right panel (orange) represents transcript abundance 
categorised into quartiles. Dendogram generated by hierarchical clustering in R 
based on transcript upregulation patterns.
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5.5.2. Pir expression in IT 
r if  and stevor transcription profiles were explored in two IT samples, an original 
aliquot grown from the IT obtained from Sanger (IT original) and another that was 
kept in continuous culture in our laboratory for over 40 cycles (IT passaged). The rifA 
to rifB transcript proportions were more skewed to rifA in IT as compared to other 
laboratory isolates analysed (Figure 5.8. C). Despite the high proportion o f rifA 
transcripts, the number of unique rifA was much smaller than what was observed in 
the other 2 laboratory isolates, with only 5 dominant transcripts across the IDC 
(Figure 5.12. A). This restricted diversity o f transcripts was previously observed in 
the capillary sequencing data (Chapter 4 figure 4.6). A single rifA pseudogenic 
transcript PFIT0536700 dominated the first half o f the IDC (ER-ET) and was 
maintained at high levels in the rest o f the IDC. This r i f  is related to the conserved 
3D7 pseudogene PFE1635w that was expressed in low levels in the early stages in 
3D7 (Appendix table 9.8). In IT and 3D7 genomes this r if  (PFITbin2300), that was 
previously observed to be highly transcribed in rings in the capillary data, was also 
highly expressed in rings in the 454 data. Two other rifA genes, PFIT0835500 and 
PFIT 0900150, were dominantly transcribed in trophozoite and schizont stages as 
previously observed in our capillary data (Figure 4.6 A Chapter 4). There was no 
significant change in rifA transcription in IT passaged in culture (Figure 5.12. B)
There was a much more restricted diversity o f rifB in mid to late stages (Figure 5.12. 
A). Three dominant transcripts were observed in early rings, and a single dominant 
transcript PFIT_0733200 came up in late rings and dominated transcription in the 
later stages. This r i f  is 99% identical to the 3D7 MAL13P1.495, which came up in 
mid trophozoites (Figure 5.9 sequence “ 13”). There was very little difference in rifB
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transcription between IT original and IT passaged. The transcript PFIT_bin 10000 was 
dominantly transcribed in original IT ring stage but not recovered in the passage IT 
line (Figure 5.12. B).
Stevor showed a similar transcription pattern as rifB, with multiple transcripts in rings 
and a switch to a single dominant transcript in the later stages. In rings two stevor 
PFIT0700100 and PFIT_bin00600, and a pseudogene PFIT0400200 were 
dominantly transcribed. The pseudogene PFIT_0400200 is 95% identical to the 3D7 
pseudogene PFD0065w. This was the dominant ring transcript and was maintained at 
a low level through out the rest o f the IDC. In the late ring stage there was a switch to 
a new dominant transcript PFIT_bin03800 that was maintained at high levels through 
the later stages o f the IDC (Figure 5.12. B). In late rings to schizonts PFIT_bin03800 
was the most abundant stevor transcript.
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Figure 5.12. r if  and stevor repertoires and proportion o f  transcripts in (A) IT  
(original) at 6 IDC stages, early ring (ER), late ring (LR), early trophozoite (ET), mid  
trophozoite (MT), late trophozoite (LT) and schizont (S) and (B) IT(passaged) at 2 
IDC stages, mixed rings (R) and mixed trophozoites (T). The pies represent 
proportions o f  reads that mapped to rifA (first panel), rifB (second panel) or stevor 
(third panel). Coloured regions o f  the cDNA pies represent transcripts that accounted 
fo r  10% and above o f  the total expression in at least one time point, while in gDNA 
pies, coloured regions indicate genes whose read counts represent >10% o f  the total 
reads obtainedfrom amplification o f  matched cDNA. The numbers indicate the gene 
labels fo r  transcripts that represent 10% and above o f  the total expression within a 
time point (table C). *: pseudogene. (C) Table showing most abundant rif/stevor 
transcripts in IT. * pseudogene. a rifl, Palo Alto (PAR+/PAR-) (Kyes et ah, 1999), h 
rif3, PaloAlto (PAR-) (Kyes et al., 1999).
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In IT r if  transcript upregulation was weakly correlated with transcript abundance 
(mean correlation coefficient of and 0.45). Cluster 1, which contains the 5 dominant 
rifA and 1 dominant rifB transcript, is upregulated in most IDC stages (Figure 5.13. 
A). The two dominant ring transcripts PFIT_bin02300 and PFIT_0536700 were 
among the most highly upregulated in rings and group together within cluster 1. 
Cluster 2, which is purely made up of rifA , appears to have no clear upregulation 
pattern with some members coming up in the early stages, some in the middle stage 
and others in the late stage. Cluster 3 appears to be upregulated in the mid stages. 
Cluster 4, which mostly contained rifB, is upregulated mainly in the early stages with 
the majority showing two peaks o f upregulation in the early and middle stages. This 
cluster contains all the dominant rifB transcripts, suggesting that the most abundant 
rifB in IT have similar transcription profiles. Members o f cluster 5 do not appear to be 
upregulated in any stage.
Stevor transcript abundance and upregulation correlated well in IT (mean correlation 
coefficient o f 0.95) (Figure 5.13. B). The most abundant transcripts fell into cluster 1 
with the exception o f PFIT_bin00600, which fell in cluster 2. The dominant ring 
transcript PFIT 0700100 was upregulated in the early to mid stages (rings to 
trophozoites) while the dominant mid and late stage transcript PFIT_bin03800 was 
upregulated in mid to late stages (early trophozoites to schizonts). Cluster 4 was 
upregulated mainly in the late stages while cluster 5 was slightly up in early and late 
stages, patterns similar to their peak transcription time points from the transcript 
abundance analysis (Figure 5.12).
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Figure 5.13. Heatmaps showing r if  (A) and stevor (B) transcript upregulation on the 
left panel and transcript abundance on the right panel in IT  with the top heat map 
showing r i f  patterns in IT  (original) at 6 IDC stages, early ring (ER), late ring (LR), 
early trophozoite (ET), mid trophozoite (MT), late trophozoite (LT) and schizont (S), 
and I  T(passaged) at ring (Rp) and trophozoite (Tp) stages. The two heatmaps on the 
left (purple) shows log 10 fo ld  change o f  upregulated r if  across the IDC while the 
right panel (orange) represents transcript abundance categorised into quartiles. The 
lower heatmaps show stevor patterns in IT  (original) across 6 IDC stages. The 
dendogram was generated by hierarchical clustering in R based on transcript
upregulation patterns.
0 1 2 3 4 M ax
Transcript abundance 
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5.5.3. Pir expression in HB3
For HB3 there was very little change in /'//'transcription across the IDC (Figure 5.14). 
The three most abundant rifA transcripts, PfHB3_BroadWash530300, 
PfHB3_BroadWash520600 and PfHB3_BroadWash536100 were maintained across 
the IDC with PfHB3_BroadWash530300 being the dominant rifA. The dominant rifA 
was 94% identical to the IT n/PFIT_1401300 whose transcription maxima was in 
early rings and 92% identical to the 3D7 PFI0020w also maximally transcribed in 
rings. Unlike in IT and 3D7 in HB3 this r i f  is maintained at high transcription levels 
through out the IDC. Another rifA and rifA pseudogene were also dominantly 
expressed across the IDC.
PfHB3_BroadWash530200 and PfHB3_BroadWash551000 were the most abundant 
rifB transcripts with PfHB3_BroadWash530200 predominating transcription. 
PfHB3_BroadWash262300 came up in the mid to late stages while 
PfHB3_BroadWashl 61200 peaked in late trophozoites.
Similarly there was little change in stevor transcription across the IDC. 
PfHB3_BroadWashl61300 and PfHB3_BroadWash532500 were the most abundant 
transcripts in early rings with PfHB3_BroadWashl61300 staying up in the rest o f the 
IDC. Two other dominant ring transcripts were observed (Figure 5.14). 
PfHB3_BroadWash521400 dominated transcription in the late rings to mid 
trophozoites, and schizonts. A schizont stevor transcript PfHB3_BroadWash544800 
belongs to a conserved stevor pseudogene group that includes the 3D7 PFD0065w,
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transcribed in rings and schizonts (Figure 5.9 sequence “ 17”) and expressed in all the 
laboratory isolates (Figure 5.9 and Figure 5.12).
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rifA
rifB
L R LR
cDNA _____ __
ET MT LT
3
gDNA
:
J
S te v o r
3 > > 9  y '  9 X  9 i t*  9 ^
_  14 / * *  14 1 4 ______ ^  14
v w  &< a  w  • • *  <
13 13 11 : 13
B Label pir ID n/A /B 3D 7/ IT BLAST hit Identities
1 rif PfHB3 BroadWash530300 A PFIT 1401300 975/1035 (94%)
2 rif PfHB3 BroadWash520600 A PF3D7 0324400(PFC1095w) 858/1059 (81%)
3 rif(c) PfHB3 BroadWash536100* A* PF3D7 0533000 (PFE1635w)* 633/639 (99%)
. 4 rif PfHB3 BroadWash551000 B PF3D7 0425900 (PFD1240w) 497/596 (83%)
5 rif PfHB3 BroadWash530200 B PFIT bin01700 807/957 (84%)
6 rif PfHB3 BroadWash529000 B PFIT 0100400 885/934 (94%)
7 rif (c) PfHB3 BroadWash262300 B PF3D7 1000600 (PF10 0006) 1061/1086(97%)
8 rif PfHB3 BroadWashl61200 B PF3D7 0701200* 694/887 (78%)
9 stevor PfHB3 BroadWashl61300 na PFIT 0700500 734/800 (91%)
10 stevor PfHB3 BroadWash532500 na PF3D7 1254100 (PF07 0130) 798/898 (88%)
11 stevor PfHB3 BroadWash528600 na PFIT bin09500* 551/558 (98%)
12 stevor PfHB3 BroadWashl62000 na PF3D7 0300400 809/893 (90%)
13 stevor PfHB3 BroadWash521400 na PF3D7 125410 (PFL2610w) 767/892 (85%)
14 stevor (c) PfHB3 BroadWash544800* na PF3D7 0401500(PFD0065w)* 451/458 (98%)
15 stevor PfHB3 BroadWash538600 na PF3D7 1149900 (PF11 0516) 816/933 (87%)
Figure 5.14. HD3 r if  and stevor repertoires and proportion o f  transcripts in 6 IDC  
stages, early ring (ER), late ring (LR), early trophozoite (ET), m id trophozoite (MT), 
late trophozoite (LT) and schizont (S). The pies represent proportions o f  reads that 
mapped to r if  A (top panel), rifB (middle panel) or stevor (lower panel). Coloured 
regions o f  the cDNA pies represent transcripts that accounted fo r  10% and above o f  
the total expression in at least one time point, while in gDNA pies, coloured regions 
indicate genes whose read counts represent >10% o f  the total reads obtained from  
amplification o f  matched cDNA (see table below). The numbers indicate the gene 
labels fo r  transcripts that represent 10% and above o f  the total expression within a 
time point.
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R if  transcript upregulation and transcript abundance were weakly correlated in HB3 
(mean correlation coefficient = 0.52). There was a temporal pattern of transcript 
upregulation (Figure 5.15. A). Cluster 1, which was made up purely of rifA, was 
mostly upregulated in the early rings, with a sub cluster staying on in the middle and 
late stages. Cluster 3 and 4, which contained the dominant rifA and rifB transcripts 
respectively, were upregulated through most o f the IDC. Cluster 5 was upregulated in 
late rings to mid trophozoites, switched off in late trophozoites and back on in 
schizonts. Cluster 6 was upregulated in the early and late stages. Cluster 7 was mostly 
off all through the IDC (Figure 5.15).
Similarly, the correlation between stevor transcript upregulation and transcript 
abundance was weak (mean correlation coefficient = 0.33). Cluster 1 was upregulated 
in early and late stages. Cluster 2 was up in early and middle stages, with some 
members staying on in late stages. Cluster 3 was predominantly upregulated in late 
trophozoites. Cluster 4 and 5 were mostly turned off (Figure 5.15. B).
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Figure 5.15. Heatmaps showing r if  (A) and stevor (B) transcript upregulation 
(purple) and transcript abundance (orange) in HB3 at 6 IDC stages, early ring (ER), 
late ring (LR), early trophozoite (ET), mid trophozoite (MT), late trophozoite (LT) 
and schizont (S). The left panel (purple) indicates loglO fo ld  change transcript 
upregulation across the IDC. The right panel (orange) represents transcript 
abundance categorised into quartiles. The dendogram was generated by hierarchical 
clustering in R based on transcript upregulation patterns.
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5.6. r i f  and stevor expression patterns in wild isolates under different
selection pressures.
To understand whether selection pressure has any effect on r i f  and stevor gene 
expression, analysis of transcription patterns was carried out in wild isolates from 
Kilifi and Kisumu that had undergone different selection pressure, within host 
selection pressure, culture-adaptation, and selection for binding to human brain 
endothelial cell line (HBEC) or rosetting. R if  and stevor profding was carried out at 
different time points in two to three different lines per isolate; acute (fresh-from-the- 
arm) rings (R) and ex vivo trophozoite (T), rings (R), late rings to early pigmented 
trophozoites (LR/ET or P), mid and late trophozoites (T) and schizont (S) in culture- 
adapted lines and selected lines.
5.6.1. R if  and stevor transcription in acute and culture-adapted 9215
R if  and stevor transcription was analysed in 9215 acute and culture-adapted parasites. 
This parasite originated from a patient with severe malaria with respiratory distress. 
Although the same sets o f transcripts were observed in both the acute and culture- 
adapted lines there was a change in the relative proportions (Figure 5.16). Multiple 
rifA transcripts were recovered in the acute rings with no clear dominants. Two o f the 
ring transcripts PF8443_8_4_U539500 and PF8443_8_4_U509100 dominated 
transcription in the acute trophozoites. After culture adaptation one o f the acute 
transcripts PF8443_8_4_U539500 dominated ring rifA transcription and was 
maintained all through the IDC while two other minor rifA transcripts 
PF8443_8_4_U522000 and PF8443_8_4_U509100 became more prominent. The 
same dominant rifA transcripts in acute trophozoites were observed in cultured
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trophozoites. A conserved rifA pseudogene PF8443_8_4_U512100 (PFE1635w in 
3D7) came up in the culture-adapted line and was expressed in all time points.
For rifB the dominant acute ring transcript PF8443_8_4_U539500 was also dominant 
in culture. A minor transcript in the acute parasite PF8443_8_4_U512100 became 
dominant in culture peaking at rings and schizonts. The dominant rifB in acute 
trophozoites PF8443_8_4_U537200 was turned off in culture.
Multiple dominant stevor transcripts were observed in acute rings. One o f these, 
PF8443_8_4_U026200, the conserved stevor pseudogene (PFD0065w in 3D7) 
became the dominant transcript in the ex vivo trophozoites, and in the cultured rings 
and early trophozoites. One of the other dominant stevor transcripts in acute rings, 
PF8443_8_4_U546300, was dominantly transcribed in the culture-adapted line in the 
late ring to early trophozoite stage. PF8443_8_4_U533600 that was a minor transcript 
in acute parasites was predominantly transcribed in cultured trophozoites and 
schizonts (Figure 5.16).
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Figure 5.16. r if  and stevor genomic repertoires and transcription profiling in 9215 at 
acute rings and ex vivo trophozoites (top panel) and after culture adaptation at 4 time 
points. The pies represent proportions o f  reads that mapped to rifA (top panel), rifB 
(middle panel) or stevor (lower panel). Coloured regions o f  the cDNA pies represent 
transcripts that accountedfor 10% and above o f  the total expression in at least one 
time point, while in gDNA pies, coloured regions indicate genes whose read counts 
represent >10% o f  the total reads obtainedfi'om amplification o f  matched cDNA (see 
table).
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For some rifs there was a clear upregulation pattern, especially in the cultured 
parasites, but for most there was little difference in upregulation between acute and 
cultured parasites (Figure 5.17. A). The r if  transcripts upregulation in the cultured 
parasites belonged to cluster 1. This cluster contained the dominantly transcribed rifs, 
which were more clearly seen in the cultured lines than in the acute/ ex vivo parasites. 
Cluster 3 and 4 were mostly upregulated in acute rings.
One stevor was markedly upregulated in cultured parasites. PF8443_8_4_U533600 
was significantly upregulated in mid and late stage parasites in the culture-adapted 
line (Figure 5.17. B). PF8443_8_4_U026200 was upregulated in acute trophozoites 
but in culture this stevor was most upregulated in rings (Figure 5.17. B). While most 
stevors stayed constant in acute and cultured parasites some were marginally 
upregulated in acute rings and cultured trophozoites and schizonts.
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Figure 5.17. Heatmaps showing r i f  (A) and stevor (B) transcript upregulation 
(purple) and transcript abundance (orange) in acute rings (R )  and ex vivo 
trophozoites ( f >) and in cultured parasites at 4 IDC stages, ring (R ), late ring to 
early trophozoites (P1), trophozoite (T1), and schizont (S1). The left panel (purple) 
indicates log 10 fo ld  change transcript upregulation across the IDC. The right panel 
(orange) represents transcript abundance categorised into quartiles. The dendogram  
was generated by hierarchical clustering in R based on transcript upregulation 
pattern.
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5.6.2. R i f  and stevor transcrip tion  in acute, culture- adapted, and 
culture-adapted and HBEC-selected 9106 lines.
For a second Kilifi isolate 9106, profiles were analysed for acute, culture-adapted and 
culture-adapted and HBEC-selected parasite lines. For this isolate RNA was not 
available for the ex vivo trophozoites, therefore only the acute ring transcription 
profile was analysed. There was insufficient r i f  sequence data for the HBEC-selected 
trophozoites due to problems during sequencing.
There was a higher diversity of rifA transcripts in acute parasites than in cultured or 
HBEC-selected parasites. Similar dominant rifA were observed in all lines in the ring 
stage, but there was a slight change in proportions. PF8443_8_7_U525700 was 
dominant in rings in all lines while PF8443_8_7_U439800 and 
PF8443_8_7_U484300 were predominantly transcribed in the HBEC-selected line. In 
the culture-adapted line there was a switch at the late ring-early trophozoite stage to a 
new dominant rifA PF8443_8_7_U503900 that stayed on in trophozoites and 
schizonts. No dominant rifA were unique to the HBEC-selected line, but two were 
dominantly transcribed in early stages in the HBEC-line with another two staying 
constant through the IDC (Figure 5.18).
In rifB the proportions o f the dominant transcripts changed with the different selection 
pressures. PF8443_8_7_U443900, a pseudogene, was highly transcribed in rings in all 
the lines and in all the IDC stages o f cultured line. In the HBEC-selected line this 
gene was expressed in much lower levels. PF8443_8_7_U499600 was most abundant 
in cultured rings and schizonts, and HBEC-selected schizonts. PF8443_8_7_U555300
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was dominant in HBEC-selected rings and PF8443_8_7_U502300 was the dom inant 
rifB in cultured and HBEC-selected late rings and early trophozoites (Figure 5.18).
Similar to what was observed for r i f  there was higher diversity o f stevor transcripts in 
the acute rings than in the culture-adapted or HBEC-selected rings. Although the most 
abundant stevor transcripts were similar in the different lines, there were clear 
dominants uniquely associated with either the cultured or HBEC-selected lines. Three 
most abundant stevor in acute rings PF844_8_7_U536400, PF844_8_7_U503200 and 
PF844_8_7_U5557100 were also highly transcribed in cultured and selected 
parasites. PF844_8_7_U536400, the conserved stevor pseudogene (PFD0065w in 
3D7), was predominantly transcribed across the IDC in the culture-adapted line. A 
different stevor PF844_8_7_U557100 not highly transcribed in culture was the most 
abundant transcript in HBEC-selected parasites. The culture-associated stevor 
PF844_8_7_U536400 was the second most abundant transcript in the HBEC-selected 
line.
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Figure 5.18. r if  and stevor genomic repertoires and transcription profiling in 9106 at 
acute rings and ex vivo trophozoites (top panel), at 4 time points in culture-adapted 
parasites (middle panel) and HBEC-selected parasites (bottom panel). The pies 
represent proportions o f  reads that mapped to rifA, rifB or stevor. Coloured regions 
o f  the cDNA pies represent transcripts that accountedfor 10% and above o f  the total 
expression in at least one time point, while in gDNA pies, coloured regions indicate 
genes whose read counts represent >10% o f  the total reads obtained from  
amplification o f  matched cDNA. The table (B) list the dominant transcripts (genes 
that took up at least 10% o f  total transcripts at any time point). !: piecharts from  time 
points with insufficient sequence data.
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There were some clearly differentially upregulated rif'm  the different parasite lines, 
under different selection pressures (Figure 5.19. A). Cluster 1, which contained most 
of the dominant transcript was upregulated in cultured and HBEC selected lines. 
Cluster 3 was off in acute rings but upregulated in the cultured and selected lines. 
Clusters 4 and 5 were upregulated in acute rings, switched off in culture and turned 
back on after HBEC selection. Cluster 6 on the other hand was upregulated only in 
the cultured line. Cluster 2 was maintained on in the three lines while clusters 7 and 8 
were mostly off.
A few stevor were differentially upregulated stevor transcripts (Figure 5.19. B). The 
dominantly transcribed stevor pseudogene in the cultured line PF8443_8_7_U563400 
was upregulated in all lines (outlier on branch 1 Figure 5.19. B). 
PF8443_8_7_U560500 was upregulated in acute and HBEC selected rings but 
switched off in the culture-adapted parasites. PF8443_8_7_U557100 was exclusively 
upregulated in the middle stages in the HBEC-selected line. Cluster 5 came up only in 
the HBEC-selected parasites while cluster 7 was upregulated in acute rings and in the 
HBEC-selected line.
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Figure 5.19. Heatmaps showing r i f  (A) and stevor (B) transcript upregulation 
(purple) and transcript abundance (orange) in a Kilifi isolate 9106, in acute rings 
(R°), in the cultured line at 4 1DC stages, ring (R ), late ring to early trophozoites 
(P1), trophozoite (T1), and schizont (S1)  and in the HBEC-selected line, ring (R2), late 
ring to early trophozoites (P2), trophozoite (T2), and schizont (S2). The left panel 
(purple) indicates log 10 fo ld  change transcript upregulation across the IDC. The 
right panel (orange) represents transcript abundance categorised into quartiles. The 
dendogram was generated by hierarchical clustering in R based on transcript 
upregulation patterns.
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5.6.3. R if  and stevor transcrip tion  in acute, culture- adapted, and 
culture-adapted and HBEC-selected 10668 lines.
The third Kilifi isolate 10668 was sampled from a severe malaria patient with 
impaired consciousness and respiratory distress, r i f  and stevor transcription profdes 
were analysed in the acute, cultured and HBEC-selected parasite lines. For this isolate 
there was insufficient r i f  sequence data for the ex vivo trophozoites due to problems 
during sequencing.
For this isolate there was high diversity o f rifA transcripts in acute and HBEC- 
selected lines, with the cultured line showing a very homogenous transcription profile 
(Figure 5.20). The culture-adapted fraction had undergone three rounds o f rosette 
selection using Gelatin (0.75%) floatation to increase its rosetting frequency. Rosette 
selection was stopped because there was no change in rosetting frequency, from 6.8% 
at acute to 4.5% after the third round of selection on the culture-adapted parasites.
The dominant rifA in acute rings PF8443_8_8_U533400 was transcribed in 
trophozoites and schizonts in the cultured line, and in all stages in HBEC-selected 
lines but at lower levels. In the culture-adapted parasites a single rifA, 
P F 8 4 4 3 8 8 U 5 17800 dominated transcription in rings, early trophozoites and 
schizonts. In trophozoites a new dominant rifA PF8443_8_8_U293700 came up. This 
r i f  was transcribed in high levels in the HBEC-selected line, peaking in the 
trophozoite stage. Unlike for rifA there were multiple dominant rifB in rings all 
parasite lines. The two dominant rifB in acute rings PF8443_8_8_U 505900 and 
PF8443_8_8_U521100, were turned off in culture but were recovered after HBEC 
selection. There was a clear switch to a different dominant rifB between the cultured
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and selected lines. While PF8443_8_8_U484000, a rifB pseudogene predominated 
transcription in cultured parasites PF8443_8_8_U521100 dominated transcription in 
HBEC-selected line, peaking in the trophozoite stage (Figure 5.20).
Multiple stevor transcripts were highly transcribed in acute rings, but a dominant 
transcript PF8443_8_8_U501200 was detected in cultured rings, and a different one 
PF8443_8_8_U542300 dominated in HBEC-selected rings. Very similar profiles were 
observed in the cultured and HBEC-selected lines in the middle stages o f the IDC.
One stevor PF8443_8_8_U561500 was predominant in the cultured line, while two 
other transcripts PF8443_8_8_U542300 and PF8443_8_8_U488800 were more 
abundant in the HBEC line (Figure 5.20).
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Figure 5.20. r if  and stevor genomic repertoires and transcription profiling in 10668 
at acute rings and ex vivo trophozoites (top panel), at 4 time points in culture-adapted 
parasites (middle panel) and HBEC-selected parasites (bottom panel). The pies 
represent proportions o f  reads that mapped to rifA, rifB or stevor. Coloured regions 
o f  the cDNA pies represent transcripts that accountedfor 10% and above o f  the total 
expression in at least one time point, while in gDNA pies, coloured regions indicate 
genes whose read counts represent >10% o f  the total reads obtainedfrom  
amplification o f  matched cDNA. The table (B) list the dominant transcripts (genes 
that took up at least 10% o f  total transcripts at any time point). !: piecharts from  time 
points with insufficient sequence data.
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Certain rifs were preferentially upregulated under the different selection pressures.
The rifs in cluster 1 were upregulated in acute and cultured lines, with marginal 
upregulation in the HBEC-selected line. The most abundant rifA were clustered in this 
group, including the dominant rifA, PF8443_8_8_U517800 in the early stages in the 
culture-adapted line. Cluster 2, which contained two of the most abundant rifB was 
preferentially upregulated in the middle stages o f the IDC in HBEC-selected 
parasites. Cluster 4 was mostly up in acute while clusters 5 came up after HBEC 
selection. Cluster 6 was on in acute and HBEC-selected parasites (Figure 5.21. A).
For stevor few transcripts were significantly upregulated. Stevors in cluster 1 were 
upregulated in acute, cultured and HBEC-selected lines. Cluster 2 was off in acute 
and culture-adapted lines but upregulated after HBEC-selection. Cluster 3 was most 
upregulated in acute, stayed on in cultured parasites and switched off in the middle 
stages o f the HBEC line. Cluster 6 was predominantly upregulated in acute parasites 
Figure 5.21. B).
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Figure 5.21. He at maps showing r if  (A) and stevor (B) transcript upregulation 
(purple) and transcript abundance (orange) in a Kilifi isolate 10668, in acute rings 
(R°) and ex vivo trophozoites (1°), in the cultured line at 4 IDC stages, ring (R1), late 
ring to early trophozoites (P1), trophozoite (T1), and schizont (S1)  and in the HBEC- 
selected line, ring (R2), late ring to early trophozoites (P2), trophozoite (V), and  
schizont (S2). The left panel (purple) indicates log 10 fo ld  change transcript 
upregulation across the IDC. The right panel (orange) represents transcript 
abundance categorized into quartiles. The dendogram was generated by hierarchical 
clustering in R based on transcript upregulation patterns.
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5.6.4. R if  and stevor transcription in a rosetting culture-adapted wild
isolate SA075.
Analysis of r i f  and stevor transcription in a rosetting culture-adapted wild isolate 
SA075 was carried out to determine whether any r i f  stevor were associated with 
rosetting phenotype. The highly rosetting isolate was sampled from a patient with 
severe malaria anaemia residing in Kisumu, an area o f high malaria transmission. The 
acute sample was not available for this study therefore transcription profiling was 
done for the rosetting clone (R+) and the non-rosetting uncloned fraction (R-) at 4 
IDC stages.
A rifA pseudogene PFSA075_PN48 was dominantly transcribed in rings in both the 
rosetting and non-rosetting lines, and was sustained through the IDC in the non- 
rosetting fraction, with a second peak in the schizont stage. In the middle stages 
PFSA075_071800 came up in the R- while PFS A 075J 28200 and PFSA075_PN57 
dominated transcription in the R+ trophozoites and schizonts. The pseudogene 
PFSA075 PN48 was also highly transcribed in the R+ schizonts (Figure 5.22).
There was an observable difference in the rifB transcribed by the different parasite 
lines especially in the middle o f the IDC (Figure 5.22). In rings the dominant 
transcript was PFSA075_PN19 in R- and PFSA075_494000 in R+. PFSA075_PN19 
stayed dominant in R- late rings to trophozoites decreasing in abundance in schizonts. 
PFSA075_220500 was the dominant R+ late rings/early trophozoites, trophozoites 
and schizonts (Figure 5.22).
Stevor transcription profile was similar to rifB profile with a marked switch in the 
middle stage to a different dominant stevor after rosette selection. PFSA075_128400
288
was the dominant transcript in R+ late rings to trophozoites while PFSA075_493100 
was dominant in R- (Figure 5.22).
Similar results were previously obtained in the capillary data showing differential 
expression o f r i f  and stevor in rosetting and non-rosetting parasites especially at 
trophozoite stage (Chapter 4). Comparing the two data sets revealed a difference in 
transcripts abundance o f certain genes, due to the difference in coverage by the two 
methods but overall the dominant transcripts observed in the different parasite lines 
were similar in the two data sets.
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Figure 5.22. r if  and stevor genomic repertoires and transcription profiling in SA075 
rosetting clone (top panel) and non-rosetting fraction (bottom panel) at 4 time point across 
the IDC. The pies represent proportions o f  reads that mapped to rifA, rifB or stevor Coloured 
regions o f  the cDNA pies represent transcripts that accounted fo r  10%and above o f  the total 
expression in at least one time point, while in gDNA pies, coloured regions indicate genes 
whose read counts represent >10% o f  the total reads obtained from amplification o f  matched 
gDNA. The table (B) list the dominant transcripts (gene that took up at least 10% o f  total 
transcripts at any time point). *: pseudogene.
Differential transcript upregulation was observed for SA075 r if  PFSA075_PN48 falls out 
of the clusters because it is the only r//tha t was strongly upregulated (over 100 fold 
upregulation) in both the R+ and R- parasites. Clusters 2 and 3 were mostly upregulated 
in the R+ parasites with a slight upregulation in R- late rings/ early trophozoites and 
trophozoites. Cluster 4 was upregulated in the middle stages o f the R- parasites. Cluster 5 
was upregulated in R+ rings and R- schizonts. Cluster 6 was slightly upregulated in R+ 
more than in R-. Overall abundance and upregulation of r i f  transcripts were correlated 
(Figure 5.23. A).
stevor cluster 1 was uniquely upregulated in the non-rosetting fraction while cluster 2 was 
predominantly upregulated in the rosetting clone. Cluster 6 was only slightly upregulated 
in the rosetting clone (Figure 5.23. B).
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Figure 5.23. Heatmaps showing r if  (A) and stevor (B) transcript upregulation (purple) 
and transcript abundance (orange) in a rosetting Kisumu isolate SA075, in the rosetting 
clone (+) and the non-rosetting fraction (-) in 4 IDC stages, ring (R )/(R ), late ring to 
early trophozoites (P ) /  (P~), trophozoite (T ) /  (T), and schizont (S ) /  (S'). The left panel 
(purple) indicates log 10 fo ld  change transcript upregulation across the IDC. The right 
panel (orange) represents transcript abundance categorised into quartiles. The 
dendogram was generated by hierarchical clustering in R based on transcript 
upregulation patterns.
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5.7. Analysis o fpir  transcript diversity across the IDC in laboratory and
field isolates.
We used the Simpson’s diversity index to analyse homogeneity o f r i f  expressed across 
the IDC in different parasite lines. There was no clear pattern in transcript diversity 
across the isolates (Figure 5.24). As observed in the pie charts acute parasites showed the 
least homogeneity in r i f  expression. There was no consistent pattern in transcript diversity 
by stage. Some parasites, culture-adapted 10668, HBEC-selected 9106, SA075 R+ clone, 
IT and HB3, showed highest homogeneity in rings while others, 3D7, HBEC-selected 
10668 and culture-adapted 9106 showed highest homogeneity in the mid IDC stages. 
SA075 R- fraction had a divergent pattern with the least transcript diversity observed in 
rings and schizonts (Figure 5.24).
For stevor highest diversity was observed in rings with the middle stages having the least 
diversity. In schizonts there was a general decrease in homogeneity. Overall acute 
parasites showed higher diversity o f stevor transcripts than the corresponding culture- 
adapted and cultured and HBEC-selected lines (Figure 5.24).
289
A9106 Acute 
9106 Culture 
9106 HBEC
SA075 R+clone
S Genomic
3D7
IT
HB3
A. 9215 Acute 
9215 Culture 
9106 Acute 
9106 Culture 
9106 HBEC 
10668 Acute 
10668 Culture 
10668 HBEC 
SA075 R+ 
SA075 R-
I  1.......  ""I"
LR/ET T S
Developmental stage
Figure 5.24. Simpson’s diversity index for r if  (A) and stevor (B) transcripts across the 
IDC in laboratory and wild isolates.
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5.8. Discussion
Expression patterns of r if  and stevor genes have been analysed in laboratory isolates and 
in a few wild isolates and the evidence showed these genes to be expressed in multiple 
stages of the parasite life cycle, importantly in multiple stages of the IDC. These genes 
are not under mutually exclusive expression with multiple transcripts detected in a 
population and for stevor multiple transcripts have been detected in a single IE (Kaviratne 
et al., 2002). One study that carried out in depth expression profiles in 5 patient isolates 
revealed that there were 2 stages o f peak VSA expression at rings and trophozoites, with 
the same pir  variants in rings and trophozoites (Bachmann et al., 2012).
For other members of the pir  multigene family, cir, bir and yir, vir, expression studies 
have revealed that multiple variants are expressed in parasite populations, and in 
individual IE (Femandez-Becerra et al., 2005, Cunningham et al., 2009, Cunningham et 
al., 2010). A recent study on phylogeny and expression of pir  from rodent malaria 
parasites showed that distinct groups o fpirs were expressed in asexual and sexual stages 
of P. berghei, suggesting functional divergence (Otto et al., 2014a). In P. chabaudi A and 
B cir subgroups were expressed at similar levels in parasite populations, although the 
dominant transcripts belonged to the A subgroup (Lawton et al., 2012). In another study, 
mosquito transmitted parasites showed a more even transcription of many cir genes while 
continuously blood passaged parasites selected for expression o f a dominant cir and this 
resulted in increased virulence (Spence et al., 2013). This showed a direct link between 
pir gene expression and disease virulence.
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To understand P. falciparum pir gene expression, temporal transcription profiles were 
explored in laboratory and wild P. falciparum  isolates by deep amplicon sequencing. 
Dynamic expression patterns in the different isolates were observed. Clear temporal 
expression patterns were observed, with certain genes dominating expression at certain 
stages o f the IDC. Different dominant transcripts were observed at the early (ring), mid 
(trophozoite) and late (schizont) IDC stages. The clear temporal expression pattern 
suggests that some r if  and stevor function at specific stages o f the IDC. For instance, the 
genes transcribed in the early and mid trophozoites might be expressed on the surface o f 
the iRBC, while the transcripts that come up in late trophozoites and schizonts might be 
expressed on the surface of merozoites and play a role in immune evasion o f the 
merozoites or during invasion. A previous study identified two r i f  transcripts, 
PF3D7_0900500 (PFI0025c) and PF3D7_1300600 (PF13_0006), that were expressed in 
the early (early ring) and late (schizont) stages o f the parasite’s IDC (Wang et al., 2009). 
In a later study PF3D7_1300600 was shown to be expressed in late stage schizonts and 
the protein detected in merozoites and gametes (Mwakalinga et al., 2013). The early 
transcripts could be carried over mRNA from late stages o f the parasite IDC. The 
question as to whether or not these transcripts are translated into proteins is remains to be 
explored. There is evidence that mRNA half-life increases as parasites mature (Shock et 
al., 2007), mRNA from early stages is degraded much faster than in later stages. Whether 
this has an effect on protein expression levels is still unclear.
In the wild isolates the temporal expression pattern was observed but in addition, 
differential expression of pir  was observed under the different selection pressures. For 
rifA there was more even expression in ex vivo parasites, while culture-adapted and ^  
HBEC-selected or rosette-selected parasites had more focused expression to a few
dominant variants. For rifB and stevor the differential expression profiles was more 
evident, with distinct dominant variants in ex vivo parasites, and in culture-adapted and 
parasites selected for binding phenotypes (HBEC-binding and rosetting). A noteworthy 
observation was the differential transcription of r if  and stevor in the rosetting 
trophozoites. There is evidence of upregulation o f certain r i f  genes after selection for 
rosetting or binding to HBEC, but this is as a result of linked expression between UpsA 
var and their neighbouring UpsArif that share promoter regions (Claessens et al., 2011, 
Claessens et al., 2012). In our case the dominant r if  genes in selected lines did not belong 
to the UpsArif group, by BLAST analysis, and did not lie in close proximity to the 
upregulated var, although this will need to be verified after correction and manual 
curation of genome assemblies o f the wild isolates is done. This suggest that r i f  and 
stevor upregulation was independent o f var expression in the patient isolates. A recent 
study has shown that rifA (Goel et al., 2015) and stevor mediate rosetting (Niang et al., 
2014) and it is plausible that pir  genes are involved in cytoadhesion. The dominant stevor 
in 3D7 PF10_0395 was previously shown to bind to human RBC and mediate rosetting in 
A4 in the aforementioned study (Niang et al., 2014). Our 3D7 parasite line did not form 
rosettes to any notable degree, implying that other factors come into play to result in a 
specific adhesion property, including post transcription and translation regulations, and 
protein translocation to iRBC surface.
The number o f transcripts detected even in laboratory-adapted lines was notably high, 
suggesting an important role for post-transcriptional modifications in regulation o f pir  
expression. Posttranscriptional regulation for mutually exclusive expression was recently
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demonstrated for upsA var genes, which involved degradation of nascent RNA by the 
newly discovered exoribonuclease PfRNasell (Zhang et al., 2014). The detection of 
pseudogenic transcripts, some dominantly expressed in some isolates raise the question of 
the role of pseudogenes and whether pseudogenes may play a role in gene expression 
regulation.
There was a bias towards rifA transcription in laboratory isolates and in 3 out o f 4 
culture-adapted wild isolates. In the wild isolates there was an increase in rifB transcripts 
in the ex vivo and HBEC-selected parasites lines. This finding was unexpected because 
according to the current dogma rifB do not play a role in host-parasite interactions, and 
are not trafficked to the surface o f iRBC. Therefore the expectation was that rifB would 
be downregulated in ex vivo parasites. Previous studies suggested that rifA and rifB had 
diverged functionally, with rifA playing a role in host-parasite interactions on the surface 
of the iRBC and rifB staying inside the PVM (Petter et ah, 2007). In a case study o f one 
splenectomized patient it was shown that all VS A except rifB and pfmc2tm  were switched 
off and mature parasites were found in peripheral circulation (reflecting lack of 
cytoadhesion). These parasites did not bind the common endothelial receptors suggesting 
that the rifB and pfmc2tm do not play a role in adhesion to endothelial cells (Bachmann 
et ah, 2009). Our data indicates that rifB were upregulated in ex vivo parasites and 
selected lines, but turned off in culture, suggesting a function within the host 
environment. In addition there was restricted diversity o f rifB transcripts, with a single or 
few dominantly expressed. Further studies on localisation and binding might elucidate the
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role o f these highly expressed rifB, after validating their upregulation either by whole 
transcriptome sequencing or quantitative realtime PCR.
In line with previous studies, upregulation of UpsA var genes in 3D7 was linked with the 
upregulation of the neighbouring r i f  gene in rings. This could be as a result o f switching 
on of the strong var promoter, because the transcription pattern of the rifAl was similar to 
that of var. It has been shown that UpsA associated r i f  are upregulated in parasites that 
express their associated var (Wang 2009, Claessens 2012). Three members o f this 
conserved group of rifs in 3D7 PF13_0004, PF11_0009 and PF11_0520 were the most 
prominent transcripts in 3D7 rings, but not in the mid and late stages. From the transcript 
upregulation data, the UpsA r i f  PFD1230c, was the most upregulated r if  in 3D7 rings.
The neighbouring var PFD1235c that is in head-to-head orientation with this r i f  was the 
second most dominantly expressed var gene by tag analysis (Andisi et al., personal 
communication). In fact three o f the four UpsA r i f  recovered in our analysis cluster 
together in cluster 4 by transcript upregulation pattern (Figure 5.10) suggesting they have 
similar transcription patterns, with highest upregulation in the early stages, lowest in mid 
and late trophozoites and slight increase in schizonts. The observed increase in transcript 
upregulation in schizont stage is most likely due to contamination o f the schizonts with 
rings, as the cultures lost synchrony towards the end of the IDC (see Appendix table 9.5, 
parasite staging).
A highly transcribed IT pseudogene lies in a conserved region between a conserved r i f  
and the conserved varlcsa. In 3D7 this region on chromosome 5 is also conserved with a
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conserved n /P F E l 630vv and the varlcsa  PFE1640w. The fact that the r if  pseudogene is 
transcribed in the early stages of the IDC, similar to var transcription timing raises the 
question whether there is a link in transcription for genes in close proximity even though 
they are not in head-to-head orientation. Epigenetic regulation o f gene expression may 
play a role. Studies on transcription regulation have shown that nuclear positioning is a 
factor for var gene transcription regulation and this might be true forpir  genes.
It is important to note that isolates that were selected for rosetting phenotype by gelatin 
floatation had a very restricted r i f  transcript diversity, with a few transcripts dominating 
in certain stages of the IDC. In IT, three rifA transcripts dominated most of the IDC, a 
pseudogene in the early stages, and two intact rifA in the mid and late stages. A single 
rifB dominated from late rings to schizonts. In 10668 cultured line that underwent rosette 
selection (but never displayed any significant rosetting capacity), a single rifA dominated 
transcription in the first half o f the IDC. In SA075, for both the rosetting and non- 
rosetting parasites, one rifA dominated the early stages. rifB transcription was restricted 
to a single dominant transcript in the mid and late stages. Similarly stevor transcription 
was also restricted to some extent, after selection using gelatin. For the few isolates in 
our study that underwent selection, it appears as though contact with gelatin modified r i f  
and stevor transcription. This is from the observation that all parasite isolates that 
underwent rosette selection using gelatin had a switch in preference to rifA expression 
(Figure 5.8. C, F and G). Our rosette enrichment protocol utilizes gelatin floatation to 
separate out the high density rosettes already formed in culture. This switch by selected 
parasites to predominantly expressing rifA could be as a result o f parasites coming into 
contact with gelatin itself, or as a result of selection of a subpopulation o f the
parasites that formed rosettes. This effect will need to be validated further with other 
isolates.
A major limitation o f this study was our inability to capture the complete r i f  and stevor 
repertoire using the degenerate primers. The primers, which were designed on 3D7 
genome, performed much better in Kenyan isolates and IT that they did in HB3. Still a 
minor proportion of the r i f  and stevor repertoire was not captured. Therefore there still 
remains a gap in describing transcription o f r i f  and stevor in wild isolates that can only be 
filled using transcriptomics. This study has provided a first exploration of r i f  and stevor 
transcription in patient isolates under different selection pressures.
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CHAPTER 6
6. De novo assembly of r i f  and stevor amplicon sequencing reads: An alternative 
analysis of 454 sequence reads in the absence of whole genome data.
6.1. Introduction
This chapter follows on from Chapter 5 on analysis of pir  (r if  and stevor) amplicon 
sequence data generated using the 454 sequencing platform. The focus of this chapter is 
the de novo analysis of 454 sequence data by contig assembly. The data presented was 
generated from pir  amplicons from P. falciparum  field isolates that lacked whole genome 
sequences. Therefore analysis o f reads by directly mapping them onto a homologous 
genome was not possible. Because of suboptimal 454 sequencing runs (Figure 5.3) many 
reads obtained were short and did not span full-length r i f  or stevor amplicons (Figure 
5.2). De novo assembly of reads into contigs that would potentially cover the full-length 
pir amplicon was done using the Newbler assembly package. Newbler assembler merges 
short reads to form a long contig by identifying the best sequence overlaps between the 
reads.
The pir  genes are highly variable, especially the r i f  gene family, which has few conserved 
orthologs across different parasite repertoires. The stevor genes are relatively conserved 
especially the major group stevorA (as discussed in Chapter 3). For this reason analysis of 
next generation sequence data by mapping onto non-homologous reference genomes 
could be inaccurate, as only a small proportion o fpirs would map. Whole genome 
sequence data from wild parasite isolates is now available from a large global collection
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of isolates, but the VS A data from these is still sparse because of the difficulty in 
assembly of short NGS correctly into full length VSA. For this reason laboratory lines 
such as 3D7 are still used as reference. Therefore analysis of pir  expression from patient 
isolates is inherently difficult. De novo assemblies of 454 read data provided a robust 
alternative approach to analyse r if  and stevor expression in wild isolates.
6.2. Objectives
i.) Optimize protocol for de novo contig assembly of pir  reads from 454- 
amplicon sequencing.
ii.) Account for sequence errors and length differences in the de novo 
assembled contigs using a combination o f CD-HIT clustering and BLAST.
iii.) Analysis o f pir  expression profiles through a single ex vivo blood stage 
cycle in clinical isolates.
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6.3. Methods
The methods used in this chapter are described in Chapter 2 and in Chapter 5 Methods. 
The data analysed in this chapter was obtained by 454 amplicon sequencing of pir  genes 
from 3D7 and patient isolate IDC time series samples. The parasite isolates used are 
described in Chapter 5, Figure 5.1. and Table 5.1. In brief, 3D7 time course RNA was 
extracted from synchronous cultures at 6 time points across a single 48-hour blood stage 
cycle, and gDNA from asynchronous cultures. 8383, a culture-adapted Kilifi isolate with 
poor whole genome sequence data had been obtained from an ongoing study on var 
expression led by Dr. Peter Bull. RNA had been extracted from isolate 8383 rings 
sampled at the acute stage of infection, and trophozoites, sampled 24 hours after growth 
in culture (ex vivo). In addition, RNA was extracted from four asexual stages o f the 
culture-adapted 8383 isolate, rings (R), late rings to early trophozoites (LRET), mid to 
late trophozoites (T) and schizonts (S). For the Kilifi ex vivo isolates the time course 
experiment was carried out by culturing the isolates for a single IDC. RNA was extracted 
at 7 time points every 10 hours across the IDC (Appendix table 9.5). The parasites and 
time points for which pir  amplicon sequencing was done are summarized in Table 6.1. 
Preparation of cDNA was carried out as described in Chapter 2, sections 2.6.1 and 2.6.2. 
Purified amplicons were sequenced using the 454 sequencing platform at WTSI as 
described in Chapter 2, section 2.8. For many of the ex vivo patient isolates only limiting 
amounts o f RNA and DNA were available for pir  amplification and sequencing. For this 
reason many samples had to be artificially loaded with carrier DNA of bovine origin 
(from the 454 sequencing team at the Sanger Institute) to make up to required starting 
amplicon quantities o f 1 OOng total DNA per sample.
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6.3.1. Newbler assembly of 454 reads
Assembly of 454 reads into contigs was carried out using Newbler assembler version
2.5.3 in a script (done by Dr. Etienne de Villiers, KWTRP head o f bioinformatics, See 
Appendix, script 9.1). The assembly was run using default newbler parameters (appendix 
9.1). In summary, the following basic parameters were used, minimum read length o f 20 
nucleotides for the input, a minimum overlap length of 40 nucleotides with 90% identity 
within the overlap region. The minimum input length of 20 nucleotides was not altered 
in the newbler script because the restriction on the length o f overlap, 40 nucleotides, as 
well as the minimum output length of 100 nucleotides would ensure that we obtained 
contigs longer than 100 nucleotides for downstream analysis.
6.3.2. Cleaning up de novo assembled contigs.
The de novo assembled contigs contained many non-target sequences. These non -pir 
sequences were made up o f contaminants from non-specific PCR amplifications (arising 
because o f the highly degenerate primers used to capture the diverse pir  gene families), 
bovine carrier DNA (added to amplicons that did not meet the required concentration for 
sequencing), human and bacterial DNA.
For the r if  contigs, these non-target sequences were identified by a combination of 
multiple sequence alignments, clustering using networks and the CD-HIT algorithm (Li 
and Godzik, 2006), and a BLAST analysis o f all contigs against NCBI nr nucleotide 
database and our r i f  database containing r if  sequences from sequenced genomes and 
partial repertoires from published and unpublished data, and from our capillary
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sequencing data (described in Chapter 4). For stevor an initial BLAST search against 
NCBI nucleotide nr database enabled identification o f non-stevor contigs.
6.3.3. Clustering r i f  and stevor contigs 
An online web server CD-HIT suite (http://weizhong-lab.ucsd.edu/cdhit_suite/cgi- 
bin/index.cgi) (Huang et al., 2010) was used for clustering of contigs to obtain unique r i f  
and stevor variants. The CD-HIT clustering algorithm used is based on greedy 
incremental clustering. The contigs were first sorted by length with the longest sequence 
designated as the cluster representative. All sequences were then compared to the first 
cluster representative. If the similarity was above that of the set threshold then the 
sequence would be grouped into that cluster. If the similarity fell below the set threshold 
the sequence would become the representative o f the next cluster. Short word filtering 
was used to determine similarity between sequences. If sequence similarity could not be 
confirmed by short word filtering then an actual alignment was done (Huang et al., 2010, 
Li and Godzik, 2006). Further clustering was done to collapse sequences into only unique 
contigs. The cluster representatives from CD-HIT clustering were searched against r i f  
and stevor databases by MEGABLAST in Geneious v 6.1.5. Sequences with a BLAST 
hit above 96% pairwise identity were grouped into one cluster.
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6.4. Results
6.4.1. 454 amplicon sequence reads assembly.
All the reads from the successful 454 sequencing runs (563,980 reads from r if  amplicon 
sequencing and 793,118 reads from stevor amplicon sequencing) were assembled into 
contigs using Newbler software carried out in house. The parameters with which the 
assembly was run are described in the methods section above. Assembly was carried out 
for each isolate per sample (time point). Therefore for each time point a set of contigs 
was obtained. The contigs were named to reflect the isolate name, gene {rif or stevor), 
isolate sample type, whether acute (AC), cultured (CU), or selected for binding to human 
brain endothelial cell lines (HB), time point of RNA sampling, stage and sequence run. 
For example the first r i f  contig from 3D7 early ring sample would be named 
PF3D7_RIF_CU_00_ER_3_1. A total of 8246 and 2601 contigs from r if  and stevor 
amplicon sequencing respectively were assembled (Table 6.1 and Figure 6.2 and 6.3).
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Figure 6.1. Length distribution graphs fo r raw reads and assembled and cleaned 454 
contigs from r if  (left) and stevor (right). A) Raw 454 reads from all amplicons sequenced 
prior to assembly, 563,980 r if  reads (left) and 793,118 stevor reads (right). B) Newbler 
assembled contigs after removal o f  non-target sequences from all the isolates, 7931 r if  
contigs (left) and 2625 stevor contigs (right).
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6.4.2. Cleaning up r if  and stevor de novo assembled contigs.
Cleaning up the contigs by using BLAST was carried out to remove non-target 
sequences. A total of 8246 r if  and 2601 stevor contigs were assembled from the 454 
amplicon sequencing reads above. An initial BLAST analysis o f all contigs against NCBI 
nucleotide nr database identified 80 non-target sequences from r i f  contigs and 75 non­
target sequence from stevor contigs (Figures 6.1 and 6.2). The remaining 8166 rif and 
2526 stevor contigs were searched against r i f  and stevor databases that contained 
sequences from laboratory and field isolates from Brazil, Gabon and Kenya, as well as 
amplicon sequences from Kenyan isolates generated by capillary sequencing (discussed 
in Chapter 4). For stevor all the remaining contigs had matches to stevor sequences in our 
database. For r i f  108 contigs had no hit after BLAST searches for the remaining 8166 
contigs against r i f  database. Because o f the high diversity within the r i f  gene family it is 
possible that some divergent r i f  contigs had no match to any o f the rif'm  our database. A 
better approach was used, where all the 8166 contigs were clustered using networks and a 
representative sequence from each cluster was searched by BLAST against the NCBI 
nucleotide nr database. O f these contigs 7955 hit against r i f  sequences, with the rest 
hitting sequences from other Plasmodium genes, human genes and bovine genes. The 
remaining 7955 contigs were clustered (discussed in subsequent section). MEGABLAST 
analysis was run for each cluster was against our r i f  database as well as NCBI nucleotide 
nr database. This searches identified an additional 24 non-rif contigs. The remaining 7931 
contigs had matches to rifs in our database (Table 6.1).
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Figure 6.2. Flow diagram o f  r i f  contig analysis fo r  amplicons, from  all the isolates, 
sequences by 454. 8246 contigs were obtained by assembling 454 reads from r if  
amplicons. After cleanup 7391 r i f  contigs were obtained. These contigs were clustered 
into 1685 unique r if  variant types, using CD-HIT. The total number o f  unique variants 
from  all the isolates was 1997.
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Figure 6.3. Flow diagram o f  stevor contig analysis. 2601 contigs were obtained by 
assembling 454 reads from stevor amplicons from  all the isolates, sequences by 454. 
After cleanup 2526 stevor contigs were obtained. The contigs were clustered into 322 
stevor variant types using CD-HIT. A second BLAST analysis against a database o f  all 
stevor from published and unpublished repertoires collapsed the number o f  unique 
variants from all isolates to 287.
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The non-target sequences from r if  contigs were predominantly made up of the carrier 
DNA of bovine origin that was added to samples of low concentration prior to 
sequencing (Figure 6.4.A). The second most abundant contaminant was other P. 
falciparum  genes including 18s and 28s ribosomal RNA (rRNA) that were non- 
specifically amplified by the primers. For stevor the predominant contamination was 
from human genomic material followed by other Plasmodium genes mostly ribosomal 
RNA (Figure 6.4.B). Two var gene sequences were recovered from contigs assembled 
from stevor amplicons.
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Figure 6.4. Composition o f  contigs generated by de novo assembly o f  reads from  r if  (A) 
and stevor (B) amplicons from 3 laboratory and 11 wild isolates, pir sequences (blue 
region o f  the pie chart) were predominantly recovered but there was a small number o f  
non-target contaminating sequences displayed in the bar graph.
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Table 6.1. Summary o f  de novo assembly o f 454 sequence reads from r if  and stevor 
amplicons from 3D 7and wild isolates that lacked WGS data.
Isolate
rif (563,980 reads) stevor (793,118 reads)
Total contigs rif contigs
Unique rif 
contigs Total contigs stevor contigs
Unique stevor 
contigs
3D7 532 508 126 180 180 29
8383 692 686 137 189 180 21
10727 382 362 193 166 163 44
10735 196 181 124 28 28 27
10739 173 155 137 30 30 30
10747 417 410 241 203 201 53
10761 340 319 206 43 43 27
10814 383 355 355 121 112 56
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6.4.3. Clustering r if  and stevor de novo assembled contigs into unique 
sequence types.
The assembly o f reads into contigs was carried out per sample (i.e. per time point) as 
described earlier (Section 6.3.1). A set of contigs was therefore obtained from each time 
point within an isolate. In order to relate the contigs to one another across the whole time 
series dataset, and to account for abundant sequence errors, r i f  and stevor contigs were 
clustered by percent sequence identity resulting in unique contigs that represent different 
pir variants. This was important to enable temporal expression analysis of pir variants 
across time points as well as across isolates. The online CD-HIT application was used for 
sequence clustering, using cd-hit-est (Huang et al., 2010) (Figure 6.2 and 6.3). The 
application clusters sequences based on a set identity threshold (see section 6.3.3 above). 
The sequences are ordered by length and the longest sequence becomes the cluster 
representative. All sequences are compared to the representative and if they fail to meet 
the identity threshold they form the representative of the next cluster. In this way clusters, 
which represent unique gene variants, are generated with the longest sequence within the 
cluster as the cluster representative.
6.4.4. Determination of sequence identity thresholds using the 3D7 rif/stevor 
repertoire in order to derive unique variant types
In order to collapse all the pir  contigs into unique clusters it was important to identify the 
optimal similarity threshold for the CD-HIT clustering algorithm. Because of the high 
error rates o f 454 sequencing a very high clustering stringency resulted in non-unique pir  
clusters (Figure 6.5). 3D7 was used to optimize clustering stringency because both
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mapping data from 454 amplicon sequencing as well as whole genome sequence data was 
available. Reads from 3D7 amplicon samples were assembled into 511 r if  and 180 stevor 
contigs. The contigs were clustered using CD-HIT with identity thresholds between 80% 
and 100% (Figure 6.5). The clustering stringency was considered to be optimal when the 
number of clusters from the 454 de novo contigs was equal to the number o f clusters 
from the unique pir  variants observed in the mapping data. The mean percent pairwise 
identity cutoff was set at 97% for r i f  and 95.3% for stevor.
All the contigs were then clustered using the thresholds identified above initially 
resolving into 1954 unique r i f  from the 7955 contigs, and 322 unique stevor from the 
2526 contigs ( 6.2 and 6.3). A limitation that the clustering approach was not able to 
resolve was the short read lengths obtained after 454 sequencing (see Chapter 5 Figure
5.3 and 6.3 above). The short reads assembled into short contigs much shorter than the 
expected length o f r if  and stevor amplicons (Chapter 5 Figure 5.1). Therefore some of the 
unique contigs identified might represent non-overlapping'fragments o f the same gene. 
For this reason a second BLAST search against our r if  and stevor database was carried 
out to further cluster sequences into truly unique variants. The BLAST analysis enabled 
identification of 24 non-rif sequences from the 7955 rif contigs, which were discarded 
from the analysis. The remaining 7931 contigs were clustered at 97% identity cutoff 
resulting into 1685 unique clusters (Figure 6.2). Some of the unique r i f  genes were 
conserved across isolates and therefore the contigs were split up into their respective 
isolates of origin resulting in a total o f 1997 unique r i f  clusters (Figure 6.2). For stevor 
contigs the 322 clusters were further collapsed into 287 unique clusters (Figure 6.3).
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Figure 6.5. Plot showing the number of3D 7 r i f  (A) and stevor (B) clusters obtained by 
running CD-HIT at different identity thresholds (80-100%), on 454 de novo assembled 
contigs (blue line), pirs recovered from 454 mapping data (red line) and genomic pir 
repertoires from 3D7 v3 genome (black line). The green arrows indicate the optimal 
clustering thresholds fo r  r i f  (97%) and stevor (95.3%) where the blue line (de novo 
contigs) touched the red line (unique r if  by from 454 mapping data).
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6.4.5. Validation of the de novo assembly analysis approach.
A comparison of the results obtained by de novo assembly of contigs and mapping reads 
onto the genome was carried out to determine whether similar repertoire coverage and 
transcript abundance were attained. The comparison was based on 3D7 amplicon 
sequence reads.
For both r i f  and stevor similar overall results were observed (Figure 6 .6 .1), with only 
slight differences in proportions of certain genes in some time points. For r if  the similar 
dominant transcripts were observed, with the exception o f a few, with high correlation 
between results obtained by the two methods (Figure 6.6. II). The most notable difference 
was in the mid trophozoite stage (MT) where the dominant rifB  PF3D7_1372600 by 
mapping was not recovered in the de novo analysis data. One rifA transcript,
PF3D7_011560 that predominated expression in the early trophozoites in the mapping 
data (11% transcript abundance) was not as highly expressed in the de novo data (7% 
transcript abundance). Another rifA PF3D7_110030 that was not highly expressed in the 
mapping data came ups as a dominant transcript in the de novo data (11% transcript 
abundance) at the late ring stage (Figure 6 .6 .1 and III). For stevor transcript abundance 
across the time points was similar. The major difference was in the gDNA where the 
correlation between de novo and mapping data was much lower (0.387) than in the 
cDNA (Figure 6.7. II). This was mainly caused by the difference in recovery o f one gene 
PF3D7 0101800. This stevor gene was abundant in the mapping data (9% of gDNA 
reads mapped) but was completely missed in the de novo assembly data. Additionally 
there was a significant difference in the number of reads assigned to one gene 
PF3D7_1479500 in the mapping data (6% of gDNA reads mapped) which was only
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recovered at low abundance in the de novo data, with only 1% of the gDNA reads 
belonging to this gene (Figure 6.7.1 and III).
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ER LR ET MT LT S G
3D 7 rif ER LR ET MT LT S G
C orrelation  b e tw e e n  m ap p in g  and  d e n o v o  d ata 0 .9 5 9 0 .9 7 2 0 .9 5 6 0 .9 8 2 0 .9 9 0 0 .9 7 7 0 .9 1 1
Total reads by mapping 3877 6290 4407 3642 4702 4432 4904
Total reads by de novo assembly 2786 4465 3208 2294 3156 2917 3608
Number of unique variants by mapping 102 121 100 103 113 104 115
Number of unique variants by de novo assembly 48 79 47 54 74 62 101
Label r if /s te v o r Cluster ID New ID Old ID n/A/B
rif RIF_0193 PF3D7 1300400 PF13 0004 A
rif RIF_0326 PF3D7JL150300 PF11_0520 A
rif RIF_0280 (a) PF3D7_1100300 PF11_0009 A
____ rif RIF_0336 PF3D7_0701100 new rifA A
rif RIF_0284 PF3D7 0425900 PFD1240w A
rif RIF_0001 PF3D7_0421500 PFD1020C A*
rif RIF_0294 (b) PF3D7_0115600 PFA0760W A
rif RIF_0255 PF3D7_1200500 PFL0025C A
rif RIF_0537 PF3D7_1400300 PF14_0003 B
rif RIF_0277 PF3D7_1000300 PF10_0003 B
rif RIF_0409 PF3D7_0701200 new rifB B*
rif RIF_0043 PF3D7_1000600 PF10_0006 B
____ rif RIF_0276 PF3D7_1300600 PF13 0006 B
rif RIF_0395 PF3D7_0900500 PFI0025C B
rif NA (c) PF3D7_1372600 MAL13P1.495 B
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Figure 6.6. (I) r if  transcript abundance by (A) de novo assembly o f  reads into contigs (B) 
mapping o f  reads onto the genome. The pies represent proportions o f  reads that mapped 
to rifA (top panel) and rifB (lower panel Coloured regions o f  the cDNA pies represent 
transcripts that accounted fo r  10% and above o f  the total expression in at least one time 
point, while in gDNA pies, coloured regions indicate genes whose read counts represent 
>10% o f  the total reads obtained from amplification o f  matched cDNA. (II) Correlation 
between r if  transcript abundance by de novo contig assembly and mapping. (Ill) Table 
showing most abundant r i f  transcripts by both analysis methods.
a - PF3D7_1100300, a dominant rifA transcript in LR in de novo data (11% o f  the 
proportion) but not dominant by mapping data (9%) .
b — PF3D7_0115600, a dominant rifA transcript in ET in mapping data (11% 
proportion) but not dominant in the de novo data (7%).
c -  PF3D7_1372600 a dominant rifB transcript in M T in the mapping data (33% 
proportion) but completely missing in the de novo data.
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II Time point ER LR ET MT LT S G
corelation between mapping and de novo data 0.998 0.995 0.997 0.995 0.998 0.997 0.387
Total reads by mapping 2340 4714 2212 3046 2873 4093 2231
Total reads by de novo assembly 2032 3914 1783 2372 2466 3509 1495
Number of unique variants by mapping 28 28 29 27 28 27 29
Number of unique variants by de novo assembly 27 27 19 20 25 27 28
III Label Cluster ID New ID Old ID
STE 454 006 PF3D7 0617600 PFF0850C
STE 454 001 PF3D7 0401500 PFD0065w
STE 454 038 PF3D7 1040200 PF10 0395
STE 454 092 PF3D7 0901600 PFI0080W
STE 454 082 PF3D7 1479500 PF14 0767
Figure 6 .7. (I) stevor transcript abundance by (A) de novo assembly o f  reads into contigs 
(B) mapping reads onto the genome, a: (II) Correlation between stevor transcripts 
abundance by de novo contig assembly and mapping reads to the genome. (Ill) Table 
showing most abundant stevor transcripts that were similarly recovered by both analysis 
approaches.
a: stevor PF3D7 1479500predominantly recovered in 3D7gDNA amplicon sequence 
data by mapping but very few  reads by de novo assembly o f  contigs.
6.4.6. Analysis o fpir  expression profiles in patient isolates.
To analyse r i f  and stevor expression profiles in the patient isolates unique pir  contigs 
from the de novo assembly data were considered as unique variants. For each isolate a set 
of unique variants (unique contigs) were generated. Transcript abundance for each unique 
variant was determined from the number of reads that were used in generation o f the 
contigs. For contigs that were collapsed by CD-HIT clustering or by BLAST analysis the 
number o f reads that generated the contigs were summed up.
For many o f the patient isolates the amount and quality o f RNA and DNA was low, 
therefore amplifying pir  genes from this material was problematic, and completely failed 
for some samples. In addition the significant setback encountered during 454 sequencing 
where two sequencing runs failed and the successful run resulting in suboptimal read 
lengths subsequently lead to poor sequence data (discussed in Chapter 5). Due to these 
limitations the data on pir  repertoires and transcription patterns described in subsequent 
sections was incomplete for some patient isolates (Table 6.2). For the samples with 
adequate data transcript abundance was analysed for each contig, the contigs representing 
unique pir  variants. Transcript abundance was considered the proportions o f reads that 
went into assembly o f a contig out o f the total number o f reads of all the contigs in a time 
point.
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Table 6.2. Summary o f  the 454 de novo assembled contigs data from patient parasite 
isolates.
Isolate
Clones by 
MSP2 
genotyping
rif stevor
IDC stage Total reads
Reads 
assembled 
into contigs
Unique rif 
contigs Total reads
Reads 
assembled 
into contigs
Unique stevor 
contigs
8383 Acute 1
R 1425 973 48 5510 4304 17
T 2296 2110 83 18573 17857 20
Genomic 2443 1804 96 11399 9233 19
8383 Culture- 
adapted 1
R 2459 1884 48 X X X
LR/ET 2614 1684 46 7,334 5898 16
T 2877 1776 55 7,869 5141 13
S 3819 2558 64 6,077 3914 18
Genomic 2352 1596 98 2268 1686 17
10727 1
ER ns ns ns 782 465 14
R 1257 308* 14 7790 6890 29
T 3186 2108 77 6888 7406 29
S 1328 40* 6 6390 5562 30
Genomic 3424 3269 170 6512 5668 29
10735 nd
MR! 4238 258* 32 ns ns ns
LR/ET 443 155* 9 ns ns ns
ET 2489 448* 27 ns ns ns
Genomic 3808 2406 109 3517 2957 27
10739 4
R 3080 56* 7 ns ns ns
T 1875 162* 15 ns ns ns
Genomic 7129 5023 129 6725 6464 30
10747 4
RN 4153 2671 111 6103 5509 46
ET 3413 2045 134 5056 4343 47
ND-60 2481 1463 105 6190 5278 46
Genomic 8694 301* 35 7492 6589 49
10761 1
MR 2603 653 41 ns ns ns
ET ns ns ns 2853 2125 13
LT 4464 32* 5 ns ns ns
S-ER2 3247 2873 123 1391 1111 26
Genomic 2645 1683 125 ns ns ns
10814 2
ER 6664 2043 41 ns ns ns
RN 1993 185* 21 2579 1473 38
MR 2407 211* 17 ns ns ns
LR 1580 52* 4 ns ns ns
PR 3745 1983 46 2108 1548 21
ET 2803 513 41 ns ns ns
Genomic 4597 3221 176 4554 4131 50
ER: early rings
RJ RN: rings
MR: mid rings
LR: late rings
ET: early trophozoites
PR: late ring to early trophozoites
T: trophozoites
S: schizonts
*: Sub-optimal read depth (<500 reads)
ns: no sample (cDNA or gDNA sample or amplicon)
x: sequencing failed
6.4.7. Differential expression of pir  genes in a patient isolate before and 
after culture adaptation.
A field isolate 8383 sampled from a patient with non-severe malaria that had been 
culture adapted was obtained from an ongoing var study (led by Dr. Pete Bull). 
Expression profiling for r i f  and stevor genes was carried out in the ex vivo ring and 
trophozoite samples, and at four time points across the IDC in the culture-adapted 
parasite line to test the effects o f different selection pressures on pir  gene expression. 
There was a clear difference between ex vivo parasites and culture adapted parasites 
in rifA expression. Four dominant transcripts were observed in rings, one o f which 
was shared between the acute and cultured parasite lines (Figure 6.8). The dominant 
rifA transcript in ex vivo rings 454 RIF 0002 is conserved in IT, DD2, HB3 and 5 
Kenyan isolates. The ortholog o f this n/PF8443_8_7_U439800 was also 
predominantly expressed in ex vivo rings of a severe malaria isolate 9106 (discussed 
in Chapter 5). The dominant rifA transcript cultured rings 454_RIF_0080 remained 
dominant in cultured late ring and early trophozoites and schizonts. In ex vivo 
trophozoites no clearly dominant rifA was detected but in the cultured trophozoites 
the conserved pseudogene 454_RIF_0001 (PF3D7_0412600 in 3D7) predominated 
expression. Similar dominant rifB transcripts were observed in acute and cultured 
parasites, with the exception o f PF3D7_0711900 that was only seen in the cultured 
rings, and 454_RIF_0286 mainly recovered in the cultured schizonts (Figure 6.8).
For stevor a very strict stage-specific expression profile was observed. There were 
clearly different dominant transcripts at the different.stages. 5 dominant stevor 
transcripts were detected in acute rings, one o f which was a conserved stevor 
pseudogene 454_STE_001 (PF3D7_0401500 and PFIT_0400200 in 3D7 and IT 
respectively), which was predominantly expressed in 3D7 (Figure 6.7) and IT (Figure
5.12) rings, and in HB3 in the mid and late stages (Figure 5.14). This pseudogene 
dominated stevor expression in both the acute and cultured trophozoites. 3 new 
dominant transcripts were observed in the cultures schizonts. For stevor there was a 
bias towards the gene STE_454_103 based on the number o f gDNA reads assigned to 
this gene (Figure 6.8). This gene came up as a dominant ring transcript in the acute 
parasite but this could have been as a result of the bias.
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Figure 6.8. r if  and stevor genomic repertoires and transcription profiling in an ac 
and culture-adapted patient isolate 8383 at ex vivo rings trophozoites (top pane after 
culture adaptation at 4 time points rings, late ring to early trophozoites (L trophozoites 
and schizonts. (A) Piecharts representing proportions o f  reads that 
up the rifA (top panel), rifB (middle panel) or stevor (lowerpanel) de novo as contigs. 
Coloured regions o f  the cDNA pies represent transcripts that account 10% and above o f  
the total expression in at least one time point, while in gDNA coloured regions indicate 
genes whose read counts represent >10% o f  the tot obtained from  amplification o f  
matched cDNA (see table below). (B) Table showi the dominant transcripts (>10% o f  
total transcript abundance) at any time poi the BLAST search results against rif/ stevor 
databases.
6.4.8. R i f  and stevor transcrip t upregulation in a patient isolate (8383). 
Analysis of pir  differential expression was carried out using DESEQ in R (described 
in Chapter 5). Upregulation was defined as the number of reads from cDNA divided 
by the number o f reads from gDNA.
The temporal expression pattern of r i f  genes could be seen from transcript 
upregulation analysis (Figure 6.9. A), r i f  genes in cluster 1 were upregulated at all 
stages in the acute and culture-adapted parasite lines. Cluster 2 r i f  genes were mostly 
upregulated in the cultured parasite line, at ring, trophozoite and schizont stages. 
Cluster 3 was mostly up in trophozoite stages in the acute and cultured parasites, 
although a subset was upregulated in acute rings. Cluster 4 was upregulated in the 
early stages, in acute rings and cultured rings and late ring/ early trophozoite stage. 
Cluster 5 stayed low through out the IDCs o f acute and cultured parasites.
There was good correlation between transcript abundance and transcript upregulation 
for stevor from 8383 (Figure 6.9.B). Stevor clustered into 3 groups based on transcript 
upregulation. Genes in cluster 1 were upregulated in all time points but peaked in 
trophozoites o f the cultured parasites. This cluster was made up o f the dominant 
stevor transcripts (Figure 6.8). Cluster 2 was upregulated in schizonts o f the cultured 
line while cluster 3 was not upregulated at any stage.
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Figure 6.9. Transcript upregulation o f  pir genes in acute and culture-adapted Kilifi 
patient isolate 8383. Heatmaps showing r if  (A) and stevor (B) transcript upregulation 
(purple) and transcript abundance (orange) in ex vivo rings (R°) and trophozoites (I*1)  
and in cultured parasites at 4 IDC stages, ring (R1), late ring to early trophozoites 
(P1), trophozoite (T1), and schizont (S1). The left panel (purple) indicates log 10 fo ld  
change transcript upregulation across the IDC. The right panel (orange) represents 
transcript abundance categorized into quartiles. The dendogram was generated by 
hierarchical clustering in R  based on transcript upregulation pattern.
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6.4.9. Pir expression profiling in patient isolates.
Expression patterns of r if  and stevor genes were analysed in 6 ex vivo parasite isolates 
through a single IDC. The ex vivo time point samples had been collected for an 
ongoing microarray study (led by Dr. Margaret Mackinnon) as previously discussed 
(Chapter 5). For many of the patient isolates analysed in this section only small 
amounts o f RNA were available for the p ir  expression study. For this reason there 
were gaps in the pir  genomic and expression data in the patient isolates, a major 
limitation in the analysis as described above (see table 6.2). For some samples there 
was adequate data to analyse p ir  expression across time points (Figure 6.10 and Table 
6.3). Transcript abundance was analysed from the available data but transcript 
upregulation could not be analysed because o f the missing time points as well as few 
number o f reads from the available time points and gDNA samples.
As previously observed r i f  expression varied across IDC stage in an isolate specific 
manner (Figure 6.10). For the isolate 10727 there was limited data for rings and 
schizonts (308 and 40 reads respectively). A single dominant rifA transcript 
454_RIF_0009 was observed in rings. Although this could be as a result o f the 
missing data, expression of an ortholog in rings stages o f a different patient isolate 
supports this observation. The ortholog, a pseudogene, PFSA075 PN48, (99% 
pairwise identity) was also dominantly expressed in rings and schizonts o f the 
rosetting patient isolate SA075 (discussed Chapter 5). This r i f  was closely related to 
the 3D7 PF3D7_1372700 that was not expressed in 3D7 time points. This r i f  went off 
in the trophozoites and three new dominant transcripts came up, one o f which was 
carried on into schizonts. Because o f the limited number o f reads in schizonts (40 
reads) it was not possible to determine the dominant schizont transcripts (Figure
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6.10). Different rifB transcripts were detected at the different stages, one shared 
between rings and trophozoites. Only two rifB variants were detected in schizonts.
For stevor 4 transcripts were highly expressed in 10727 (Figure 6.10). The 2 dominant 
ring transcripts observed stayed on in later stages but at low levels. Two transcripts 
dominated expression in the late stages, including the conserved pseudogene 
STE_454_001 that was dominant in the patient isolate 8383 discussed above (Figure 
6 .8).
For the isolate 10747, a large number o f pir  variants was detected, 241 r i f  and 53 
stevor (Table 6.1) indicating more than one repertoire due to multiple parasite 
genomes in this isolate (4 MSP2 genotypes detected, Table 6.2). For this reason 
interpreting the expression data was complicated because o f the many transcripts 
detected (Figure 6.10). rifA was similar at all time points, dominated by two 
transcripts. rifB expression changed only slightly between rings and late ring/ early 
trophozoite stage. 4 dominant transcripts were observed in rings, one o f these staying 
on as the dominant transcript in the following two stages. The late ring/ early 
trophozoite and schizont stage were similar in rifB expression profile. Similarly stevor 
expression profile changed very little across time points with only two transcripts 
dominating, STE_454_001 and STE_454_203.
10761 pir  sequence data had many gaps, but the time-specific expression o f pirs  was 
observed (Figure 6.10). For rifA 3 dominant transcripts were detected in rings, one o f 
them, 454_RIF_0298 was the only transcript detected in trophozoites and another, 
454_RIF_0451, dominated expression in schizonts. For rifB 4 dominant transcripts 
were detected across the IDC. 2 o f them, 454_RIF_0043 and 454_RIF_0673 were
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shared in ring and trophozoite stages. One of the ring transcripts 454_RIF_0280 was 
also detected in schizonts. A different transcript 454_RIF_0060 was dominant in 
schizonts. r if  gene expression for this isolate had been previously analyzed by cloning 
and capillary sequencing (Chapter 4). The dominant transcripts detected by capillary 
sequencing were also recovered in the 454 data with the exception of one (Figure 4.7), 
and at similar time points with slight differences in proportions. Some of the dominant 
r i f  transcripts in the capillary data were only detected in low amounts in the 454 data. 
The dominant ring and schizont rifA transcript in the capillary data (RIF_K011) was 
also dominant in rings and schizonts in the 454 data (454 RIF 0451). The dominant 
rifA transcript in trophozoites the 454 data (454 RIF 0298) was only a minor 
transcript in the capillary data in the early stages (RIFJR525). One of the dominant 
rifB in rings and schizonts in the 454 data was also dominant in schizonts in the 
capillary sequence data. One of the dominant rifB in schizonts in the 454 data 
(454_RIF_0060) was not captured in the capillary sequencing data.
Stevor expression profiling was possible for only two stages, the late ring/ early 
trophozoites and schizonts (Figure 6.10). For both stages the same 2 stevor genes 
were predominantly expressed, the conserved pseudogene STE_454_001 and 
STE_454_152. There was little similarity between the capillary sequence data and the 
454 data. Only 8 stevor sequences were shared in the results o f the two analyses, none 
of which was dominantly expressed at any stage.
For the isolate 10814p ir  gene expression data was available for the first 2 stages o f 
the IDC. For r i f  expression data from the early ring, the late ring/ early trophozoite 
and early trophozoite stages (ER, PR and ET in Table 6.2) was analyse for transcript 
abundance. For stevor data was available for only 2 stages, rings and late ring/ early
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trophozoite stage (RN and PR in Table 6.2). The pir  repertoire was larger than that of 
a single genome with 355 unique r if  variants and 56 unique stevor variants (the 
expected repertoire is about 180 r i f  and 40 stevor genes) because of the multiple 
clones in this isolate as MSP2 genotyping detected 2 clones (Table 6.2). Despite the 
many pir  variants detected in this isolate clear stage-specific dominant transcripts 
were detected (Figure 6.10). For rifA 2 dominant transcripts were observed in rings 
and a different set o f 3 transcripts observed in the late ring and early trophozoite 
stage. For rifB unique transcripts were detected at each different IDC stage. Only one 
transcript was recovered in the ring stage. A different transcript was dominantly 
expressed in the late ring early trophozoites and a completely different set expressed 
in the early trophozoite stage. For this isolate the capillary sequence data and the 454 
data showed some similarities. For the 2 stages that were analysed by both approaches 
(rings and late rings) two of the dominant rifA transcripts were shared in the 2 data 
sets. The ring transcripts 454_RIF_0580 and 454_RIF_0352 in the 454 data were also 
dominant in rings in the capillary data (RIF_K036 and R IF K 018  respectively). The 
late ring/ early trophozoite dominant rifA transcript 454_RIF_0397 and 
454_RJF_0387 were dominant in the late rings in capillary sequence data (RIF_K058 
and RIF_K027). A rifB late ring/ early trophozoite dominant transcript 
454_RIF_0562 was predominantly recovered in trophozoites in the capillary data 
(R IFK 009).
The expression data for stevor in 10814 was only available for 2 stages, rings and late 
ring early trophozoite stage (Figure 6.10). In both stages the same two dominant 
stevor transcripts were observed, STE_454_057 and the conserved pseudogene 
STE_454_001 (Figure 6.10). The stevor gene STE_454_057 was also dominantly 
expressed in late rings/ early trophozoites in another patient isolate 8383 (Figure 6.8).
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These two stevor genes were not detected in the capillary sequencing data (Chapter
4).
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Table 6.3. Dominant r if  and stevor transcripts in the I DCs o f  patient isolates
Cluster ID Type Cluster rep resen tative Isolate
Stage of peak 
expression
Capillary 
sequence ID BLAST hit Identities
434  RIF 0009 r t f  (c) A PF727 RIF AC 00 ER 2 1 10727 R N/A PFSA075 PN48 869/877 (99%)
454_RIF_0660 r i f A PF727 RIF AC 22 T2 2 29 10727 T N/A PF3D7J3700200 (MAL8P1.219) 716/783 (91%)
4S4 RIF 0481 " f A PF727 RIF AC 00 G1 2 48 10727 T N/A PF8443 8 7 U558000 711/806 (88%)
454 RIF_0475 r i f A PF727 RIF AC 22 T1 2 21 10727 S N/A PF8443 8 7 U561000 838/844 (99%)
434 RIF 0237 r i f B PF727 RIF AC 00 G2 30 10727 R N/A PFIT 0100400 785/791 (99%)
454 RIF 0518 " f i e ) B PF727 RIF AC 22 T2 2 43 10727 R 735 g43 PF3D7 0 6 3 2300(PFF1570W) 595/599 (99%)
434 RIF 0564 r i f B PF727 RIF AC 00 G1 2 60 10727 R N/A PFDG 00191 735/778 (94%)
454_RIF_0621 r i f B PF727 RIF AC 22 T2 2 15 10727 R N/A PF8443 8 1 U512800 753/861 (87%)
454 RIF 0487 r i f B PF727 RIF AC 00 G1 2 69 10727 T N/A PfHB3 BroadW ash516500 754/756 (99%)
454_RIF_0714 r i f A PF747 RIF AC 20 RN 2 7 10747 R Srif 19A PF3D7 0632000 (PFF1555w) 856/918 (93%)
454 RIF 0479 r i f A PF747 RIF AC 40 ET 2 37 10747 S N/A PFDG 02074 707/812 (87%)
454_RIF_0559 r i f B PF747 RIF AC 00 GE 9 10747 R 594g 13 PF3D7 0 2 2 2500(PFB1005w) 696/736 (94%)
4 3 4  31F DC05 r i f B PF747 RIF AC 60 ND 2 8 10747 R 10594-23 PF3D7.073 2 7 0 0 (PF07 0136) 825/880 (93%)
454 RIF 0662 r i f B PF747_RIF_AC_60_ND_2_30 10747 R N/A PF8443 8 6 U546300 638/774 (82%)
434 r il 0669 r i f B PF747 RIF AC 60 ND 2 35 10747 s N/A PF8443 8 6 U544300 683/776 (88%)
r i f A PF761 RIF AC 00 GE 2 11 10761 .......R ... RIF K071 PF3D7 0937700 (PFI1825W) 742/950 (78%)
434 RIF 0398 r i f A PF761 RIF AC 34 SZ 2 7 10761 T RIF K524 PF3D7 0 2 0 0600(PFB0035c) 760/944 (80%)
454 RIF 0451 r i f l e ) A PF761 RIF AC 00 ER 2 10761 s RIF K011 DQ265365 (PFL2S85c) 890/895 (99%)
454_RIF_0043 r i f l e ) B PF761 RIF AC 16 MR 11 10761 R/T RIF K169 PF3D7 1000600(PF10_0006) 839/854 (98%)
454 RIF 0673 r i f l e ) B* PF761 RIF AC 34 SZ 2 60 10761 R/T RIF K032 PF3D7 0701200* 743/744 (99%)
454 RIF 0280 r i f B PF761 RIF AC 34 SZ 2 32 10761 R RIF K254 PF3D7 0900400 (PFI0020w) 814/853 (95%)
454 RIF 1030 r i f B PF761 RIF AC 26 LT 6 10761 ..... T ..... RIF K239 PF8443 8 6 U562600 649/661 (98%)
454 RIF 0060 r i f B PF761 RIF AC 34 SZ 2 59 10761 S N/A PFSA075 101100 755/761 (99%)
454 RIF 0352 r i f A PF814 RIF AC 10 ER 1 10814 R RIF K018 PFSA075 493700 764/9S1 (80%)
454 RIF 0380 r i f A PF814 RIF AC 10 ER 2 10814 R RIF K036 Gb rif57 737/934(78% )
454 RIF 0387 r i f A PF814 RIF AC 16 MR 5 10814 LR/ET RIF K027 PF8443 8 3 U532500 747/888 (84%)
434 RIF 0397 r i f A PF814 RIF AC 00 GE 2 57 10814 LR/ET RIF K058 PF3D7 0223100 727/845 (86%)mmm r i f A PF814 RIF AC 16 MR 3 10814 LR/ET RIF K314 PF8443 8 10 U509700 701/791 (88%)
454 RIF 0317 r i f B PF814 RIF AC 10 ER 22 10814 R N/A PFSA075 490000 759/771 (98%)
454 RIF 0562 r i f B PF814 Rl F AC_ 16_MR 8 10814 LR/ET RIFK009 PFDG 04789 660/755 (87%)
454 RIF 0728 r i f B PF814 RIF AC 00 GE 2 51 10814 T N/A PF8443 8 1 U507700 850/857 (99%)
STE 454 073 s t e v o r na PF727 STE AC 22 T1 3 23 10727 R nd PFIT bin09500* 530/544 (97%)
STE 454 109 s t e v o r na PF727 STE AC 22 T1 3 16 10727 R nd PfH83 Broad Wash 162000 537/538 (99%)
s t e v o r  (c) na PF727 STE AC 32 SI 3 9 all T nd PF3D7 0 4 0 1500(PFDO065w) 590/594 (99%)
5TE 454 156 s t e v o r na PF727 STE AC 22 T1 3 8 10727 T nd DQ265628.1 j Pf1544 38 553/555 (99%)
STE 454 203 s t e v o r  (c) na PF747 STE AC 00 GE 3 18 10747 R/S nd PF3D7 0300400 (PFC0025c) 496/538 (92%)
SXl  454 152 s t e v o r na PF761 STE AC 34 SZ 3 4 10761 T/S none PF8443 8 1 U539200 568/575 (98%)
IsiE_454_057 s t e v o r na PF814 STE AC 12 RN 3 12 10814 T none PFIT 1100300 454/573 (79%)
na: the A and B grouping was not applicable fo r  stevor.
N/A: The sequence was not recovered in capillary sequencing data.
nd: Isolates where pir expression profiling by cloning and capillary sequencing was
not done.
none: No sequence match in the cloning and capillary sequence data.
In two other patient isolates, 10735 and 10739, /7/expression had been previously 
analysed by cloning and capillary sequencing (Chapter 4). For these isolates left over 
purified amplicon from the cloning and sequencing experiment were sequenced by 
454. The quantities o f the remaining amplicons was limited and therefore carrier 
bovine DNA was added to these samples prior to library preparation and sequencing. 
The resulting 454 reads and assembled contigs were contaminated with many bovine 
genes (identified by BLAST searches against the NCBI nucleotide nr database), as 
well as other P. falciparum non-pir genes and human genes. For this reason many 
contigs were discarded leaving few pir  contigs for expression analysis (Table 6.1 and 
6.2). Despite the limited data expression profiling was done for 2 stages in both 
isolates, and repertoire coverage assessed using data from the gDNA (Figure 6.11).
For the isolate 10735 expression data was obtained from rings and late ring/ early 
trophozoite stage (the late ring/ early trophozoite stage and early trophozoite stage 
was combined). As expected there was an overlap between transcripts detected by 454 
amplicon sequencing and cloning and capillary sequencing data. 8 o f the 9 dominant 
r i f  transcripts in this isolate were also detected in the capillary sequencing data. 4 rifA 
were dominantly expressed in this isolate (Figure 6.11), all o f which were detected in 
the capillary sequence data at similar stages. One rifA transcript 454_RIF_1089 was 
dominant in rings and the other 3 were dominant in the late ring/ early trophozoite 
stage. For rifB 5 transcripts were dominantly expressed (Figure 6.11), 3 dominant in 
rings, 454_RIF_0518, 454_RIF_0755, and 454_RIF_0993. O f these only 
454_RIF_0993 was recovered in rings in the capillary data (RIF_K017) at low levels. 
For the transcript 454_RIF_0518 one read was recovered in trophozoites in the 
capillary data, while 454_RIF_0755 was not recovered at all. 3 rifB were dominant in
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the late ring/ early trophozoite stage, 454_RIF_0803, 454_RIF_0906 and 
454_RIF_0755. 454_R1F_0906 was detected in the late ring/ early trophozoite stage 
in capillary data while for the other 2 no transcripts were detected in capillary data. 
For the isolate 10739 very few reads were recovered from the two cDNA samples, 56 
reads from rings and 162 reads from trophozoites (Table 6.2). 3 rifA were dominantly 
expressed in rings, 454 RIF 0589, 454_RIF_1943, and 454_RIF_0768, o f which 
454_RIF_0768 was maintained as a dominant transcript in trophozoites (Figure 6.11). 
Four other rifA were dominantly expressed in trophozoites, one of which was 
recovered in trophozoites in the capillary data (454_RIF_0733), while 3 were not 
detected (454_RIF_0733,454_RIF_0935 and 454_RIF_0951). For rifB 5 transcripts 
dominated expression in the 2 time points, 3 unique to rings and 2 unique to 
trophozoites. The dominant ring transcript 4 5 4 R IF 0 8 1 4  was also detected in rings 
in the capillary data (RIF_K122). The other 2 transcripts were not detected in any 
time point in the capillary data. One o f the 2 dominant transcripts in trophozoites 
454_RIF_1663 was detected in rings in the capillary data while the other one 
454 RIF 1372 was not recovered.
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Figure 6.11. Piecharts showing r if  genomic repertoires and transcript abundance in 
the IDC o f  patient parasite isolates, 10735 and 10739 Coloured regions o f  the cDNA 
pies represent transcripts that accounted for 10% and above o f  the total expression in 
at least one time point, while in gDNA pies, coloured regions indicate genes whose 
read counts represent >10% o f  the total reads obtained from  amplification o f  
matched cDNA (see Table 6.4 below). !: Poor sequence depth (below 1000 reads).
Table 6.4. Dominant r if  transcripts in the IDCs o f  2 patient isolates 10735 and 10739
Cluster ID pir Type Cluster representative Isolate
Stage of 
peak 
expression
Capillary 
sequence ID
BLAST hit Length of overlap 
(% identity)
454_RIF_1089 rif A PF735 RIF AC 00 MR 1 10735 R RIF K124 PF3D7 1000400 780/990 (78%)
454 RIF 0535 rif A PF735 RIF AC 30 ET 10 10735 LR/ET RIF_K028 PF8443_8_10_U528800 736/873 (84%)
454 RIF 0578 rif A PF735 RIF AC 20 PR 1 10735 LR/ET RIFJC019 PF3D7_0900200 792/976 (81%)
454 RIF 0620 rif A PF735 RIF AC 00 MR 6 10735 LR/ET RIF_K215 PF3D7_0833400 733/888 (82%)
454 RIF 0518 rif B PF735_RI F_AC_00_M R_3 10735 R RIF_K051 PF8443_8_10_U526900 874/887 (98%)
454 RIF 0993 rif B PF735 RIF AC 00 MR 13 10735 R RIF_K017 PF3D7_1149800 655/775 (84%)
454 RIF 0755 rif B PF735_R 1 F_AC_00_G E_2_49 10735 LR/ET none PF8443_8_3_U486000 783/835 (93%)
454 RIF 0803 rif B PF735 RIF AC 00 MR 11 10735 LR/ET RIF_K051 PF3D7_0201000 663/778 (85%)
454_RIF_0906 rif B PF735 RIF AC 00 GE 2 23 10735 LR/ET RIF_K212 PF3D7_1041100 712/887 (80%)
454 RIF 0589 rif A PF739 RIF AC 00 GE 2 11 10739 R RIF_K407 PF3D7_1200500 739/969 (76%)
454 RIF 0768 rif A PF739 RIF AC 00 MR 1 10739 R RIF_K057 PF3D7_0200200 807/812 (99%)
454 RIF 1943 rif AX PF739 RIF AC 10 RN 4 10739 R none PRCDC_0059300 109/118 (92%)
454 RIF 0733 rif A PF739 RIF AC 40 TR 2 10739 T none PFSAO75_258400 704/882(79%)
454 RIF 0935 rif A PF739 RIF AC 40 TR 4 10739 T none PF8443_8_1_U554500 728/851 (85%)
454 RIF 0951 rif A PF739 RIF AC 00 GE 2 71 10739 T none PF3D7_0300200 604/664 (90%)
454 RIF 1515 rif A PF739 RIF AC 40 TR 9 10739 T none PF8443_8_12_U347300 503/587 (85%)
454_RIF_0814 rif B PF739 RIF AC 00 GE 2 111 10739 R RIF_K122 PF3D7_0401000 640/738 (86%)
454 RIF 0991 rif B PF739 RIF AC 00 GE 2 88 10739 R RIFJ272 PF8443_8_7_U438500 740/778 (95%)
454 RIF 1581 rif BX PF739 RIF AC 00 MR 6 10739 R none PF8443_8_3_U454900 462/523 (88%)
454 RIF 1371 rif B PF739 RIF AC 00 GE 2 102 10739 T RIFJG45 PFDG_00091 644/747 (86%)
t a w rif B PF739 RIF AC 50 MT 7 10739 T RIF_K073 PF3D7_0900300 382/383 (99%)
3 3 7
6.5. Discussion.
Although efforts towards sequencing as many field isolates as possible from different 
geographical regions continue to be made, there still is little whole genome sequence 
(WGS) data from patient parasite isolates. Analysis of transcriptome sequence data 
generated by next generation sequencing involves mapping o f reads to a reference 
genome. For the large variant multigene families o f P. falciparum var, r i f  and stevor, 
mapping o f reads to non-homologous genomes is complicated by the high variability in 
these genes resulting to poor mapping. As discussed before, sharing o f r if  and stevor 
genes across parasite isolates is limited, especially if they are from different geographical 
locations or between laboratory and field isolates (Chapter 3). It is therefore difficult to 
analyse next generation p ir  amplicon data by mapping to non-homologous genomes. In 
this section, an alternative approach to analyse the data was adopted, where 454 amplicon 
sequence reads were assembled into contigs using the assembly tool Newbler. The 
assembled contigs were then clustered using an online tool CD-HIT to identify unique 
variants. Using this approach it was possible to estimate repertoire coverage from the 
number o f unique contigs recovered per isolate, and using the number o f reads that went 
into generating each contig it was possible to estimate sequence depth, and therefore 
expression for each contig.
A major limitation o f this analysis was the recovery o f short sequence reads from 
suboptimal 454 sequence runs (discussed in Chapter 5). This resulted in assembly o f 
short contigs that did not span the length o f r i f  or stevor amplicon (typically about 900 
and 600 nucleotides respectively). Because o f the short length o f the contigs it is possible
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that contigs that span non-overlapping regions of the same pir  gene might have been 
classified as unique, while in actual sense the contigs represent the same gene. To address 
this problem, further clustering of contigs was done using BLAST searches, where 
contigs that had high identity match to the same gene from BLAST searches the contigs 
were clustered into one group. The limitation with this approach was the isolate-specific 
p ir  variants that did not result in any significant match in the BLAST search. Another 
limitation in the analysis though minor is linked to the CD-HIT clustering strategy in 
order to identify unique variants and estimate p ir  repertoires. This approach assumes that 
there are no pir  paralogs within an isolate when actually there are a few paralogs, as seen 
in the 3D7 genome. In 3D7 three sets o f r i f  paralogs exists; PF3D7 0631700, 
PF3D7_0701300 and P F 3 D 7 J 101400 at 99.9% pairwise identity, PF3D7_0901100 and 
PF3D 7J301000 at 99.5% pairwise identity and PF3D7_0222400 and PF3D7_1040000 
at 98.4% pairwise identity. It is therefore possible to underestimate the number o f unique 
pir  in an isolate using this clustering approach.
Another significant problem with the data generated from this analysis was errors from 
the 454 sequencing as well as errors in assembly, which resulted in many reads without 
clear open reading frames. It was difficult to tell apart genuine pseudogenes from contigs 
with sequence and/or assembly errors. In addition, because o f the short contigs with 
missing segments it was not possible to classify a small number o f contigs r i f  genes into 
the A or B subgroups. For contigs that could not be classified because o f missing 
sequence regions or because o f sequencing errors, the A and B grouping was assigned 
based on the BLAST top hit’s group. The r if  and stevor universal primers were highly
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degenerate and amplified non-target genes including other P. falciparum  genes like 
ribosomal RNA and proteins o f  unknown function. Reads from these non-target genes 
resulted into non-target contigs that required to be filtered out o f  the data, reducing read 
coverage for target genes.
Overall pir  genomic repertoire data and expression data for most time points for all the 
patient isolates was available. From the data isolate-specificp ir  expression patterns were 
observed. Different r i f  genes dominated expression at the different stages with few 
overlapping time points. This observation was different from the expression patterns in 
laboratory and culture-adapted wild isolates from our previous analysis, where the 
dominant n/transcripts were expressed over multiple stages. Stevor expression was 
stable across time points for most isolates as observed in laboratory and culture-adapted 
wild isolate.
For isolates where pirs  expression was analysed by both capillary and 454 sequencing 
differences were observed in the results detected in this analysis were not recovered in 
the amplicon cloning and capillary sequencing data (Chapter 4) from the same isolates. 
This was due to the difference in sequencing depth between the two approaches. Much 
more coverage was observed with the 454 sequencing and therefore more p ir  variants 
were detected. For rz/the cloning bias detected in the capillary data contributed to the 
difference in results obtained by the two approaches. The capillary data was biased to 
recovery o f short, mostly rifB sequences. This bias was not experienced using the clone- 
free 454 amplicon sequencing approach. Overall all the sequences recovered in the
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cloning and capillary sequencing experiment were detected in the 454 sequencing data 
with many of the dominant /v/transcripts in the 454 sequencing data observed in similar 
stages in the capillary data. For stevor the use of different primers between the 454 and 
capillary sequencing introduced differences in the results. The primers used in capillary 
amplicon sequencing had significant bias (Chapter 4), resulting in recovery o f few stevor 
variants. Improved primer coverage and sequence depth in the 454 data resulted in 
recovery o f all stevor genes belonging to the major group, stevot'A group. The minor 
group is more divergent (Chapter 3) and none o f the stevor genes were captured by our 
degenerate primers.
The recovery o f a conserved pseudogene predominantly in cDNA in all the patient 
isolates analysed here was unusual. This was reminiscent o f the stevor capillary 
sequencing results where a different stevor pseudogene dominated expression in all three 
patient isolates (Chapter 4 figure 4.9). These two stevor were different with 72.4% 
pairwise identity and having different orthologs in 3D7 (PF3D7_0401500 for the 454 
stevor pseudogene and PF3D7_0102100 for the capillary sequence data). The expression 
o f these conserved pseudogenes might suggest some importance o f pseudogenic 
transcripts for example in regulation o f gene expression. That the pseudogenes are highly 
conserved across isolates might suggest that these genes are not under selection pressure.
The non-mapping analysis approach in this chapter enabled exploration o f r i f  and stevor 
expression in patient isolates without WGS data. The ex vivo parasite isolates provide a 
means to explore p ir  gene expression patterns in vivo, and what genes might be involved
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in host-parasite interactions during malaria infections. The identified major/;//' transcripts 
may be involved in immune evasion or cytoadhesion o f the IE and can be targeted for 
functional studies in future. Although a major limitation was the huge number of errors in 
the 454 sequences resulting in contigs with inframe stops, and additional step for error 
corrections will be necessary to improve this analysis approach.
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7. Expression profiling of a specific r i f  gene PFL2585c.
7.1. Introduction
Typically VSAs show low sequence homology across different isolates. Few exceptions 
exist such as the conserved var gene var2csa (Templeton, 2009a). Although the r i f  family 
is hypervariable, strain-transcendent variants have been identified in this study (Chapter 
3) and in previous studies (Wang et al., 2009, Joannin et al., 2011, Claessens et al., 2011). 
One particular PFL2585c (PF3D7_1253700) is highly conserved in laboratory and wild 
isolates, with 99% pairwise identity between 3D7 and HB3, and 96% pairwise identity 
between 3D7 and IT (Claessens et al., 2011). A previous study looking at ex vivo 
transcriptomes o f patient isolates showed PFL2585c to be significantly up regulated in 
relation to the other r i f  genes in the patient isolates by microarray and real time PCR 
(Lemieux et al., 2009).
Analysis o f r i f  expression by RT-PCR using the complex r i f  primers revealed clear 
temporal pattern o f expression across the IDC (Chapter 5 and 6). For certain genes, peak 
expression was in the early stages of the IDC, for some peak expression was the middle 
or late stages. The expression patterns could give an indication as to the role played by 
specific variants, for example transcripts that come on in late stages might play a role in 
invasion while transcripts that have maximal expression in early to mid-IDC could play a 
role in immune evasion o f the IE. These results however were not able to clearly define 
expression patterns for genes expressed at low levels or genes that are not well captured
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by the degenerate complex r i f  primers, such as PFL2585c. Gene-specific PCR would 
better elucidate expression profiles for such genes. For this reason reverse transcriptase 
PCR (RT-PCR) was employed to profile expression for this specific r if  PFL2585c, 
across IDCs in laboratory and wild isolates in order to identify peak expression time 
points. This r if  is the focus o f an on going study within our research group aimed at 
determining whether RIFIN HVLs are exposed to host antibodies on the infected red cell 
surface (Kibwana E., et al, manuscript in preparation). PFL2585c hypervariable region 
from 3D7 gDNA was expressed as a recombinant protein with a FLAG tag. This 
recombinant antigen was used to purify antibodies from highly reactive human sera from 
immune Kenyan adults. The aims o f the experiments in this chapter were to identify 
Kilifi isolates that expressed PFL2585c, and identify the peak expression point in order to 
target these isolates for surface localisation studies in live immunofluorescense assays 
using the anti-PLF2585c antibodies.
7.2. Objectives
i.) To identify PFL2585c orthologs in wild isolates sampled from patients in
Kilifi.
ii.) To identify wild and laboratory isolates expressing PFL2585c and identify 
peak expression time points in these isolates.
iii.) To determine whether RIFIN HVRs are accessible to antibodies on the 
surface o f IE.
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7.3. M ethods
7.3.1. Retrieval of PFL25865c orthologs from  laboratory  and wild
isolates.
PFL2585c sequences were retrieved from PlasmoDB (3D7), whole genome sequence 
data from the WTSI (HB3, IT and 3 Kilifi isolates), from published data for the Brazilian 
field isolate (Albrecht et al., 2006) and from whole genome sequence data from culture- 
adapted Kilifi isolates (9215, 9605 and 10668) and from de novo assembled 454 
amplicon sequencing data for ex vivo Kilifi isolates (8383, 10727, 10535 and 10814) as 
described in Chapter 6. 3D7 PLF2585c (PF3D7 1253700) was used to retrieve orthologs 
from other genomes by BLAST analysis against all r i f  database on Geneious® v6.1.5. 
Multiple sequence alignments were carried out in Geneious® using MUSCLE with 
default parameters.
7.3.2. Amplification of PFL25865c by reverse transcriptase (RT) PCR.
Samples used in this study include laboratory isolates 3D7, IT, HB3, A4, P4 and R29, 
and Kilifi patient isolates. RNA was extracted using Trizol® as described in the methods 
chapter (2.5.1). Reverse transcriptase PCR (RT-PCR) for RNA and regular PCR for 
gDNA to amplify the hypervariable region o f PFL2585c was done using specific primers, 
PFL2585cloop-L 5’ TCC CCC GGG TTA TCC CAA AGA CCA TGT ATT TGC CTC 
G 3’ and PFL2585cloop -R  5’ GGC ATG CCA TGG ACT ACA AGG ACG ACG ATG 
ACA AGT TAT TAA CAG ATG CTG CTG CAA AAC 3’. The PCR for PFL2585c 
detection was set up as follows; 2mM MgCb, 0.4uM dNTPs, 0.4uM PFL2585c loop 
primers, IX colourless GoTaq® PCR reaction buffer (with final MgCC concentration o f
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1.5mM) and 1 unit o f  GoTaq® polymerase. 2ul o f  cDNA or 1 ul o f  gDNA was used in a 
final reaction volume o f  50ul. PFL2586c amplicons for sequencing were generated using 
Platinum® Taq HiFi the PCR was set up as follows: 2mM M gS04, 0.4uM dNTPs,
0.4uM PFL2585c loop primers, IX HiFi buffer, and 0.5 units of Platinum® Taq HiFi. 
PCR was performed for 35 cycles under the following conditions: 94°C for 30 seconds, 
64°C for 30 seconds and 68°C for 60 seconds.
PFL2585c amplicons from Platinum Taq PCR were purified prior to cloning and 
sequencing as described in the methods chapter (2.6.4 and 2.6.5). Sequence analysis was 
done in BioEdit Sequence Alignment editor (v 7.0.5.3) and Geneious Pro (5.3.4-6.1.5) as 
explained in the methods chapter (2.9.1).
PFL2585c HVR amplicons from 3D7 gDNA were cloned into an expression vector pEU- 
E01 for RIFIN protein expression using the cell free wheat germ expression system 
(Tsuboi et al., 2008). The cell-free expression system overcomes many limitations o f 
using bacterial cell expression systems for Plasmodium proteins including insolubility, 
toxicity and incorrect conformation o f expressed proteins.
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Table 7.1. PFL2585c sequences from laboratory and wild isolates.
I s o la te s e q u e n c e  ID S e q u e n c e  n a m e L eng th S o u rc e
3D 7 3D 7 P F 3 D 7 JL 2 5 3 7 0 0 1 ,0 7 7 P lasm oD B 3
IT IT PFIT _0801500 1 ,077 WGS
HB3 HB3 P fH B 3 _ B ro a d W ash 5 1 5 9 0 0 1 ,071 WGS
B razilian is o la te F I D Q 26 5 3 6 5 .1 9 9 1 P u b lish ed  d a t a b
9 2 1 5 K l-G P F 8 4 4 3 _ 8 _ 4 _ U 5 0 9 5 0 0 1 ,0 7 1 W GS
96 0 5 K2-G P F 8 4 4 3 _ 8 _ 6 _ U 5 4 1 7 0 0 1 ,0 7 1 W GS
1 0 6 6 8 K3-G P F 8 4 4 3 _ 8 _ 8 _ U 4 8 7 8 0 0 1 ,0 7 1 WGS
83 8 3 K4-A P F383 RIF AC 0 0  GE 2 33  PFL 88 9 4 5 4  am p lic o n  s e q u e n c in g
107 2 7 K5-A P F727 RIF AC 0 0  G 1 2 9 0  PFL 55 1 4 5 4  a m p lic o n  s e q u e n c in g
107 3 5 K6-A PF735 RIF AC 0 0  GE 2 88  PFL 74 5 4 5 4  a m p lic o n  s e q u e n c in g
1 0 8 1 4 K7-A P F814 RIF AC 0 0  GE 2 36  PFL 85 8 4 5 4  a m p lic o n  s e q u e n c in g
107 6 1 K8-A P F761 RIF AC 0 0  ER 2 895 4 5 4  a m p lic o n  s e q u e n c in g
a: PlasmoDB 13.0 release, 
b: (Albrecht et al., 2006)
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7.3.3. Live imm unofluorescence assays (IFA).
As previously described anti PFL2585c antibodies were purified from immune sera 
using PFL2585c HVRs expressed as FLAG-tagged protein as previously described 
(Chapter 2.12.1) (Kibwana E., Kadasia K. et al., manuscript in preparation).
Early to mid trophozoites from parasites identified as high expressers by RT-PCRs were 
used in the IFA as previously described (Chapter 2.12.2). Briefly 500ul of the cultures 
were spun down and washed three times in incomplete media prior to incubation with the 
antibody solution at 37°C for 30 minutes to an hour in a 1:1 ratio of iRBC and purified 
antibody solution in 1% BSA solution. The pellets were then washed three times in 
lOOOul cold PBS with 1% BSA and then incubated with 50ul o f the secondary antibody, 
goat anti-human IgG Alexa 488 F(ab)’ conjugate at 37°C for 30 minutes in the dark. In 
the last 5 to 10 minutes o f incubation with secondary antibody the nuclei stain Hoechst/ 
DAPI at lpg/m l was added, 50ul o f a 1:1000 DAPI/Hoechst (ljig/ml, diluted in 1% 
BSA/PBS). The pellets were then washed three times inlOOOpl o f cold PBS with 1% 
BSA, resuspended in 50|iil o f 1% BSA in PBS and 20pl o f the washed pellet placed on a 
glass slide and sealed with a coverslip. The slides were examined using 40x or lOOx (oil) 
objective, and incident light o f 450-49nm for FITC fluorescence, 390-440nm for 
DAPI/Hoechst.
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7.4. Results
7.4.1. High sequence conservation of PFL2585c in laboratory  and wild
isolates.
In addition to 3D7 10 orthologs from IT, HB3, a Brazilian isolate and 7 Kilifi isolates. 
Multiple sequence alignment on the 11 sequences showed high sequence homology even 
within the Hypervariable region (Figure 7.1). The overall pairwise identity of PFL2585c 
orthologs is 98.2% over the full length o f the sequences. The actual mean pairwise 
identity is probably higher as most o f the disagreement was at the sequence ends o f  three 
wild isolates probably due to PCR and sequencing errors. Sequences from Kilifi isolates 
were obtained by cloning and capillary sequencing PFL2585c amplicons from cDNA or 
gDNA (an example o f gel purification o f amplicons from 10594 in Appendix Figure 9.4). 
The mean pairwise identity within the HVL in laboratory and wild isolates was 99.2 % 
(Appendix Figure 9.5).
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Figure 7.1. Multiple sequence alignments o f  PFL2585c and 10 orthologs from IT, HB3, a 
Brazilian isolate (FI), and 7 Kilifi isolates, 9215 (Kl-G), 9605 (K2-G), 10668 (K3-G), 
8383 (K4-A), 10727 (K5-A), 10735 (K6-A) and 10814 (K7-A). The mean pairwise identity 
over all the pairs in the column is shown above the sequence alignment. Green: 100% 
identity. Green-brown: at least 30% but below 100%. Black vertical lines indicate 
disagreement between sequence in alignment and the consensus sequence.
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7.4.2. PFL2585c expression profiling by R T-PC R  in laboratory  isolates.
To profile expression of a specific n/PFL2585c specific RT-PCR was used to detect 
transcripts in laboratory and wild isolates. Specific primers were used to amplify 
PFL2585c from cDNA from 6 timepoints in 3D7, HB3 and IT and from ring and 
trophozoite cDNA from A4 laboratory lines. PCR on gDNA from the same samples was 
included as a positive control for PCR. PFL2585c transcripts at the expected size, 400bp, 
were detected in HB3, IT and A4 (Figure 7.2). Different PFL2585c expression profiles 
were observed in different laboratory isolates. In F1B3 transcripts were detected in most 
stages o f the IDC, peaking in late rings and going off in schizonts (Figure 7.2. A II). In IT 
PFL2585c expression was restricted to small window between late rings and early 
trophozoites, staying very low in later stages (Figure 7.2. B). In A4 PFL2585c transcripts 
were mainly detected in schizonts (Figure 7.2. C) but low intesity band could be seen in 
trophozoites. PFL2585c was not expressed in 3D7 as no signal was detected in 3D7 
cDNA (Figure 7.2. A. I and Appendix Figure 9.3). Expression in HB3 was validated by 
results from total r i f  amplicon deep sequencing. Reads mapping to the PFL2585c 
ortholog in HB3, PfHB3_BroadWash515900 were recovered in amplicons from late rings 
to schizonts in the 454 data (Appendix table 9.8), with most reads mapping from 
amplicons from schizont stage. Very few reads from 3D7 and IT cDNA mapped to 
PFL2585c and it’s ortholog in IT, PFIT_0801500, an average read count 1.3 in 3D7 and 
1.6 in IT across time points (Appendix table 9.8).
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Figure 7.2. 1.5% agarose gel electrophoresis images o f  PFL2585c amplicons in 
laboratory isolates. (A) Amplicons from  3D7 cDNA at 6 time points (I) and 3 D7 gDNA 
(Gl), and HB3 at 6 cDNA time points (II). (B) PFL2585c amplicons from  IT cDNA at 6 
timepoints and fro  IT gDNA (G2). (C) PFl2585c amplicons from  A4 ring (R), trophozoite 
(T) and schizont (S) cDNA and A4 gDNA (G3). L: 1 kb plus DNA ladder. + and  -  indicate 
RT enzyme positive or negative cDNA samples respectively.
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7.4.3. PFL2585c expression profiling by R T-PC R  in Kilfi isolates
In previous literature it was observed that PFL2585c expression was higher in patient 
isolates as compared to 3D7 (Lemieux et al., 2009). Expression profiles were analysed in 
culture-adapted isolates as well as ex vivo patient isolates. For the cultured-adapted wild 
isolates, PFL2585c specific RT-PCR was carried out on timepoint RNA samples from 4 
IDC stages rings, late rings to early pigmented trophozoites, mid to late trophozoites and 
schizonts. PFL2585c expression was also analysed in an additional high rosetting 
laboratory clone R29 at four timepoints same as the cultured wild isolates.
PLF2585c was expressed at low levels in one culture-adapted patient isolate 10668, and 
in R29. In 10668 PFL2585c transcripts were detected in all timepoints with a peak in 
band intesnity in rings (Figure 7.3. A). In R29 the peak expression was in the late ring to 
early trophozoite stage, with very little transcription in trophozoites and schizonts (Figure
7.3. A). A very intense signal was observed in gDNA from both parasites. PFL2585c 
transcripts were detected in rings and trophozoites o f a culture-adpated Kilifi isolate 8383 
(Figure 7.3. C and Appendix figure 9.2)
SA075 R+ and 9106 did not express PLF2585c because o f a deletion o f this gene loci as 
no band was detected in gDNA samples (Figure 7.3. B). To verify lack o f expression 
rather than cDNA degradation, a confirmatory experiment was carried using cDNA 
freshly prepared from the same SA075 R+ RNA samples and similar results were 
obtained (Appendix Figure 9.1). Genomic deletion in SA075 R+ and 9106 was confirmed 
using BLAST against r i f  sequences from whole genome sequence data from the two 
isolates. PFL2585c orthologs were not identified in the two genomes. For two other Kilifi 
isolates, 6816 and 8948, no signal was detceted from cDNA but it was not clear whether
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the gene was switched off  or deleted because no gDNA sample was available to confrim 
deletion (Appendix figure 9.2).
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Figure 7.3. 5% agarose gel electrophoresis images o f  PFL2585c expression profiles in 
wild cincl cultured isolates. PFL2585c transcripts at 4 stages o f  the IDC, rings (1), late 
ring to early trophozoites (2), trophozoites (3) and schizonts (4) in culture-adapted wild 
isolates: (A) 10668 and R29, (B) SA075 R+ and 9106. (C) PFL2585c transcripts from  
rings (R) and trophozoites (T) in culture-adapted Kilifi isolates, IT  and from  A4  
trophozoites. PCR products fi'om gDNA are labelled as G1 fo r  10668, G2 fo r  R29, G3 fo r  
SA075, G4 fo r  8383, G5 fo r  9106 and G6 fo r  A4. L:1 kb plus DNA ladder. + and -  
indicate R T  enzyme positive or negative cDNA samples respectively.
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Analysis of PFL2585c expression in ex vivo parasite isolates sampled from children in 
Kilif with non-severe malaria was assessed to determine whether patient isolates showed 
a much higher level of expression. For two isolates, 10594 and 10595 cDNA had been 
prepared directly from total RNA without prior gDNA digestion. No RNA samples were 
available for these isolates to repeat the experiment with DNA-free cDNA. For two other 
patient isolates 10735 and 10739 RNA was DNase digested prior to cDNA preperation.
The expected PFL2585c amplicon at 400bp was observed in one o f the isolates, 10594 at 
all time points, with peak in band intensity at the fourth time point corresponding to 
trophozoites (Figure 7.5 A. II). A non-specific amplification product 750bp in size was 
detected in this isolate (Figure 7.5. A). The non-specific 750bp band was identified as 
human hemoglobin beta gene by sequencing the band and performing a BLAST search 
againts NCBI nucleotide nr database. This contaminant originated from reticulocytes in 
the patient sample.
No bands were detected in 10595 cDNA. PFL2585c PCR on gDNA revealed a deletion 
of this gene in 10595 (Figure 7.5. B). This explained why no transcripts could be detected 
in this isolate. Genomic DNA quality was confirmed by total r//P C R  on all the gDNA 
samples. A smear o f bands at 800 to 950bp corresponding to r i f  amplicons were detected 
in all the 4 isolates tested, 3D7, IT, 10594 and 10595 (Figure 7.5. C). This deletion in 
10595 was confirmed by comparative genomic hybridisation (CGH) data from colleagues 
(Simam, J unpublished) and (Appendix figure 9.6).
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Figure 7.4. PLF2585c expression profiling in patient isolates. (A) RT-PCR products from  
10595 (I) and 10594 (II) at 7 time points across a single I DC ex vivo, and regular PCR 
products from  3D7 gDNA (G4) and IT gDNA (G3). (B) PFL2585c PCR products and (C) 
total r if  PCR product from  gDNA from  3D7 (Gl'), IT  (G2), 10594 (G3) and 10595 (G4). 
The specific PFL2585c amplicon was detected at 400bp (red arrow) in all time points in 
10594 and in all gDNA samples with the exception o f 10595. The blue arrow points to the 
500bp band on the DNA ladder. A non-specific amplification product was detected at 
750bp in 10594 cDNA (green arrow). The expected total r i f  PCR product complex r i f  was 
observed at about 800-950bp in all gDNA samples. L: lkb  plus DNA ladder.
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PFL2585c expression was analysed in two other patient isolates 10735 and 10739. No 
transcripts were detected in 10739 (Figure 7.6. A). In 10735 very low intesity bands 
were detected at time point 3 and 4 corresponding to the late rings and early trophozoite 
stages (Figure 7.6. B). The gDNA samples were not analysed by PFL2585c-specific 
PCR for these two isolates, but were analysed by 454 total r i f  amplicon sequencing data. 
From the 454 data PFL2585c sequences were not recovered in 10739 cDNA or gDNA, 
implying that there was a deletion of this locus in this isolate. In 10735 PFL2585c 
sequences were detected in amplicons from gDNA but not from cDNA. Microarray data 
from our collaborators (Mackinnon) indicated that PFL2585c was expressed in 10735 
with peak expression in the 3rd timepoint corresponding to late rings and early 
trophozoites (Appendix figure 9.7).
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Figure 7.5. PLF2585c expression profiling in two patient isolates 10739 (A) and 10735 
(B) at 7 time points across one IDC ex vivo, and regular PCR products from  A4 gDNA 
(G6). The specific PFL2585c amplicon was detected at 400bp (red arrow) in the gDNA 
samples and at very low intensity in the 3,d and 4lh time points in 10735 (*). L: Ikb plus 
DNA ladder.
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Consolidating all the data on PFL2585c expression, PFL2585c RT-PCR, total /-//454 
amplicon sequencing and microarray, 12 isolates out of a total of 22 were identified as 
expressing this specific r i f  gene. O f these 5 were laboratory lines, 3 were culture-adapted 
wild isolates and 4 were ex vivo patient isolates (Table 7.2). For most isolates peak 
PLF2585c expression was observed in late rings to early trophozoites. Only one isolate 
10668 showed maximal expression in rings. For 5 Kilifi isolates, a deletion in the 
PFL2585c loci was detected (Table 7.2). This was supported by whole genome sequence 
data (for SA075 and 9106) and microarray CGH data (for 10595). Previous studies 
(Kidgell et al., 2006, Ribacke et ah, 2007) as well as an ongoing study by our 
collaborators (Simam J., and Mackinnon M.) have shown that the region within which 
this gene lies is within a CNV and the deletion is not uncommon in Kilifi patient isolates. 
For 2 isolates 6816 and 8948 PFL2585c deletion could not be confirmed because we 
lacked parasite gDNA to test this by PCR.
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Table 7.2. Summary o f  PFL2585c expression in laboratory and wild isolates.
PFL2585c expression summary
Lab
Parasite isolate PFL2585c Expression Peak expression point PLF2585c surface expression*
3D7 OFF (g) (s) na N/A
IT ON (g) Late ring/early trophozoite YES#
HB3 ON (g) Late ring/early trophozoite Not tested
A4 ON (g) Late trophozoite to schizont Not tested
P4 ON (g) Rings and trophozoites Not tested
R29 ON (g) Rings to early trophozoite NO
Culture-adapted pateint isolates
Parasite isolate PFL2585c Expression Peak expression point
8383 ON (g) Trophozoite YES
10668 ON (g) Rings YES
9106 Deletion (g) na N/A
SA075C Deletion (g) na N/A
9215 ON Rings YES
6816 OFF (b) na N/A
8948 OFF (b) na N/A
Patient isolates
10739 Deletion (s) na N/A
10735 ON (?) (m) Late ring/ early trophozoite Not tested
10594 ON (g) Late trophozoite Not tested
10595 Deletion (g) na N/A
10593 ON (g)
10727 OFF (s) (m) na N/A
10747 Deletion (s) na N/A
10761 ON (s) (m) Schizonts N/A
10814 OFF (s) (m) N/A
a: cDNA potentially had gDNA contamination 
b: no gDNA sample tested
#: Observed some non-specific staining with secondary antibody
?: Very fa in t band by TR-PCR, no reads from  cDNA in 454 data, but on in microarray
data
g : Expression data from  PCR and gel
s: Expression data from  total r i f454 and capillary sequence data
m: Expression data from  microarray data (Rono M., and Mackinnon, M  unpublished)
*: Work done by other members o f  our research group (Kibwana E., et al, manuscript in 
preparation).
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7.5. Surface labelling of PFL2585c antigens on the surface of infected 
erythrocytes.
The previous analysis on expression o f PLF2585c by RT-PCR enabled identification of 
parasite isolates that showed high levels o f transcripts at one or more IDC stages. The 
high expressers included HB3, IT, and culture-adapted field isolates 8383, 9215 and 
10668. HB3 parasites in our laboratory were obtained already infected with antibiotic 
resistant mycoplasma and could not be cultured for IFA. IT, 8383 and 10668 parasites 
were cultured to above 5% parasitemia and harvested at early to mid trophozoite stages 
for staining. Clear surface labeling o f PFL2585c with immune serum and the affinity- 
purified (AP) antibodies was observed in the culture-adapted Kilifi patient isolates 8383, 
9215 and 10668 (Figure 7.6 and 7.7). 9215 and 10668 were sampled from patients with 
severe malaria, 9215 being a rosetting isolate. 8383 was sampled from a patient with non- 
severe malaria. Low level background staining could be seen in 8383 with the 
hyperimmune serum 17H (Figure 7.6 upper panel) and in 9215 with the AP anti-RlFIN 
antibodies (Figure 7.7. In one patient isolate, 10668, staining was observed in a rosette 
(Figure 7.6 lower panel). Although staining was observed in the laboratory isolate IT 
there was significant background staining observed on non-infected erythrocytes. It was 
therefore unclear whether the labeling on the IE was from the anti-RIFIN antibodies or as 
a result o f non-specific staining. Despite a large population o f cells staining with DAPI, 
only a small proportion was stained with the anti-RIFIN antibodies (Figure 7.7). This is 
an indication o f the specificity o f the antibodies. As observed in the RT-PCR results 
PFL2585c transcript signal was low for most isolates and therefore few IE were expected 
to express this antigen on their cell surface. No staining was detected with nonimmune
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serum from UK. donors, or after staining with the secondary antibody alone. Staining with 
immune sera from African donors resulted in many more labeled IE as compared to the 
number of IE labeled when using the purified anti-RIF antibodies, suggesting specificity 
of these antibodies.
Although surface labeling was observed for few IE in live IFA this result shows that 
RIFINs are localised to the surface o f IE and are targets o f naturally acquired antibodies 
giving evidence for a role in host parasite interactions including immune evasion.
363
PHASE FITC ENHANCED OVERLAY
x
»—i
rooo
ro
00
Cl
<
no
oo
rooo
Cl
<
I
00uo
IDO
Figure 7.6. Live immunofluorescence analysis in trophozoite stages o f  two culture-
adapted patient parasite isolates 8383 (upper and middle panel) and 10668 (lower
panel), using a hyper immune serum 17H  (upper panel) and affinity purified anti-
PFL2585c antibodies (middle and lower panels).
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Figure 7.7. L/ve immunofluorescence analysis in trophozoite stages o f  two culture- 
adapted patient parasite isolates 8383 (upper panels) and 9215 (lower panels), using the 
affinity purified anti-PFL2585c antibodies. The nuclei were stained with DAPI (blue).
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7.6. Discussion.
PFL2585c orthologs were identified in all the laboratory lines analysed and in 8 Kilifi 
isolates with high sequence conservation even within the HVL (99.3%).
It was clear that PFL2585c was not the predominant r i f  expressed in the isolates sampled 
as evidenced by low intensity bands from RT-PCR, in comparison to total n /bands 
(Appendix Figure 9.3). Low level expression could be detected with the highly sensitive 
RT-PCR in 12 out o f 22 isolates. A larger proportion o f laboratory isolates expressed this 
gene as compared to pateint isolates. PFL2585c lies within a CNV region, therefore 
deletions o f this gene is expected. There was a high frequency o f deletions o f this region 
in ex vivo isolates (5 out o f 16 isolates with a deletion) but not in any o f the laboratory 
lines. This deletions could explain the low frequency o f PFL2585c expressers from 
patient isolates. In the isolates that expressed PFL2585c we observed different peak 
expression time points in different isolates. Low level transcription in HB3 and 10668 
was observed in the 454 amplicon sequencing results (14.2 and 1.5 average reads mapped 
from all timepoints in HB3 and 10668 repsectively), though this could also be due to poor 
coverage o f this gene by the degenerate r i f  primers.
Other members in my research group have expressed the hypervariable domain of 
PFL2585c as a recombinant fusion protein containing a FLAG tag. Sera from adults and 
children in Kilifi reacted to this recombinant antigen. The antigen was then used to 
purified antibodies from immune sera from the adults. Trophozoite stage parasites from 3 
isolates identified as expressing the PFL2585c gene, by RT-PCR, IT, 8383 and 10668,
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were obtained for immunofluorescence assays (IFA). The purified antibodies were able to 
label native antigen on the surface o f  infected erythrocytes from IT and three Kilfif 
isolates in live IFA (Figure 7.6 and 7.7 and Table 7.2), giving evidence o f PFL2585c role 
in antigenic variation o f  the infected erythrocyte (Kibwana E., et al, unpublished).
Althoug FIB3 was one o f the highest PFL2585c this parasite line was not used as it was 
contaminated with antibiotic resistant mycoplasma.
Previous work on localisation o f RIFINs showed that type A RIFINs were localised out 
of the parasitophorous vacuole and into the maurer’s clefts and were associated with the 
IE surface. Type B RIFINs however remained within the parasite vacuole and did not 
localise to the maurer’s clefts (Petter et al., 2007). This differential localisation that 
would suggest a divergence in function in the two RIFIN subgroups was shown for a 
laboratory parasite lines. It has been suggested that VS As are more highly expressed in 
patient isolates than in laboratory isolates (Daily et al., 2005, Bachmann et al., 2012) and 
therefore it would be useful to repeat RIFIN localisation studies with patient isolates to 
validate that B type RIFINs are not exported to the IE surface.
Future work will involve quantifying expression in larger numbers o f patient isolates 
using quantitative real time PCR (qPCR), to ascertain whether patient isolates have 
higher gene expression levels. In addition qPCR will be used to determine whether 
expression o f this gene is associated with any clinical phenotype by using patient isolates 
with clearly defined clinical phenotypes. The purified antibodies were only able to label a 
small population o f infected erythrocytes in three culture adapted patient isolates but this
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provides good evidence that RIFINs are coexpressed with PfEMPl on the surface of 
infected red blood cells and are targets o f naturally acquired immunity to malaria. These 
results gives evidence for a role of RIFINs in host-parasite interactions including immune 
evasion and cytoadhesion.
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CHAPTER 8
8. Discussion and conclusions
Variant surface antigens of P. falciparum modify the antigenic and cytoadhesive 
characteristics of the infected erythrocyte (IE) therefore play an important role in disease 
pathogenesis and acquisition o f immunity to malaria. These roles have been mainly 
ascribed to the var encoded PfEM Pl. Recent literature suggests that other VSAs are 
coexpressed on the IE surface and may complement the functions o f PIEMP1. The r i f  and 
stevor multigene families encode the VSAs RIFIN and STEVOR. These genes belong to 
the larger pir  multigene family found in other Plasmodium species. The objectives o f this 
work were to explore sequence diversity and expression profiles o f pir  multigene families 
of P. falciparum  in natural malaria infections, and to determine whether RIFIN proteins 
are targets o f naturally acquired immune antibodies on the surface o f infected 
erythrocytes. Most studies looking at sequence diversity o f r i f  and stevor genes have been 
focused on laboratory isolates because o f scarcity of data from patient isolates. Very few 
studies have analysed pir  expression patterns in patient isolates.
Exploration o f p ir  sequence diversity was carried out in Chapter 3. Phylogenetic studies 
have demonstrated that r i f  genes can be classified into functionally divergent groups and 
that the groups are conserved across isolates (Joannin et ah, 2008, Petter et ah, 2007). The 
stevor genes subdivide into 2 main groups but no evidence o f functional divergence exists 
(Joannin et ah, 2011, Schreiber et ah, 2008). Phylogenetic approaches were used to 
classify r i f  and stevor genes from parasites geographically diverse origins. Pir repertoires 
were conserved in terms o f number o f sequences and subgrouping across isolates from
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distinct geographical locations, including Kenyan isolates. Conserved groups as well as 
highly conserved orthologs were identified. Pir genes from Kenyan isolates grouped into 
previously described conserved groups. The r i f  genes grouped into the two major groups 
r if  A and rifB as previously observed, with rifB falling into 3 subgroups, B l, B2 and a 
diverse B3 group (Joannin et al., 2008, Joannin et al., 2011). Different sequence 
subgrouping was observed when different regions o f the genes, N terminal, and the 
hypervariable regions, were phylogenetically clustered. This is an indication o f the 
different selection pressures on the different regions, the HVR under diversifying 
selection while the N terminal regions are constrained to limited variability. The centrally 
located p ir  genes form a conserved group, as they lie within stable regions o f the genome 
with infrequent recombination events. These central pirs  have orthologs in wild isolates 
from different geographical locations. Conserved r i f  and stevor genes have been 
identified in laboratory and wild isolates, some of which have ancient origins as evidence 
by having orthologs in P. reichenowi.
To characterize expression profiles in different parasite isolates, gene family-specific 
reverse transcriptase (RT) PCR was employed using sets o f universal r i f  and stevor 
primers. The universal pir  primers were able to amplify r i f  and stevor genes from gDNA 
and cDNA from laboratory and wild isolates. Although the primers were designed on 
3D7, they showed good coverage o f pir  repertoires in IT and Kenyan patient isolates, 
with slightly reduced coverage in HB3. This might be due to the probable close 
relationship between 3D7, an African isolate and the Kenyan isolates, whereas HB3, a 
laboratory isolate originally from Honduras might not be as closely related.
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As a first step in characterizing expression profiles of pir  genes, r i f  and stevor ampl icons 
were cloned and sequenced using capillary Sanger sequencing approach as described in 
Chapter 4. The results o f this approached revealed temporal pir  expression patterns that 
were parasite-specific. There was high A/Transcript diversity within an isolate across time 
points and across isolates. There was little sharing of transcripts across isolates, with only 
2 r i f  transcripts shared in 2 patient isolates. Dominant r i f  and stevor transcripts were 
observed in different timepoints. For r i f  genes a more focused expression to a single 
dominant variant was seen in the schizont stage. There was clear differential upregulation 
o f r i f  and stevor genes in the rosetting clone and the non-rosetting fraction o f a rosetting 
patient isolate. For stevor, primer bias resulted in preferential recovery o f a stevor 
pseudogene from all the patient isolates.
In Chapter 5 and 6 a more in depth analysis o f expression profiles in laboratory and 
patient isolates was carried out using next generation deep sequencing o f amplicons on 
the 454 platform. Two approaches were used to analyse the 454 reads, 1) mapping o f 
reads to homologous genomes and 2) de novo assembly o f reads into contigs for isolates 
with no whole genome sequence data. High transcript diversity and little sharing of 
expressed sequences across parasite isolates as seen in the capillary data was confirmed. 
The temporal pattern o f p ir  expression was more clearly observed in the deep sequence 
data. Stage-specific dominant r i f  and stevor transcripts were observed, for most isolates 
different transcripts dominated expression at rings trophozoites and for r i f  in some cases 
different sets came up in schizonts. A previous study o f VS A expression profiling the
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same dominant transcripts were observed at the two different peaks o f expression, in 
rings and trophozoites (Bachmann et al., 2012). Our study had much greater sequencing 
depth and better primer coverage, which could explain the difference in results. To 
analyse the effect o f selection pressure on p ir  gene expression, profiling was carried out 
in patient isolates that had undergone different selection treatments, 1) ex vivo parasite 
lines to test effect o f host immune selection pressure, 2) adaptation to culture conditions 
to test effect o f culture adaptation and 3) parasites selected for binding phenotypes, 
binding to endothelial cells (HBEC) and to uninfected erythrocytes (rosetting). Different 
r if  and stevor transcription profiles were observed in isolates put under different selection 
pressures. There was more even expression in ex vivo parasites that have been under host 
immune selection pressure but in culture expression was focused to a few variants that 
were dominantly expressed. Different sets o f transcripts were upregulated after culture- 
adaptations, and different sets after selection for HBEC binding or rosetting. In previous 
microarray analysis o f VSA expression in laboratory parasites selected for rosetting or 
binding to HBEC lines, upregulation o f UpsArif genes neighbouring the upregulated 
UpsAvar genes was observed (Claessens et al., 2012, Claessens et al., 2011). This link in 
r i f  and var expression was not clear in our results. The upregulated r i f  genes after 
selection for binding did not belong to the conserved upsArif group by BLAST analysis. 
It was not possible to determine whether the upregulated pirs  were in close proximity to 
the dominantly expressed var genes because o f missing chromosomal location data for 
the genomes o f wild isolates.
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In the Northern blotting analysis full length r if  transcripts were detected in IT and a 
patient isolate from Kenya using RNA probes generated from homologous cDNA form 
these isolates. The low sensitivity of the non-radioactive labeled Digoxygenin probes 
meant that a lot more RNA was required to reach detection limit, and longer exposures of 
the blots during visualization, and both these would result in even higher background 
signal from ribosomal RNA, therefore more difficult to detect r i f  mRNA signal.
Therefore it was not possible to carry out temporal expression profiling by northern 
blotting in this study. To overcome these limitations future analysis beyond the scope of 
this thesis will utilize purified mRNA rather than total RNA to enable detection o f less 
abundant transcripts.
To explore whether transcripts detected by RT-PCR were expressed into protein that 
were localized to the surface o f infected erythrocytes, and whether these native antigens 
were recognized by immune sera, the experiments described in Chapter 7 were carried 
out. A unique and strain-transcendent rifA PFL2585c was chosen because o f its 
conservation in laboratory and wild isolates, and because previous literature had shown 
this gene to be upregulated in field isolates (Lemieux et al., 2009). PFL2585c was 
expressed in most o f the laboratory isolates (5/6) and few wild isolates from Kenya (7/16) 
tested but was switched off in some isolates including the laboratory isolate 3D7. As this 
gene lies within a CNV region a few isolates had a deletion o f this gene (5/17). Unique 
expression profiles were observed with peak expression occurring at different time points 
in different isolates. To test whether RIFIN variant domains are accessible to antibodies 
at the IE surface and whether they are targets o f naturally acquired protective antibodies
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isolates identified to express this r i f  by RT-PCR were cultured for localization analysis by 
live IFA. First the hypervariable domain of PFL2585c was generated as a FLAG-tagged 
recombinant protein. This antigen was used to affinity purify naturally occurring human 
antibodies from highly responsive sera from immune Kenyan adults. The antibodies 
labeled a minor population o f IE from parasites that were identified to transcribe this 
gene at a population level in live IFA. This study contributes to the existing evidence for 
surface localization o f A-RIFIN, and their role in immune evasion of IE.
8.1. Limitations of the study
8.1.1. Incomplete coverage o f p ir  repertoires by primers.
A major limitation o f this study was the inability to capture all r i f  and stevor variants 
using universal primers. Although coverage was good of most isolates (about 70% 
coverage) certain key genes were missed out. The divergent strain-transcendent r if  
PFD0070c which has been previously shown to be the dominant n /transcrip t in 3D7 was 
not captured. The stevorB subgroup was completely missed out by stevor primers. In 
addition our RT-PCR approach was only semi-quantitative. Therefore there remain gaps 
in expression profiling o f pirs  in terms o f coverage and quantification. Future studies 
would benefit from using approaches such as RNAseq to obtain whole transcriptome 
sequences for pir  expression profiling. To validate the dominant transcripts observed 
quantitative realtime PCR will be carried out in future studies.
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8.1.2. Short reads and sequence e rro r in the 454 amplicon sequencing 
results.
Suboptimal results obtained from the 454 amplicon sequencing resulted to recovery o f 
short reads and this proved a major shortcoming during de novo contig assembly. In 
addition there were many errors in the sequences. These resulted in short assembled 
contigs with many sequence errors complicating analysis of variant types by our 
clustering approaches. Therefore it is possible that we overestimated the number o f pir 
variants in the de novo assembly data. Future analysis beyond this thesis will involve 
error corrections for the assembled contigs and mapping sequence reads to pseudogenes 
generated from assembled contigs.
8.2. Future work
The direct functions o f pir  genes in malaria disease pathogenesis and in acquisition of 
natural immunity to malaria still need to be explored. A direct role o f the related cir 
multigene family in virulence of the rodent malaria parasite P. chabaudi has been 
demonstrated (Spence et al., 2013). In the study mosquito transmitted parasites were less 
virulent than serially blood passaged parasites. This was dependent on an intact immune 
response, and was attributed to differences in cir gene expression in the two parasites.
The mosquito transmitted parasites expressed many different cir variants, and in an 
animal with an intact immune response, the parasitemia was controlled, resulting in a low 
parasitemic chronic infection. On the other hand, serially passaged parasites expressed 
one dominant cir gene. These parasites induced the immune system towards a more 
proinflammatory response, and grew to uncontrollably high parasitemia resulting in
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virulence. The mechanisms of virulence may be the same for P. falciparum, in that 
parasites with high homogeneity o f pir expression may trigger more inflammatory 
responses that are unable to keep parasitemia in check, resulting in severe malaria. The 
significance o f this findings is that vector transmission regulates parasite gene 
expression in asexual blood stages, which impacts on the host immune response to the 
parasite and therefore on parasite virulence. It is therefore the interplay between vector, 
parasite and host immune system that seems to underlie parasite virulence. Mosquito 
transmission regulates virulence o f he parasite in the mammalian host, by modifying 
variant gene expression, where the mosquito-transmitted parasites express many 
variants as observed P. chabaudi in the aforementioned study (Spence et al., 2013) and 
in P. falciparum (Peters et al., 2007). The mosquito part o f the parasite life cycle 
therefore appears to be crucial for regulating the inherent virulence o f the parasite in the 
mammalian host, by acting like a reset switch ensuring that every new infection is not 
transmitting highly virulent parasites from one person to the next. These parasites with 
attenuated virulence can be cleared by the immune response o f an immune host, but in a 
non-immune host the parasitemia increase uncontrollably resulting in severe disease. In 
P. falciparum, virulence has been mainly associated with var genes. Expression of 
certain groups o f var genes has been associated with severe malaria (Warimwe et al., 
2009, Salanti et al., 2003). This link is missing for P. falciparum pir  genes.
Transcription profiling o f pir  genes in P. falciparum  isolates sampled from patients with 
different malaria clinical phenotypes will enable identification o f pir  genes associated 
with severe disease or low host immunity.
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Attempts to understand the function of rif and stevor genes relies on the ability to 
properly classify them into distinct groups for which expression profiles can be 
associated with specific phenotypes such as binding to endothelial cells or rosetting. 
Phylogenetic trees are not appropriate for clustering highly variable and recombining 
sequences such as rif and stevor. This is supported by the limitations observed in 
chapter 3, where the resultant phylogenetic trees had low statistical support, low 
branch support and long branch lengths. In addition we observed phylogenetic 
incongruence where different regions o f the genes, N-terminal, HVR and full length 
sequences resulted in different clade structures. With these limitations, phylogenetic 
trees can only be used as an initial step in resolving these variant gene families into 
large groups that should be further refined using other alignment free approaches such 
as networks. Network analysis, as has been previously used in classifying var gene 
(Bull et al., 2008) should be utilized in pir gene clustering in future analyses.
Recent studies have identified r i f  and stevor genes as additional mediators o f rosetting 
and invasion in P. falciparum  (Goel et al., 2015, Niang et al., 2014), and it is likely that 
they are also involved in mediating binding to endothelial cells. This study has 
identified dominantly expressed r i f  and stevor genes in parasites selected for binding to 
HBEC binding and rosetting. More targeted localization and functional studies can be 
designed to determine whetherpirs play a direct role in binding phenotypes.
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9. APPENDIX
Appendix Table 9.1. Old and new 3D7 r if  gene IDs.
3D7 rif n=184
n e w  g e n e  ID o ld  g e n e  ID n e w  g e n e  ID o ld  g e n e  ID n e w  g e n e  ID old  g e n e  ID
PF3D 7 0100 2 0 0 PFA 0010C PF3D 7 0617700 P FF0855C P F 3 D 7 _ 1 040500 P F 10  0398
PF3D 7 0100400 PFA0020W PF3D 7 0631700 PFF1540W P F3D 7 1040600 P F 10  0399
PF3D 7 0100600 PFA 0030C PF3D 7 0631800 PFF1545W P F 3 D 7 _ 1 040700 P F 1 0  0400
PF3D 7” 0100800 PFA0040W P F 3D 7 _ 0 6 3 2 0 0 0 PFF1555W P F3D 7 1040800 P F 1 0  0401
PF3D 7 0100900 PFA 0045C P F 3D 7 0632100 P FF1560C P F3D 7 1040900 P F 1 0  040 2
PF3D 7 0101000 PFA 0050C PF3D 7 0632200 P FF1565C P F3D 7 1041000 P F 1 0 _ 0 4 0 3
PF3D 7 0101600 PFA0080C PF3D 7 0632 3 0 0 PFF1570W P F 3 D 7 _ 1 041100 P F 1 0  0404
PF3D 7 0101900 PFA0095C PF3D 7 0632 4 0 0 PFF1575W P F3D 7 1041200 P F 1 0  0405
PF3D 7 0114700 PFA0710C P F 3D 7 0632 6 0 0 PFF1585W PF3D 7 1100300 P F 11_0009
P F3D 7 0115200 PFA0740W P F 3D 7 0632 7 0 0 PFF1590W PF3D 7 1100400 PF11 0010
P F 3 D 7 ' 0115300 PFA0745W P F 3D 7 _ 0 7 0 0 2 0 0 M A L8P1.219 P F 3D 7_1100500 PF11 0011
P F3D 7 0115600 PFA0760W PF3D 7 0700 3 0 0 M A L8P1.218 PF3D 7 1101100 P F 11_0529
P F3D 7 0200200 PFB 0015C P F 3D 7 0700 5 0 0 M A L8P1.216 PF3D 7 1101200 PF11 0020
P F3D 7 0200 5 0 0 PFB 0030C P F3D 7 0701100 N ew  rif P F3D 7_1101300 PF11 0021
P F3D 7 0200 6 0 0 PFB 0035C P F 3D 7 0701 2 0 0 N ew  rif P F3D 7 1101400 PF11 0022
P F3D 7 0 200 7 0 0 PFB 0040C P F 3D 7 0701 3 0 0 M A L7P1.200 PF3D 7 1149800 PF11 0515
P F3D 7 0201 0 0 0 PFB 0055C P F 3D 7 _ 0 7 0 1 8 0 0 P F 0 7  0003 P F 3D 7_1150000 PF11 0517
P F3D 7 0201 2 0 0 PFB0060W P F3D 7 0711900 M AL7P1.43 P F3D 7 1150100 PF11 0518
P F3D 7 0 222 4 0 0 PFB1000W P F 3D 7 0 712200 M AL7P1.47 P F3D 7 1150200 P F 11_0519
PF3D7~ 0222 5 0 0 PFB1005W P F3D 7 0 712500 M A L7P1.52 P F 3D 7_1150300 PF11 0520
P F3D 7 0222 6 0 0 PFB1010W P F3D 7 0 713000 M A L7P1.57 P F 3 D 7 _ 1 200200 PFL0010C
PF3D 7 .0 222700 PFB 1015W P F 3D 7 0 731900 M A L7P1.179 P F3D 7 1200300 PFL0015C
PF3D 7 0223 1 0 0 PFB1035W P F3D 7 0 732200 P F 07  0132 P F3D 7 1200500 PFL0025C
PF3D 7 0 223200 PFB1040W PF3D 7 0 732300 M A L7P1.184 P F 3 D 7_1219200 PFL0933W
P F3D 7 0 223400 PFB 1050W P F 3 D 7_0732400 P F 07  0134 P F 3 D 7 _ 1 240700 PFL1965W
P F3D 7 0 300200 PFC 0010C P F 3D 7 0 732500 M A L7P1.185 P F3D 7 1253600 PFL2580W
P F3D 7 '0 3 0 0 5 0 0 PFC 0030C P F 3D 7 0 732700 P F 0 7  0136 P F3D 7 1253700 PFL2585C
P F3D 7 030 0 7 0 0 PFC 0035W P F 3 D 7_0732900 P F 0 7  0138 P F3D 7 1254000 PFL2605W
P F3D 7 030 0 8 0 0 PFC 0040W P F 3D 7 _ 0 8 0 0 4 0 0 P F 08  0139 P F3D 7 1254200 PFL2615W
P F3D 7 0 324400 PFC 1095W PF3D 7 0800 5 0 0 P F 08  0138 P F3D 7 1254400 PFL2625W
P F3D 7 0 324500 PFC1100W PF3D 7 0808 8 0 0 P F 08  0105 PF3D 7 1254500 PFL2630W
P F3D 7 0 324800 PFC1115W P F3D 7 0808900 P F 08  0104 PF3D 7 1254700 PFL2640C
P F3D 7 0400 3 0 0 PFD 0015C P F 3 D 7_0832100 M A L7P1.226 PF3D 7 1254800 PFL2645C
P F3D 7 0400 5 0 0 PFD 0025W P F 3D 7 0832500 M A L7P1.222 P F 3 D 7 _ 1 255000 PFL2655W
P F3D 7 '0 4 0 0 7 0 0 PFD 0030C P F 3D 7 0832800 M A L7P1.219 P F 3D 7 _ 1 2 5 5 1 0 0 PFL2660W
PF3D 7 .0 4 0 0 9 0 0 PFD 0040C P F3D 7 0833000 M A L7P1.217 P F 3D 7 1300200 M A L13P1.2
PF3D 7 .0 4 0 1 0 0 0 PFD 0045C P F 3D 7 0833100 M A L7P1.216 P F 3D 7 1300400 P F 13  0004
PF3D 7 .0 4 0 1 2 0 0 PFD 0050W P F 3 D 7_0833200 M A L7P1.215 P F 3D 7 1300500 P F 1 3 _ 0 0 0 5
P F3D 7 0401300 PFD 0055W P F 3D 7_0833400 M A L7P1.213 P F 3 D 7 _ 1 300600 P F 13  0006
P F3D 7 '0 4 0 1 4 0 0 PFD 0060W P F3D 7 0900 2 0 0 PFI0010C P F 3 D 7 _ 1 300700 M A L13P1.4
P F3D 7 '0 4 0 1 6 0 0 PFD 0070C P F3D 7 0900300 PFI0015C P F 3D 7 1301000 M A L13P1.8
P F3D 7 '0 4 0 2 5 0 0 PFD 0120W P F3D 7 0 900400 PFI0020W P F3D 7 1372600 MALI 3 P 1 .495
P F3D 7 0402700 PFD 0135C P F3D 7 0 900500 PFI0025C P F 3 D 7 _ 1 372700 MALI 3 P 1 .500
P F3D 7 0412 6 0 0 PFD 0620C P F 3D 7 0 900600 PFI0030C P F3D 7 1373000 M A L 13P1.515
P F3D 7 '0 4 1 3 2 0 0 PFD 0640C P F 3 D 7_0900700 PFI0035C PF3D 7 1373100 MALI 3 P 1 .520
P F3D 7 0413300 PFD 0645W P F 3D 7_0901000 PFI0050C P F 3 D 7 _ 1 373300 M A L 13P1.530
PF3D 7 [0421200 PFD 1010W P F 3D 7 0901100 PFI0055C P F 3D 7 1373400 M A L 13P1.535
PF3D 7 0 421500 PFD 1020C P F3D 7 0 901300 PFI0065W P F 3D 7 1400200 P F 1 4 _ 0 0 0 2
PF3D 7 0 425600 PFD 1225W P F3D 7 0 901400 PFI0070W P F 3 D 7 _ 1 4003 0 0 P F 14  0003
PF3D 7 [042 5 7 0 0 PFD 1230C P F 3D 7 0 901500 PFI0075W P F 3D 7 1400400 P F 14  0004
PF3D 7 0425900 PFD 1240W P F 3D 7 0 937300 PFI1805W PF3D 7 1400500 P F 14  0005
PF3D 7 0500300 PFE 0015C PF3D 7 0 937400 PFI1810W P F 3 D 7 _ 1 400 6 0 0 P F 14  0006
PF3D 7 [050 0 4 0 0 PFE 0020C PF3D 7 0937500 PFI1815C P F 3D 7 1400800 P F 1 4  000 8
PF3D 7 0500500 PFE 0025C PF3D 7 0937700 PFI1825W P F 3D 7 1479400 P F 1 4  076 6
PF3D 7 0500700 PFE 0035C P F 3D 7 1000200 P F 10  0002 P F 3D 7 1479600 P F 1 4 _ 0 7 6 8
PF3D 7 '0 5 3 2 9 0 0 PFE1630W P F 3D 7 1000300 P F 10  0003 P F 3D 7 1479700 P F 1 4  076 9
PF3D 7 0 533000 PFE1635W PF3D 7 1000400 P F 10  0004 P F3D 7 1479800 P F 14  077 0
P F3D 7 0 600300 P FF 0015C P F3D 7 1000500 P F 10  0005 P F3D 7 1480000 P F 14  07 7 2
P F3D 7 0 600500 PFF0025W PF3D 7 1000600 P F 1 0 _ 0 0 0 6
P F3D 7 0 600700 PFF0035C PF3D 7 1040000 P F 10  03 9 3
P F3D 7 0 600800 PFF0040C PF3D 7 1040100 P F 10  03 9 4
P F3D 7 "0600900 PFF0045C PF3D 7 1040300 P F 10  03 9 6
P F3D 7 '0 6 1 7 5 0 0 PFF0847W PF3D 7 1040400 P F 10  0397
Appendix Table 9.2. Old and new 3D7 stevor gene IDs.
3D7 s te v o r n=42
new  g en e  ID old g en e  ID
PF3D7_0532800 
PF3D7_0200400 
PF3D7_0114600 
PF3D7_0115400 
PF3D7_0200900 
PF3D7_0300900 
PF3D7_0300400 
PF3D7_0324600 
PF3D7_0400800 
PF3D7_0401500 
PF3D7_0402600 
PF3D7_0425500 
PF3D7_0500600 
PF3D7_0900900 
PF3D7_0901600 
PF3D7_1000800 
PF3D7_1040200 
PF3D7_0832900 
PF3D7_1149900 
PF3D7_1300900 
PF3D7_1372500 
PF3D7_1372800 
PF3D7_0832600 
PF3D7_0832400 
PF3D7_0832000 
PF3D7_0700400 
PF3D7_0700700 
PF3D7_0102100 
PF3D7_0101800 
PF3D7_0732000 
PF3D7_0222800 
PF3D7_0221400 
PF3D7_0201300 
PF3D7_0631900 
PF3D7_0617600 
PF3D7_1254600 
PF3D7_1254300 
PF3D7_1254100 
PF3D7_1100700 
PF3D7_1479900 
PF3D7_1479500 
PF3D7 1400700
PFE1627C
PFB0025C
PFA0705C
PFA0750W
PFB0050C
PFC0045W
PFC0025c
PFC1105w
PFD0035C
PFD0065W
PFD0125C
PFD1220C
PFE0030C
PFI0045C
PFI0080w
PF10_0009
PF10_0395
MAL7P1.218
PF11_0516
PF13_0009
MALI 3P1.490
MALI 3P 1.505
MAL7P1.310
MAL7P1.223
MAL7P1.227
MAL8P1.217
MAL8P1.214
PFA0105w
PFA0090c
PF07_0130
PFB1020W
PFB0955W
PFB0065W
PFF1550W
PFF0850C
PFL2635w
PFL2620w
PFL2610w
PF11_0013
PF14_0771
PF14_0767
PF14 0007
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Appendix Table 9.3. Conserved r if  genes.
Ups sequence
Group
(members)
Idnetitical Patient isolate 
with ortholog
Idnetitical Group mean Identical
Lab Isolate Gene ID Old ID (3D7) Type nucleotides (% 
pairwise identity)
Gene ID of ortholog nucleotides (% 
pairwise identity)
% pairwise 
identity
nucleotides (% 
pairwise identity) 
for IT and 3D7
3D7 PF3D7_0808900 PF08_0104 A Query 6816 PF8443_8_1_U073300 916/1000 (91%) 91.3 946/1010 (93%)
IT PFIT_1240200 921/999 (92%) 6816 PF8443_8_1_U547100 916/999 (91%)
HB3 PfHB3_BroadWashl72400 912/999 (91%) 10936 PF8443_8_10_US48000 939/999 (93%)
IT PFIT_bin08400 916/1005 (91%) 9626 PF8443_8_2_U 143100 917/999 (91%)
DD2 PFDG_04323 928/999 (92%) 9626
11019
11019
PF8443_8_2_U513000 
PF8443_8_3_U 164800 
PF8443_8_3_U477700
918/1002 (91%) 
965/1020 (94%) 
923/999 (92%)
1(21) 9215
9215
9775
9605
9106
10668
11014
11014
PF8443_8_4_U071400 
PF8443_8_4_U195200 
PF8443_8_5_U165400 
PF8443_8_6_U548500 
PF8443_8_7_US13600 
PF8443_8_8_U 293700 
PF8443_8_9_U 142300 
PF8443 8 9 U162600
876/961 (91%) 
911/1001 (91%) 
884/950 (93%) 
923/1002 (92%) 
908/999 (90%) 
952/999 (95%) 
951/999 (95%) 
916/999 (91%)
3D7 PF3D7_0412600 (s) PFD0620C Aps Query 6816 PF8443_8_1_U561100 980/1023 (95%) 93.4 946/1042 (90%)
IT PFIT.0411200 (s) 975/1023 (95%) 10936 PF8443_8_10_U489500 986/1023 (96%)
3D7 PF3D7_0711900 MAL7pl.43 1013/1074 (94%) 10936 PF8443_8_10_U489700 985/1073 (91%)
IT PFIT_0811700 851/934 (91%) 10936 PF8443_8_10_U489800 959/1036 (92%)
HB3 PfH B3_Broad Wa sh 144100 1019/1074 (94%) 9626 PF8443_8_2_U283400 885/939 (94%)
HB3 PfHB3_Broad Wash054500 971/1053 (92%) 11019 PF8443_8_3_U 116300 970/1023 (94%)
2(20) 11019 PF8443_8_3_U546400 787/816 (96%)9215
9215
9775
10668
11014
SA075
SA075
PF8443_8_4_U515500
PF8443_8_4_U515600
PF8443_8_5_U058900
PF8443_8_8_U508400
PF8443_8_9_U052000
PFSA075_071600
PFSA075 137600
909/959 (94%) 
853/905 (94%) 
825/859 (96%) 
828/870 (95%) 
928/970 (95%) 
978/1074 (91%) 
951/1023 (92%)
3D7 PF3D7_0114700 (s) PFA0710C B3 Query 10668 PF8443_8_8_U549400 970/972 (99%) 98.9 992/1004 (98%)
IT PFIT_0113500 (s) 971/972 (99%) 6816 PF8443_8_1_U531100 970/972 (99%)
DD2 PFDG_03938 971/972 (99%) 11019 PF8443_8_3_U570000 970/972 (99%)
HB3 PfHB3_BroadWash537700 603/603 (100%) 9215 PF8443_8_4_U546500 968/972 (99%)
3(15) PRCDC PRCDC_0014300 915/967 (94%) SA075 PFSA075_011200 967/973 (99%)Brazilian
10738
10936
9106
9605
DQ265207
10739
PF8443_8_10_U493400 
PF8443_8_7_U526900 
PF8443 8 6 U262000
866/868 (99%) 
803/803 (100%) 
603/603 (100%) 
603/603 (100%) 
602/603 (99%)
3D7 PF3D7_0713000 (s) MAL7P1.57 A Query 10936 PF8443_8_10_U 132900 508/525 (96%) 97.4 946/1025 (92%)
IT PFIT_0711100 (s) 1021/1041 (98%) 10975 PF8443_8_12_U137000 924/963 (95%)
HB3 PfHB3_BroadWashl44500 512/525 (97%) 9626
11019
9215
PF8443_8_2_U127100
PF8443_8_3_U123700
PF8443_8_4_U144300
1026/1041 (98%) 
1010/1041 (97%) 
1025/1041 (98%)
4(14) 9775
9605
9106
10668
11014
SA075
PF8443_8_5_U139700 
PF8443_8_6_U140200 
PF8443_8_7_U060200 
PF8443_8_8_U 135200 
PF8443_8_9_U121800 
PFSA075 137800
1009/1041 (96%) 
1027/1041 (98%) 
994/1041 (95%) 
1022/1024 (99%) 
1010/1041 (97%) 
508/525 (96%)
3D7 PF3D7_1101400 PF11_0022 B ps Query SA075 PFSA075_128500 1038/1041 (99%) 95.5 843/1001 (84%)
IT PFIT_1100600 1011/1083(93%) SA075 PFSA075_154900 1080/1083 (99%)
3D7 PF3D7_0631700 PFF1540W 1083/1083(100%) 6816 PF8443_8_1_U557500 878/879 (99%)
5(14) 3D7 PF3D7_0701300 MAL7P1.200 1083/1084 (99%) 11019 PF8443_8_3_U549100 870/875 (99%)
3D7 PF3D7_0222400 1002/1077 (93%) 9605 PF8443_8_6_U525800 831/879 (94%)
3D7 PF3D7_1040000 995/1077 (92%) 10936 PF8443_8_10_U495700 804/873 (92%)
DD2 PFDG 04006 872/891 (97%) 11019 PF8443 8 3 U533700 656/699 (93%)
3D7 PF3D7_0402500 (s) PFD0120W A ps 9605 PF8443_8_6_U068900 982/990 (99%) 95.6 995/1004 (99%)
IT PFIT_0401200 (s) 970/990 (97%) 9215 PF8443_8_4_U069900 975/990 (98%)
HB3 PfHB3_BroadWash070900 923/1000 (92%) 10668
9106
10936
PF8443_8_8_U066200
PF8443_8_7_U55080
PF8443_8_10_U523100
971/990 (98%) 
966/990 (97%) 
964/990 (97%)
6(14) SA075
11019
Brazilian
10975
6816
9775
PFSA075_052700
PF8443_8_3_U516200
DQ265340
PF8443_8_12_U068800 
PF8443_8_1_U071700 
PF8443 8 5 U069200
962/990 (97%) 
923/1000 (92%) 
808/815 (99%) 
835/897 (93% 
731/753 (97%) 
692/706 (98%)
380
7(13)
3D7
IT
PRCDC
PF3D7_1219200 (s) 
PFIT_1218900 (s) 
PRCDC_1218500 (s)
PFL0933W A ps Query
704/704 (100%) 
688/704 (97%)
10936
10975
9626
11019
9215
9775
9106
10668
11014
SA075
PF8443_8_10_U495100
PF8443_8_12_U312700
PF8443_8_2_U300600
PF8443_8_3_U279800
PF8443_8_4_U3 27700
PF8443_8_5_U324600
PF8443_8_7_U276900
PF8443_8_8_U309400
PF8443_8_9_U278200
PFSA075 318800
625/629 (99%) 
701/704 (99%) 
700/704 (99%) 
640/644 (99%) 
626/629 (99%) 
701/704 (99%) 
626/629 (99%) 
625/629(99%) 
701/704 (99%) 
701/704 (99%)
99.4 970/1030(94%)
8(13)
3D7
IT
DD2
PRCDC
PF3 D7_0413300 (s) 
PFIT_0411800 (s) 
PFDG_03424 
PRCDC_0410800*
PFD0645W A Query
1017/1041 (97%) 
1037/1041 (99%) 
765/1049 (72%)*
6816
10975
9626
11019
9215
9775
10668
11014
SA075
PF8443_8_1_U061600 
PF8443_8_12_U07020 
PF8443_8_2_U053400 
PF8443_8_3_U052600 
PF8443_8_4_U 059600 
PF8443_8_5_U059100 
P F8443_8_8_U056700 
PF8443_8_9_U052300 
PFSA075 061500
1031/1041 (99%) 
846/860 (98%) 
1029/1041(98%) 
1015/1041 (97%) 
945/1041 (90%) 
1037/1041 (99%) 
945/1041 (90%) 
1037/1041 (99%) 
1016/1041 (97%)
96 990/1010 (98%)
9(13)
3D7
IT
HB3
DD2
PRCDC
PF3D7_0401600
PFIT.0400300.2
PfHB3_BroadWash518600
PFDG_04771
PRCDC_0046400
PFD00700C A2 Query
1029/1081 (95%) 
1020/1065 (95%) 
825/897 (91%) 
839/974 (86%)*
6816
9215
11019
9605
9106
10936
8383
SA075
PF8443_8_1_U501500 
PF8443_8_4_U026100 
PF8443_8_3_U495100 
PF8443_8_6_U553500 
PF8443_8_7_U563300 
PF8443_8_10_U484500 
PF8443_8_11_U383500 
PFSA075 051800
963/1048(91%) 
1025/1050 (97%) 
859/867 (99%) 
864/871 (99%) 
1030/1065 (96%) 
1035/1044 (99%) 
838/839 (99%) 
863/871 (99%)
93.2 961/1038(92%)
10(13)
3D7
IT
HB3
PF3D7_0421500 
PFIT_0419700 
PfHB3_BroadWash075100
PFD1020C A ps
769/769 (100%) 
771/786(98%)
9215
6816
9605
11019
11014
10936
10668
10595
9775
10975
PF8443_8_4_U06700
PF8443_8_1_U068700
PF8443_8_6_U066300
PF8443_8_3_U059600
PF8443_8_9_U059200
PF8443_8_10_U065900
PF8443_8_8_U063400
595
PF8443_8_5_U066400 
PF8443 8 12 U065600
769/769(100%) 
768/769 (99%) 
767/769 (99%) 
764/769 (99%) 
764/769 (99%) 
769/784 (98%) 
761/769 (98%) 
648/648 (100%) 
586/587 (99%) 
565/572 (98%)
99 999/1000 (99%)
11(11)
3D7
IT
DD2
HB3
PF3D7_0731900 (s) 
PFIT_0730900 (s) 
PFDG_02022
PfHB3_BroadWash532400
MAL7P1.179 B ps Query
942/958 (98%) 
590/601 (98%) 
558/560 (99%)
SA075
10668
6816
10936
9605
9106
9215
PFSA075_154300
PF8443_8_8_U526000
PF8443_8_1_U542300
PF8443_8_10_U545400
PF8443_8_6_U529600
PF8443_8_7_U471900
PF8443 8 4 U530800
956/957 (99%) 
865/867 (99%) 
831/867 (95%) 
559/560 (99%) 
559/560 (99%) 
559/560 (99%) 
559/560 (99%)
99.2 779/1086 (71%)
12(10)
3D7
HB3
DD2
PF3D7_0532900
PfH B3_B road Wash53 6000
PFDG_02919
PFE1630W B3 Query
956/957 (99%) 
868/958 (90%)
9106
10668
9605
SA075
6816
10936
Brazilian
PF8443_8_7_U444000
PF8443_8_8_U484100
PF8443_8_6_U537200
PFSA075_101100
PF8443_8_1_U511400
PF8443_8_10_U 150700
DQ265354
956/957 (99%) 
956/957 (99%) 
948/957 (99%) 
882/958 (92%) 
868/958 (90%) 
867/958 (90%) 
745/791 (94%)
94.8 N/A
13 (10)
3D7
IT
HB3
DD2
PF3D7_1372600
PFIT_0733200
PfHB3_BroadWash519800
PFDG_00493.1
MAL13P1.49 B3 Query
817/819 (99%) 
727/727(100%) 
819/819 (100%)
9215
9106
9606
SA075
10936
6816
PF8443_8_4_U557600
PF8443_8_7_U551100
PF8443_8_6_U517200
PFSA075_412900
PF8443_8_10_U549400
PF8443 8 1 U512500
768/772 (99%) 
682/708 (96%) 
761/769 (98%) 
812/819 (99%) 
768/772 (99%) 
760/769 (98%)
98.8 992/1008 (98%)
14(10)
3D7
IT
HB3
PRCDC
PF3D7_0533000 (s) 
PFIT_0536700 (s) 
PfHB3_BroadWash536100 
PRCDC_0531900
PFE1635W A ps Query
968/1029 (94%) 
633/639 (99%) 
906/1015 (89%)*
SA075
10936
6816
9605
9215
11019
PFSA075_PN22
PF8443_8_10_U544600
PF8443_8_1_U511300
PF8443_8_6_U537300
PF8443_8_4_U512100
PF8443 8 3 U507000
884/891 (99%) 
686/697 (98%) 
633/639 (99%) 
628/639 (98%) 
596/617 (96%) 
540/556 (97%)
97.5 955/1040 (91%)
15 (9)
3D7 PF3D7_0632300 PFF1570W B Query 10595
10668
10936
SA075
9605
Brazilian
10594
11019
595g_ll
PF8443_8_8_U522100
PF8443_8_10_U490800
PFSA075_127700
PF8443_8_6_U519500
DQ265189.11 Pf42_541B
594g_28
PF8443 8 3 U564000
858/879 (97%) 
847/878 (96%) 
878/878 (100%) 
877/878 (99%) 
876/878 (99%) 
875/878 (99%) 
849/878 (96%) 
868/878 (98%)
97.9 N/A
381
16(9)
3D7
DD2
PF3D7_0308300
PFDG_04322
PF08_0L05 A Query
1008/1114(90%)
9215
10668
6816
9626
11014
6816
11019
PF8443_8_4_U171000 
PF8443_8_8_U293600 
PF8443_8_1_US60100 
PF8443_8_2_U143 200 
PF8443_8_9_U502600 
PF8443_8_1_U547200 
PF8443 8 3 U568200
993/1070(93%) 
1022/1113 (91%) 
1020/1113 (91%) 
879/891 (98%) 
1014/1116(90%) 
964/1038 (92%) 
923/976 (94%)
91.4 N/A
17 (8)
3 07 PF3D7_0413200 PFD0640C A Query 6816
9626
11019
9775
9605
10668
SA075
PF8443_8_1_U061500 
PF8443_8_2_U053300 
PF8443_8_3_U052500 
PF8443_8_S_U059000 
PF8443_8_6_U059100 
PF8443_8_8_U056600 
PFSA075 061400
1050/1134 (92%) 
1131/1131(100%) 
1103/1131 (97%) . 
889/939 (94%) 
1102/1131 (97% 
1105/1131 (97%) 
1021/1131(90%)
94.1 N/A
18 (8)
3D7
3D7
3D7
PF3D7_042S600
PF3D7_0700300
PF3D7_1100500
PFD1225W
MAL8P1.218
PF11_0011
A ps Query
852/855 (99%) 
865/915 (94%)
10668
Brazilian
10936
SA075
9106
PF8443_8_8_U553400 
DQ265170.1 
PF8443_8_10_US61800 
PFSA075__128300 
PF8443 8 7 U447200
784/788 (99%) 
781/786 (99%) 
783/788 (99%) 
784/788 (99%) 
782/788 (99%)
98.5
19(8)
3D7
IT
HB3
PF3D7_1240700
PFIT_1240800
PfHB3_BroadWash054500
PFL1965W A ps Query
773/808 (95%) 
759/809 (93%)
9215
10936
10936
SA075
9626
PF8443_8_4_U561700 
PF8443_8_10_U294000 
PF8443_8_10_U489800 
PFSA075_071600 
PF8443 8 2 U283400
710/750 (94%) 
699/731 (95%) 
740/809 (91%) 
749/832 (90%) 
675/704 (95%)
92.8 941/1015 (92%)
20(7)
3D7 PF3D7_0500300 PFE0015C B ps Query 9106
9215
10594
10668
9215
10936
PF8443_8_7_U458100
PF8443_8_4_U523700
594_1_2
PF8443_8_8_U097200 
PF8443_8_4_U506700 
PF8443 8 10 U548700
847/847 (100%) 
463/463 (100%) 
839/839 (100%) 
374/389 (96%) 
889/939 (94%) 
931/931 (100%)
97.7 N/A
21 (7)
IT
DD2
PFIT.0616600
PFDG_02423
A Query
663/725 (91%)
10936
9215
9775
9106
SA075
PF8443_8_10_U110500 
PF8443_8_4_U134400 
PF8443_8_5_U130900 
PF8443_8_7_U112500 
PFSA075 PN18
1048/1148 (91%) 
1137/1147 (99%) 
1137/1147 (99%) 
1049/1148 (91%) 
1059/1069(99%
94 N/A
22(7)
3D7
IT
HB3
PF3D7_1253700
PFIT_0801500
PfHB3_BroadWash515900
PFL2585C A Query
1125/1128 (99%) 
1048/1050(99%)
Brazilian
9605
10668
9215
DQ265365
PF8443_8_6_U541700 
PF8443_8_8_U487800 
PF8443 8 4 US09500
875/923 (94%) 
1049/1050 (99% 
1049/1050 (99%) 
1048/1050 (99%)
95.6 588/1101(53%)
23 (7)
3D7
3D7
HB3
PRCDC
PF3D7_0901100 
PF3D7_1301000 
PfHB3_BroadWash534600 
PRCDC 0006200
PFI0055C
MAL13P1.8
A Query
1048/1052 (99%) 
702/703 (99%) 
854/1052(81%)*
6816
9215
11019
PF8443_8_1_U546400
PF8443_8_4_U550500
PF8443_8_3_U511600
1050/1053 (99%) 
714/715 (99% 
702/703 (99%)
99.8 N/A
24 (7)
3D7
IT
PF3D7_0402700 (s) 
PFIT_0401400 (s)
PFD0135C Aps Query
981/990 (99%)
SA075
9106
10975
10936
6816
PF5A075_052900 
PF8443_8_7_U471700 
PF8443_8_12_U068900 
PF8443_8_10_U522900 
PF8443 8 1 U071900
941/1007 (93%) 
789/796 (99%) 
734/795 (92%) 
734/795 (92%) 
734/795 (92%)
92.5 1000/1000 (100%)
25(6)
3D7
IT
DD2
PF3D7_0712500 
PF1T.0411700 
PFDG 00027
MAL7P1.52 A Query
995/997 (99%) 
1106/1139 (97%)
9775
9626
6816
PF8443_8_5_U139500 
PF8443_8_2_U126900 
PF8443 8 1 U141200
1107/1137 (97%) 
1089/1137 (95%) 
1043/1065 (97%)
98.4 690/1113 (61%)
26(5)
3D7
HB3
PF3D7_1000600
PfHB3_BroadWash262300
PF10_0006 B1 Query
1061/1086 (97%)
6816
SA075
9106
PF8443_8_1_U554200 
PFSA075_220500 
PF8443 8 7 U502300
1031/1087 (94%) 
1025/1087 (94%) 
936/957 (97%)
96.1 N/A
27(4)
3D7 PF3D7_0617500 PFF0847W A Query 9106
SA075
9775
PF8443_8_7_U100400 
PFSA075_071100 
PF8443 8 5 U530200
886/892 (99%) 
582/586 (99%) 
582/586 (99%)
99.5 N/A
28(4)
3D7 PF3D7_0600900 PFF0045C B Query 10975
11019
6816
PF8443_8_10_U566400 
PF8443_8_3_U548900 
PF8443 8 1 U561800
832/845 (98%) 
884/970 (91%) 
720/771 (93%)
93 N/A
29 (3)
3D7 PF3D7_0617700 PFF0855C A Query 9106
SA075
PF8443_8_7_U100500 
PFSA075 071300
906/1003 (90%) 
717/752 (95%)
92.6 N/A
30 (3) 3D7 PF3D7_0712200 MAL7P1.47 A Query
9775
11014
PF8443_8_5_U 139300 
PF8443 8 9 U435200
1014/1017 (99%) 
944/1018 (92%)
94.9 N/A
31(3) 3D7DD2
PF3D7_0900300 
PFDG 00601
PFI0015C B2 Query
997/1081(92%)
9106 PF8443_8_7_U511400 947/1011 (93%)
32 (3) 3D7
IT
PF3D7_0832100 (s) 
PFIT 0835100 (s)
MAL7P1.226 A ps
895/903 (99%)
SA075 PFSA075_184200 942/950 (99%) 99.3 644/1354 (47%)!
33 (2) 3D7 PF3D7 0222700 PFB1015W B Query 6816 PF8443 8 1 U550200 845/845 (100%) 100 N/A
34 (2) 3D7 PF3D7 0833400 MAL7P1.213 A Query SA075 PFSA075 PN57 798/878(90%) 90.9 N/A
35 (2) 3D7IT
PF3D7_1253600 
PFIT 0801600
PFL2580W A ps
770/774 (99%)
99.5 584/1140 (51%)
382
Appendix Table 9.4. Conseved stevor genes.
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nucleotides (% 
pairwise identity)
Patient 
isolate with 
ortholog
Gene ID of ortholog
Idnetitical 
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for IT and 3D7
1(12) 3D7
IT
DD2
HB3
PF3D7_0402600 (s) 
PFIT_0401300 (s) 
PFDG_01541
PfHB3_BroadWash071000
PFD0125C B Query
905/906 (99%) 
897/907 (98%) 
594/594 (100%)
SA075
9605
11019
9775
10936
9215
6816
9106
PFSA075_052800 
PF8443_8_6_U069000 
PF8443_8_3_U516100 
PF8443_8_5_U069100 
PF8443_8_10_U523000 
PF8443_8_4_U070000 
PF8443_8_1_U071800 
PF8443 8 7 U550700
902/907 (99%) 
859/859 (100%) 
594/594 (100%) 
594/594 (100%) 
594/594 (100%) 
594/594 (100%) 
593/594 (99% 
593/594 (99%)
99.7 984/1016 (96%)
2(11) 3D7 PF3D7_0201300 PFB0065W A Query SA075
11019
10936
6816
10668
Brazilian
Brazilian
Brazilian
Brazilian
Brazilian
PFSA075_011900
PF8443_8_3_U441000
PF8443_8_10_U343600
PF8443_8_1_U528400
PF8443_8_8_U560900
DQ265680
DQ265679
DQ265676
DQ265677
DQ26568
915/918 (99%) 
896/897 (99%) 
896/897 (99%) 
895/897 (99%) 
892/897 (99%) 
716/725 (98%) 
716/725 (98%) 
715/725 (98%) 
714/725 (98%) 
696/717 (97%)
98.7 N/A
3(11) 3D7
IT
HB3
PF3D7_0832000 (s) 
PFIT_0835000 (s) 
PfHB3_BroadWash548600
MAL7P1.227 B Query
877/939 (93%) 
869/939 (92%)
11019
10668
9605
9215
9775
6816
SA075
9106
PF8443_8_3_U527500 
PF8443_8_8_U498100 
P F8443_8_6_U188700 
PF8443_8_4_U529500 
PF8443_8_5_U188600 
PF8443_8_1_U187900 
PFSA075_184100 
PF8443 8 7 U438100
894/939 (95%) 
891/939 (94%) 
879/912 (96%) 
879/939 (93%) 
878/948 (92%) 
869/939 (92%) 
868/948(91%) 
749/820 (91%)
95.9 995/1004 (99%)
M il) 3D7
IT
HB3
DD2
PF3D7_1000800 (s) 
PFIT_1000100 (s) 
PfHB3_BroadWash262600 
PFDG_0102
PF10_0009 B ps Query
823/874 (94%) 
872/879 (99%) 
872/879 (99%)
9605
SA075
9215
10936
11019
6816
10668
PF8443_8_6_U552400
PFSA075_220700
PF8443_8_4_U265400
PF8443_8_10_U546500
PF8443_8_3_U439500
PF8443_8_1_U523900
PF8443 8 8 U556300
876/879 (99%) 
876/879 (99%) 
875/879 (99%) 
874/879 (99%) 
699/702 (99%) 
566/567 (99% 
565/567 (99%)
98.4 912/1022 (89%)
3(10) 3D7
IT
HB3
PF3D7_0102100 (s) 
PFIT_0100600 (s) 
PfHB3_BroadWash529200
PFAOlOSw A ps Query
833/846 (98%) 
483/495 (97%)
9106
9215
10975
10936
10668
6816
11019
PF8443_8_7_U55480
PF8443_8_4_U537400
PF8443_8_12_U009100
PF8443_8_10_U524300
PF8443_8_8_U489700
PF8443_8_1_U009600
PF8443 8 3 U497500
494/495 (99% 
494/495 (99%) 
483/495 (97%) 
483/495 (97%) 
483/495 (97%) 
483/495 (97%) 
483/495 (97%)
98.7 989/1010 (97%)
6(6) 3D7 PF3D7_0400800 PFD0035C A Query 6816
10936
9215
11019
Brazilian
PF8443_8_1_U514100
PF8443_8_10_U551900
PF8443_8_4_U503300
PF8443_8_3_U487900
DQ265674
848/849 (99% 
822/871 (94%) 
810/874 (92%) 
707/720 (98%) 
668/677 (98%)
96 N/A
7(6) 3D7 PF3D7_1400700 PF14_0007 A Query SA075
6816
9106
Brazilian
Brazilian
PFSAO75_258600
PF8443_8_1_U548900
PF8443_8_7_U486000
DQ265669
DQ265668
819/882 (92%) 
817/882 (92%) 
810/882 (91%) 
680/685 (99%) 
681/689 (98%)
93.3 N/A
8(6) 3D7
IT
PF3D7_0221400 (s) 
PFIT_0220800 (s)
PFB0955W B Query
923/924 (99%)
SA075
9106
10936
Brazilian
PFSA075_029900
PF8443_8_7_U454500
PF8443_8_10_U552700
DQ265703
917/924 (99%) 
856/857 (99%) 
855/857 (99%) 
717/726 (98%)
99.4 999/1000(99%)
9(6) 3D7
3D7
PF3D7_0700700
PF3D7_1100700
MAL8P1.214
PF11_0013
B ps 
B ps
Query
822/864 (95%)
10668
9605
11019
9215
PF8443_8_8_U550900 
PF8443_8_6_U503000 
PF8443_8_3_U567200 
PF8443 8 4 U551500
492/492 (100%) 
492/492(100%) 
491/492 (99%) 
462/462 (100%)
97.9 N/A
10(6) 3D7
IT
PRCDC
PF3D7_0222800 
PFIT_0700300 
PRCDC 0045000
PFB1020W A Query
829/915 (90%) 
812/915 (88%)*
10936
11019
SA075
PF8443_8_10_U521200 
PF8443_8_3_U525000 
PFSAQ75 128400
823/849 (96%) 
843/927 (90%) 
831/915 (90%)
90.2 604/1116 (54%)
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11(5) 3 07 
IT 
IT
PF3D7_0732000 
PFIT_0900900 
PFIT 0900800
PF07_0130 A Query
815/894 (91%) 
815/894 (91%)
SA075
9106
9106
PFSAO75_348400 
PF8443_8_7_U561400 
PF8443 8 7 U472600
827/891 (92%) 
821/895 (91%) 
811/890 (91%)
90.3 543/1191 (45%) !
12(5) 3D7 PF3D7_0425500 PFD1220c B Query 6816
9106
9605
Brazilian
PF8443_8_1_U530000
PF8443_8_7_U451500
PF8443_8_6_U542100
DQ265704
912/915 (99%) 
912/915 (99%) 
865/867 (99%) 
728/736 (98%)
99.5 N/A
13(5) 3D7
IT
DD2
PRCDC
PF3D7_0114600 (s) 
PFIT_0113400 (s) 
PFDG_03937 
PRCDC 0058900
PFA0705C A ps Query
924/924 (100%) 
852/864 (98%) 
678/700 (96%)
SA075 PFSA075_011100 924/924(100%) 98.5 998/1002 (99%)
14 (5) 3D7 PF3D7_0200900 PFB0050c A ps Query 10668
10668
9106
SA075
PF8443_8_8_U537100 
PF8443_8_8_U535700 
PF8443_8_7_U543200 
PFSA075 154400
853/912 (93%) 
819/900 (91%) 
620/624 (99%) 
820/909 (90%)
92.2 N/A
15(5) 3D7
3D7
PF3D7_1254300
PF3D7_1254600
PFL2620W
PFL2635W
A
A
Query
856/909 (94%)
10668
SA075
10668
PF8443_8_8_U540800 
PFSA075_154400 
PF8443 8 8 U535700
891/909 (98%) 
833/909 (91%) 
829/909 (91%)
92 N/A
16(4) 3D7 PF3D7_0617600 PFF0850C A Query 9106
SA075
9775
PF8443_8_7_U112400 
PFSA075_071200 
PF8443 8 5 U530300
909/918 (99%) 
903/909 (99%) 
905/925 (97%)
98.3 N/A
17(4) 3D7
HB3
IT
PF3D7_1300900 
PfHB3_BroadWash534700 
PFIT 0731100
PF13_0009 A Query
923/927 (99%) 
854/931 (91%)
9215 PF8443_8_4_U550600 923/923(100%) 95.7 594/1102 (53%)
18(4) 3D7
HB3
HB3
PF3D7_1372800 
PfHB3_BroadWash549600 
PfHB3 BroadWash528000
MAL13P1.505 A Query
876/899 (97%) 
806/887 (90%
9605 PF8443_8_6_U544600 856/899 (95%) 93.5 N/A
19(4) 3D7
IT
PF3D7_1372500 (s) 
PFIT 0733100 (s)
MAL13P1.490 B ps Query
850/858 (99%)
SA075
SA075
PFSA075_412800 
PFSA075 348200
904/906 (99%) 
901/906 (99%)
99.3 998/1001 (99%)
20(4) 3D7
HB3
PF3D7_1479500 
PfHB3 BroadWash531600
PF14_0767 A Query
825/902(91%)
9215
10668
PF8443_8_4_U516100 
PF8443 8 8 U553100
833/915 (91%) 
819/902 (90%)
91.4 N/A
21(4) 3D7
IT
PF3D7_0401500 (s) 
PFIT 0400200 (s)
PFD0065W A ps Query
932/933 (99%)
SA075
Brazilian
PFSA075_051700
DQ265618
927/933 (99%) 
691/736 (93%)
978/1017(96%)
22(3) 3D7
DD2
PF3D7_0200400 
PFDG 01019
PFB0025C A Query
849/894 (94%)
9605 PF8443_8_6_U56000 882/915 (96%) 94.8 N/A
23 (3) 3D7
IT
PF3D7_0500600 (s) 
PFIT 0500700 (s)
PFE0030C B Query
919/924 (99%)
SA075 PFSA075_073300 923/924 (99%) 99.6 994/1006(98%)
24(3) 3D7
PRCDC
PF3D7_0532800 
PRCDC 0531800
PFE1627C A ps Query
708/771 (91%)
SA075 PFSA075_101000 700/705 (99%)
25(3) 3D7 PF3D7_0631900 PFF1550w A Query 9106
SA075
PF8443_8_7_U436400 
PFSA075 493100
911/912 (99%) 
845/912 (92%)
95.1 N/A
26(3) 3D7 PF3D7_0700400 MAL8P1.217 A Query 11019
9106
PF8443_8_3_U562300 
PF8443 8 7 U541900
882/903 (97%) 
850/903 (94%)
96 N/A
27(2) 3D7
HB3
PF3D7_0300400 
PfHB3 BroadWashl62000
PFC0025c
805/891 (90%)
90.3 N/A
28(2) 3D7
3D7
PF3D7_0832400 
PF3D7 0900900
MAL7P1.223
PFI0045C
A
A
Query
Query
Brazilian
SA075
DQ265697 
PFSA075 PN63
712/722 (98%) 
758/810 (93%)
98.6
93.6
N/A
N/A
29 (2) 3D7 PF3D7 1149900 PF11 0516 A Query SA075 PFSA075 001200 853/927 (92%) 92 N/A
Yellow highlights indicate the centrally located rifs.
The reference gene was used to search fo r  orthologs using BLAST search in Geneious 
(version 6.1.5).
s indicates syntenic orthologs
* non-orthologs because o f  the low pairwise sequence identity suggesting
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Appendix Table 9.5. Parasite IDC time points, time in culture, staging by giemsci- stained 
slide, and fo r  ex vivo patient isolates, estimated age in hours by micorcirray.
Laboratory isolates
Iso la te T im e p o in t H ours in cu ltu re
IDC s ta g e  by slide  (in ca se s  of m u ltip le  s ta g e s  
th e  d o m in a n t s ta g e  is h igh ligh ted  in bold)
T1 0 Early r in g / m id ring
T2 12 Late r in g / ea rly  tro p h o z o ite
3D7
T3 18 Early t r o p h o z i te /  m id tro p h o z o ite /  la te  ring
T4 24 M id t r o p h o z o i te /  la te  tro p h o z o ite
T5 30 la te  tro p h o z o ite
T6 42 S c h iz o n t/  la te  tro p h o z o ite /  ea rly  ring
T1 0 Early ring
T2 12 M id r in g / la te  ring
IT
T3 18 Early t r o p h o z o i te /  la te  ring
T4 24 M id  t r o p h o z o i te /  ea rly  tro p h o z o ite
T5 30 L ate t r o p h o z o ite
T6 40 S c h iz o n ts / la te  t ro p h o z o ite
T1 0 Early ring
T2 12 L ate r in g / ea rly  t ro p h o z o ite
HB3
T3 18 Early tro p h o z o ite
T4 24 M id tro p h o z o ite
T5 30 L ate tro p h o z o ite
T6 42 S c h iz o n t/  la te  tr o p h o z o ite /  ea rly  ring
Laboratory-adapted Kilifi isolates
Iso la te T im e p o in t H ours in cu ltu re
IDC s ta g e  by s lide  (in c a se s  o f m u ltip le  s ta g e s  
th e  d o m in a n t s ta g e  is h igh ligh ted  in bold)
T1 0 Early to  m id  ring
8383
T2 6 Late r in g / ea rly  t ro p h o z o ite
T3 18 M id / la te  tro p h o z o ite
T4 30 S ch izon t
T1 0 Early / m id ring
9106
T2 8 Late r in g / ea rly  t ro p h o z o ite
T3 18 M id / la te  tro p h o z o ite
T4 26 M id / la te  tro p h o z o ite /S s c h iz o n t
T1 0 Early ring
9106HBEC
T2 13 Late r in g / ea rly  tro p h o z o ite
T3 25 E arly / m id  tro p h o z o ite
T4 44 S c h iz o n t/  ea rly  ring
T1 0 Early / m id ring
9215
T2 10 Late r in g /  ea rly  tro p h o z o ite
T3 19 M id /  la te  tro p h o z o ite
T4 30 L ate t r o p h o z o i te /  sch izo n t
T1 0 M id ring
10668  R+3
T2 6 Late r in g / ea rly  t ro p h o z o ite
T3 20 M id tro p h o z o ite
T4 31 L ate t r o p h o z i te /  s c h iz o n t/  ea rly  ring
T1 0 Early ring
10668HBEC
T2 20 Late r in g / ea rly  tro p h o z o ite
T3 25 Early / m id  tr o p h o z o ite
T4 32 S c h iz o n t/  ea rly  ring
T1 0 Early ring
10668  CU
T2 20 Late r in g / ea rly  t ro p h o z o ite
T3 30 E arly / m id tro p h o z o ite
T4 40 S c h iz o n t/  ea rly  ring
T1 0 M id ring
SA075C R+
T2 10 Late ring/  ea rly  t ro p h o z o ite
T3 24 M id / la te  tro p h o z o ite
T4 31 S ch izon t
T1 0 Early t o  m id  ring
SA075C R-
T2
T3
22
29
Late ring/  ea rly  t ro p h o z o ite  
M id tr o p h o z o ite
T4 48 S ch izon t
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Ex-vivo fie ld  isolates (M JM 's study) QC based on DD2
Isolate Timepoint
Time in 
culture
IDC stage by slide (in cases of multiple 
stages the dom inant stage is highlighted 
in bold)
Array Estimated 
age (hrs)
pir expression by 
capillary Sanger 
sequencing 
(chapter 4)
Stage label on 
piecharts in 
chapter 4
pir expression by 
454 sequencing 
(chapter 6)
Stage label on 
piecharts in 
chapter 6
T1 0 Early ring N/A rif & stevor
T2 10 N/A N/A R
T3 20 Mid ring 12 rif & stevor
10727 T4 30 Early troph 14
T5 40 Mid troph 22 rif & stevor T
T6 50 late troph N/A
T7 60 Schizont 32 rif & stevor S
T1 0 Early ring N/A rif & stevor R
T2 10 Mid ring 12 rif R
T3 20 Mid ring 16 rif & stevor LR-ET rif
10761 T4 30 Early troph 22 stevor T
T5 40 Late troph 26 rif T rif T
T6 50 Schizont 34 rif & stevor
17 60 Early ring N/A rif & stevor S rif
11 0 Early ring N/A
12 10 Early ring N/A
T3 20 N/A N/A rif & stevor R
10747 T4 30 Mid ring N/A
T5 40 Early troph N/A rif & stevor LR-ET
T6 50 N/A N/A
T7 60 N/A N/A rif & stevor S
T1 0 Mid ring N/A rif R
T2 10 Late ring/ mid ring N/A rif R
10735
T3
T4
20
30
Late ring/ early  trophozoite
Early trophozoite
N/A
N/A
rif
rif LR-ET
rif
rif
LR-ET
T5 40 Mid trophozoite N/A rif
T6 50 Mid trophozoite N/A rif
17 60 Late trophozoite/ schizont N/A
11 0 Mid ring N/A rif & stevor rif
12 10 Late ring  mid ring N/A rif rif
T3 20 Late ring/early trophozoite 12 rif & stevor LR-ET
10739 T4 30 Early trophozoite/ mid trophozoite N/A rif
T5 40 Mid trophozoite N/A rif & stevor rif
T6 50 Late trophozoite N/A rif rif
17 60 Late trophozoite/ schizont N/A rif & stevor S
11 0 N/A 10 rif & stevor ER
12 10 N/A 12 rif & stevor R
13 20 Mid ring 16 rif & stevor LR-ET
10814 T4 30 Mid ring 20 rif & stevor PR
T5 40 N/A 26 rif & stevor T
T6 50 N/A 38
17 60 Early troph 46 rif & stevor S rif & stevor T
11 0 M id ring 12 rif rif
12 10 Late ring/early trophozoite 12
13 20 M id trophozoite 18 rif rif
10594 14 30 Late trophozoite 22 rif
15 40 Late trophozoite/ early schizont 34
16 50 Schizont/early ring 42 rif rif
17 60 Late schizont/ early ring 46
11 0 Mid ring 10 rif rif
12 10 Late ring/early trophozoite 12 rif rif
13 20 mid trophozoite 20 rif rif
10595 14 30 Late trophozoite 16 rif rif
15 40 Late trophozoite/ early schizont 30
16 50 Schizont 40 rif rif
17 60 Schizont/ early ring 46
Green highlight indcates overlapping time points where data were pooled fo r  analysis by 
averaging the read counts o f  the two stages. 
The stages in bold represent the dominant IDC stage in a time point with mixed stages.
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7
*: Noticeably incomplete pir repertoire 
#; Additional 55 rifs and 9 stevors annotated in house
§: pir partial repertoires from de novo assembly o f 454 amplicon sequencing 
reads
3
Appendix Table 9 .7. List o f  primers used.
# Prim er N am e S equence (space after each se t o f  3) Procedure
1 A lbrech t R 5' - CAT A A A  T O T  T T C  T T G  CAY TCA  TO 454 sequencing
2 Stevor-prim er3 F 72 5' - W D H  A G A  A CC  NAT G TC  A AC G 454 sequencing
3 L avazec L 5' - C A A  A A G  GAA  G A G  ATA A G T  AT PC R  for c loning and cap illa ry  sequencing
4 L avazec R 5, _ G T T  T C T  T G C  ATT CAT G T T  TC C PC R  for c loning and cap illa ry  sequencing
5 K yes-rifF l 5' - C RT C A C  G AK  T G T  TAA  G C G P C R  for c loning and cap illa ry  sequencing /454  sequencing
6 K ves-rifF2 5 '-  C G A  RY G  T G A  A TT GTA TG C PC R  for c lon ing  and cap illa r)' sequencing /454  sequencing
7 Kves-rifF3 5' - CYA CYA G RT TAT TAT G C G PC R  for c lon ing  and cap illa ry  sequencing /454  sequencing
8 K ves-rifR ev 5' - C TT  CAW  ATT RTT W T T  T Y K  D C G  ATA A C G PC R  for c loning and cap illa ry  sequencing
9 K ves-rifR l 5' - C TT  CAW  T T T  R TT W T T  T Y K  D C G  ATA A C G P C R  for c lon ing  and cap illa ry  sequencing
10 K ves-rifR l-V T 5' - C TT  CAW  T T T  Y TT  W T T  TY K  D C K  ATA A C G PC R  for c lon ing  and  cap illa ry  sequencing /454  sequencing
11 K ves-rifR l-T 7
5' - cag  aga tgc  ata  ata cga etc  act ata ggg  C TT  CAW  T T T  RTT W T T  TY K  D CG  ATA 
A C G  " r i f  northern  probe
12 K yes-rifF  1-T7 5' - cag  aga tgc ata  ata  cga etc  act ata g g g  C RT C A C  G A K  T G T  TAA  G C G r i f  northern  probe
13 K ves-rifF2-T 7 5' - cag  aga tgc  ata ata  cga e tc  act ata  ggg  C GA  RY G  T G A  A TT GTA TG C r i f  northern  probe
14 K ves-rifF3-T 7 5' - cag  aga tgc ata  ata cg a  etc act ata ggg  CYA CYA G RT TAT TAT G C G r i f  northern  probe
15 K ves-rifR l-V T -T 7
5' - cag  aga tgc ata  ata cga etc act ata g g g  C T T  CAW  T T T  Y T T  W T T  T Y K  D CK  ATA 
A C G r i f  northern  probe
16 D B L aB R -T 7 ■ 5' - cag  ag a  tgc ata  ata cga etc  act ata ggg  G C C  CAT T C S T C G  A A C  CA var northern  probe
17 D B L aA F'-T7 5' - cag  aga tgc a ta  ata cga etc act ata  g g g  G C A  C G M  A G T  T T Y  G C var northern  probe
18 M SP1F 5’ - CTA G A A  G C T  TTA G A A  GAT G C A  GTA TTG m s p l genotyp ing , no trhem  probe
20 M SP1 R 5' - C T T  A A A  T A G  TAT T C T  A A T TCA  A G T  G G A  T C A m s p l genotyp ing
21 M S P lR K im ura 5' - A TC CAT C A A  TTA A AT ATT T G A  A A C  C m s p l northern  probe
22 M S P lR K im ura-T 7
5' - cag  aga tgc  ata  ata cga etc  act ata g g g  ATC CAT C A A  TTA A A T A TT T G A  A AC 
C m s p l northern  probe
23 m sp2 F 5' - ATG A A G  GTA ATT A A A  A C A  T T G  T C T  A TT ATA m sp2 geno typ ing
24 m sp2 R 5, _ C TT  T G T  TAC CAT C G G  TAC ATT C TT m sp2 genotyping
25 V ar-C IF 5' - A A A  A A A  C A A  AAT CAT C A G  T A G  G A A  A TT TAT T (C /T )C var northern  probe
26 Var-C2R 5' - TAT C C C  ATA AAT C T G  C(A7T)A T (A /T )G  G (A /G )T  A var northern  probe
27 Var-C1F-T7
51 - cag  aga tgc ata  ata cga etc  ac t ata g gg  A A A  A A A  C A A  AAT CAT C A G  TAG  
G A A  ATT TAT T(C /T )C var northern  probe
28 V ar-C2R-T7
5' - cag  aga tgc ata ata cga  etc act ata g gg  TAT C C C  ATA A AT C TG  C (A /T )A  
T (A /T )G  G (A /G )T  A var northern  probe
29 calm odulinF 5' - T G G C A G A C A A G TT A A C A G A A G A A C A calm odulin  northern  probe
30 calm odulinR 5' - TGG CTA TCA TCA TTTTAA C AA AC TCT calm odulin  northern  probe
31 calm odulinF -T 7 5’ - cag  aga tgc ata  ata cg a  etc  a c t ata g gg  TG G C A G A C A A G TT A A C A G A A G A A C A calm oduhn  northern probe
32 calm odulinR -T 7 5' - cag  aga tgc ata  ata cg a  etc  act ata g gg  TG G C TA TCA TCA TTTTA A C A A A C TCT calm odulin  northern  probe
33 T 7-F  sequencing  prim er 5' - TAA  TAC G A C  TCA  CTA TAG  GG sequencing, northern  probe
34 M S PI K1 F (7  bp-tail) 5' -  A A A  T G A  A G A  A G A  AAT TAC TAC A A A  A G G  TG C m s p l genotyp ing
35 M SP1 K I R  (N E D ™ -yellow ) 5 ' - G C T  TG C  ATC A G C  T G G  A G G  G C T  T G C  A C C  A G A m s p l genotyp ing
36 M SP I M A D 20 F (7 bp-tail) 5 ’ - A A A  T G A  A G G  A A C  A A G  T G G  A A C  A G C  T G T  TAC m s p l genotyp ing
37 M S P I M A D  20 R (P E T ® -re d ) 5' - ATC T G A  A G G  ATT T G T  A C G  T C T  T G A  A TT A CC m s p l genotyp ing
38 M S P I R 0 3 3 F  (7  bp-tail) 5‘ - TAA A G G  A TG  G A G  C A A  ATA C TC  A A G  T T G  T T G m s p l genotyp ing
39 M S P I R 0 3 3  R (V IC ® -g re e n ) 5' - CAT C T G  A A G  GAT TT G  C A G  C A C  C T G  G A G  ATC m s p l genotyp ing
40 M S P 2 F C 2 7 F  (7  bp-tail) 5' - AAT A C T  A A G  A G T  GTA G G T  G C A  RAT G C T  C CA m sp 2 genotyp ing
41 M SP2 F C 27 R  (6-FA M ™  -blue) 5' - T T T  TAT T T G  G T G  CAT T G C  C A G  A A C  T T G  A A C m sp 2 geno typ ing
42 M S P 2 IC F  (7  bp-tail) 5' - A G A  A G T  A TG  G C A  G A A  A G T  AA K C C T  Y C T  A C T m sp2 geno typ ing
43 M SP2 I C R  (V 1 C S -g reen ) 5' - GAT T G T  A AT T C G  G G G  GAT T C A  G T T  T G T  T C G m sp2 genotyp ing
62 PFL 2585cloop-L 5 ’ TC C  C CC  G G G  TTA T C C  C A A  A G A  C CA  T G T  ATT T G C  C TC  G PC R , clon ing  and  cap illa ry  sequencing
63 P F L 2 5 8 5 c lo o p -R
5’ G G C  ATG C CA  T G G  A C T  A C A  A G G  A C G  A C G  ATG A C A  A G T  TAT TAA C A G  
ATG C T G  C T G  C A A  A A C PC R , clon ing  and cap illa ry  sequencing
64 M13 F orw ard (-20) 5 ' - GTA A A A  C G A  C G G  C CA  G sequencing
65 M13 Reverse 5 ’ - C A G  G A A  A C A  G C T  A TG  A C sequencing
66 SP 6 Forw ard 5 ' - GAT TTA  G G T  G A C  A C T  ATA G sequencing
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Appendix M ethod 9.1. Draft genome assembly and annotation (developed by Thomas 
Otto).
From genomic DNA samples of 13 culture-adapted patient isolates, we generated whole 
genomes draft sequences using the Illumina technology. First we generate noPCR 
libraries (Kozarewa et al., 2009) with around 500bp fragment length, that were sequenced 
on the HiSeq result in lOObp reads with a coverage o f 60-1 OOx.
After a quick quality control, the reads were de novo assembled with velvet (Zerbino and 
Birney, 2008), k-mer o f 61. Next the resulting scaffolds were further scaffolded with 
SSPACE (Boetzer et al., 2011). The new scaffold were further improved as described in 
(Swain et al., 2012). In short, the scaffolds were ordered against the Plasmodium 
falciparum  reference version 3 (geneDB (Logan-Klumpler et al., 2012)), where the 
subtelomeric regions were masked with ABACAS (Assefa et al., 2009). Sequencing gaps 
were closed with image (Tsai et al., 2010).
The genomes were annotated by a combination of transferring the gene models from 
there reference (RATT (Otto et al., 2011)) and ab initio calling by Augustus (Stanke and 
Morgenstern, 2005). The gene models from the two methods were merged as described in 
(Otto, 2015).
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N ew bler configu ra tion :
minimumReadLength 20 
overlapSeedStep 12 
overlapSeedLength 16 
overlapM inSeedCount 1 
overlapSeedHitLimit 70 
overlapHitPositionLimit 1000000 
overlapMinMatchLength 40
overlapM inM atchldentity 90
overlapM atchldentScore 2
overlapMatchDiffScore -3 
overlapM atchllniqueThresh 12 
isogroupThresh 500 
isotigThresh 100 
isotigContigCountThresh 100
isotigContigLengthThresh 3
aceM ode Auto 
aceReadM ode Default 
pairAlignMode None 
alignlnfoM odeAuto 
mapMinContigDepth 1 
allContigThresh 100 
largeContigThresh 500 
expected Depth 0
cDNAMode false 
referenceM ode Auto 
largeGenome false 
ripM ode false 
heterozygoteM ode false 
assemblerBatchSize 0 
numCPU 1
showSingleReadVariations false 
nimblegenM appingM ode false 
backwardCompatibleContigging false 
finishMode false 
autoTrimming true
Appendix Method 9.1. Parameters fo r  Newbler assembly o f 454 amplicon sequence 
reads into contigs.
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Appendix Table 9.8. Raw r if  read counts from 454 amplicon sequencing o f  cDNA and 
gDNA from  laboratory iolates. The data in the table was generated by mapping 454 
reads onto homologous genomes and read counts computed using the Artemis 
application. An average read count was taken when samples were sequenced in 
duplicates or triplicates. Genes in the table had greater than 5X read coverage.
Isolate Gene ID A/B ER LR ET MT LT S G
3D7 PF3D7_0421500 A 4 551 1069 1057 491 74 27
3D7 PF3D7_0425900 A 291 587 604 214 289 844 138
3D7 PF3D7_1200500 A 48 108 16 101 700 690 20
3D7 PF3D7_1300400 A 760 440 103 75 72 55 80
3D7 PF3D7_0701100 A 405 464 185 154 149 141 184
3D7 PF3D7_0900400 A 64 392 359 172 162 201 131
3D7 PF3D7_0115600 A 109 379 412 90 111 87 15
3D7 PF3D7_1100300 A 332 223 95 76 55 27 31
3D7 PF3D7JL150300 A 398 195 31 48 44 33 27
3D7 PF3D7_0833400 A 63 79 40 68 164 204 89
3D7 PF3D7_0200200 A 155 137 36 52 45 69 61
3D7 PF3D7_0632700 A 47 86 13 74 134 133 20
3D7 PF3D7_0100200 A 26 91 34 17 131 181 43
3D7 PF3D7_0600500 A 179 109 37 54 54 16 55
3D7 PF3D7_0223400 A 35 64 50 21 154 120 23
3D7 PF3D7_0808900 A 33 142 103 3 63 54 163
3D7 PF3D7_0533000 A 65 146 70 38 50 27 41
3D7 PF3D7_0223100 A 4 110 100 129 34 8 35
3D7 PF3D7_1373400 A 71 55 14 37 95 93 54
3D7 PF3D7_0324800 A 56 58 37 33 92 79 30
3D7 PF3D7_0400300 A 30 68 11 60 64 40 6
3D7 PF3D7_0100400 A 22 45 36 24 90 55 28
3D7 PF3D7_0600300 A 31 28 16 30 51 68 19
3D7 PF3D7_0700200 A 30 65 48 28 9 14 40
3D7 PF3D7_1000500 A 5 25 3 29 53 66 42
3D7 PF3D7_1101100 A 25 47 16 18 38 29 18
3D7 PF3D7_0900600 A 5 23 13 24 47 60 26
3D7 PF3D7_1400200 A 14 33 4 8 73 40 11
3D7 PF3D7_0425600 A 1 43 41 27 37 12 89
3D7 PF3D7_0617700 A 8 35 12 9 49 32 8
3D7 PF3D7_0425700 A 73 23 3 3 18 4 2
3D7 PF3D7_0937700 A 13 21 2 6 36 35 18
3D7 PF3D7_1300200 A 25 20 8 4 29 21 21
3D7 PF3D7_1100500 A 0 36 33 11 18 7 62
3D7 PF3D7_0901300 A 25 21 17 16 5 13 34
3D7 PF3D7_1101300 A 2 25 42 12 6 6 15
3D7 PF3D7_0300200 A 17 22 17 3 19 14 3
3D7 PF3D7_0324400 A 11 17 10 18 28 7 101
3D7 PF3D7_0900200 A 15 14 3 10 29 20 9
3D7 PF3D7_1372700 A 7 11 4 16 16 10 81
3D7 PF3D7_0632200 A 23 13 7 5 4 9 74
3D7 PF3D7_1254700 A 1 21 10 8 13 5 82
3D7 PF3D7_0901500 A 10 16 7 4 3 18 46
3D7 PF3D7_0732900 A 5 6 4 8 23 8 0
3D7 PF3D7_0632400 A 2 22 5 9 10 0 11
3D7 PF3D7_1040500 A 2 23 11 4 4 1 68
3D7 PF3D7_0937500 A 5 5 3 3 16 12 25
3D7 PF3D7_0700300 A 0 10 11 12 6 3 12
3D7 PF3D7_0800400 A 6 10 0 1 14 10 53
3D7 PF3D7_1040300 A 1 8 3 23 5 0 0
3D7 PF3D7_0600700 A 0 6 7 11 7 7 39
3D7 PF3D7_1150000 A 3 9 4 6 9 4 41
3D7 PF3D7_0413200 A 0 5 4 7 8 5 72
3D7 PF3D7_1200200 A 1 7 1 2 9 9 2
3D7 PF3D7_0400700 A 2 7 1 2 4 7 14
3D7 PF3D7_1254200 A 2 5 5 3 2 5 15
3D7 PF3D7_1255100 A 4 7 0 1 2 6 38
3D7 PF3D7_1100400 A 1 6 1 8 4 0 2
3D7 PF3D7_0900700 A 2 7 0 2 6 2 12
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Isolate Gene ID A/B ER LR ET MT LT S G
3D7 PF3D7_0400900 A 0 6 3 2 1 1 37
3D7 PF3D7_0732400 A 0 4 3 1 4 0 9
3D7 PF3D7_1150200 A 1 4 0 4 3 0 9
3D7 PF3D7_1479700 A 0 4 1 4 0 3 8
3D7 PF3D7_0100900 A 1 3 2 1 3 1 35
3D7 PF3D7_0400500 A 2 2 1 2 3 1 0
3D7 PF3D7_0300700 A 1 4 0 0 3 2 25
3D7 PF3D7_1041000 A 0 1 0 0 1 8 0
3D7 PF3D7_0712500 A 0 6 0 1 1 1 30
3D7 PF3D7_0732500 A 0 1 2 2 0 4 16
3D7 PF3D7_1253700 A 1 2 0 0 3 2 7
3D7 PF3D7_1400400 A 0 3 0 0 5 0 7
3D7 PF3D7_1300700 A 1 0 2 1 2 2 2
3D7 PF3D7_1480000 A 1 1 0 4 2 0 0
3D7 PF3D7_0300800 A 0 2 1 0 4 0 0
3D7 PF3D7_1254800 A 2 1 2 0 1 0 4
3D7 PF3D7_0712200 A 0 1 0 3 0 2 0
3D7 PF3D7_1301000 A 0 1 0 2 1 1 15
3D7 PF3D7_1254400 A 1 2 0 0 0 2 13
3D7 PF3D7_0833100 A 0 2 0 0 2 0 12
3D7 PF3D7_0200500 A 1 1 1 1 0 0 2
3D7 PF3D7_1040700 A 0 2 0 0 0 1 26
3D7 PF3D7_0401200 A 2 0 0 0 0 0 7
3D7 PF3D7_0222600 A 0 1 0 0 0 0 18
3D7 PF3D7_1000600 B 22 579 354 284 235 162 3
3D7 PF3D7_1300600 B 13 33 10 11 76 130 30
3D7 PF3D7_1372600 B 0 3 0 206 3 0 0
3D7 PF3D7_0900500 B 1 7 5 14 52 132 28
3D7 PF3D7_0701200 B 32 39 14 13 37 17 225
3D7 PF3D7_0100600 B 14 20 9 15 44 31 74
3D7 PF3D7_1479800 B 6 41 50 9 12 5 48
3D7 PF3D7_1000300 B 27 34 7 11 23 11 67
3D7 PF3D7_1400300 B 37 33 5 6 26 3 36
3D7 PF3D7_1149800 B 11 13 32 0 13 6 56
3D7 PF3D7_0201000 B 5 23 6 4 10 9 19
3D7 PF3D7_0101900 B 10 11 2 5 10 13 39
3D7 PF3D7_0324500 B 1 10 9 1 17 11 203
3D7 PF3D7_1400500 B 2 18 3 3 16 i 35
3D7 PF3D7_1255000 B 10 16 1 5 6 2 60
3D7 PF3D7_0900300 B 5 13 4 4 11 3 33
3D7 PF3D7_1479400 B 6 13 4 1 12 3 45
3D7 PF3D7_1040100 B 13 5 1 4 11 3 128
3D7 PF3D7_1400800 B 3 5 3 3 17 4 60
3D7 PF3D7_0500300 B 2 6 2 4 11 8 31
3D7 PF3D7_0732700 B 2 6 9 2 4 4 39
3D7 PF3D7_0300500 B 3 6 1 0 10 7 33
3D7 PF3D7_0632300 B 11 5 1 1 4 3 39
3D7 PF3D7_1040600 B 3 2 4 0 7 8 193
3D7 PF3D7_1041100 B 13 1 1 0 3 3 57
3D7 PF3D7_1040800 B 7 9 2 0 1 0 156
3D7 PF3D7_1040400 B 2 3 7 2 4 1 70
3D7 PF3D7_0833200 B 4 5 1 2 5 1 32
3D7 PF3D7_0901000 B 0 7 2 1 2 3 59
3D7 PF3D7_0631800 B 2 5 0 2 3 3 35
3D7 PF3D7_0832800 B 2 5 0 0 6 2 6
3D7 PF3D7_0532900 B 7 6 0 1 0 0 0
3D7 PF3D7_1040900 B 0 1 1 0 5 6 7
3D7 PF3D7_1254000 B 4 1 1 2 3 0 25
3D7 PF3D7_0222700 B 0 7 1 0 1 0 41
3D7 PF3D7_1101200 B 1 0 3 1 3 1 34
3D7 PF3D7_1254500 B 0 1 0 5 0 0 1
3D7 PF3D7_0114700 B 1 1 0 0 2 0 22
3D7 PF3D7_0222500 B 1 2 0 0 0 1 5
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Iso la te Gene ID A/B ER LR
IT PFIT_0536700 A 3612 4135
IT PFIT_0900150 A 357 821
IT PFIT_0835500 A 56 1125
IT PFIT_0424300 A 460 1454
IT PFIT_bin02300 A 1000 454
IT PFIT_0537500 A 62 105
IT PFIT_1240200 A 21 48
IT PFIT_bin04400 A 95 81
IT PFIT_1401300 A 122 82
IT PFIT .1401400 A 122 82
IT PFIT_1401500 A 84 51
IT PFIT_0100200 A 165 41
IT PFIT_1400400 A 2 10
IT PFIT_bin08400 A 11 16
IT PFIT_0537200 A 4 24
IT PFIT_bin08800 A 20 26
IT PFIT_0731600 A 15 14
IT PFIT_0537100 A 15 17
IT PFIT_bin05000 A 28 11
IT PFIT_0419700 A 4 6
IT PFIT_1400300 A 0 16
IT PFIT_0411700 A 1 3
IT PFIT_0500500 A 25 17
IT PFIT_bin07100 A 6 3
IT PFIT_bin01100 A 16 15
IT PFIT_bin04900 A 9 18
IT PFIT_0734200 A 0 3
IT PFIT_bin06000- A 2 8
IT PFIT_0200500 A 1 10
IT PFIT_1100200 A 0 4
IT PFIT_bin03700 A 0 0
IT PFIT_0616600 A 6 8
IT PFIT_0731500 A 0 4
IT PFIT_1150500 A 2 4
IT PFIT_bin04600 A 8 2
IT PFIT_1100400 A 0 2
IT PFIT_0300600 A 3 3
IT PFIT_0800400 A 3 2
IT PFIT_0733300 A 3 0
IT PFIT_bin03500 A 2 5
IT PFIT_0800700 A 5 4
IT PFIT_0S36500 A 8 4
IT PFIT_bin02800 A 3 1
IT PFIT_0424000 A 2 5
IT PFIT_0200200 A 2 1
IT PFIT_0801500 A 0 6
IT PFIT_1150200 A 1 6
IT PFIT_0400100 A 0 1
IT PFIT_bin06700 A 0 2
IT P F IT _b in l0200 A 2 4
IT P F IT .0300700 A 3 2
IT PFIT_bin05900 A 0 1
IT PFIT_0500400 A 0 0
IT PFIT_bin02900 A 2 1
IT PFIT_0411800 A 0 0
IT PFIT_bin00500 A 1 0
IT PFIT_0901100 A 2 3
IT PFIT_0700400 A 0 0
IT PFIT_0901700 A 0 1
IT PFIT_bin03400 A 0 0
IT PFIT_bin06800 A 2 3
IT PFIT_bin07900 A 1 0
IT PFIT_bin08000 A 1 0
IT PFIT_bin08100 A 1 0
IT PFIT_0537000 A |p s 12 20
M T LT S G R-p T-p
1736 2355 1942 157 461 135
2671 3220 1190 34 70 180
754 755 2408 44 81 128
213 193 155 58 90 81
22 110 302 54 47 34
30 103 324 61 26 5
42 60 89 200 1 1
33 58 122 9 8 2
10 12 •21 124 0 0
10 12 21 124 0 0
28 29 24 103 0 1
10 12 17 1 2 0
26 10 21 121 1 1
8 10 13 117 1 1
34 16 24 52 0 4
17 19 43 53 1 1
6 11 15 77 4 0
11 22 28 40 2 3
1 6 5 92 1 0
20 14 17 72 1 0
2 4 13 91 0 0
0 8 8 98 1 0
3 6 1 41 5 0
42 10 10 6 0 0
2 7 11 46 0 0
9 6 32 5 9 0
0 1 4 82 0 0
3 10 3 62 0 0
5 14 13 37 1 0
1 5 3 60 0 0
0 0 9 58 0 0
3 8 8 28 0 0
1 0 6 30 0 0
0 2 2 44 0 0
7 9 3 14 5 0
0 4 1 39 0 0
0 4 2 33 0 0
0 2 2 33 0 0
1 6 1 31 0 0
9 8 2 13 0 0
4 10 9 1 2 0
8 2 5 5 0 0
0 0 4 20 0 0
0 1 1 21 0 0
2 3 1 20 0 0
0 1 1 18 0 0
1 2 1 13 0 0
0 0 0 22 1 0
3 1 3 9 0 0
0 8 0 0 0 0
1 1 4 5 0 0
0 4 1 6 0 0
2 3 0 4 0 0
0 0 1 2 0 0
0 1 2 5 0 0
0 6 0 0 0 0
0 1 0 0 0 0
1 0 1 3 0 0
0 0 0 4 0 0
2 0 0 1 0 0
0 0 0 0 0 0
0 3 0 0 0 0
0 3 0 0 0 . 0
0 3 0 0 0 0
11 20 34 36 2 4
ET
2831
1184
2495
153
45
23
82
17
36
36
9
9
31
32
40
16
9
11
5
8
2
1
9
27
6
5
1
0
6
0
0
0
14
1
0
1
1
3
0
2
4
2
4
0
0
3
2
0
5
5
1
0
1
3
0
1
0
0
0
2
0
1
1
1
10
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Isolate Gene 10 A/B ER LR ET MT LT s G R-p
IT PFIT_0733200 B 7 109 101 256 572 82 1 0
IT PFIT_1150600 B 10 4 3 5 23 106 64 22
IT PFIT_0100400 B 13 24 0 6 13 3 102 37
IT PFIT_bin04800 B 25 30 3 9 17 17 88 7
IT PFIT_0424100 B 19 22 4 17 7 8 108 5
IT PFIT_0700600 B 8 11 1 14 20 14 108 0
IT PFIT_0300400 B 4 8 11 11 6 14 98 0
IT PFIT_0300500 B 4 8 11 11 6 14 98 0
IT PFIT_bin03600 B 7 15 2 13 13 9 65 7
IT PFIT_0800300 B 5 15 12 14 5 7 67 0
IT PFIT_0901200 B 6 9 2 6 5 1 95 1
IT PFIT_0733S00 B 1 5 8 7 4 1 93 0
IT PFIT_0901300 B 6 3 0 4 2 1 95 0
IT PFIT_bin03900 B 0 1 1 3 1 0 89 0
IT PFIT_binlOOOO B 21 1 0 3 3 6 61 0
IT PFIT_bin01200 B 0 7 3 2 2 4 68 0
IT PFIT_0537400 B 11 0 1 0 3 4 25 2
IT PFIT_0536600 B 4 3 0 3 2 6 13 1
IT PFIT_0113500 B 1 3 0 2 0 0 28 0
IT PFIT_bin01700 B 0 1 0 0 0 0 21 0
IT PFIT_bin00800 B 0 0 2 2 0 0 8 0
IT PFIT_0200300 B 0 3 0 1 1 1 5 0
IT PFIT_0733400 B 1 0 0 2 1 5 0 0
IT PFIT_binl0400 B 0 0 1 0 0 1 7 0
T-p
1
0
0
0
1
1
1
1
0
0
0
0
0
1
0
1
0
4
0
0
0
0
0
0
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Isolate Gene ID A/B ER LR ET MT LT S G
HB3 PfHB3_BroadWash530300 A 1227 686 1235 808 697 958 165
HB3 PfHB3_BroadWash520600 A 311 294 240 290 166 239 163
HB3 PfHB3_BroadWash536100 A 229 94 158 158 273 223 177
HB3 PfHB3_BroadWash524200 A 170 93 134 189 136 226 57
HB3 PfHB3_BroadWash524700 A 247 123 160 167 136 157 13
HB3 PfHB3_BroadWash534900 A 58 65 141 158 61 159 33
HB3 PfHB3_BroadW ashl62300 A 94 76 166 127 18 105 81
HB3 PfHB3_BroadWash523800 A 69 82 81 134 68 144 80
HB3 PfHB3_BroadWash521900 A 14 46 89 76 12 168 49
HB3 PfHB3_BroadWash520100 A 41 68 75 90 35 104 39
HB3 PfHB3_BroadWash074000 A 8 49 63 55 121 104 49
HB3 PfHB3_BroadWash075100 A 0 54 97 58 20 89 104
HB3 PfHB3_BroadW ashl72400 A 9 38 56 64 17 73 114
HB3 PfHB3_BroadWash520900 A 0 45 60 72 20 85 85
HB3 PfHB3_BroadWash539200 A 20 76 57 42 32 72 18
HB3 PfHB3_BroadWash526000 A 5 70 60 36 5 96 34
HB3 PfHB3_BroadW ashl61400 A 6 57 93 60 8 67 12
HB3 PfHB3_BroadWash511900 A 53 22 28 36 64 43 47
HB3 PfHB3_BroadWash363600 A 8 18 11 29 28 24 159
HB3 PfHB3_BroadWash520700 A 62 29 38 40 21 29 42
HB3 PfHB3_BroadWash516900 A 25 30 48 39 1 52 61
HB3 PfH B3_BroadW ash525700 A 0 6 15 9 2 17 165
HB3 PfHB3_BroadWash509300 A 29 37 36 35 13 31 11
HB3 PfHB3_BroadWash530100 A 3 21 26 41 9 55 23
HB3 PfHB3_BroadWash578000 A 34 7 13 19 13 39 24
HB3 PfHB3_BroadWash528900 A 8 3 6 11 17 46 56
HB3 PfHB3_BroadWash522500 A 8 20 23 20 18 31 7
HB3 PfHB3_BroadWash531500 A 2 9 5 6 9 19 62
HB3 PfHB3_BroadWash515900 A 0 13 19 14 3 22 27
HB3 PfHB3_BroadWash531000 A 2 9 . 7 11 1 3 65
HB3 PfHB3_BroadWash528800 A 1 7 12 21 4 11 25
HB3 PfHB3_BroadW ashl93800 A 0 2 1 0 8 4 65
HB3 PfHB3_BroadWash512400 A 5 14 10 12 4 19 16
HB3 PfH B3_BroadW ash512200 A 0 7 20 11 2 11 22
HB3 PfHB3_BroadWash556100 A 0 8 13 5 0 7 31
HB3 PfHB3_BroadW ashl35100 A 0 1 2 0 2 18 36
HB3 PfHB3_BroadWash526100 A 0 6 6 8 6 8 24
HB3 PfHB3_BroadWash545000 A 1 13 5 4 0 14 18
HB3 PfHB3_BroadWash544900 A 6 1 1 7 6 5 21
HB3 PfHB3_BroadWash071100 A 2 3 3 5 2 3 21
HB3 PfHB3_BroadWash538700 A 1 2 0 3 0 1 32
HB3 PfHB3_BroadWash531200 A 7 0 2 2 4 5 18
HB3 PfHB3_BroadWash534600 A 0 1 3 2 1 5 24
HB3 PfHB3_BroadWash509800 A 0 1 2 0 0 3 24
HB3 PfHB3_BroadWash539400 A 0 1 0 2 0 4 18
HB3 PfHB3_BroadWash531300 A 5 0 2 0 8 4 4
HB3 PfHB3_BroadWash011500 A 4 1 1 0 12 1 2
HB3 PfHB3_BroadW ashl72300 A 0 1 0 1 1 4 14
HB3 PfH B3_BroadW ash509500 A 1 0 2 1 4 9 2
HB3 PfHB3_BroadWash541200 A 0 3 1 4 1 2 8
HB3 PfHB3_BroadWash538400 A 5 0 0 1 1 6 5
HB3 PfHB3_BroadWash541500 A 1 2 3 5 0 2 4
HB3 PfHB3_BroadWash578300 A 7 0 1 1 4 3 0
HB3 PfHB3_BroadWash519900 A 0 0 0 1 1 6 7
HB3 PfHB3_BroadW ashl61900 A 1 0 0 0 5 0 6
HB3 PfHB3_BroadWash527700 A 2 0 1 0 5 2 0
HB3 PfHB3_BroadWash526400 A 1 1 0 1 0 2 4
HB3 PfHB3_BroadWash526800 A 0 0 0 2 1 2 4
HB3 PfH B3_BroadW ash523500 A 2 0 0 0 2 0 3
HB3 PfHB3_BroadWash542500 A 0 2 3 0 1 1 0
HB3 PfHB3_BroadW ashl92400 A 0 0 0 0 0 0 6
HB3 PfHB3_BroadWash531100 A 0 1 1 1 0 0 3
HB3 PfHB3_BroadWash550900 A 0 0 1 0 5 0 0
HB3 PfH B3_Broa dWash 162100 A 0 1 0 2 1 1 0
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Isolate Gene ID A/B ER LR ET MT LT S
HB3 PfHB3_BroadWash530200 B 65 340 350 298 340 308
HB3 PfHB3_BroadWash551000 B 55 168 185 194 36 176
HB3 PfHB3_BroadW ashl61200 B 20 26 30 31 99 83
HB3 PfHB3_BroadWash526600 B 11 27 37 37 12 57
HB3 PfHB3_BroadWash262300 B 11 58 83 83 29 152
HB3 PfHB3_BroadWash509700 B 10 16 28 26 3 34
HB3 PfHB3_BroadWash526200 B 2 31 29 42 7 47
HB3 PfHB3_BroadWash539500 B 2 21 31 37 8 49
HB3 PfH B3_BroadW ash529000 B 26 4 5 13 49 14
HB3 PfHB3_BroadWash516500 B 0 3 8 16 4 6
HB3 PfHB3_BroadWash521500 B 1 25 41 39 13 14
HB3 PfH B3_BroadW ash509400 B 4 4 5 16 27 8
HB3 PfHB3_BroadWash531700 B 2 1 0 2 3 3
HB3 PfHB3_BroadWash539300 B 15 0 4 2 2 4
HB3 PfHB3_BroadWash528700 B 6 0 1 2 5 2
HB3 PfHB3_BroadWash541300 B 1 0 0 1 2 3
HB3 PfHB3_BroadWash537700 B 0 1 1 0 2 1
HB3 PfHB3_BroadWash519800 B 1 2 4 3 4 6
HB3 PfHB3_BroadWash512000 B 0 0 0 3 1 1
HB3 PfHB3_BroadWash532400 B 1 0 1 1 1 0
HB3 PfHB3_BroadWash536000 B 1 0 1 1 3 0
HB3 PfHB3_BroadWash520000 B 0 0 0 0 2 4
HB3 PfHB3_BroadWash526300 B 0 0 0 0 0 3
G
75
131
385
462
46
133
84
85 
117 
185 
62 
74 
105. 
21 
12 
20 
18 
0 
4
3
1
0
2
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Appendix Table 9.9. Raw stevor read counts from 454 amplicon sequencing o f  cDNA and 
gDNA from laboratory isolates. The data in the table was generated by mapping 454 
reads onto homologous genomes and computing read counts using Artemis. An average 
read count was taken when samples were sequenced in duplicates or triplicates. Genes in 
the table had greater than 5X  read coverage.
Isolate Gene ID ER LR ET MT LT S G
3D7 PF3D7_1040200 106 1424 836 1518 772 648 26
3D7 PF3D7_0617600 453 765 377 506 697 682 71
3D7 PF3D7_1479500 106 426 216 161 208 284 134
3D7 PF3D7_0401500 292 251 28 18 94 345 45
3D7 PF3D7_1149900 133 178 62 140 174 169 82
3D7 PF3D7_0901600 61 37 11 61 209 445 48
3D7 PF3D7_0732000 202 183 24 33 76 190 158
3D7 PF3D7_0631900 30 145 142 204 117 105 68
3D7 PF3D7_1300900 63 313 126 37 20 83 113
3D7 PF3D7_0324600 64 212 99 37 65 136 135
3D7 PF3D7_0101800 68 57 16 17 24 192 198
3D7 PF3D7_0400800 97 92 28 13 51 108 146
3D7 PF3D7_1400700 128 102 30 25 41 71 94
3D7 PF3D7_1479900 88 40 24 80 40 58 43
3D7 PF3D7_1254600 32 70 46 55 27 54 70
3D7 PF3D7_0900900 58 36 7 21 35 68 113
3D7 PF3D7_0300400 66 41 11 3 29 24 116
3D7 PF3D7_0200900 40 42 1 3 26 62 113
3D7 PF3D7_0700400 37 46 4 9 16 85 81
3D7 PF3D7_0115400 18 79 36 21 21 30 58
3D7 PF3D7_0201300 29 42 9 7 22 87 20
3D7 PF3D7_1254100 36 31 15 19 24 40 40
3D7 PF3D7_0832400 44 26 22 11 21 42 33
3D7 PF3D7_0832900 21 23 33 36 19 38 29
3D7 PF3D7_0222800 21 21 3 0 18 15 119
3D7 PF3D7_0114600 25 18 2 6 18 24 47
3D7 PF3D7_0200400 21 12 1 1 8 8 15
3D7 PF3D7_1254300 1 2 2 4 1 0 14
IT PFIT_bin03800 139 180 1727 3908 2132 2527 188
IT PFIT_0400200 459 1049 450 383 269 518 206
IT PFIT_0700100 372 189 487 221 205 415 331
IT PFIT_0100300 135 103 111 392 354 383 375
IT PFIT_bin00600 325 207 277 131 123 192 515
IT PFIT_0900800 156 55 20 13 97 118 564
IT PFIT_0900900 156 55 20 13 97 118 564
IT PFIT_0835400 142 63 121 153 166 191 115
IT PFIT_1300300 185 125 16 27 86 77 384
IT PFIT_0800600 30 59 15 20 99 411 180
IT PFIT_0700500 110 71 12 20 67 102 370
IT PFIT_0733800 33 15 100 114 86 171 200
IT PFIT_1100300 159 79 41 42 44 65 212
IT PFIT_bin05300 42 32 14 30 26 31 363
IT PFIT_1401700 91 51 10 9 43 29 249
IT PFIT_0731100 79 29 14 7 39 67 195
IT PFIT_0113400 53 40 11 5 14 49 228
IT PFIT_bin09500 31 34 5 4 21 12 190
IT PFIT_0734100 8 3 10 11 15 14 183
IT PFIT_bin03100 58 26 29 12 18 15 73
IT PFIT_bin03200 58 26 29 12 18 15 73
IT PFIT_bin03300 58 26 29 12 18 15 73
IT PFIT_bin01600 41 5 4 4 10 5 103
IT PFIT_0300100 13 2 3 16 22 36 50
IT PFIT_0200600 2 2 7 2 2 5 7
IT PFIT_0100600 0 0 0 0 0 0 5
398
Iso la te G ene ID ER LR ET MT LT S
HB3 P fH B 3_B roadW ash l61300 117 4 60 506 627 4182 869
HB3 PfH B 3_B roadW ash532500 99 137 115 191 4861 373
HB3 PfH B 3_B roadW ash521400 15 699 648 456 1743 569
HB3 PfH B 3_B roadW ash538600 46 57 64 71 3167 157
HB3 P fH B 3_B roadW ash544800 54 279 355 381 1583 551
HB3 P fH B 3_B roadW ash534700 15 297 252 232 1263 168
HB3 P fH B 3_B roadW ash528600 68 139 238 258 648 300
HB3 P fH B 3_B roadW ash549600 38 80 134 137 559 122
HB3 P fH B 3_B roadW ash530000 52 14 14 48 774 65
HB3 P fH B 3_B roadW ash l62000 71 2 2 10 797 30
HB3 P fH B 3_B roadW ash531600 9 38 43 91 433 119
HB3 P fH B 3_B roadW ash509900 9 15 37 20 383 68
HB3 P fH B 3_B roadW ash509600 10 34 27 26 318 60
HB3 P fH B 3_B roadW ash537600 7 30 24 23 294 37
HB3 P fH B 3_B roadW ash516600 2 9 13 13 165 8
HB3 P fH B 3_B roadW ash523400 0 1 3 2 44 2
HB3 P fH B 3_B roadW ash529200 0 0 0 0 8 1
HB3 P fH B 3_B roadW ash541100 0 0 0 0 9 0
G
275
227
208
159
70
122
51
176
9 
3
131
84
54
73
10 
0 
0 
0
399
Appendix Table 9.10. Raw r i f  read counts from 454 amplicon sequencing o f  cDNA and 
gDNA from patient iolates that were put under differential selection pressure. AC (acute), 
CU (culture-adapted) HB (HBEC-slelected), R+ (rosetting clone), R- (non-rosetting 
fraction). The data in the table was generated by mapping 454 reads onto homologous 
genomes and computing read counts using Artemis. An average read count was taken 
when samples were sequenced in duplicates or triplicates. Genes in the table had greater 
than 5X  read coverage.
400
Isolate
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
9215
G ene ID A/B AC_R ACT
PF8443_8_4_U509100 A 87 68
PF8443_8_4_U518700 A 99 117
PF8443_8_4_U517400 A 63 103
PF8443_8_4_U511800 A 28 125
PF8443_8_4_U071400 A 9 81
PF8443_8_4_U519000 A 126 84
P F8443_8_4_U515700 A 42 152
PF8443_8_4_U515000 A 44 75
PF8443_8_4_U552000 A 17 53
PF8443_8_4_U504400 A 118 104
PF8443_8_4_U546100 A 23 20
PF8443_8_4_U520100 A 35 37
PF8443_8_4_U530100 A 33 76
PF8443_8_4_U520300 A 9 79
PF8443_8_4_U195200 A 10 16
PF8443_8_4_U067000 A 7 40
PF8443_8_4_U549800 A 15 41
PF8443_8_4_U503200 A 25 4
PF8443_8_4_U134400 A 13 58
PF8443_8_4_U546800 A 1 0
PF8443_8_4_U560200 A 13 60
PF8443_8_4_U559500 A 5 1
PF8443_8_4_U557300 A 46 22
PF8443_8_4_U560400 A 17 46
PF8443_8_4_U519200 A 12 13
PF8443_8_4_U511300 A 7 22
PF8443_8_4_U519100 A 11 10
PF8443_8_4_U502800 A 10 11
PF8443_8_4_U515800 A 45 32
PF8443_8_4_U515300 A 12 5
PF8443_8_4_U517600 A 12 29
PF8443_8_4_U161400 A 27 25
PF8443_8_4_U561400 A 12 17
PF8443_8_4_U543000 A 1 0
PF8443_8_4_U519300 A 21 16
PF8443_8_4_U059500 A 1 0
PF8443_8_4_U518500 A 24 7
PF8443_8_4_U161600 A 3 0
PF8443_8_4_U555200 A 4 21
PF8443_8_4_U561300 A 7 4
PF8443_8_4_U161700 A 8 7
PF8443_8_4_U560300 A 9 24
PF8443_8_4_U504500 A 12 12
PF8443_8_4_U534200 A 6 11
PF8443_8_4_U509500 A 4 42
PF8443_8_4_U510300 A 11 0
PF8443_8_4_U503100 A 1 6
PF8443_8_4_U518100 A 5 15
P F8443_8_4_U516000 A 7 3
PF8443_8_4_U560100 A 18 19
PF8443_8_4_U548600 A 6 5
PF8443_8_4_U502900 A 1 3
PF8443_8_4_U517800 A 5 8
PF8443_8_4_U070100 A 9 1
P F8443_8_4_U 511400 A 4 5
PF8443_8_4_U512300 A 4 10
PF8443_8_4_U530000 A 8 3
PF8443_8_4_U546200 A 3 0
PF8443_8_4_U548500 A 1 1
PF8443_8_4_U504800 A 0 2
PF8443_8_4_U557200 A 5 1
PF8443_8_4_U162100 A 3 0
PF8443_8_4_U549100 A 1 0
PF8443_8_4_U161500 A 0 0
PF8443_8_4_U530400 A 2 0
CU_R CU_LRET CU_T c u _ s CU_G
197 230 85 85 20 811
10 8 10 7 29 610
44 22 135 58 52 590
12 19 41 71 34 420
6 56 24 38 65 417
11 10 1 4 7 383
11 9 31 30 18 371
21 65 20 82 10 345
5 3 1 7 69 313
14 12 4 7 11 286
19 15 15 10 59 277
14 18 9 11 37 264
17 27 . 16 22 22 260
9 11 20 14 24 250
9 14 17 23 43 224
14 29 15 12 19 191
21 24 17 12 19 183
10 8 12 6 33 181
8 10 8 24 16 174
8 14 90 50 3 173
11 14 13 16 23 165
125 15 2 2 3 158
6 12 10 14 17 149
8 11 9 12 14 146
1 3 2 3 28 144
4 7 3 11 25 143
2 1 2 4 26 142
10 10 4 6 25 134
2 1 1 2 1 132
4 2 3 14 20 119
3 6 11 8 11 119
6 5 3 2 7 103
4 2 3 5 14 89
11 30 11 7 8 86
6 5 4 8 6 85
1 0 2 2 14 84
1 4 0 1 4 82
1 4 2 2 26 81
4 16 9 7 7 81
7 11 8 14 7 79
20 4 3 3 8 79
7 3 7 4 6 76
4 4 4 9 11 76
2 11 11 8 7 73
3 2 4 3 4 71
10 5 9 4 10 71
2 3 2 2 14 65
2 9 14 9 5 62
5 1 4 2 6 57
1 2 0 2 2 56
0 3 2 0 6 51
2 1 2 2 11 51
3 1 3 2 10 49
0 6 4 3 10 49
2 2 2 0 14 48
3 '6 4 4 5 46
1 8 5 3 8 46
4 0 3 4 12 36
0 1 4 2 3 19
2 3 1 1 2 14
0 2 1 1 1 14
1 2 0 0 2 12
0 1 2 0 3 12
0 0 1 1 0 10
2 1 1 2 1 9
AC G
40
332
113
91
140
141
79
31
159
17
116
104
48
85
94
56
35
85
38
8
15
6
24
30
83
66
88
59
49
60
40
29
33
20
20
64
42
45
14
23
27
16
22
18
10
24
38
5
29
13
30
30
19
16
20
11
11
11
8
4
3
5
6
9
2
401
Iso la te G ene ID A/B AC_R ACT
9215 PF8443_8_4_U 534100 A 0 0
9215 PF8443_8_4_U 518200 A 1 0
9215 PF8443_8_4_U 518000 A 1 1
9215 PF8443_8_4_U 503000 A 0 0
9215 PF8443_8_4_U 549600 A 1 1
9215 PF8443_8_4_U 560800 A 0 1
9215 PF8443_8_4_U 069900 A 3 0
9215 PF8443_8_4_U 532500 A 0 0
9215 PF8443_8_4_U 539500 A 177 282
9215 P F8443_8_4_U521600 A 96 362
9215 PF8443_8_4_U 522000 A 41 25
9215 PF8443_8_4_U 522700 A 107 108
9215 PF8443_8_4_U 522200 A 91 107
9215 PF8443_8_4_U 521100 A 77 42
9215 PF8443_8_4_U 521300 A 16 73
9215 PF8443_8_4_U 520800 A 78 15
9215 PF8443_8_4_U 521800 A 48 0
9215 PF8443_8_4_U 521200 A 32 23
9215 PF8443_8_4_U 522300 A 3 11
9215 PF8443_8_4_U 520600 A 7 44
9215 PF8443_8_4_U 541400 A 7 4
9215 PF8443_8_4_U 550500 A 1 22
9215 PF8443_8_4_U 534400 A 6 4
9215 PF8443_8_4_U 526100 A 5 4
9215 P F8443_8_4_U523700 A 1 10
9215 PF8443_8_4_U 541300 A 6 3
9215 PF8443_8_4_U 540500 A 1 4
9215 PF8443_8_4_U 515100 A 0 0
9215 PF8443_8_4_U 512100 A p s 57 53
9215 PF8443_8_4_U 525300 A tru n c 17 9
9215 P F8443_8_4_U526400 A tru n c 16 19
9215 PF8443_8_4_U 504700 A tru n c 4 2
9215 PF8443_8_4_U 525900 A tru n c 1 0
9215 PF8443_8_4_U 538200 B 218 117
9215 PF8443_8_4_U 505500 B 101 78
9215 PF8443_8_4_U 537200 B 52 132
9215 PF8443_8_4_U 530500 B 71 72
9215 PF8443_8_4_U 530200 B 26 83
9215 PF8443_8_4_U 520500 B 31 40
9215 PF8443_8_4_U 549700 B 31 6
9215 PF8443_8_4_U 506700 B 25 61
9215 PF8443_8_4_U 510600 B 53 39
9215 PF8443_8_4_U 509200 B 44 38
9215 PF8443_8_4_U 161800 B 25 27
9215 PF8443_8_4_U 541500 B 7 40
9215 PF8443_8_4_U 505600 B 12 104
9215 PF8443_8_4_U 507500 B 13 19
9215 PF8443_8_4_U 552100 B 38 24
9215 PF8443_8_4_U 548400 B 23 12
9215 PF8443_8_4_U 510400 B 11 13
9215 PF8443_8_4_U 508000 B 8 23
9215 PF8443_8_4_U 559200 B 8 9
9215 PF8443_8_4_U 559800 B 10 15
9215 PF8443_8_4_U 512200 B 8 4
9215 PF8443_8_4_U 507800 B 3 6
9215 PF8443_8_4_U 162000 B 5 1
9215 PF8443_8_4_U 551800 B 2 1
9215 PF8443_8_4_U 545500 B 2 4
9215 PF8443_8_4_U 161900 B 1 1
9215 PF8443_8_4_U 546500 B 1 1
9215 PF8443_8_4_U 555100 B 2 1
9215 PF8443_8_4_U 557600 B 0 0
9215 PF8443_8_4_U 505900 B 1 1
9215 PF8443_8_4_U 265100 B 0 1
9215 PF8443_8_4_U 552400 B 2 1
9215 PF8443_8_4_U 547000 B 0 0
CU_R CU_LRET CU_T c u _ s CU_G
1 1 2 1 2 8
0 0 1 1 0 7
1 1 0 0 1 7
1 0 1 0 3 7
1 1 0 0 0 5
0 1 1 0 1 4
0 1 0 0 0 4
3 0 0 0 0 4
573 344 249 207 27 1962
45 47 162 356 31 1215
157 204 104 122 20 732
46 54 36 63 26 573
3 2 2 3 5 361
5 43 15 14 14 241
3 3 10 10 27 220
38 29 21 11 3 206
12 29 9 12 10 139
1 1 3 1 4 129
4 17 18 27 5 96
2 1 2 4 12 90
2 5 1 2 8 53
3 0 0 2 13 51
1 3 2 3 13 49
9 13 5 3 1 42
4 2 1 2 6 37
3 4 4 3 5 36
1 2 0 0 1 17
0 1 0 0 1 5
263 273 175 189 34 1102
7 8 10 7 6 93
2 3 2 1 3 49
2 1 4 1 4 30
0 0 1 0 2 6
153 457 424 168 59 1725
42 46 31 47 34 520
48 50 25 32 38 468
47 33 19 22 61 440
32 43 61 37 34 389
34 51 27 28 55 349
66 61 30 28 29 337
18 14 26 19 51 333
15 11 28 17 44 324
26 14 15 22 57 265
20 18 18 17 42 259
8 7 11 10 41 228
8 12 11 20 22 222
2 9 9 9 42 196
4 5 8 5 24 186
20 16 17 6 31 171
2 4 1 3 27 112
3 6 10 8 9 104
3 3 6 2 27 96
6 6 9 10 11 85
6 3 4 7 12 56
4 2 2 2 17 50
5 3 1 6 7 30
4 1 1 3 8 25
1 0 0 0 4 24
1 0 0 1 4 14
0 1 1 4 12
1 1 1 0 2 12
1 0 0 0 1 8
1 1 0 0 0 7
1 2 0 0 1 6
1 0 1 0 1 5
1 1 1 1 1 4
AC G
3
5
3
2
1
1
1
1
103
117
59
135
150
33
79
12
20
65
12
20
25
10
19
4
11
9
9
3
59
31
3
13
2
130
142
93
117
75
84
86
120
118
50
93
105
34
93
79
48
53
39
40
19
13
15
4
6
13
8
5
4
6
4
2
0
1
402
Isolate
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
Gene ID A/B AC_R AC_G CU_R2 CU_P1
PF8443_8_7_U503900 A 8 87 50 1516
PF8443_8_7_U525700 A 182 95 203 405
PF8443_8_7_U484300 A 93 48 62 388
P F844 3_8_7_U513900 A 115 59 98 374
PF8443_8_7_U439800 A 193 67 97 11
PF8443_8_7_U541800 A 66 92 15 99
PF8443_8_7_U436600 A 8 58 5 324
PF8443_8_7_U537000 A 25 98 6 232
PF8443_8_7_U515900 A 86 100 37 126
PF8443_8_7_U518900 A 76 92 35 55
PF8443_8_7_U525800 A 21 33 16 145
PF8443_8_7_U564900 A 35 47 72 14
PF8443_8_7_U527200 A 111 45 29 34
PF8443_8_7_U443600 A 11 41 54 221
PF8443_8_7_U513600 A 11 145 1 25
PF8443_8_7_U447300 A 29 116 4 81
PF8443_8_7_U524900 A 70 120 3 33
PF8443_8_7_U560800 A 24 115 7 38
PF8443_8_7_U536000 A 9 29 2 17
PF8443_8_7_U448300 A 106 70 54 36
PF8443_8_7_U458100 A 7 62 1 .3
PF8443_8_7_U525300 A 36 41 21 48
PF8443_8_7_U503400 A 31 76 9 9
PF8443_8_7_U462400 A 4 122 0 3
PF8443_8_7_U051200 A 18 115 0 29
PF8443_8_7_U554100 A 5 120 0 1
PF8443_8_7_U490200 A 10 13 100 75
PF8443_8_7_U462300 A 4 74 5 21
PF8443_8_7_U448200 A 59 53 12 27
PF8443_8_7_U515700 A 16 77 8 13
PF8443_8_7_U112500 A 22 69 1 28
PF8443_8_7_U100500 A 6 24 2 45
PF8443_8_7_U523500 A 7 57 11 27
PF8443_8_7_U484900 A 5 56 7 26
PF8443_8_7_U460800 A 27 72 0 15
PF8443_8_7_U435600 A 5 62 8 45
PF8443_8_7_U520200 A 68 22 19 25
PF8443_8_7_U521400 A 14 30 1 20
PF8443_8_7_U530500 A 47 71 15 37
PF8443_8_7_U558000 A 16 24 4 15
P F8443_8_7_U525200 A 23 28 5 10
PF8443_8_7_U441300 A 22 43 0 6
PF8443_8_7_U554200 A 18 49 0 9
PF8443_8_7_U541300 A 61 43 6 2
PF8443_8_7_U439900 A 16 50 4 6
PF8443_8_7_U561800 A 31 52 9 8
PF8443_8_7_U438600 A 4 36 0 23
PF8443_8_7_U551000 A 14 43 0 2
PF8443_8_7_U446000 A 6 36 1 6
PF8443_8_7_U520300 A 3 37 0 16
PF8443_8_7_U437700 A 16 41 3 2
PF8443_8_7_U482200 A 11 26 0 11
PF8443_8_7_U560900 A 5 32 4 14
PF8443_8_7_U514500 A 9 15 2 7
PF8443_8_7_U515300 A 2 38 1 5
PF8443_8_7_U441200 A 8 28 0 6
PF8443_8_7_U439500 A 3 23 1 5
PF8443_8_7_U482500 A 0 15 0 2
PF8443_8_7_U529100 A 8 25 0 2
PF8443_8_7_U472000 A 7 16 4 0
PF8443_8_7_U488500 A 29 13 5 3
CU_S1 CU_G HB_R1 HB_P1 HB_T1 H8_S1 HB_G
1176 25 2 4 2 23 110
178 46 501 319 1 455 283
276 21 457 197 9 334 111
251 32 79 59 2 33 154
14 29 595 414 0 46 89
92 46 268 269 4 208 224
239 25 5 23 4 57 106
150 62 7 13 0 43 225
90 58 67 63 16 76 152
78 66 136 78 1 73 207
103 19 70 46 6 272 76
6 18 187 495 0 14 77
18 14 163 269 2 87 53
66 27 4 9 5 91 84
29 64 2 22 2 90 277
48 63 7 12 5 25 248
19 68 16 14 1 52 258
23 55 17 18 2 24 215
23 17 104 73 9 196 65
34 30 4 46 0 22 108
5 57 1 2 1 116 199
37 23 20 17 0 72 116
4 17 71 74 0 17 142
10 42 1 0 0 6 251
19 40 7 6 0 48 137
0 44 16 1 0 0 236
57 16 8 28 0 7 40
31 39 7 18 2 3 149
3 25 6 28 0 3 116
12 24 15 27 0 35 103
21 24 3 2 0 63 79
67 10 1 40 1 49 25
15 26 4 55 0 22 80
18 27 2 17 1 36 112
16 43 2 0 0 3 127
30 20 0 1 1 23 74
11 18 15 14 0 15 62
10 41 5 15 1 11 104
21 19 9 5 0 1 23
14 9 23 53 1 19 42
13 18 35 8 0 6 71
2 21 21 26 0 21 67
22 17 4 1 1 10 81
1 17 12 7 0 13 56
11 25 1 1 0 17 78
15 26 19 7 1 10 21
16 8 0 1 0 19 51
4 19 11 3 0 13 71
12 23 0 2 0 3 77
16 17 0 0 0 5 67
2 18 13 8 0 3 67
5 9 24 18 1 9 41
26 8 0 0 0 6 35
6 8 18 34 0 17 27
3 20 2 0 0 5 50
6 5 6 5 0 41 20
4 15 2 3 0 9 45
4 10 0 3 0 13 45
4 13 2 2 0 2 35
0 11 4 3 0 5 43
0 4 9 2 0 10 12
CU_T1
2112
188
470
395
10
106
443
230
140
103
166
2
24
98
43
63
34
47
20
33
4
24
4
13
27
0
42
32
10
6
20
57
21
14
11
43
14
15
16
21
12
0
11
2
10
15
35
4
14
20
6
23
22
7
4
. 2
0
13
4
1
4
403
Isolate
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
9106
Gene ID A/B AC_R AC_G CU_R2 CU_P1
PF8443_8_7_U557200 A 0 15 0 1
PF8443_8_7_U443500 A 7 12 0 9
PF8443_8_7_U473600 A 5 10 1 2
PF8443_8_7_U559400 A 1 9 0 11
PF8443_8_7_U560600 A 4 10 7 1
PF8443_8_7_U436200 A 2 11 0 2
PF8443_8_7_U460700 A 19 7 2 0
PF8443_8_7_U502900 A 2 8 0 4
PF8443_8_7_U471700 A 1 5 0 0
PF8443_8_7_U518400 A 1 4 0 5
PF8443_8_7_U447200 A 1 8 0 0
PF8443_8_7_U550800 A 0 3 1 1
PF8443_8_7_U525100 A 1 2 0 1
PF8443_8_7_U531500 A 1 0 1 1
PF8443_8_7_U522400 A 2 6 1 0
PF8443_8_7_U432400 A 1 2 0 0
PF8443_8_7_U536500 A 0 4 0 1
PF8443_8_7_U454100 A 1 8 0 0
PF8443_8_7_U520500 A 1 1 0 0
PF8443_8_7_U519300 A 1 3 0 0
PF8443_8_7_U446800 A 1 2 0 0
PF8443_8_7_U513200 A 1 2 0 0
PF8443_8_7_U513500 A 1 2 0 0
PF8443_8_7_U531800 A 0 1 0 1
PF8443_8_7JJ561000 A 1 3 0 0
PF8443_8_7_U523000 A 0 0 0 1
PF8443_8_7_U435300 A 0 2 0 1
PF8443_8_7_U538200 A 0 1 0 0
PF8443_8_7_U486200 A 0 0 0 0
PF8443_8_7_U502300 B 9 28 4 255
PF8443_8_7_U499600 B 14 60 37 64
PF8443_8_7_U458200 B 160 115 8 66
PF8443_8_7_U432500 B 42 183 9 16
PF8443_8_7_U436300 B 20 170 1 16
PF8443_8_7_U445900 B 29 154 4 9
PF8443_8_7_U555300 B 102 51 15 9
PF8443_8_7_U446900 B 47 32 24 17
PF8443_8_7_U435400 B 106 79 6 28
PF8443_8_7_U460900 B 24 82 2 4
PF8443_8_7_U434100 B 12 104 0 11
PF8443_8_7_U518800 B 39 103 3 12
PF8443_8_7_U554400 B 54 67 7 7
PF8443_8_7_U437800 B 43 69 7 21
PF8443_8_7_U519500 B 38 80 7 13
PF8443_8_7_U534800 B 13 71 1 10
PF8443_8_7_U561100 B 9 52 1 7
PF8443_8_7_U555200 B 22 60 1 3
PF8443_8_7_U542000 B 5 35 1 15
PF8443_8_7_U561700 B 7 60 2 7
PF8443_8_7_U561900 B 6 16 1 40
PF8443_8_7_U449400 B 7 16 2 6
PF8443_8_7_U526900 B 1 8 0 8
PF8443_8_7_U444000 B 1 9 1 0
PF8443_8_7_U486700 B 0 5 0 2
PF8443_8_7_U439400 B 1 9 0 1
PF8443_8_7_U470300 B 0 9 0 0
PF8443_8_7_U550900 B 0 2 0 2
PF8443_8_7_U5S1100 B 0 7 0 0
PF8443_8_7_U503300 B 0 3 0 0
PF8443_8_7_U535900 B 1 0 0 0
PF8443_8_7_U443900 B? 84 145 44 227
CU_S1 CU_G HB_R1 HB_P1 HB_T1 HB_S1 HB_G
1 1 14 8 1 39 9
8 6 3 5 0 7 17
3 7 12 15 0 3 19
4 5 3 13 0 11 11
3 6 0 4 1 12 13
2 9 1 0 0 4 24
1 2 5 2 0 3 6
3 2 0 0 0 1 8
2 5 0 3 0 1 10
3 1 0 1 0 0 4
1 2 0 1 0 1 8
1 1 1 3 0 2 3
0 1 4 3 1 4 2
4 1 2 0 0 4 0
2 1 0 0 0 0 2
0 1 0 0 0 1 7
1 2 0 0 0 0 4
0 0 0 0 1 0 1
1 1 0 1 2 2 1
0 1 1 1 0 1 2
0 0 0 0 0 1 3
2 0 0 0 0 0 4
2 0 0 0 0 0 4
3 0 0 0 0 0 2
0 0 0 0 0 0 3
2 1 1 0 0 1 0
0 1 0 0 0 0 2
0 2 0 0 0 0 3
0 1 0 3 0 1 0
56 13 31 415 3 356 66
62 29 31 133 1 641 141
41 67 44 56 0 110 332
10 86 72 169 0 23 390
6 110 4 7 0 36 464
15 82 21 10 3 13 391
5 57 163 79 0 12 175
24 75 35 72 0 73 176
38 51 3 3 0 17 211
10 75 8 4 0 67 261
17 68 0 0 1 23 248
10 38 20 32 0 31 163
5 43 19 26 0 69 129
17 28 33 28 3 30 125
12 30 19 23 0 25 153
9 32 5 15 0 34 136
8 26 15 4 0 26 136
5 34 5 14 0 10 125
7 24 4 3 0 19 90
2 53 3 0 0 5 56
28 13 1 0 0 17 5
3 8 3 7 0 5 32
4 14 0 10 0 8 35
0 2 0 0 0 10 9
0 1 0 7 0 0 8
1 0 0 0 0 2 8
0 1 2 1 0 3 7
1 1 1 1 0 2 3
0 0 0 0 0 0 5
0 1 0 0 0 0 3
1 0 1 1 0 0 1
143 67 124 134 0 108 292
CU_T1
0
10
3
7
1
1
0
3
1
4
0
5
1
0
0
1
1
1
2
0
1
0
0
0
0
0
0
0
0
96
32
77
12
28
17
4
29
37
10
6
18
7
13
11
11
4
6
13
2
34
2
3
0
0
2
0
1
0
0
0
294
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olate Sequence Name A/B AC_R AC_T AC_G CU_R
0668 PF8443_8_8_U517800 A 101 0 66 3747
0668 PF8443_8_8_U293700 A 146 1 26 33
0668 PF8443_8_8_U534400 A 22 0 39 11
0668 PF8443_8_8_U533400 A 234 0 46 17
0668 PF8443_8_8_U532600 A 28 0 40 1
0668 PF8443_8_8_U537800 A 173 1 27 27
0668 PF8443_8_8_US26900 A 64 0 47 5
0668 PF8443_8_8_U535600 A 153 0 39 11
0668 PF8443_8_8_U498600 A 34 0 73 2
0668 PF8443_8_8_U531900 A 149 0 28 11
0668 PF8443_8_8_U553200 A 12 0 118 8
0668 PF8443_8_8_U532400 A 58 0 46 0
0668 PF8443_8_8_U500800 A 75 0 55 0
0668 PF8443_8_8_U528100 A 33 0 45 1
0668 PF8443_8_8_U526600 A 37 0 45 1
0668 PF8443_8_8_U542200 A 20 1 119 1
0668 PF8443_8_8_U488600 A 57 0 30 8
0668 PF8443_8_8_U532300 A 9 0 80 1
0668 PF8443_8_8_U063400 A 11 0 87 3
0668 PF8443_8_8_U529600 A 26 0 30 2
0668 PF8443_8_8_U535300 A 21 0 61 0
0668 PF8443_8_8_U524200 A 8 0 84 2
0668 PF8443_8_8_U491300 A 25 0 89 0
0668 PF8443_8_8_U524900 A 48 0 30 2
0668 PF8443_8_8_U501700 A 59 0 25 2
0668 PF8443_8_8_U534500 A 7 0 85 0
0668 PF8443_8_8_U534600 A 20 0 15 10
0668 PF8443_8_8_U525300 A 13 0 10 0
0668 PF8443_8_8_U566900 A 46 0 28 2
0668 PF8443_8_8_U539800 A 25 0 53 0
0668 PF8443_8_8_U532900 A 69 1 12 2
0668 PF8443_8_8_U491200 A 0 0 64 0
0668 PF8443_8_8_U096900 A 0 0 82 0
0668 PF8443_8_8_U491100 A 2 4 64 1
0668 PF8443_8_8_U572400 A 10 0 85 0
0668 PF8443_8_8_U056600 A 1 0 62 0
0668 PF8443_8_8_U570200 A 18 0 36 0
0668 PF8443_8_8_U550400 A 5 0 38 0
0668 PF8443_8_8_U563500 A 6 0 63 4
0668 PF8443_8_8_U565800 A 3 0 11 3
0668 PF8443_8_8_U553500 A 1 0 7 0
0668 PF8443_8_8_U506000 A 7 0 5 1
0668 PF8443_8_8_U501600 A 7 0 46 1
0668 PF8443_8_8_U505800 A 6 0 40 0
0668 PF8443_8_8_U532100 A 11 0 29 0
0668 PF8443_8_8_U490100 A 1 0 50 0
0668 PF8443_8_8_U500900 A 19 0 34 0
0668 PF8443_8_8_U537600 A 15 0 31 1
0668 PF8443_8_8_U541100 A 3 0 45 0
0668 PF8443_8_8_U126100 A 2 0 45 0
0668 PF8443_8_8_U293600 A 21 0 23 0
0668 PF8443_8_8_U563700 A 11 0 37 3
0668 PF8443_8_8_U530500 A 8 0 35 0
0668 PF8443_8_8_U487800 A 1 0 44 1
0668 PF8443_8_8_US19000 A 12 0 35 0
0668 PF8443_8_8_U572300 A 3 0 39 0
0668 PF8443_8_8_U515800 A 1 1 23 3
0668 PF8443_8_8_U563400 A 2 0 42 0
0668 PF8443_8_8_U574400 A 0 0 42 1
0668 PF8443_8_8_U537200 A 9 0 20 0
0668 PF8443_8_8_U564500 A 3 0 37 0
0668 PF8443_8_8_U508300 A 3 0 20 0
0668 PF8443_8_8_U534900 A 2 0 48 4
0668 PF8443_8_8_U527800 A 13 0 17 2
0668 PF8443_8_8_U536900 A 12 0 14 1
0668 PF8443_8_8_U533800 A 7 0 12 1
0668 PF8443_8_8_U559000 A 1 0 34 0
CU_MT cu_s CU_G HB_R H8J.R-ET HB_T HB_S HB_G
1098 1620 43 15 51 20 110 30
2173 240 76 161 869 809 493 86
436 313 49 38 365 258 302 44
255 635 17 37 54 27 158 20
118 659 17 9 2 2 44 18
73 202 35 48 62 34 127 24
136 350 16 16 18 9 121 22
60 95 22 53 103 52 88 22
3 6 44 89 194 74 143 39
26 131 15 21 39 22 120 23
6 16 120 5 12 2 39 114
8 46 2 11 73 46 130 30
2 1 48 10 83 76 24 65
20 87 29 11 73 27 34 39
22 49 36 16 107 20 37 24
6 14 105 2 5 4 16 84
39 38 12 20 36 25 44 22
6 9 58 5 86 44 20 39
10 2 54 8 60 18 17 52
18 96 35 9 25 8 18 34
7 5 69 0 9 4 14 65
2 7 54 1 2 2 17 73
2 4 59 1 2 1 7 50
17 20 12 13 37 11 31 16
16 35 11 5 35 9 20 10
1 3 32 11 37 7 23 27
34 52 14 9 22 9 28 14
1 8 2 15 101 33 37 4
18 15 18 11 8 4 33 27
5 8 33 7 16 7 28 30
12 28 12 12 15 11 21 11
0 0 86 0 1 0 7 55
7 1 44 3 2 3 5 52
6 7 45 3 9 8 9 37
1 7 35 0 6 2 3 42
0 3 43 0 9 4 1 66
0 0 25 4 37 21 12 34
1 2 22 4 44 30 16 23
0 7 1 1 11 8 11 63
9 6 5 8 36 18 60 9
6 4 6 11 70 22 16 13
2 3 6 5 60 38 23 4
2 2 31 5 6 0 10 41
3 3 30 3 18 6 8 31
5 3 31 4 4 3 12 42
5 2 30 2 11 10 8 23
2 12 12 7 24 11 8 11
9 14 13 8 18 9 9 10
0 2 30 0 2 2 13 28
2 2 21 0 5 0 15 30
8 12 8 4 11 6 12 12
1 2 20 0 1 3 18 18
2 7 21 5 2 0 12 20
2 1 17 1 9 1 13 15
5 6 15 2 0 2 28
2 3 17 1 11 8 4 12
6 17 20 1 0 10 9
0 0 0 16 2 5 24
1 1 16 1 5 5 2 17
1 11 12 9 2 4 16
1 0 18 1 4 0 0 19
2 5 4 2 4 32 10
1 4 11 1 0 1 8
1 2 8 12 1 4 11
1 11 3 7 5 5 5 4
0 3 14 1 5 0 10 16
0 2 14 0 0 0 4 11
CU_LR-ET
4385
78
29
82
4
47
38
49
1
37
10
1
0
6
8
3
28
1
1
7
4
0
0
2
7
0
4
0
8
4
7
0
1
0
2
0
0
0
2
3
1
0
0
0
0
0
2
1
0
0
1
0
1
2
0
2
10
0
0
1
1
0
1
1
3
0
2
405
Isolate Sequence Name A/B AC_R AC_T AC_G CU_R
10668 PF8443_8_8_U520400 A 0 0 24 0
10668 PF8443_8_8_U066400 A 0 0 16 0
10668 PF8443_8_8 J J 5 10500 A 0 0 8 0
10668 PF8443_8_8_U532200 A 3 0 14 0
10668 PF8443_8_8_U548600 A 0 0 9 0
10668 PF8443_8_8_U067400 A 1 0 22 0
10668 PF8443_8_8_U491800 A 1 0 11 0
10668 PF8443_8_8_U540600 A 0 3 1
10668 PF8443_8_8_U510600 A 0 0 7 0
10668 PF8443_8_8_U097000 A 3 2 13 0
10668 PF8443_8_8_U530300 A 1 0 4 0
10668 PF8443_8_8_U510300 A 0 0 13 0
10668 PF8443_8_8__U529500 A 0 0 8 0
10668 P F8443_8_8__U536500 A 2 0 2 0
10668 PF8443_8_8_U540900 A 0 0 0 0
10668 PF8443_8_8_U097300 A 0 0 13 0
10668 PF8443_8_8_U527200 A 0 0 4 1
10668 PF8443_8_8_U536800 A 0 0 7 0
10668 PF8443_8_8_U541000 A 1 0 7 0
10668 PF8443_8_8_U572200 A 0 0 4 0
10668 PF8443_8_8_U532800 A 0 0 1 0
10668 PF8443_8_8_U553400 A 0 0 2 0
10668 PF8443_8_8_U533300 A 0 0 1 1
10668 PF8443_8_8_U560700 A 0 0 3 0
10668 PF8443_8_8_U550300 A 0 0 5 0
10668 PF8443_8__8_U497400 A 0 0 1 1
10668 PF8443_8_8_U521000 A 0 0 1 0
10668 PF8443_8_8_U501900 A 0 0 2 1
10668 PF8443_8_8_U521100 B 186 0 44 1
10668 PF8443_8_8_U505900 B 267 0 88 1
10668 PF8443_8_8_U489900 B 48 0 95 1
10668 PF8443_8_8_U574500 B 47 0 139 4
10668 PF8443_8_8_U522100 B 71 6 70 0
10668 P F8443_8_8_U500600 B 34 0 95 0
10668 P F8443_8_8_U564300 B 76 0 8 0
10668 PF8443_8_8_U512100 B 19 0 78 0
10668 PF8443_8_8_U559100 B 21 0 64 2
10668 P F8443_8_8_U5 28900 B 6 0 129 0
10668 P F8443_8_8_U488500 B 13 0 83 1
10668 P F8443_8_8_U529300 B 12 0 108 0
10668 P F8443_8_8_U574300 B 60 0 45 1
10668 PF8443_8_8_U533900 B 31 0 77 0
10668 PF8443_8_8_U511600 B 27 0 65 0
10668 PF8443_8_8_U553000 B 13 0 93 0
10668 PF8443_8_8_U523300 B 19 0 96 0
10668 PF8443_8_8_U506900 B 24 0 56 0
10668 PF8443_8_8_U563600 B 20 2 96 0
10668 PF8443_8_8_U540700 B 7 0 52 0
10668 PF8443_8_8_U528700 B 4 0 74 0
10668 PF8443_8_8_U493000 B 4 0 46 0
10668 PF8443_8_8_U507200 B 45 0 27 0
10668 PF8443_8_8_U566700 B 2 0 56 0
10668 PF8443_8_8_U563800 B 9 0 33 4
10668 PF8443_8_8_U490000 B 7 3 12 3
10668 PF8443_8_8_U559200 B 4 1 27 0
10668 PF8443_8_8_U563900 B 1 0 12 5
10668 PF8443_8_8__U550600 B 0 0 7 0
10668 PF8443_8_8__U549400 B 0 0 6 0
10668 P F8443_8_8_U5 21900 B 1 0 14 0
10668 PF8443_8_8_U484100 B 2 0 2 0
10668 PF8443_8_8_U501800 B 0 0 0 0
10668 PF8443_8_8_U497500 B 0 0 4 0
10668 PF8443_8_8_U097200 B 0 0 1 0
10668 PF8443_8_8_U520200 B 0 0 0 0
10668 PF8443_8_8JJ484000 B? 47 2 85 10
10668 PF8443_8_8_U567200 B? 0 0 16 1
10668 PF8443_8_8JJ532700 B? 0 0 3 0
10668 PF8443_8_8_U505500 B? 0 0 0 0
CIMVIT cu_s CU_G HB_R HBJ.R-ET HB_T HB_S HB_G
2 4 13 2 1 7
3 0 13 2 3 1 2 12
0 0 12 1 4 0 13
0 0 5 2 2 0 11
0 5 4 0 5 1 9 7
1 6 0 0 1 4
4 9 4 1 0 1 7
2 6 3 1 2 1 14 3
1 0 10 0 9 1 4
0 0 8 1 1 1 2 4
1 0 4 0 2 1 3 5
0 1 3 1 0 0 0 1
0 5 2 0 0 0 2 2
1 1 5 1 0 0 2 5
2 0 1 1 6' 2 6 1
0 0 3 0 0 0 0 3
0 1 3 1 2 1 0 5
0 0 2 0 2 1 1 3
0 1 3 0 0 0 1 1
1 2 1 0 0 0 2 4
1 6 0 1 1 0 0 1
1 0 4 0 0 0 0 4
0 1 0 1 0 1 2 1
1 0 0 0 0 2 1
1 0 1 0 0 0 0 0
0 0 1 0 0 0 0 2
0 0 3 0 0 0 1 1
0 0 0 0 0 0 1 2
15 35 28 77 415 234 807 24
3 3 114 62 32 21 98 133
11 32 116 3 3 4 262 132
9 8 98 26 33 22 92 102
17 13 59 12 126 32 110 52
7 17 111 8 52 35 84 116
5 8 7 27 54 80 192 7
7 7 61 6 43 19 119 60
6 10 111 8 29 11 49 93
7 7 , 84 1 5 4 45 109
4 16 77 3 14 6 56 75
3 11 49 3 13 9 22 69
8 11 34 13 26 13 51 33
15 8 54 5 0 2 27 51
0 4 39 8 42 26 11 47
2 5 34 3 14 2 8 58
6 1 44 2 2 1 7 49
2 4 39 5 7 4 27 49
0 0 0 2 2 1 32 59
4 7 32 2 2 1 54 30
0 0 57 2 3 1 7 40
2 2 51 2 3 2 6 51
2 4 22 10 12 5 27 15
1 4 30 1 11 0 17 40
1 14 21 1 2 0 4 32
1 0 35 1 0 1 2 51
3 3 28 1 2 0 22 24
10 1 5 0 1 0 1 17
0 0 19 0 0 0 4 21
2 1 11 0 0 0 0 22
0 0 0 0 1 2 3 12
4 9 2 0 0 3 6 1
0 0 0 2 4 0 7 1
0 0 1 0 0 0 2 4
0 1 1 0 0 0 0 5
0 1 1 2 0 0 1 1
45 27 80 10 54 41 65 95
3 1 8 0 1 2 3 12
0 0 1 0 0 0 0 4
0 0 5 0 0 0 0 1
J_LR-
2
4
000
000
00
010
10
00
000
10
0001
0
00
5
7
2
2
30
4
46
1
51
51100020
4
0
161
0202000
000
10000
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Isolate Gene ID A/B R+R R+LRET R+T R+S R+G R-R R-LRET R-T R-S R-G
SA075 PFSA075_PN48 A 2438 291 141 489 82 3102 581 571 2256 67
SA075 PFSA075_128200 A 32 869 1071 687 52 2 26 33 5 42
SA075 PFSA075_PN57 A 48 598 684 534 22 11 96 138 18 20
SA075 PFSA075_PN56 A 30 226 356 362 22 3 12 47 19 15
SA075 PFSA075_PN28 A 151 1 11 35 40 319 2 6 301 43
SA075 PFSA075_071800 A 0 2 98 62 5 9 228 302 9 6
SA075 PFSA075_PN07 A 1 91 225 67 74 8 4 5 3 79
SA075 PFSA075_154500 A 0 4 6 3 29 3 194 154 2 22
SA075 PFSA075_PN52 A 68 41 47 89 124 8 8 8 10 13
SA075 PFSA075_415400 A 9 99 161 69 11 0 1 1 0 12
SA075 PFSA075_PN46 A 24 19 75 59 22 2 72 59 4 24
SA075 PFSA075_PN41 A 8 87 132 48 16 7 6 6 2 11
SA075 PFSAO75_PN50 A 25 29 44 31 46 6 26 30 24 34
SA075 PFSA075_071500 A 5 22 31 38 117 7 1 3 1 67
SA075 PFSAO75_494200 A 24 9 11 18 60 39 16 8 26 44
SA075 PFSA075_185100 A 6 5 11 13 21 5 34 99 31 21
SA075 PFSA075_PN24 A 11 16 11 14 91 4 1 6 2 78
SA075 PFSA075_061400 A 0 1 3 1 66 5 11 7 0 101
SA075 PFSA075_PN33 A 13 0 3 19 65 5 5 6 9 50
SA07S PFSA075_PN22 A 14 10 8 4 30 7 24 21 4 40
SA075 PFSA075_302500 A 0 8 21 13 10 0 44 46 4 12
SA075 PFSAO75_347900 A 0 8 21 13 10 0 44 46 4 12
SA075 PFSA075_030300 A 9 8 7 9 54 12 3 7 3 45
SA075 PFSA075_PN43 A 1 0 92 14 20 1 0 0 3 15
SA075 PFSA075_PN53 A 31 9 15 10 31 8 4 6 1 30
SA075 PFSA075_030700 A 5 3 7 2 49 11 3 0 3 60
SA075 PFSA075_127900 A 1 31 37 20 28 2 3 2 1 13
SA075 PFSAO75_493800 A 7 8 9 14 23 2 8 35 8 23
SA075 PFSA075_302300 A 10 2 3 7 36 11 0 5 32 27
SA075 PFSA075_PN55 A 7 15 34 20 24 2 7 9 1 13
SA075 PFSA075_051600 A 45 4 7 8 21 1 2 9 2 22
SA075 PFSA075_PN36 A 1 0 5 9 39 5 2 3 3 51
SA075 PFSA075_PN38 A 6 1 2 6 54 1 0 0 0 43
SA075 PFSA075_072700 A 3 2 7 0 40 5 8 5 1 41
SA075 PFSAO75_492300 A 4 3 5 3 44 2 2 0 9 36
SA075 PFSA075_PN51 A 6 3 13 2 30 5 0 5 1 30
SA075 SAO75_PN01 A 0 1 0 2 31 3 2 1 2 50
SA07S PFSAO75_PN10 A 3 0 5 4 32 1 2 3 3 34
SA075 PFSA075_PN29 A 7 1 4 16 29 2 0 3 2 21
SA075 PFSA075_494100 A 4 9 4 3 24 4 1 11 3 16
SA075 PFSA075_PN18 A 1 4 6 6 20 0 1 4 9 26
SA075 PFSA075_PN54 A 10 2 3 4 23 4 1 0 1 27
SA075 PFSAO75_PN30 A 0 2 6 5 23 0 2 6 0 22
SA075 PFSA075_PN14 A 0 2 0 0 28 4 0 0 1 23
SA075 PFSA075_PN37 A 0 1 16 6 17 0 3 0 0 15
SA075 PFSA075_PN49 A 1 0 1 1 30 2 2 1 0 17
SA075 PFSAO75_258400 A 1 1 4 5 21 1 2 0 2 16
SA075 PFSA075_PN13 A 1 3 5 5 19 2 1 0 1 13
407
Isolate Gene ID A/B R+R R+LRET R+T R+S R+G R-R R-LRET R-T R-S R-G
SA075 PFSA075_011500 A 2 1 0 0 16 1 0 0 0 23
SA075 PFSA075_030600 A 0 2 1 0 16 0 8 11 0 3
SA075 PFSAO75_PN04 A 0 0 1 0 24 2 0 0 0 14
SA075 PFSA075_PN21 A 0 0 2 0 11 0 0 0 2 24
SA075 PFSAO75_493600 A 1 1 3 1 20 1 0 1 1 10
SA075 PFSA075_PN35 A 0 0 0 0 10 2 0 0 0 27
SA075 PFSA075_030400 A 0 1 2 0 13 0 1 0 0 14
SA075 PFSA075_052900 A 0 1 1 1 11 1 0 0 0 14
SA075 PFSAO75_PN05 A 0 2 1 3 20 0 0 0 1 2
SA075 PFSAO75_492900 A 0 0 0 0 11 0 0 1 0 9
SA075 PFSAO75_492600 A 0 0 0 0 5 0 2 0 0 10
SA075 PFSA075_128600 A 0 1 1 2 4 0 0 0 3 3
SA075 PFSA075_PN26 A 2 0 0 2 4 0 0 0 1 4
SA075 PFSA075_PN32 A 1 2 0 0 3 0 0 2 2 2
SA07S PFSA075_PN27 A 2 0 0 0 2 0 0 0 0 7
SA075 PFSA075_302400 A 0 0 0 0 1 0 0 0 0 5
SA075 PFSA075_258500 Atrunc 0 2 1 0 6 2 0 1 0 1
SA075 PFSA075_PN19 B 15 6 62 43 107 28 352 528 50 102
SA075 PFSA075_220500 B 6 88 168 67 31 1 42 81 5 39
SA075 PFSA075_PIM02 B 7 0 0 13 90 7 2 7 60 75
SA075 PFSA075_101100 B 7 3 2 5 111 12 16 19 3 78
SA075 PFSA075_494000 B 46 0 10 10 49 11 4 11 57 43
SA075 PFSA075_PN42 B 6 6 30 15 71 5 21 13 2 66
SA075 PFSA075_PN34 B 7 10 6 6 77 11 7 7 11 83
SA075 PFSAO75_PN40 B 0 1 1 5 83 5 0 3 0 96
SA075 PFSA075_490000 B 5 2 4 3 85 3 1 5 5 70
SA075 PFSA075_101400 B 2 0 3 0 78 4 3 5 2 69
SA075 PFSA075_PN15 B 0 2 1 1 32 2 49 30 1 32
SA075 PFSA075_101300 B 39 0 11 12 42 1 0 4 1 35
SA075 PFSA075_PN44 B 0 3 2 3 45 1 0 5 1 83
SA075 PFSA075_PN23 B 9 0 3 8 51 5 3 5 21 24
SA075 PFSA075_413400 B 2 0 2 1 63 3 3 3 2 48
SA075 PFSAO75_493900 B 5 3 9 11 55 3 0 1 1 36
SA075 PFSA075_491400 B 2 2 3 1 52 4 1 1 10 34
SA075 PFSA075_PN39 B 0 3 2 0 55 3 1 0 0 38
SA075 PFSA075_071400 B 0 0 1 2 33 1 2 5 2 50
SA075 PFSA075_PN45 B 3 0 2 2 44 0 2 2 0 21
SA075 PFSA075_413900 B 0 0 0 0 31 0 0 2 3 39
SA075 PFSA075_PN25 B 0 0 0 0 48 0 1 2 0 4
SA075 PFSA075_PN31 B 1 1 3 1 23 2 1 0 0 22
SA075 PFSA075_011200 B 1 0 0 0 7 0 11 11 1 4
SA075 PFSA075_PN16 B 1 0 0 1 15 2 0 0 1 12
SA075 PFSA075_127700 B 0 3 5 2 19 0 0 0 0 2
SA075 PFSA075_011600 B 5 1 2 0 4 1 0 0 4 5
SA075 PFSA075_PN12 B 0 0 2 2 9 0 0 0 0 6
SA075 PFSA075_030900 B 5 1 2 0 3 1 0 0 3 4
SA075 PFSAO75_348600 B 1 0 0 1 7 0 0 0 0 8
SA075 PFSA075_412900 B 0 0 0 0 3 1 0 0 0 2
SA075 PFSA075_348000 B 0 0 0 0 3 1 0 0 0 1
408
Appendix Table 9.11. Raw r if  read counts from  454 amplicon sequencing ofcDNA and 
gDNA from a patien isolate 8383 put under differential selection pressure. AC (acute 
rings and ex vivo trophozoites) and CU (culture-adapted) andfresh-from-the-arm patient 
samples that were matured in culture fo r  a single IDC, (acute rings, and ex vivo late 
rings to schizonts). These isolates lacked whole genome sequence data. Therefore the 
data in the table was generated by de novo assembly o f 454 reads. The numbers o f  reads 
that went into contig assembly were computed per sample and these numbers were used 
at the read count data. !: samples with limited sequence depth (>1000 reads).
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Iso late C luster ID A/B G ene ID AC_R AC_T AC_G CU_R CU_LRET CU_T CU_S CU_G
8383 454_RIF_0080 A PF383_RIF_CU_00_G1_2_3 83.5 51.5 34 363 411 121 284 21
8383 454_RIF_0001 A PF383 RIF CU 00 G2 4 0 21.5 24 18 17 311 130 20
8383 454_RIF_0225 A PF383 RIF CU 00 RN 2 13 64 127.5 16 70 34 111 103 14
8383 454_RIF_0002 A PF383 RIF AC 00  R1 2 14 183 30.5 59 77 38 0 25 54
8383 454_RIF_0120 A PF383 RIF CU 00 G1 2 47 0 8 31 158 91 77 62 20
8383 454_RIF_0172 A PF383 RIF CU 00  RN 2 25 47 118 26 46 16 83 93 10
8383 454_RIF_0023 A PF383 RIF AC 24 T2 2 47 28.5 33 33 77 116 0 78 37
8383 454_RIF_0177 A PF383 RIF AC 00 GE 2 19 31.3 26.5 17 137 62 37 65 14
8383 454_RIF_0250 A PF383 RIF CU 00 RN 2 4 26.5 141 14 24 49 35 48 16
8383 454_RIF_0209 A PF383 RIF CU 18 TR 2 1 26.5 21.5 21 95 108 16 53 9
8383 454_RIF_0189 A PF383 RIF AC 24 T2 2 38 8.5 138 22 23 11 32 59 25
8383 454_RIF_0211 A PF383 RIF CU 00 RN 2 2 23.5 18 6 28 123 20 31 0
8383 454_RIF_0181 A PF383_Rl F_AC_24_T 1_2_5 22.3 138 10 0 12 13 22 16
8383 454_RIF_0323 A PF383_Rl F_AC_00_R2_2_18 28 16 7 59 62 25 29 0
8383 454_RIF_0231 A PF383 RIF AC 24 T1 2 24 10 74.5 26 5 0 56 13 27
8383 454_RIF_0261 A PF383 RIF CU 18 TR 2 5 2 6 25 6 0 45 104 15
8383 454_RIF_0142 A PF383 RIF AC 00  GE 2 25 10.5 13.5 31 30 11 31 41 30
8383 454_RIF_0312 A PF383 RIF AC 24 T2 2 19 14 106 7 0 0 21 9 18
8383 454_RIF_0158 A PF383_RIF_CU_00_G1_2_57 10.5 19 44 0 5 44 14 31
8383 454_RIF_0361 A PF383_Rl F_AC_00_G E _2_l 6 5.5 0 29 28 56 0 24 15
8383 454_RIF_0148 A PF383 RIF CU 00 RN 2 15 15.5 42 17 21 19 0 18 19
8383 454_RIF_0123 A PF383 RIF AC 24 T1 2 33 0 18 0 0 0 116 0 7
8383 454_RIF_0178 A PF383 RIF AC 24 T1 2 3 19.5 27.5 11 8 10 45 10 8
8383 454_RIF_0214 A PF383_RI F_AC_00_G E_2_13 31.5 15.5 14 21 17 4 9 12
8383 454_RIF_0364 A PF383_RI F_CU_30_SZ_2_3 7 11 7 11 0 13 58 7
8383 454_RIF_0440 A PF383 RIF CU 30 SZ 2 7 0 .0 16.5 15 0 0 53 8 13
8383 454_RIF_0430 A PF383 RIF AC 24 T2 2 9 0.0 18.5 7 0 0 39 33 7
8383 454_RIF_0234 A PF383_RIF_CU_00_G 1_2_58 0 7 40 0 0 15 0 36
8383 454_RIF_0368 A PF383_RIF_AC_24_T1_2_11 0 21 0 8 0 34 24 5
8383 454_RIF_0629 A PF383 RIF AC 24 T2 2 37 0 9 32 0 4 0 16 28
8383 454_RIF_0522 A PF383_RIF_A C_00_G E_2_3 8 0 6 45 0 0 0 2 30
8383 454_RIF_0712 A P F3 83_R 1 F_C U_00_G 1_2_8 0 69 5 0 0 0 0 7
8383 454_RIF_0434 A PF383 RIF CU 00  G1 2 10 0.0 18 0 0 4 18 20 13
8383 454_RIF_0455 A P F383_R 1 F_C U_30_SZ_2_17 0.0 12 16 0 0 16 10 18
8383 454_RIF_0304 A PF383_R 1 F_AC_24_T 1_2_2 7 18 10 10 0 9 7 10
8383 454_RIF_0265 A PF383_Rl F_CU_00_G 1_2_29 0 6.5 14 15 0 14 8 13
8383 454_RIF_0422 A PF383 RIF CU 30 SZ 2 1 0 7 12 0 8 0 27 13
8383 454_RIF_0521 A PF383_RI F_AC_24_T2_2_26 0 14 15 0 0 0 22 12
8383 454_RIF_0946 A PF383 RIF AC 00 GE 2 50 0 0 13 18 10 0 0 21
8383 454_RIF_0429 A PF383 RIF AC 24 T2 2 7 0.0 26 15 0 0 4 7 10
8383 454_RIF_0010 A PF383 RIF CU 00  G1 2 56 0 10 13 0 0 20 9 9
8383 454_RIF_0180 A PF383_RIF_CU_18_TR_2_9 0 0 29 3 0 13 0 13
8383 454_RIF_0538 A PF383_RI F_AC_24_T2_2_44 0 23 7 9 10 0 8 0
8383 454_RIF_1610 A PF383_RI F_CU_30_SZ_2_57 0 0 0 0 0 0 56 0
8383 454_RIF_0787 A PF383 RIF CU 30 SZ 2 37 0 0 26 0 0 0 5 23
8383 454_RIF_0635 A PF383 RIF CU 00 G1 2 50 0 0 16 0 0 8 0 28
8383 454_RIF_0543 A PF383_Rl F_AC_00_R 2_2_20 5.5 0 8 11 0 0 27 0
8383 454_RIF_0013 A PF383_RIF_AC_00_GE_2_33 0 9 13 0 0 0 7 22
8383 454_RIF_0438 A PF383_RIF_AC_00_R2_2_10 21.5 3 10 0 9 0 0 6
410
Iso la te C luster ID A/B G ene ID AC_R AC_T AC_G CU_R CU_LRET CU_T c u _ s CU_G
8383 454_RIF_0403 A PF383 RIF AC 24 T2 2 52 0 5 18 0 6 0 0 19
8383 454_RIF_0754 A PF383_RIF_AC_00_GE_2_48 0 5 34 0 0 0 0 7
8383 454_RIF_0576 A PF383 RIF CU 00 G1 2 12 5 0 14 0 11 0 0 13
8383 454_RIF_0658 A PF383 RIF CU 00 G1 2 65 0 11 13 0 0 6 0 13
8383 454_RIF_0702 A PF383 RIF CU 00 G1 2 9 0 0 20 0 0 8 0 13
8383 454_RIF_0772 A PF383 RIF CU 00 G1 2 53 0 14 0 0 0 9 0 18
8383 454_RIF_0385 A PF383_RIF_AC_00_GE_2_30 3 7 17 0 3 0 0 10
8383 454_RIF_1223 A PF383_RI F_AC_24_T2_2_39 0 40 0 0 0 0 0 0
8383 454_RIF_0436 A PF383 RIF AC 00 GE 2 11 0.0 7 12 0 0 0 3 17
8383 454_RIF_0424 A PF383 RIF AC 24 T2 2 3 11.5 10.5 8 0 0 0 0 8
8383 454_RIF_0496 A PF383 RIF CU 00 G1 2 4 0.0 16 8 3 0 0 0 11
8383 454_RIF_0510 A PF383 RIF CU 00 G1 2 14 7 6 10 0 5 0 0 9
8383 454_RIF_0005 A PF383 RIF AC 00  GE 2 32 0 0 24 0 0 0 0 12
8383 454_RIF_0513 A PF383_RIF_AC_24_T2_2_13 11 9 12 0 0 0 0 0
8383 454_RIF_0333 A PF383 RIF CU 00  G1 2 60 0 7 8 0 0 2 0 13
8383 454_RIF_0499 A PF383 RIF CU 00  G1 2 5 0.0 6 9 0 7 0 0 8
8383 454_RIF_0911 A PF383 RIF AC 24 T2 2 35 0 13 0 0 0 0 0 14
8383 454_RIF_0520 A PF383 RIF AC 24 T2 2 24 1 9.5 7 0 0 0 0 9
8383 454_RIF_0770 A PF383 RIF AC 24 T1 2 28 0 21 0 0 0 0 0 5
8383 454_RIF_0505 A PF3 8 3_R 1 F_AC_00_G E_2_2 0.0 5 9 5 0 0 4 0
8383 454_RIF_0693 A PF383_R 1 F_AC_00_G E_2_10 0 0 11 0 0 0 0 10
8383 454_RIF_1050 A PF383_RIF_AC_00_G E_2_91 0 0 10 0 0 0 0 9
8383 454_RIF_0939 A PF383_R 1 F_AC_00_G E_2_49 0 0 16 0 0 0 0 2
8383 454_RIF_0771 A PF383_R 1 F_AC_00_R 1_2_18 11.5 6 0 0 0 0 0 0
8383 454_RIF_0857 A PF383_RI F_AC_00_G E_2_21 0 0 10 0 0 0 0 7
8383 454_RIF_0854 A PF383_R 1 F_CU_00_G 1_2_13 0 0 9 0 0 0 0 7
8383 454_RIF_1446 A PF383_R 1 F_AC_00_R 1_2_31 11 0 0 0 0 0 0 0
8383 454_RIF_1178 A PF383_RIF_AC_00_R1_2_12 10 0 0 0 0 0 0 0
8383 454_RIF_1579 A PF383_RIF_CU_00_G2_19 0 0 0 0 0 0 0 10
8383 454_RIF_0495 A PF383_RIF_AC_00_GE_2_3 0.0 0 9 0 0 0 0 0
8383 454_RIF_0900 A PF383_RIF_CU_00_G1_2_32 0 0 0 0 0 0 0 9
8383 454_RIF_1062 A PF383_RIF_CU_00_G2_21 0 0 0 0 0 0 0 8
8383 454_RIF_1230 A P F383_R 1 F_AC_00_G E_2_44 0 0 8 0 0 0 0 0
8383 454_RIF_1487 A PF383_RIF_AC_00_G E_2_83 0 0 8 0 0 0 0 0
8383 454_RIF_1224 A PF383_R 1 F_CU_00_G 1_2_44 0 0 0 0 0 0 0 7
8383 454_RIF_1497 A PF383_RIF_CU_06_PR_2_29 0 0 0 0 7 0 0 0
8383 454_RIF_0126 A PF383_RIF_AC_00_GE_2_54 0 0 6 0 0 0 0 0
8383 454_RIF_1245 A PF383_RIF_CU_00_G1_2_46 0 0 0 0 0 0 0 6
8383 454_RIF_1467 A PF383_R 1 F_AC_00_R2_2_29 6 0 0 0 0 0 0 0
8383 454_RIF_0531 A PF383_RIF_CU_00_G2_27 0 0 0 0 0 0 0 5
8383 454_RIF_1671 A PF383_RIF_AC_00_R2_2_39 5 0 0 0 0 0 0 0
8383 454_RIF_1091 A PF383_RIF_CU_00_G2_1 0 0 0 0 0 0 0 4
8383 454_RIF_1465 A PF383_R 1 F_AC_00_G E_2_79 0 0 4 0 0 0 0 0
8383 454_RIF_0476 A PF383_RIF_CU_30_SZ_2_68 0.0 0 0 0 0 0 2 0
8383 454_RIF_1686 A PF383_RIF_CU_18_TR_2_50 0 0 0 0 0 2 0 0
8383 454_RIF_1894 A PF383_RIF_CU_00_RN_2_53 0 0 0 2 0 0 0 0
8383 454_RIF_1870 AX P F383_R 1 F_AC_24_T 1_2_59 0 13 0 0 0 0 0 0
8383 454_RIF_1031 AX PF383_R 1 F_AC_00_G E_2_81 0 0 8 0 0 0 3 0
8383 454_RIF_1411 AX PF383_RIF_CU_00_RN_2_34 0 0 0 11 0 0 0 0
411
Iso la te C luste r ID A/B G ene ID AC_R AC_T AC_G CU_R CU_LRET CU_T CU_S CU_G
8383 454_RIF_1520 AX PF383 RIF CU 18 TR 2 43 0 0 0 0 0 11 0 0
8383 454_RIF_1919 AX PF383 RIF AC 00 GE 2 99 0 0 8 0 0 0 0 0
8383 454_RIF_1684 AX PF383 RIF AC 24 T1 2 51 0 6 0 0 0 0 0 0
8383 454_RIF_0171 B PF383 RIF AC 24 T1 2 42 29.5 50 42 119 94 31 259 58
8383 454_RIF_0012 B PF383 RIF AC 24 T1 2 15 0 14.5 59 20 40 23 103 44
8383 454_RIF_0275 B PF383 RIF AC 24 T2 2 31 18.5 35 0 51 49 34 69 23
8383 454_RIF_0286 B PF383 RIF AC 24 T1 2 39 0 12 34 14 12 9 164 13
8383 454_RIF_0163 B PF383 RIF AC 24 T1 2 36 6 22.5 38 21 35 6 16 52
8383 454_RIF_0143 B PF383 RIF CU 30 SZ 2 13 16.5 42 23 0 8 40 47 13
8383 454_RIF_0196 B PF383 RIF AC 24 T2 2 57 13.5 13.5 49 24 0 0 19 29
8383 454_RIF_0282 B PF383 RIF AC 00  R l 2 17 16.5 13 22 47 15 0 12 20
8383 454_RIF_0222 B PF383 RIF AC 00  GE 2 27 10 12 17 41 5 10 12 23
8383 454_RIF_0128 B PF383 RIF CU 00 G1 2 69 5 8 37 14 5 10 14 36
8383 454_RIF_0324 B PF383 RIF AC 24 T1 2 22 0 39.5 18 7 17 0 38 7
8383 454_RIF_0675 B PF383 RIF AC 00  GE 2 68 0 36.5 46 0 0 0 0 43
8383 454_RIF_0116 B PF383 RIF AC 00  GE 2 31 0 7 11 62 0 9 10 19
8383 454_RIF_0417 B PF383 RIF AC 24 T2 2 58 6 0 29 0 0 7 26 35 f
8383 454_RIF_0388 B PF383 RIF CU 30 SZ 2 16 6 0 21 27 20 6 11 10
8383 454_RIF_0150 B PF383 RIF AC 00  GE 2 45 0 0 30 13 16 12 14 14
8383 454_RIF_0321 B PF383 RIF AC 24 T1 2 19 0 9.5 10 10 0 27 15 20
8383 454_RIF_0491 B PF383 RIF AC 24 T1 2 40 16 18 21 0 0 0 0 20
8383 454_RIF_0818 B PF383 RIF CU 00 RN 2 38 0 0 14 10 0 0 0 13
8383 454_RIF_0161 B PF383 RIF CU 00 G1 2 75 0 0 28 0 0 0 0 8
8383 454_RIF_1551 B PF383_RI F_CU_30_SZ_2_55 0 0 0 0 0 0 30 0
8383 454_RIF_0685 B PF383_RI F_AC_24_T2_2_1 0 16 9 0 0 4 0 0
8383 454_RIF_0822 B PF383 RIF CU 30 SZ 2 53 0 0 7 0 0 0 9 10
8383 454_RIF_0748 B PF383_RI F_AC_24_T2_2_33 0 7 10 0 0 5 0 0
8383 454_RIF_0736 B PF383_RIF_AC_00_GE_2_40 0 6 7 0 0 0 0 0
8383 454_RIF_0412 B PF383 RIF CU 00  G1 2 77 0 0 0 0 0 0 0 8
8383 454_RIF_1044 B PF383 RIF AC 24 T2 2 69 0 6.5 0 0 0 0 0 0
8383 454_RIF_1400 B PF383_RI F_CU_00_G2_9 0 0 0 0 0 0 0 6
8383 454_RIF_1501 B PF383 RIF CU 18 TR 2 39 0 0 0 0 0 6 0 0
8383 454_RIF_1531 B PF383 RIF AC 24 T1 2 45 0 5 0 0 0 0 0 0
8383 454_RIF_1809 B PF383 RIF CU 06 PR 2 43 0 0 0 0 5 0 0 0
8383 454_RIF_0007 B PF383 RIF CU 00 G1 2 80 0 0 0 0 0 0 0 3
8383 454_RIF_1801 BX P F38 3_R 1 F_AC_00_R 1_2_40 15 0 0 0 0 0 0 0
8383 454_RIF_1692 BX PF383 RIF CU 06  PR 2 39 0 0 0 0 11 0 0 0
8383 454_RIF_1571 BX PF383_RIF_CU_00_G2_18 0 0 0 0 0 0 0 4
8383 454_RIF_1815 BX PF383_RI F_AC_24_T1_2_54 0 4 0 0 0 0 0 0
8383 454_RIF_1587 XA PF383 RIF CU 00  RN 2 43 0 0 0 4 0 0 0 0
412
Iso la te C luste r A /B G en e  ID R T S
10727 454_R IF_0660 A PF727 RIF AC 22 T2 2 29 0 316 .7 0
10727 454_RIF_0475 A PF727 RIF AC 22 T1 2 21 8 292 15
10727 454_RIF_0481 A PF727 RIF AC 00  G1 2 48 0 292 0
10727 454_RIF_0009 A PF727 RIF AC 00  ER 2 1 235 0.0 0
10727 454_R IF_0444 A PF727 RIF AC 22 T3 6 0 83.7 5
10727 454_RIF_0509 A PF727 RIF AC 22 T1 2 6 0 96.3 4
10727 454_RIF_0776 A PF727 RIF AC 00  G2 51 0 0 0
10727 454_RIF_0630 A PF727 RIF AC 22 T3 17 0 36.7 0
10727 454_RIF_0723 A PF727 RIF AC 22 T1 2 9 0 87.7 0
10727 454_R IF_0298 A PF727 RIF AC 00  G2 4 0 0.0 0
10727 454_R IF_0597 A PF727 RIF AC 00  G2 28 0 0 .0 0
10727 454_R IF_0550 A PF727 RIF AC 00  G2 40 0 0.0 0
10727 454_R IF_0357 A PF727 RIF AC 00  G1 2 4 0 30 7
10727 454_R IF_0027 A PF727 RIF AC 00  G2 24 0 0 .0 0
10727 454_RIF_0636 A PF727 RIF AC 00  G2 21 0 0 .0 0
10727 454_R IF_0534 A PF727 RIF AC 22 T3 11 4 41 .7 0
10727 454_RIF_0623 A PF727 RIF AC 22 T1 2 13 0 43 0
10727 454_RIF_0613 A PF727 RIF AC 22  T3 9 0 38 0
10727 454_RIF_0738 A PF727 RIF AC 22 T1 2 11 0 5.5 0
10727 454_RIF_0230 A PF727 RIF AC 00  G1 2 80 4 2 0
10727 454_R IF_0234 A PF727 RIF AC 00  G1 2 46 0 7 0
10727 454_RIF_0581 A PF727 RIF AC 22 T1 2 2 0 43 0
10727 454_RIF_0523 A PF727 RIF AC 00  G2 13 0 0 .0 0
10727 454_RIF_0591 A PF727 RIF AC 00  G1 2 10 0 22 0
10727 454_R IF_0608 A PF727 RIF AC 00  G2 15 0 0.0 0
10727 454_RIF_0586 A PF727 RIF AC 00  G1 2 7 0 26.3 0
10727 454_RIF_0612 A PF727 RIF AC 00  G2 31 0 0 .0 0
10727 454_R IF_0840 A PF727 RIF AC 22 T2 2 1 0 29 0
10727 454_RIF_1436 A PF727 RIF AC 00  G1 2 78 0 0 0
10727 454_RIF_0546 A PF727 RIF AC 22 T3 22 0 23.3 0
10727 454_RIF_0688 A PF727 RIF AC 00  G1 2 9 0 4.5 0
10727 454_R IF_0588 A PF727 RIF AC 22 T2 2 4 0 27.3 0
10727 454_R IF_0494 A P F727_R 1 F_AC_00_G 2_10 0 0 .0 0
10727 454_RIF_0123 A P F727_R 1 F_AC_22_T2_2_23 0 17 0
10727 454_RIF_0503 A P F727_R 1 F_AC_00_G 2_8 0 0 .0 0
10727 454_R IF_0280 A PF727_RIF_AC_00_G2_42 0 0 .0 0
10727 454_R IF_0450 A PF727 RIF AC 22 T2 2 10 0 18 0
10727 454_R IF_0819 A P F727_R 1 F_AC_00_G 2_49 0 0 0
10727 454_R IF_0704 A P F727_R 1 F_AC_00_G 2_2 9 0 0 0
10727 454_RIF_1543 A PF727_RIF_AC_00_G2_52 0 0 0
10727 454_RIF_1902 A P F727_R 1 F_AC_2 2_T2_2_58 0 29 0
10727 454_RIF_0603 A PF727 RIF AC 0 0  G1 2 19 0 0.0 0
10727 454_RIF_0191 A PF727 RIF AC 22 T2 2 21 0 9.5 0
10727 454_RIF_0627 A PF727_RIF_A C_00_G 1_2_30 0 18.3 0
10727 454_RIF_0706 A P F727_R 1 F_AC_00_G 2_23 0 0 0
10727 454_RIF_0002 A P F727_R 1 F_AC_00_G 1_2_28 0 21.7 0
10727 454_RIF_0476 A P F727_R 1 F_AC_00_G 2_27 0 0 0
10727 454_R IF_0944 A PF727_RIF_AC_00_G2_46 0 0 0
10727 454_RIF_1133 A PF727_RIF_A C_00_G 1_2_13 0 0 0
10727 454_RIF_0654 A PF727_RIF_A C_00_G 1_2_47 5 5.5 0
10727 454_RIF_1195 A P F727_R 1 F_AC_00_G 1_2_27 0 0 0
10727 454_R IF_0590 A P F727_R 1 F_AC_22_T1_2_7 0 14.7 0
10727 454_RIF_0610 A P F727_R 1 F_AC_00_G 2_7 2 0 0 .0 0
10727 454_R IF_0780 A P F727_R 1 F_AC_22_T2_2_26 0 12.5 0
10727 454_R IF_0554 A PF727_RIF_AC_00_G2_44 0 0.0 0
10727 454_RIF_0816 A P F727_R 1 F_AC_00_G 2_43 0 0 0
10727 454_RIF_0901 A P F727_R 1 F_AC_00_G 2_14 0 0 0
10727 454_RIF_0789 A P F727_R 1 F_AC_00_G 2_45 0 0 0
10727 454_RIF_0536 A P F727_R 1 F_AC_00_G 2_19 0 0 .0 0
10727 454_RIF_0646 A PF727_RIF_AC_22_T3_20 0 5 0
10727 454_RIF_0716 A PF727_RIF_AC_00_G2_25 0 0 0
10727 454_RIF_0926 A P F727_R 1 F_AC_00_G 1 _ 2 _ 4 1 0 9 0
10727 4 5 4  RIF 1086 A P F727_R 1 F_AC_00_G 1_2_5 0 0 0
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Iso la te C luste r A/B G en e  ID R T S
10727 454_RIF_1182 A PF727 RIF AC 22 T3 7 0 16 0
10727 454_RIF_0815 A PF727 RIF AC 22 T1 2 30 0 15.5 0
10727 454_RIF_0533 A PF727 RIF AC 0 0  G2 39 0 0.0 0
10727 454_RIF_0713 A PF727 RIF AC 00  G2 11 0 0 0
10727 454_R IF_0694 A PF727 RIF AC 00  G2 55 0 0 0
10727 454_R IF_0760 A PF727 RIF AC 00  G1 2 39 0 4 0
10727 454_RIF_0925 A PF727 RIF AC 00  G1 2 31 0 5 0
10727 454_RIF_0971 A PF727 RIF AC 00  G1 2 40 0 3 0
10727 454_RIF_1110 A PF727 RIF AC 00  G1 2 11 0 0 0
10727 454_RIF_1213 A PF727 RIF AC 00  G1 2 35 0 0 0
10727 454_RIF_0511 A PF727 RIF AC 00  G1 2 77 0 0 .0 0
10727 454_RIF_0693 A PF727 RIF AC 00  G1 2 16 0 0 0
10727 454_RIF_0735 A PF727 RIF AC 0 0  G2 17 0 0 .0 0
10727 454_RIF_1266 A PF727 RIF AC 00  G1 2 42 0 0 0
10727 454_RIF_0038 A PF727 RIF AC 00  G1 2 18 0 2 0
10727 454_RIF_0684 A PF727 RIF AC 0 0  G1 2 2 0 6 0
10727 454_R1F_0695 A PF727 RIF AC 0 0  G2 76 0 0 0
10727 454_RIF_0703 A PF727 RIF AC 0 0  G1 2 6 0 5 0
10727 454_RIF_0873 A PF727 RIF AC 0 0  G2 79 0 0 0
10727 454_R IF_1100 A PF727 RIF AC 00  G2 3 0 0 0
10727 454_R IF_1334 A PF727 RIF AC 00  G1 2 50 0 0 0
10727 454_R IF_0616 A PF727 RIF AC 22 T2 2 19 0 6 0
10727 454_RIF_0690 A PF727 RIF AC 00  G2 2 0 0 0
10727 454_R IF_0886 A PF727 RIF AC 00  G2 5 0 0 0
10727 454_R IF_0887 A PF727 RIF AC 00  G2 9 0 0 0
10727 454_RIF_1161 A P F727_R 1 F_AC_00_G 1_2_22 0 0 0
10727 454_R IF_1328 A PF727 RIF AC 00  G2 32 0 0 0
10727 454_RIF_0001 A PF727_RIF_AC_00_G2_18 0 0 0
10727 454_RIF_0005 A P F727_R 1 F_AC_00_G 1_2_85 0 0 .0 0
10727 454_RIF_0833 A P F727_R 1 F_AC_00_G 2_6 0 0 0
10727 454_RIF_1623 A P F727_R 1 F_AC_00_G 2_60 0 0 0
10727 454_R IF_0848 A P F727_R 1 F_AC_00_G 1_2_8 0 2 0
10727 454_R IF_1240 A PF727_RIF_A C_00_G 1_2_32 0 0 0
10727 454_R IF_1776 A P F727_R 1 F_AC_22_T 1_2_45 0 9 0
10727 454_R IF_0004 A PF727 RIF AC 00  ER 2 2 8 0.0 0
10727 454_RIF_0266 A PF727 RIF AC 0 0  G2 71 0 0 0
10727 454_RIF_0953 A P F727_R 1 F_AC_00_G 2_3 7 0 0 0
10727 454_RIF_1111 A PF727 RIF AC 0 0  G1 2 15 0 0 0
10727 454_RIF_1141 A PF727 RIF AC 0 0  G1 2 14 0 0 0
10727 454_RIF_0251 A PF727 RIF AC 0 0  G2 66 0 0 0
10727 454_RIF_0451 A PF727 RIF AC 22 T3 14 0 7 0
10727 454_RIF_1121 A PF727_RIF_AC_00_G1_2_1 0 0 0
10727 454_RIF_1335 A P F727_R 1 F_AC_00_G 1_2_63 0 0 0
10727 454_RIF_1401 A P F727_R 1 F_AC_22_T 1_2_29 0 7 0
10727 454_RIF_0013 A P F727_R 1 F_AC_00_G 1_2_90 0 0.0 0
10727 454_RIF_0403 A PF727_RIF_AC_00_G2_47 0 0 0
10727 454_RIF_0497 A PF727_R 1 F_AC_22_T1_2_3 0 0 .0 0
10727 454_RIF_0551 A P F727_R 1 F_AC_00_G 2_53 0 0 .0 0
10727 454_RIF_0719 A PF727_RIF_AC_00_G2_26 0 0 0
10727 454_RIF_0831 A P F727_R 1 F_AC_00_G 2_1 0 0 0
10727 454_RIF_1001 A PF727_RIF_AC_00_G2_38 0 0 0
10727 454_R IF_1150 A P F727_R 1 F_AC_00_G 2_7 0 0 0
10727 454_RIF_1187 A PF727_RIF_AC_22_T3_8 0 6 0
10727 454_RIF_1251 A PF727_RIF_AC_22_T3_15 0 6 0
10727 454_RIF_1601 A P F727_R 1 F_AC_00_G 1_2_94 0 0 0
10727 454_R IF_0872 A P F727_R 1 F_AC_00_G 2_48 0 0 0
10727 454_R IF_0892 A P F727_R 1 F_AC_00_G 2_57 0 0 0
10727 454_RIF_0909 A P F727_RI F_AC_00_G 2_20 0 0 0
10727 454_RIF_1282 A P F727_R 1 F_AC_00_G 1_2_45 0 0 0
10727 454_RIF_0015 A PF727_R 1 F_AC_00_G 1_2_82 0 0 .0 0
10727 454_RIF_0827 A P F727_R 1 F_AC_00_G 1_2_98 0 0 0
10727 454_RIF_0835 A P F727_R 1 F_AC_00_G 1_2_100 0 0 0
10727 454_RIF_1506 A PF727_RIF_AC_00_G1_2_83 0 0 0
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Iso la te C luste r A/B G en e  ID R T S G
10727 454_RIF_1652 A PF727 RIF AC 00  G2 70 0 0 0 3
10727 454_RIF_0820 AX PF727 RIF AC 0 0  G2 50 0 0 0 27
10727 454_RIF_1602 AX PF727 RIF AC 0 0  G2 62 0 0 0 13
10727 454_RIF_1787 AX PF727 RIF AC 22 T3 44 0 8 0 0
10727 454_RIF_1015 AX PF727 RIF AC 0 0  G2 41 0 0 0 7
10727 454_RIF_1029 AX PF727 RIF AC 0 0  G2 63 0 0 0 6
10727 454_RIF_1037 AX PF727 RIF AC 0 0  G2 56 0 0 0 6
10727 454_RIF_1858 AX PF727 RIF AC 0 0  G2 74 0 0 0 5
10727 454_R IF_1807 AX PF727 RIF AC 22 T3 45 0 3 0 0
10727 454_R IF_1060 AX PF727 RIF AC 00  G2 73 0 0 0 2
10727 454_RIF_0043 B PF727 RIF AC 00  G2 16 0 0 0 134
10727 454_RIF_0487 B PF727 RIF AC 00  G1 2 69 0 46 .7 0 70
10727 454_R IF_0890 B PF727 RIF AC 00  G2 12 0 0.0 0 73
10727 454_R IF_0564 B PF727 RIF AC 00  G1 2 60 7 18.7 0 43
10727 454_RIF_0029 B PF727 RIF AC 00  G1 2 74 0 9.5 0 51
10727 454_RIF_0556 B PF727 RIF AC 22 T1 2 22 0 21.3 0 39
10727 454_R IF_0990 B PF727 RIF AC 00  G1 2 87 0 0 0 48
10727 454_RIF_1075 B PF727 RIF AC 00  G1 2 95 0 10 0 37
10727 454_R IF_0380 B PF727 RIF AC 00  G1 2 23 0 19 4 23
10727 454_R IF_0668 B PF727 RIF AC 22 T3 25 0 8.7 0 33
10727 454_RIF_0979 B PF727 RIF AC 22 T1 2 24 0 5 0 36
10727 454_R IF_0810 B PF727 RIF AC 00  G1 2 68 4 12 0 24
10727 454_RIF_0518 B PF727 RIF AC 22 T2 2 43 6 5.5 0 28
10727 454_RIF_0060 B PF727 RIF AC 00  G2 33 0 5 0 31.5
10727 454_RIF_0237 B PF727 RIF AC 00  G2 30 10 9 0 14
10727 454_RIF_0621 B PF727 RIF AC 22 T2 2 15 12 6.5 0 14
10727 454_RIF_0786 B PF727 RIF AC 00  G1 2 54 0 11 0 19
10727 454_RIF_0667 B PF727 RIF AC 22 T2 2 33 1 9 0 19
10727 454_RIF_0673 B PF727 RIF AC 00  G2 34 0 0 .0 0 28
10727 454_RIF_1394 B PF727 RIF AC 00  G1 2 67 0 0 0 25
10727 454_RIF_0614 B PF727 RIF AC 00  G1 2 26 0 5 0 19
10727 454_RIF_1528 B PF727 RIF AC 00  G1 2 86 0 0 0 24
10727 454_RIF_0753 B PF727_RIF_AC_00_G2_64 0 0 .0 0 22
10727 454_RIF_0992 B PF727 RIF AC 00  G1 2 62 0 6 0 16
10727 454_RIF_0321 B PF727 RIF AC 22 T3 23 0 6.5 0 13
10727 454_RIF_0271 B P F72 7_R 1 F_AC_2 2_T 1_2_16 0 12.3 0 7
10727 454_RIF_0343 B PF727 RIF AC 00  G1 2 61 0 0 0 19
10727 454_RIF_1347 B P F727_R 1 F_AC_00_G 1_2_5 9 0 0 0 19
10727 454_R IF_0807 B PF727_RIF_AC_00_G2_35 0 0 .0 0 18
10727 454_R IF_0648 B PF727_RIF_AC_22_T1_2_19 0 8 0 9
10727 454_RIF_1272 B PF727_RIF_AC_22_T3_21 0 17 0 0
10727 454_R IF_0978 B PF727_RIF_A C_00_G 1_2_55 0 6 0 9
10727 454_R IF_1402 B P F727_R 1 F_AC_00_G 1_2_6 6 0 0 0 15
10727 454_RIF_0345 B PF727_RIF_A C_00_G 1_2_88 0 0 0 14
10727 454_RIF_0007 B P F727_R 1 F_AC_00_G 1_2_84 0 0 .0 0 12
10727 454_RIF_0728 B PF727_RI F_AC_00_G 1_2_24 0 0 .0 0 12
10727 454_RIF_0986 B P F727_R 1 F_AC_00_G 2_3 6 0 0 0 12
10727 454_RIF_1388 B P F727_RI F_AC_00_G 1_2_65 0 0 0 12
10727 454_RIF_1927 B PF727_RIF_AC_22_T1_2_52 0 11 0 0
10727 454_RIF_0069 B PF727_RI F_AC_00_G2_22 0 0 0 10
10727 454_RIF_0165 B PF727_RIF_A C_00_G 1_2_72 0 4 0 6
10727 454_RIF_0449 B PF727_RIF_AC_00_G2_78 0 0 .0 0 9
10727 454_RIF_0805 B PF727_RIF_AC_00_G2_58 0 0 .0 0 7
10727 454_RIF_1039 B P F727_R 1 F_AC_00_G 2_6 7 0 0 0 7
10727 454_RIF_0161 B PF727_RIF_A C_00_G 1_2_73 0 0 0 5
10727 454_RIF_0342 B P F727_R 1 F_AC_00_G 2_6 8 0 0 0 5
10727 454_RIF_0395 B PF727_RIF_AC_32_S2_10 0 0 5 0
10727 454_RIF_0726 B P F727_R 1 F_AC_00_G 2_ 6 1 0 0 .0 0 5
10727 454_RIF_0934 B PF727_RIF_AC_22_T3_18 0 5 0 0
10727 454_RIF_1425 B P F727_R 1 F_AC_22_T 1_2_2 8 0 5 0 0
10727 454_RIF_1431 B PF727 RIF AC 22 T2 2 37 0 4 0 0
10727 454_RIF_1711 B P F727_RI F_AC_00_G 2_69 0 0 0 4
10727 454_R IF_0918 B PF727_RIF_AC_00_G2_59 0 0 .0 0 3
10727 454_RIF_0143 B PF727_RIF_AC_12_R2_15 2 0 0 0
10727 454_R IF_0412 B PF727_RIF_AC_12_R2_10 2 0 0 o 415
10727 454_RIF_1019 B P F727_R 1 F_AC_00_G 2_7 5 0 0 0 2
10727 454_RIF_1713 BX PF727_RIF_AC_22_T3_43 0 3 0 0
Iso la te C luste r A/B G en e  ID R LRET ET
10735 454_RIF_0001 A PF735 RIF AC 0 0  GE 2 33 0 0 0
10735 454_RIF_0002 A PF735 RIF AC 0 0  GE 2 26 5 0 0
10735 454_RIF_0013 A PF735 RIF AC 0 0  GE 2 88 0 0 0
10735 454_RIF_0015 A PF735 RIF AC 00  GE 2 61 0 0 0
10735 454_RIF_0023 A PF735 RIF AC 00  GE 2 51 0 0 0
10735 454_RIF_0212 A PF735 RIF AC 00  GE 2 9 0 0 0
10735 454_RIF_0266 A PF735 RIF AC 00  GE 2 22 0 0 0
10735 454_RIF_0431 A PF735 RIF AC 00  MR 37 3 0 0
10735 454_RIF_0526 A PF735 RIF AC 00  GE 2 32 0 0 0
10735 454_RIF_0535 A PF735 RIF AC 30  ET 10 12 57 117
10735 454_RIF_0547 A PF735 RIF AC 30  ET 12 6 8 10
10735 454_R IF_0578 A PF735 RIF AC 20  PR 1 8 19 58
10735 454_RIF_0620 A PF735 RIF AC 00  MR 6 6 27 40
10735 454_RIF_0625 A PF735 RIF AC 20 PR 4 3 4 6
10735 454_RIF_0643 A PF735 RIF AC 00  MR 9 14 10 19
10735 454_RIF_0650 A PF735 RIF AC 00  GE 2 54 0 0 0
10735 454_RIF_0687 A PF735 RIF AC 00  GE 2 2 10 0 5
10735 454_RIF_0695 A PF735 RIF AC 0 0  GE 2 7 0 0 0
10735 454_R IF_0700 A PF735 RIF AC 30  ET 2 0 0 9
10735 454_RIF_0729 A PF735 RIF AC 00  GE 2 24 0 0 0
10735 454_RIF_0739 A PF735 RIF AC 00  GE 2 27 7 0 2
10735 454_R IF_0758 A PF735_RIF_AC_30_ET_11 0 10 20
10735 454_RIF_0765 A PF735 RIF AC 0 0  GE 2 37 5 0 0
10735 454_RIF_0838 A PF735 RIF AC 0 0  GE 2 4 7 0 0
10735 454_RIF_0841 A PF735 RIF AC 3 0  ET 3 0 0 6
10735 454_RIF_0861 A PF735 RIF AC 0 0  GE 2 14 0 0 9
10735 454_RIF_0881 A P F735_R 1 F_AC_00_G E_2_18 0 0 14
10735 454_RIF_0882 A PF735_RIF_AC_30_ET_4 0 0 7
10735 454_R IF_0888 A P F735_R 1 F_AC_00_G E _2 _ l 7 0 0 0
10735 454_RIF_0889 A PF735 RIF AC 00  GE 2 104 0 0 0
10735 454_RIF_0896 A PF735_RI F_AC_20_PR_2 0 13 22
10735 454_RIF_0922 A PF735_RIF_AC_00_M R_8 7 0 0
10735 454_RIF_0937 A PF735_RIF_AC_30_ET_13 0 0 17
10735 454_RIF_0945 A P F735_R 1 F_AC_00_G E_2_41 0 0 4
10735 454_RIF_0956 A P F735_RI F_AC_00_G E_2_43 11 0 0
10735 454_RIF_0961 A PF735_RIF_AC_00_GE_2_47 7 0 6
10735 454_RIF_0982 A P F735_R 1 F_AC_3 0_ET_16 0 0 9
10735 454_RIF_1011 A P F735_R 1 F_AC_00_G E_2_92 0 0 10
10735 454_RIF_1084 . A PF735_RIF_AC_00_GE_2_1 0 7 0
10735 454_RIF_1088 A PF735 RIF AC 00  GE 2 6 0 0 0
10735 454_RIF_1089 A P F735_RI F_AC_00_M R_1 20 0 0
10735 454_R IF_1128 A P F735_R 1 F_AC_00_G E _2_ l 0 0 0 0
10735 454_RIF_1131 A P F735_RI F_AC_00_G E_2_16 0 0 0
10735 454_RIF_1142 A P F735_R 1 F_AC_00_G E_2_5 0 0 0
10735 454_RIF_1149 A PF735 RIF AC 00  GE 2 11 0 0 0
10735 454_RIF_1151 A PF735_RIF_AC_00_G E_2_13 0 0 0
10735 454_RIF_1156 A PF735_RIF_AC_30_ET_5 0 0 21
10735 454_R IF_1158 A PF735 RIF AC 00  GE 2 15 0 0 0
10735 454_RIF_1171 A PF735_RI F_AC_00_G E_2_19 0 0 0
10735 454_R IF_1180 A PF735_RIF_AC_00_GE_2_35 0 0 0
10735 454_R IF_1184 A PF735_RIF_AC_20_PR_3 0 0 0
10735 454_RIF_1190 A PF735_RIF_AC_00_GE_2_25 0 0 0
10735 454_RIF_1197 A PF735_RIF_AC_00_GE_2_30 0 0 0
10735 454_RIF_1232 A PF735_RI F_AC_00_G E_2_31 0 0 0
10735 454_RIF_1241 A P F735_R 1 F_AC_00_G E_2_45 0 0 0
10735 454_RIF_1250 A PF735_Rl F_AC_00_G E_2_3 6 0 0 0
10735 454_RIF_1255 A PF735_RI F_AC_00_G E_2_40 0 0 0
10735 454_RIF_1260 A P F735_RI F_AC_00_G E_2_44 0 0 0
10735 454_RIF_1270 A PF735_RI F_AC_00_M R_10 5 0 0
10735 454_RIF_1274 A PF735_RIF_AC_00_GE_2_42 0 . 0 0
10735 454_RIF_1275 A P F735_R 1 F_AC_00_G E_2_48 0 0 0
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C luste r A/B G en e  ID R LRET ET
454_RIF_1277 A PF735 RIF AC 00  GE 2 58 0 0 0
454_RI F_1295 A PF735 RIF AC 00  GE 2 63 0 0 0
454_RIF_1297 A PF735 RIF AC 00  GE 2 57 0 0 0
454_RIF_1298 A PF735 RIF AC 00  GE 2 64 0 0 0
454_RIF_1304 A PF735 RIF AC 00  GE 2 60 0 0 0
454_RIF_1309 A PF735 RIF AC 00  GE 2 67 0 0 0
454_RIF_1318 A PF735 RIF AC 00  GE 2 71 0 0 0
454_RIF_1329 A PF735 RIF AC 00  GE 2 65 0 0 0
454_RIF_1340 A PF735 RIF AC 00  GE 2 68 0 0 0
454_RIF_1343 A PF735 RIF AC 00  GE 2 80 0 0 0
454_RIF_1352 A PF735 RIF AC 00  GE 2 69 0 0 0
454_RIF_1392 A PF735 RIF AC 00  GE 2 87 0 0 0
454_RIF_1427 A PF735 RIF AC 00  GE 2 91 0 0 0
454_RIF_1434 A PF735 RIF AC 00  GE 2 95 0 0 0
454_RIF_1442 A PF735 RIF AC 00  GE 2 94 0 0 0
454_RIF_1473 A PF735 RIF AC 00  GE 2 98 0 0 0
454_RIF_1474 A PF735 RIF AC 00  GE 2 97 0 0 0
454_RIF_1475 A PF735 RIF AC 00  GE 2 100 0 0 0
454_RIF_1694 A PF735 RIF AC 30  ET 29 0 0 3
454_RIF_1779 A PF735 RIF AC 00  MR 27 3 0 0
454_R IF_1804 A PF735 RIF AC 00  MR 31 9 0 0
454_RIF_1822 A PF735 RIF AC 00  GE 2 112 0 0 0
454_RIF_1846 A PF735 RIF AC 00  MR 35 4 0 0
454_RIF_1887 A PF735 RIF AC 00  MR 36 11 0 0
454_RIF_1898 A PF735 RIF AC 30  ET 31 0 0 4
454_RIF_1457 AX PF735 RIF AC 00  GE 2 99 0 0 0
454_RIF_1476 AX PF735 RIF AC 0 0  GE 2 101 0 0 7
454_R IF_1554 AX P F735_R 1 F_AC_00_G E_2_103 0 0 0
454_RIF_1624 AX PF735_RIF_AC_00_GE_2_108 0 0 0
454_RIF_1627 AX PF735_Rl F_AC_00_G E_2_107 0 0 0
454_RIF_1831 AX PF735_RIF_AC_00_M R_34 3 0 0
454_RIF_0006 B PF735_RIF_AC_00_G E_2_29 0 0 0
454_RIF_0069 B PF735 RIF AC 00  GE 2 20 0 0 0
454_RIF_0133 B PF735_Rl F_AC_00_G E_2_7 5 0 0 0
454_RIF_0239 B PF735_Rl F_AC_00_G E_2_86 0 0 0
454_RIF_0271 B P F735_R 1 F_AC_00_M R_5 6 0 0
454_RIF_0518 B PF735 RIF AC 00  MR 3 14 0 0
454_RIF_0672 B PF735_Rl F_AC_00_G E_2_77 0 0 0
454_RIF_0680 B P F735_R 1 F_AC_00_G E_2_90 0 0 0
454_RIF_0755 B P F735_R 1 F_AC_00_G E_2_49 15 0 8
454_RIF_0803 B PF735_RIF_AC_00_M  R _ l l 7 0 10
454_RIF_0906 B PF735_RIF_AC_00_G E_2_23 2 0 5
454_RIF_0940 B PF735 RIF AC 00  GE 2 53 8 0 0
454_RIF_0985 B PF735_Rl F_AC_00_M R_12 9 0 0
454_RIF_0993 B PF735_RIF_AC_00_M  R_13 17 0 0
454_RIF_1231 B PF735_RI F_AC_00_G E_2_28 0 0 0
454_RIF_1249 B P F735_RI F_AC_00_G E_2_34 0 0 0
454_RIF_1313 B PF735 RIF AC 00  GE 2 56 0 0 0
454_RIF_1319 B PF735_RI F_AC_00_GE_2_62 0 0 0
454_RIF_1345 B PF735 RIF AC 00  GE 2 73 0 0 0
454_RIF_1348 B PF735 RIF AC 00  GE 2 72 0 0 0
454_RIF_1349 B PF735 RIF AC 00  GE 2 83 0 0 0
454_RIF_1356 B P F735_RI F_AC_00_G E_2_7 6 0 0 0
454_RIF_1364 B P F735_R 1 F_AC_00_G E_2_7 0 0 0 0
454_RIF_1365 B PF735_RI F_AC_00_GE_2_79 0 0 0
454_RIF_1367 B PF735_RI F_AC_00_GE_2_74 0 0 0
454_RIF_1368 B P F735_R 1 F_AC_00_G E_2_78 0 0 0
454_RIF_1391 B P F735_RI F_AC_00_G E_2_84 0 0 0
454_RIF_1403 B P F735_RI F_AC_00_G E_2_81 0 0 0
454_RIF_1426 B PF735_Rl F_AC_00_G E_2_89 0 0 0
454_RIF_1553 B PF735_RI F_AC_00_M R_19 10 0 0
454_RIF_1054 BX P F735_RI F_AC_00_G E_2_105 0 0 0
454_RIF_1765 BX P F735_RI F_AC_00_M R_28 4 0 0
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Isolate Cluster A/B G ene ID R T
10739 454_RIF_0002 A PF739 RIF AC 00 GE 2 49 0 0
10739 454_RIF_0057 A PF739 RIF AC 00 GE 2 78 0 0
10739 454_RIF_0084 A PF739 RIF AC 00 GE 2 106 0 0
10739 454_RIF_0398 A PF739 RIF AC 00 GE 2 76 0 0
10739 454_RIF_0403 A PF739 RIF AC 00 GE 2 83 0 0
10739 454_RIF_0554 A PF739 RIF AC 00 GE 2 84 0 0
10739 454_RIF_0589 A PF739 RIF AC 00 GE 2 11 10 6
10739 454_RIF_0604 A PF739 RIF AC 00 GE 2 112 0 0
10739 454_RIF_0649 A PF739 RIF AC 00 GE 2 75 0 0
10739 454_RIF_0692 A PF739_RIF_AC_00_GE_2_6 0 0
10739 454_RIF_0705 A PF739 RIF AC 00 GE 2 15 0 12
10739 454_RIF_0733 A PF739_RIF_AC_40_TR_2 0 18.5
10739 454_RIF_0768 A PF739 RIF AC 00 MR 1 17 18
10739 454_RIF_0835 A PF739 RIF AC 00 GE 2 7 0 0
10739 454_RIF_0842 A P F739_R 1 F_AC_00_G E_2_22 0 0
10739 454_RIF_0850 A PF739 RIF AC 00 GE 2 8 0 11
10739 454_RIF_0865 A PF739_RIF_AC_00_G E_2_30 3 0
10739 454_RIF_0868 A PF739 RIF AC 00 GE 2 28 0 0
10739 454_RIF_0872 A P F739_R 1 F_AC_00_G E_2_2 9 0 0
10739 454_RIF_0913 A PF739_RI F_AC_40_TR_3 0 8
10739 454_RIF_0935 A PF739 RIF AC 40 TR 4 0 17
10739 454_RIF_0951 A P F739_R 1 F_AC_00_G E_2_71 0 15
10739 454_RIF_0953 A PF739 RIF AC 00 GE 2 81 0 0
10739 454_RIF_1013 A P F739_R 1 F_AC_00_G E_2_l 14 0 0
10739 454_RIF_1048 A PF739 RIF AC 00 GE 2 126 0 0
10739 454_RIF_1083 A P F739_R 1 F_AC_00_G E_2_l 0 0
10739 454_RIF_1085 A PF739_RIF_AC_00_GE_2_5 0 0
10739 454_RIF_1094 A PF739_RIF_AC_00_GE_2_2 0 0
10739 454_RIF_1095 A PF739_RIF_AC_00_GE_2_3 0 0
10739 454_RIF_1101 A P F739_RI F_AC_00_G E_2_20 0 0
10739 454_RIF_1102 A P F739_R 1 F_AC_00_G E_2_4 0 0
10739 454_RIF_1104 A P F739_R 1 F_AC_00_G E_2_19 0 0
10739 454_RIF_1105 A PF739 RIF AC 00 GE 2 18 0 0
10739 454_RIF_1112 A PF739_RIF_AC_00_GE_2_9 0 0
10739 454_RIF_1114 A PF739 RIF AC 00 GE 2 13 0 0
10739 454_RIF_1115 A P F739_RI F_AC_00_G E_2_16 0 0
10739 454_RIF_1116 A P F739_R 1 F_AC_00_G E_2_14 0 0
10739 454_RIF_1122 A PF739_RI F_AC_00_G E_2_17 0 0
10739 454_RIF_1123 A PF739_RI F_AC_00_G E_2_25 0 0
10739 454_RIF_1129 A P F739_R 1 F_AC_00_G E_2_21 0 0
10739 454_RIF_1132 A PF739_RIF_AC_00_GE_2_10 0 0
10739 454_RIF_1134 A PF739_RIF_AC_00_GE_2_12 0 0
10739 454_RIF_1135 A PF739 RIF AC 00 GE 2 23 0 0
10739 454_RIF_1136 A PF739_RI F_AC_00_G E_2_2 6 0 0
10739 454_RIF_1137 A P F739_R 1 F_AC_00_G E_2_3 2 0 0
10739 454_RIF_1144 A P F739_R 1 F_AC_00_G E_2_24 0 0
10739 454_RIF_1147 A P F739_R 1 F_AC_00_G E_2_31 0 0
10739 454_RIF_1148 A PF739_RIF_AC_00_GE_2_34 0 0
10739 454_RIF_1155 A P F739_R 1 F_AC_00_G E_2_3 5 0 0
10739 454_RIF_1157 A P F739_R 1 F_AC_00_G E_2_2 7 0 0
10739 454_RIF_1164 A P F739_R 1 F_A C_00_G E_2_3 3 0 0
10739 454_RIF_1169 A P F739_R 1 F_AC_00_G E_2_3 7 0 0
10739 454_RIF_1176 A P F739_R 1 F_AC_00_G E_2_44 0 0
10739 454_RIF_1185 A PF739_RIF_AC_00_GE_2_41 0 0
10739 454_RIF_1192 A PF739_RIF_AC_00_GE_2_46 0 0
10739 454_RIF_1198 A PF739_RIF_AC_00_GE_2_56 0 0
10739 454_RIF_1200 A PF739_RIF_AC_00_GE_2_50 0 0
10739 454_RIF_1201 A P F739_R 1 F_AC_00_G E_2_45 0 0
10739 454_RIF_1205 A P F739_R 1 F_AC_00_G E_2_51 0 0
10739 454_RIF_1212 A PF739_RI F_AC_00_G E_2_61 0 0
10739 454_RIF_1214 A PF739_RIF_AC_00_GE_2_62 0 0
10739 454_RIF_1218 A PF739_RIF_AC_00_GE_2_63 0 0
10739 454_RIF_1225 A PF739_RI F_AC_00_G E_2_47 0 0
10739 454_RIF_1226 A PF739_RIF_AC_00_GE_2_57 0 0
10739 454_RIF_1227 A PF739_RIF_AC_00_GE_2_65 0 0
10739 454_RIF_1237 A PF739_RI F_AC_00_G E_2_58 0 0
10739 454_RIF_1247 A PF739_RIF_AC_00_GE_2_72 0 0
10739 454_RIF_1261 A PF739_RIF_AC_00_GE_2_66 0 0
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Isolate C luster A/B G ene ID R T G
10739 454_RIF_1264 A PF739 RIF AC 00 GE 2 68 0 0 34
10739 4S4_RIF_1283 A PF739 RIF AC 00 GE 2 74 0 0 40
10739 454_RIF_1286 A PF739_RIF_AC_00_GE_2_73 0 0 6
10739 454_RIF_1287 A PF739 RIF AC 00 GE 2 80 0 0 31
10739 454_RIF_1288 A P F739_R 1 F_AC_00_G E_2_7 0 0 0 7
10739 454_RIF_1299 A PF739 RIF AC 00 GE 2 85 0 0 20
10739 454_RIF_1317 A PF739 RIF AC 00 GE 2 82 0 0 24
10739 454_RIF_1336 A PF739_RIF_AC_00_GE_2_99 0 0 26
10739 454_RIF_1389 A PF739 RIF AC 40 TR 6 0 5 0
10739 454_RIF_1422 A PF739_RIF_AC_00_GE_2_113 0 0 6
10739 454_RIF_1429 A PF739 RIF AC 00 GE 2 115 0 0 7
10739 454_RIF_1460 A PF739 RIF AC 00 GE 2 117 0 0 6
10739 454_RIF_1478 A PF739_RI F_AC_00_G E_2_l 18 0 0 94
10739 454_RIF_1488 A PF739 RIF AC 00 GE 2 121 0 0 8
10739 454_RIF_1515 A PF739_RIF_AC_40_TR_9 0 15 0
10739 454_RIF_1596 A PF739 RIF AC 00 GE 2 125 0 0 32
10739 454_RIF_1597 A PF739 RIF AC 50 MT 5 0 9 0
10739 454_RIF_1607 A PF739_R 1 F_AC_00_G E_2_124 0 0 9
10739 454_RIF_1913 A PF739 RIF AC 12 PR 4 0 4 0
10739 454_RIF_1791 AX PF739_RIF_AC_00_GE_2_127 0 0 2
10739 454_RIF_1897 AX PF739 RIF AC 00 GE 2 128 0 0 5
10739 454_RIF_1943 AX PF739_RIF_AC_10_RN_4 8 0 0
10739 454_RIF_1944 AX PF739_RIF_AC_40_TR_13 0 9 0
10739 454_RIF_0035 B PF739 RIF AC 00 GE 2 87 0 0 121
10739 454_RIF_0097 B PF739_RIF_AC_00_GE_2_120 0 0 69
10739 454_RIF_0239 B PF739_RIF_AC_00_GE_2_100 0 0 27
10739 454_RIF_0334 B PF739_RI F_AC_00_G E_2_67 0 0 64
10739 454_RIF_0419 B PF739_RIF_AC_00_GE_2_101 0 0 102
10739 454_RIF_0449 B P F739_R 1 F_AC_00_G E_2_40 0 0 17
10739 454_RIF_0671 B P F739_R 1 F_AC_00_G E_2_9 3 0 0 54
10739 454_RIF_0736 B PF739_RIF_AC_00_GE_2_52 0 0 17
10739 454_RIF_0742 B P F739_R 1 F_AC_00_G E_2_5 3 0 0 36
10739 454_RIF_0793 B P F739_R 1 F_AC_00_G E_2_l 05 0 0 12
10739 454_RIF_0804 B P F739_R 1 F_AC_00_G E_2_9 4 0 0 52
10739 454_RIF_0814 B P F739_R 1 F_AC_00_G E_2_l 11 11 0 103
10739 454_RIF_0894 B P F739_R 1 F_AC_00_G E_2_3 6 0 0 49
10739 454_RIF_0895 B PF739 RIF AC 00 GE 2 39 0 0 39
10739 454_RIF_0957 B PF739_RIF_AC_00_GE_2_77 0 0 56
10739 454_RIF_0989 B PF739 RIF AC 00 GE 2 90 0 0 82
10739 454_RIF_0990 B PF739_RIF_AC_00_GE_2_91 0 0 22
10739 454_RIF_0991 B PF739_R 1 F_AC_00_G E_2_8 8 5 0 63
10739 454_RIF_0996 B PF739_RIF_AC_00_GE_2_96 0 0 73
10739 454_RIF_1172 B P F739_R 1 F_AC_0 0_G E_2_3 8 0 0 45
10739 454_RIF_1183 B P F739_R 1 F_AC_00_G E_2_4 2 0 0 36
10739 454_RIF_1188 B PF739_RIF_AC_00_GE_2_43 0 0 6
10739 454_RIF_1210 B P F739_R 1 F_AC_00_G E_2_48 0 0 17
10739 454_RIF_1220 B P F739_R 1 F_AC_00_G E_2_54 0 0 96
10739 454_RIF_1221 B PF739_R 1 F_AC_00_G E_2_55 0 0 42
10739 454_RIF_1234 B PF739_RI F_AC_00_G E_2_59 0 0 46
10739 454_RIF_1325 B P F739_R 1 F_A C_00_G E_2_8 6 0 0 66
10739 454_RIF_1332 B P F739_R 1 F_AC_00_G E_2_9 5 0 0 12
10739 454_RIF_1350 B P F739_R 1 F_AC_00_G E_2_9 7 0 0 20
10739 454_RIF_1357 B PF739_RIF_AC_00_GE_2_89 0 0 13
10739 454_RIF_1371 B PF739_RIF_AC_00_GE_2_102 0 9 88
10739 454_RIF_1372 B P F739_R 1 F_AC_00_G E_2_9 2 0 0 54
10739 454_RIF_1374 B P F739_R 1 F_AC_00_G E_2_98 0 0 34
10739 454_RIF_1382 B P F739_R 1 F_AC_00_G E_2_104 0 0 35
10739 454_RIF_1385 B PF739_RIF_AC_00_GE_2_103 0 0 48
10739 454_RIF_1396 B PF739_RI F_AC_00_G E_2_107 0 0 57
10739 454_RIF_1397 B PF739_RI F_AC_00_G E_2_108 0 0 104
10739 454_RIF_1408 B P F739_R 1 F_AC_00_G E_2_109 0 0 129
10739 454_RIF_1415 B P F739_R 1 F_AC_00_G E_2_l 10 0 0 22
10739 454_RIF_1449 B PF739_RIF_AC_00_GE_2_116 0 0 11
10739 454_RIF_1489 B PF739_RI F_AC_00_G E_2_l 19 0 0 9
10739 454_RIF_1540 B P F739_R 1 F_AC_00_G E_2_l 2 2 0 0 69
10739 454_RIF_1546 B PF739_RIF_AC_00_GE_2_123 0 0 70
10739 454_RIF_1663 B PF739_RI F_AC_50_MT_7 0 5 0
10739 454_RIF_1581 BX PF739_RI F_AC_00_M R_6 2 0 0
10739 454_RIF_1933 BX PF739_RIF_AC_00_GE_2_129 0 0 133
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454_RIF_0001 A PF747 RIF AC 4 0  ET 2 23 14 21 17
454_RIF_0002 A PF747 RIF AC 4 0  ET 2 69 5 31 22
454_RIF_0003 A PF747 RIF AC 60  ND 2 4 38 45 31
454_RIF_0023 A PF747 RIF AC 60 ND 2 24 0 0 14
454_RIF_0027 A PF747 RIF AC 4 0  ET 2 73 0 17 9
454_RIF_0038 A PF747 RIF AC 40  ET 2 100 0 8 12
454_RIF_0041 A PF747 RIF AC 4 0  ET 2 125 0 19 0
454_RIF_0123 A PF747 RIF AC 20 RN 2 33 11 0 0
454_RIF_0213 A PF747 RIF AC 20 RN 2 107 6 0 0
454_RIF_0232 A PF747 RIF AC 60  ND 2 96 0 0 17
454_RIF_0255 A PF747 RIF AC 20 RN 2 81 9 0 0
454_RIF_0266 A PF747 RIF AC 60 ND 2 10 0 7 8
454_RIF_0280 A P F747_R 1 F_AC_2 0_R N _2_31 32 18 0
454_RIF_0297 A PF747 RIF AC 20 RN 2 114 21 0 0
454_RIF_0372 A P F747_R 1 F_AC_40_ET_2_71 0 3 0
454_RIF_0374 A PF747_RI F_AC_20_RN_2_10 11 0 0
454_RIF_0385 A PF747 RIF AC 60  ND 2 100 0 0 10
454_RIF_0441 A PF747_RIF_AC_40_ET_2_10 37 14 6
454_RIF_0479 A PF747_RI F_AC_40_ET_2_37 206 90 96
454_RIF_0492 A PF747_RIF_AC_00_GE_35 0 0 0
454_RIF_0526 A P F747_R 1 F_AC_00_G E_3 0 3 15
454_RIF_0536 A P F747_R 1 F_AC_20_R N _2_68 9 0 0
454_RIF_0551 A PF747 RIF AC 20  RN 2 63 2 0 0
454_RIF_0577 A PF747 RIF AC 40  ET 2 4 16 13 14
454_RIF_0596 A PF747_RI F_AC_40_ET_2_6 6 15 7
454_RIF_0598 A PF747_RIF_AC_60_N D_2_5 11 29 23
454_RIF_0622 A P F747_RI F_AC_60_N D _2_14 79 23 26
454_RIF_0641 A PF747 RIF AC 40  ET 2 36 182 46 21
454_RIF_0650 A PF747 RIF AC 20 RN 2 62 13 0 9
454_RIF_0683 A PF747_RI F_AC_40_ET_2_1 28 22 16
454_RIF_0699 A PF747_RI F_AC_20_RN_2_2 17 32 0
454_RIF_0701 A PF747_RI F_AC_20_RN_2_3 17 7 4
454_RIF_0707 A PF747_RIF_AC_40_ET_2_11 72 50 19
454_RIF_0714 A PF747_RIF_AC_20_RN_2_7 284 100 53
454_RIF_0731 A PF747_R 1 F_AC_40_ET_2_22 15 13 10
454_RIF_0740 A PF747_RI F_AC_40_ET_2_25 72 25 12
454_RIF_0743 A PF747_RI F_AC_40_ET_2_18 58 17 14
454_RIF_0746 A PF747_RI F_AC_60_N D_2_15 19 9 9
454_RIF_0749 A PF747 RIF AC 40  ET 2 19 108 25 13
454_RIF_0756 A PF747_RI F_AC_40_ET_2_26 94 30 11
454_RIF_0767 A PF747_R 1 F_AC_40_ET_2_35 84 23 14
454_RIF_0773 A PF747_RIF_AC_20_RN_2_32 26 26 11
454_RIF_0774 A PF747 RIF AC 4 0  ET 2 40 145 40 20
454_RIF_0775 A PF747_RI F_AC_40_ET_2_41 20 23 11
454_RIF_0781 A PF747 RIF AC 20 RN 2 35 13 15 0
454_RIF_0783 A PF747_RIF_AC_20_RN_2_37 8 22 0
454_RIF_0832 A PF747_R 1 F_AC_40_ET_2_2 5 8 0
454_RIF_0836 A P F747_R 1 F_AC_20_R N _ 2 _ l 32 0 3
454_RIF_0851 A PF747 RIF AC 40  ET 2 3 0 9 11
454_RIF_0862 A PF747_RIF_AC_20_RN_2_9 7 6 0
454_RIF_0869 A PF747_RI F_AC_20_RN_2_5 24 7 0
454_RIF_0902 A PF747_RIF_AC_20_RN_2_16 27 6 0
454_RIF_0903 A PF747_RI F_AC_40_ET_2_15 0 10 0
454_RIF_0914 A PF747_RIF_AC_60_ND_2_12 6 0 10
454_RIF_0916 A PF747_RI F_AC_40_ET_2_24 20 10 0
454_RIF_0923 A P F747_R 1 F_AC_20_R N_2_2 2 26 4 0
454_RIF_0932 A P F747_R 1 F_AC_40_ET_2_30 0 5 0
454_RIF_0936 A PF747_RIF_AC_20_RN_2_28 30 14 0
454_RIF_0942 A PF747_R 1 F_AC_00_G E_7 0 0 6
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Iso la te C luste r A/B G en e  ID R ET ND-60 (S?)
10747 454_RIF_0949 A P F74 7_R 1 F_A C_4 0_ET_2_7 2 0 11 0
10747 454_RIF_0955 A PF747 RIF AC 40  ET 2 32 0 11 3
10747 454_RIF_0956 A PF747_RIF_AC_40_ET_2_138 0 15 0
10747 454_RIF_0980 A PF747_RIF_AC_20_RN_2_41 14 0 4
10747 454_RIF_0981 A PF747 RIF AC 40  ET 2 43 0 24 23
10747 454_RIF_0997 A PF747__RIF_AC_00_GE_10 8 0 0
10747 454_RIF_1023 A PF747 RIF AC 60 ND 2 46 0 25 12
10747 454_RIF_1027 A PF747 RIF AC 4 0  ET 2 65 0 10 9
10747 454_RIF_1070 A PF747_RI F_AC_60_N D_2_61 16 0 10
10747 454_RIF_1073 A PF747_RIF_AC_60_N D_2_78 21 0 7
10747 454_RIF_1076 A PF747_RIF_AC_40_ET_2_104 0 2 2
10747 454_RIF_1103 A PF747 RIF AC 60 ND 2 1 0 0 5
10747 454_RIF_1118 A PF747_RIF_AC_20_RN_2_4 7 0 0
10747 454_RIF_1139 A PF747_RIF_AC_40_ET_2_7 0 11 0
10747 454_RIF_1152 A PF747_RIF_AC_00_GE_1 0 0 0
10747 454_RIF_1162 A PF747_RIF_AC_20_RN_2_8 9 0 0
10747 454_RIF_1173 A PF747_RIF_AC_20_RN_2_14 7 0 0
10747 454_RIF_1177 A PF747_RIF_AC_20_RN_2_13 8 0 0
10747 454_RIF_1217 A PF747_RIF_AC_20_RN_2_18 30 0 0
10747 454_RIF_1222 A PF747_RIF_AC_60_N D _2_20 0 0 31
10747 454_RIF_1228 A PF747_R 1 F_AC_40_ET_2_17 0 6 0
10747 454_RIF_1284 A PF747_R!F_AC_40_ET_2_34 0 7 0
10747 454_RIF_1285 A PF747 RIF AC 4 0  ET 2 39 0 5 0
10747 454_RIF_1291 A PF747 RIF AC 60 ND 2 25 0 0 10
10747 454_RIF_1296 A PF747_RIF_AC_20_RN_3 6 0 0
10747 454_RIF_1300 A PF747_RIF_AC_20_RN_2_36 34 0 0
10747 454_RIF_1310 A PF747 RIF AC 40  ET 2 38 0 6 0
10747 454_RIF_1324 A PF747_RIF_AC_20_RN_2_40 7 0 0
10747 454_RIF_1358 A PF747_RIF_AC_20_RN_2_43 13 0 0
10747 454_RIF_1359 A P F747_RI F_AC_20_R N _2_5 0 6 0 0
10747 454_RIF_1398 A PF747_RIF_AC_20_RN_2_49 11 0 0
10747 454_RIF_1409 A PF747_RIF_AC_20_RN_2_52 9 0 0
10747 454_RIF_1413 A P F747_RI F_AC_60_N D _2_40 0 0 11
10747 454_RIF_1419 A PF747_R!F_AC_20_RN_2_53 17 0 0
10747 454_RIF_1432 A PF747_RI F_AC_40_ET_2_57 0 15 0
10747 454_RIF_1439 A PF747 RIF AC 40  ET 2 114 0 10 0
10747 454_RIF_1450 A PF747_R 1 F_AC_40_ET_2_63 0 6 0
10747 454_RIF_1453 A PF747 RIF AC 20 RN 2 57 23 0 0
10747 454_RIF_1466 A PF747_RIF_AC_20_RN_2_59 8 0 0
10747 454_RIF_1468 A PF747_R 1 F_AC_60_N D _2_47 0 0 6
10747 454_RIF_1490 A PF747 RIF AC 4 0  ET 2 68 0 8 0
10747 454_RIF_1503 A PF747 RIF AC 4 0  ET 2 70 0 8 0
10747 454_RIF_1525 A PF747_R 1 F_AC_40_ET_2_74 0 3 0
10747 454_RIF_1532 A PF747_R 1 F_AC_20_R N _2_60 9 0 0
10747 454_RIF_1547 A PF747_RI F_AC_40_ET_2_77 0 2 0
10747 454_RIF_1550 A PF747_RIF_AC_20_RN_2_66 2 0 0
10747 454_RIF_1552 A PF747 RIF AC 40  ET 2 80 0 13 0
10747 454_RIF_1556 A P F747_R 1 F_AC_40_ET_2_81 0 2 0
10747 454_RIF_1612 A PF747_RIF_AC_40_ET_2_91 0 2 0
10747 454_RIF_1613 A P F747_R 1 F_AC_40_ET_2_93 0 5 0
10747 454_RIF_1626 A PF747_RIF_AC_00_GE_26 0 0 0
10747 454_RIF_1635 A PF747_RIF_AC_00_GE_25 0 0 0
10747 454_RIF_1637 A PF747 RIF AC 20 RN 2 77 8 0 0
10747 454_RIF_1638 A PF747_RI F_AC_20_RN_2_76 7 0 0
10747 454_RIF_1640 A PF747_R 1 F_AC_60_N D_2_65 0 0 4
10747 454_RIF_1645 A PF747_RIF_AC_60_ND_2_66 0 0 2
10747 454_RIF_1648 A PF747_RIF_AC_00_GE_27 0 0 0
10747 454_RIF_1652 A PF747_RI F_AC_60_N D_2_67 0 6 3
10747 454_RIF_1653 A PF747_RIF_AC_00_GE_28 0 0 0
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Iso la te C luste r A/B G ene ID R ET ND-60 (S?)
10747 454_RIF_1655 A PF747 RIF AC 40  ET 2 101 0 12 0
10747 454_RIF_1666 A PF747 RIF AC 60 ND 2 72 0 0 8
10747 454_RIF_1673 A PF747 RIF AC 60  ND 2 73 0 0 6
10747 454_RIF_1701 A PF747 RIF AC 00  GE 30 0 0 0
10747 454_RIF_1718 A PF747 RIF AC 60  ND 2 82 0 0 2
10747 454_RIF_1724 A PF747 RIF AC 60 ND 2 80 0 0 9
10747 454_RIF_1739 A PF747 RIF AC 40  ET 2 106 0 5 0
10747 454_RIF_1740 A PF747 RIF AC 60  ND 2 81 0 0 9
10747 454_RIF_1744 A PF747 RIF AC 40  ET 2 107 0 3 0
10747 454_RIF_1746 A PF747_RIF_AC_20_RN_8 6 0 0
10747 454_RIF_1747 A PF747 RIF AC 60  ND 2 85 0 0 3
10747 454_RIF_1760 A PF747 RIF AC 60 ND 2 88 0 0 2
10747 454_RIF_1780 A PF747 RIF AC 40  ET 2 113 0 5 0
10747 454_RIF_1794 A PF747_RIF_AC_40_ET_2_117 0 27 0
10747 454_RIF_1797 A PF747 RIF AC 20 RN 2 93 64 0 0
10747 454_RIF_1848 A PF747 RIF AC 20 RN 2 96 11 9 0
10747 454_RIF_1856 A PF747_RIF_AC_40_ET_2_128 0 4 0
10747 454_RIF_1859 A PF747 RIF AC 20 RN 2 101 3 9 0
10747 454_RIF_1866 A PF747 RIF AC 40  ET 2 131 0 3 0
10747 454_RIF_1867 A PF747_RIF_AC_20_RN_2_100 8 2 0
10747 454_RIF_1871 A PF747 RIF AC 20 RN 2 104 3 0 0
10747 454_RIF_1903 A PF747 RIF AC 60 ND 2 106 0 0 12
10747 454_RIF_1939 A PF747_RIF_AC_40_ET_2_141 0 0 0
10747 454_RIF_0823 AX PF747_RIF_AC_20_RN_2_64 11 14 7
10747 454_RIF_0828 AX PF747_RI F_AC_60_N D_2_90 0 10 12
10747 454_RIF_1036 AX PF747 RIF AC 20  RN 2 58 9 0 0
10747 454_RIF_1063 AX PF747_RI F_AC_40_ET_2_90 3 4 0
10747 454_RIF_1454 AX PF747_RIF_AC_20_RN_2_56 7 0 0
10747 454_RIF_1533 AX PF747_RIF_AC_20_RN_2_61 8 0 13
10747 454_RIF_1562 AX PF747 RIF AC 20 RN 2 69 21 0 0
10747 454_RIF_1563 AX PF747 RIF AC 20 RN 2 65 6 0 0
10747 454_RIF_1594 AX PF747_RIF_AC_00_GE_23 0 0 0
10747 454_RIF_1632 AX PF747_RI F_AC_40_ET_2_97 0 3 0
10747 454_RIF_1636 AX PF747_RIF_AC_20_RN_2_74 21 0 0
10747 454_RIF_1665 AX P F747_R 1 F_AC_60_N D _2_71 0 0 2
10747 454_RIF_1668 AX PF747_RIF_AC_20_RN_2_80 4 0 0
10747 454_RIF_1722 AX PF747 RIF AC 20 RN 2 88 4 0 0
10747 454_RIF_1754 AX PF747_RIF_AC_20_RN_2_92 6 0 0
10747 454_RIF_1755 AX PF747_RI F_AC_40_ET_2_108 0 2 0
10747 454_RIF_1799 AX P F747_RI F_AC_60_N D_2_93 0 0 1
10747 454_RIF_1827 AX PF747_RIF_AC_60_ND_2_94 0 0 2
10747 454_RIF_1837 AX P F747_R 1 F_AC_40_ET_2_123 0 4 0
10747 454_RIF_1853 AX PF747_RIF_AC_40_ET_2_127 0 3 0
10747 454_RIF_1881 AX PF747_RIF_AC_60_ND_2_102 0 0 3
10747 454_RIF_1886 AX PF747_RIF_AC_20_RN_2_102 5 0 0
10747 454_RIF_1888 AX PF747_RIF_AC_60_ND_2_101 0 0 2
10747 454_RIF_1909 AX PF747_RIF_AC_20_RN_2_106 4 0 0
10747 454_RIF_1915 AX PF747_R 1 F_AC_60_N D _2_104_ 0 0 8
10747 454_RIF_1921 AX P F747_R 1 F_AC_20_R N _ 2 _ l 10 2 0 0
10747 454_RIF_1928 AX P F747_R 1 F_AC_60_N D_2_109 0 0 4
10747 454_RIF_1951 AX PF747_RIF_AC_00_GE_38 0 0 0
10747 454_RIF_0012 B P F747_R 1 F_AC_60_N D_2_44 7 33 13
10747 454_RIF_0017 B P F747_R 1 F_AC_40_ET_2_124 0 2 0
10747 454_RIF_0034 B PF747_RIF_AC_60_ND_2_113 0 0 1
10747 454_RIF_0042 B PF747_RI F_AC_00_GE_5 0 0 0
10747 454_RIF_0043 B PF747_RIF_AC_60_ND_2_63 0 0 8
10747 454_RIF_0046 B PF747_RI F_AC_40_ET_2_129 0 42 0
10747 454_RIF_0060 B PF747_RI F_AC_40_ET_2_48 0 58 32
10747 454_RIF_0087 B PF747_RI F_AC_40_ET_2_109 0 3 0
G
0
0
0
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
0
0
0
14
0
0
0
0
422
Iso la te
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
10747
C luster A/B G ene ID R ET ND-60 (S?)
454_RIF_0203 B PF747 RIF AC 60 ND 2 38 0 0 13
454_RIF_0239 B PF747_RI F_AC_40_ET_2_67 0 7 0
454_RIF_0240 B PF747 RIF AC 60 ND 2 37 0 14 8
454_RIF_0287 B PF747 RIF AC 60 ND 2 107 0 0 18
454_RIF_0289 B PF747__RI F_AC_60_N D _2_60 0 25 9
454_RIF_0317 B PF747 RIF AC 20 RN 2 15 11 41 43
454_RIF_0380 B PF747 RIF AC 00  GE 2 0 6 0
454_RIF_0412 B PF747_RIF_AC_40_ET_2_137 0 4 0
454_RIF_0419 B PF747_RIF_AC_00_GE_13 0 47 35
454_RIF_0559 B PF747 RIF AC 00  GE 9 21 23 17
454_RIF_0561 B PF747 RIF AC 60  ND 2 32 0 8 7
454_RIF_0565 B PF747_RIF_AC_20_RN_2_44 13 15 32
454_RIF_0605 B P F747_RI F_AC_60_N D_2_8 32 24 27
454_RIF_0638 B PF747 RIF AC 60 ND 2 21 7 37 34
454_RIF_0661 B PF747_RI F_AC_40_ET_2_47 0 11 0
454_RIF_0662 B PF747_R 1 F_AC_60_N D _2_30 24 5 13
454_RIF_0669 B PF747 RIF AC 60  ND 2 35 18 54 62
454_RIF_0672 B PF747_RIF_AC_60_N D_2_34 0 23 23
454_RIF_0678 B PF747_RI F_AC_40_ET_2_53 3 7 7
454_RIF_0747 B PF747_RI F_AC_60_N D _2_17 0 21 27
454_RIF_0759 B PF747 RIF AC 60  ND 2 19 6 10 12
454_RIF_0784 B PF747_RI F_AC_40_ET_2_42 6 7 8
454_RIF_0790 B PF747_RIF_AC_40_ET_2_44 6 6 17
454_RIF_0796 B PF747 RIF AC 40  ET 2 139 0 1 0
454_RIF_0798 B PF747_RI F_AC_60_N D_2_3 6 7 38 24
454_RIF_0799 B PF747_RIF_AC_40_ET_2_52 5 29 28
454_RIF_0891 B PF747_RIF_AC_20_RN_2_83 11 0 0
454_RIF_0893 B PF747_RIF_AC_40_ET_2_13 0 14 23
454_RIF_0920 B PF747_RIF_AC_40_ET_2_21 0 8 2
454_RIF_0987 B PF747_RIF_AC_60_ND_2_31 0 11 23
454_RIF_1008 B PF747_RIF_AC_40_ET_2_112 0 3 0
454_RIF_1046 B PF747_RI F_AC_20_RN_5 7 12 0
454_RIF_1047 B PF747_R 1 F_AC_40_ET_2_75 0 17 6
454_RIF_1059 B PF747_RI F_AC_40_ET_2_88 0 4 4
454_RIF_1254 B PF747_RI F_AC_40_ET_2_28 0 9 0
454_RIF_1306 B PF747_RI F_AC_20_RN_2_39 5 0 0
454_RIF_1375 B PF747_RI F_AC_40_ET_2_45 0 9 0
454_RIF_1376 B PF747_RI F_AC_40_ET_2_50 0 6 0
454_RIF_1510 B PF747_RIF_AC_00_GE_18 0 0 0
454_RIF_1559 B PF747_RIF_AC_00_GE_21 0 0 0
454_RIF_1586 B PF747_RIF_AC_60_ND_2_57 0 0 4
454_RIF_1608 B PF747_RI F_AC_20_RN_2_71 3 0 0
454_RIF_1631 B PF747_RI F_AC_60_N D_2_62 0 ■o 5
454_RIF_1672 B PF747_RIF_AC_20_RN_2_82 5 0 0
454_RIF_1676 B PF747_RIF_AC_20_RN_2_78 7 0 0
454_RIF_1679 B PF747_RIF_AC_20_RN_2_85 3 0 0
454_RIF_1707 B PF747_RIF_AC_20_RN_2_87 6 0 0
454_RIF_1750 B PF747_RIF_AC_40_ET_2_105 0 9 0
454_RIF_1781 B PF747_RI F_AC_00_GE_33 0 0 0
454_RIF_1833 B P F747_R 1 F_AC_40_ET_2_122 0 1 0
454_RIF_1844 B PF747_RI F_AC_40_ET_2_126 0 3 0
454_RIF_1041 BX PF747_RI F_AC_60_N D_2_50 0 10 7
454_RIF_1054 BX PF747_RI F_AC_40_ET_2_84 0 6 0
454_RIF_1544 BX PF747_RI F_AC_40_ET_2_76 0 6 0
454_RIF_1575 BX PF747_RIF_AC_40_ET_2_87 0 7 0
454_RIF_1582 BX PF747_RI F_AC_40_ET_2_82 0 7 0
454_RIF_1656 BX PF747_R 1 F_AC_60_N D_2_69 0 0 10
454_RIF_1839 BX PF747_RIF_AC_40_ET_2_119 0 7 0
454_RIF_1863 BX PF747_RI F_AC_40_ET_2_130 0 3 0
454_RIF_1884 BX PF747_RI F_AC_00_GE_36 0 0 0
454_RIF_1891 BX PF747_RI F_AC_40_ET_2_135 0 0 0
454_RIF_1950 BX PF747_RIF_AC_60_ND_2_112 0 0 10
454_RIF_1953 BX PF747_RIF_AC_20_RN_2_112 7 0 0
454_RIF_1892 XB PF747_RI F_AC_40_ET_2_136 0 0 0
G
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8
0
0
0
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0
36
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10
0
6
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0
2
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0
0
0
0
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0
0
0
0
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0
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Isolate
10761
10761
10761
10761
10761
10761
10761
10761
10761
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10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
Cluster A/B Gene ID R LT S-ER2
454_RIF_0001 A PF761 RIF AC 34 SZ 2 30 0 0 17
454_RIF_0005 A PF761 RIF AC 34 SZ 2 25 0 0 16
454_RIF_0008 A P F761_RI F_AC_00_G E_2_48 0 0 0
454_RIF_0021 A PF761_RIF_AC_12_MR_7 8 0 0
454_RIF_0023 A PF761 RIF AC 34 SZ 2 43 0 0 17
454_RIF_0027 A PF761 RIF AC 00 GE 2 39 3 0 18
454_R1F_0071 A PF761 RIF AC 00 GE 2 83 0 0 0
454_RIF_0120 A P F7 61_R 1 F_AC_00_G E_2_63 0 0 0
454_RIF_0123 A PF761 RIF AC 00 GE 2 37 0 0 0
454_RIF_0237 A PF761 RIF AC 00 GE 2 73 0 0 4
454_RIF_0251 A P F7 61_R 1 F_AC_00_G E_2_103 0 0 0
454_RIF_0298 A PF761 RIF AC 34 SZ 2 7 74 9 44
454_RIF_0331 A P F7 6 1_R 1 F_AC_00_G E_2_31 0 0 0
454_RIF_0339 A PF761_RIF_AC_34_SZ_2_55 0 0 7
454_RIF_0350 A PF761 RIF AC 34 SZ 2 54 0 0 13
454_RIF_0386 A PF761_RIF_AC_34_SZ_2_113 0 0 3
454_RIF_0400 A PF761 RIF AC 34 SZ 2 42 0 0 10
454_RIF_0403 A PF761_RI F_AC_00_G E_2_68 0 0 0
454_RIF_0405 A PF761 RIF AC 34 SZ 2 88 0 0 7
454_RIF_0408 A PF761_RIF_AC_34_SZ_2_126 0 0 4
454_RIF_0451 A P F761_R 1 F_AC_00_E R_2 47 0 977
454_RIF_0476 A PF761 RIF AC 12 MR 4 14 0 29
454_RIF_0494 A P F761_R 1 F_AC_16_M R_1 19 0 8
454_RIF_0498 A PF7 61_RI F_AC_34_SZ_2_71 0 0 9
454_RIF_0503 A PF761_RIF_AC_00_GE_2_3 19 0 56
454_RIF_0514 A P F761_RI F_AC_00_G E_2_109 0 0 0
454_RIF_0523 A PF761 RIF AC 16 MR 8 17 0 58
454_RIF_0533 A P F761_R 1 F_AC_16_M R_10 37 0 12
454_R!F_0536 A P F7 61_R 1 F_AC_34_SZ_2_67 7 0 18
454_RIF_0550 A PF761 RIF AC 16 MR 13 18 0 66
454_RIF_0551 A PF761 RIF AC 34 SZ 2 50 0 0 7
454_RIF_0554 A PF761_RIF_AC_12_MR_3 6 0 44
454_RIF_0583 A P F761_R 1 F_AC_34_SZ_2_4 0 0 7
454_RIF_0597 A PF761 RIF AC 00 GE 2 11 99 0 73
454_RIF_0604 A P F7 61_RI F_AC_00_G E_2_13 0 0 30
454_RIF_0608 A PF761_RI F_AC_34_SZ_2_23 7 0 6
454_RIF_0609 A PF761_RI F_AC_34_SZ_2_24 0 0 10
454_RIF_0610 A PF761 RIF AC 00 GE 2 19 0 0 9
454_RIF_0612 A P F761_RI F_AC_34_SZ_2_26 10 0 31
454_RIF_0636 A PF761_R 1 F_AC_00_G E_2_3 6 17 0 42
454_RIF_0647 A PF761 RIF AC 00 GE 2 92 0 0 0
454_RIF_0650 A PF761_RIF_AC_00_GE_2_121 0 0 0
454_RIF_0690 A PF761_RIF_AC_16_M R_6 10 0 6
454_RIF_0692 A PF761 RIF AC 34 SZ 2 6 0 0 9
454_RIF_0694 A PF761_R 1 F_AC_34_SZ_2_2 0 0 23
454_RIF_0695 A PF761_RIF_AC_16_MR_28 8 0 0
454_RIF_0704 A PF761_RIF_AC_16_M R_3 19 0 16
454_RIF_0705 A P F761_R 1 F_AC_34_SZ_2_31 0 0 4
454_RIF_0706 A PF7 61_R 1 F_AC_00_G E_2_9 0 0 16
454_RIF_0708 A PF761_RIF_AC_34_SZ_2_13 0 0 13
454_RIF_0713 A PF761 RIF AC 34 SZ 2 17 0 0 11
454_RIF_0716 A PF7 61_RI F_AC_34_SZ_2_19 0 0 20
454_RIF_0719 A PF761 RIF AC 00 GE 2 10 0 0 5
454_RIF_0724 A P F7 6 1_R 1 F_AC_00_G E_2_20 0 0 9
454_RIF_0735 A PF761 RIF AC 34 SZ 2 84 0 0 5
454_RIF_0745 A P F761_R 1 F_AC_00_G E_2_113 0 0 0
454_RIF_0757 A P F7 6 1_R 1 F_AC_0 0_G E_2_3 4 0 0 30
454_RIF_0762 A P F7 6 1_R 1 F_AC_00_G E_2_3 5 9 0 22
454_RIF_0776 A PF761_RIF_AC_16_MR_14 11 0 0
454_RIF_0789 A PF761_RIF_AC_16_MR_18 40 0 11
454_RIF_0816 A P F7 6 1_R 1 F_AC_00_G E_2_8 5 0 0 24
454_RIF_0819 A PF761_RIF_AC_16_MR_22 23 0 33
454_RIF_0831 A PF761 RIF AC 34 SZ 2 46 0 0 10
454_RIF_0833 A P F 7 6 1_R 1 F_AC_3 4_SZ_2_3 0 0 11
454_RIF_0842 A P F7 6 1_R 1 F_AC_00_G E_2_42 0 0 0
454_RIF_0863 A P F7 61_R 1 F_AC_34_SZ_2_14 11 0 8
454_RIF_0866 A P F761_R 1 F_AC_00_G E_2_5 0 0 12
454_RIF_0868 A P F7 61_R 1 F_AC_00_G E_2_79 0 0 0
454_RIF_0873 A P F761_R 1 F_AC_00_G E_2_4 0 0 0
G
19
8
12
0
0
33
6
8
24
12
17
0
6
0
0
0
0
13
0
0
7
23
5
0
12
9
12
11
0
14
7
6
0
19
23
7
0
23
7
5
19
15
0
3
28
0
0
0
11
14
5
7
16
8
0
4
26
6
6
0
64
0
0
0
5
0
9
6
18
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Isolate
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
10761
Cluster A/B Gene ID R LT S-ER2
454_RIF_0876 A PF761_RI F_AC_34_SZ_2_10 0 0 9
454_RIF_0877 A PF761 RIF AC 34 SZ 2 12 0 0 11
454_RIF_0886 A PF761_RIF_AC_00_GE_2_77 0 0 0
454_RIF_0887 A PF761 RIF AC 34 SZ 2 34 0 0 17
454_RIF_0892 A P F7 61_R 1 F_AC_34_SZ_2_21 0 0 8
454_RIF_0901 A PF761_RIF_AC_00_GE_2_17 0 0 0
454_RIF_0904 A PF761 RIF AC 00 GE 2 18 0 0 5
454_RIF_0909 A P F7 6 1_R 1 F_AC_00_G E_2_21 0 0 0
454_RIF_0915 A PF761 RIF AC 00 GE 2 23 0 0 2
454_RIF_0921 A PF761 RIF AC 00 GE 2 24 0 0 3
454_RIF_0927 A PF761_RI F_AC_00_GE_2_89 0 0 0
454_RIF_0931 A P F761_R 1 F_AC_16_M R_12 5 0 0
454_RIF_0944 A PF761_R 1 F_AC_00_G E_2_32 0 0 0
454_RIF_0949 A P F7 61_R 1 F_AC_34_SZ_2_40 0 0 22
454_RIF_0953 A PF761 RIF AC 34 SZ 2 63 3 0 5
454_RIF_1001 A PF761_RI F_AC_34_SZ_2_69 0 0 11
454_RIF_1013 A PF761 RIF AC 00 GE 2 110 0 0 0
454_RIF_1062 A PF761_RIF_AC_34_SZ_2_127 0 0 6
454_RIF_1087 A PF7 61_R 1 F_AC_34_SZ_2_1 0 0 15
454_RIF_1092 A PF761 RIF AC 00 GE 2 1 0 0 0
454_RIF_1108 A PF761_RIF_AC_00_GE_2_7 0 0 0
454_RIF_1109 A PF761 RIF AC 34 SZ 2 8 0 0 11
454_RIF_1119 A PF761_RIF_AC_00_GE_2_2 0 0 0
454_RIF_1124 A P F 7 6 1_R 1 F_AC_3 4_SZ_2_9 0 0 6
454_RIF_1145 A PF761_RIF_AC_00_GE_2_12 0 0 0
454_RIF_1154 A PF761_R 1 F_AC_00_G E_2_6 0 0 0
454_RIF_1159 A P F761_RI F_AC_34_SZ_2_20 0 0 18
454_RIF_1160 A PF761_RIF_AC_00_GE_2_8 0 0 0
454_RIF_1181 A P F761_R 1 F_AC_34_SZ_2_28 0 0 7
454_RIF_1262 A PF761_R 1 F_AC_00_G E_2_29 0 0 0
454_RIF_1278 A PF761_RI F_AC_34_SZ_2_37 0 0 8
454_RIF_1292 A P F761_R 1 F_AC_16_M R_15 5 0 0
454_RIF_1320 A P F7 61_R 1 F_AC_00_G E_2_41 0 0 0
454_RIF_1330 A P F761_R 1 F_AC_34_SZ_2_51 0 0 5
454_RIF_1366 A PF761_R 1 F_AC_00_G E_2_52 0 0 0
454_RIF_1420 A PF761_R 1 F_AC_00_G E_2_66 0 0 0
454_RIF_1424 A P F 7 61_R 1 F_AC_00_G E_2_61 0 0 0
454_RIF_1472 A P F7 61_Rl F_AC_00_G E_2_7 8 0 0 0
454_RIF_1484 A P F761_R 1 F_AC_16_M R_20 5 0 0
454_RIF_1491 A PF761_RIF_AC_00_GE_2_82 0 0 0
454_RIF_1507 A PF7 61_R 1 F_AC_00_G E_2_80 0 0 0
454_RIF_1545 A PF761_R 1 F_AC_00_G E_2_90 0 0 0
454_RIF_1578 A P F7 61_R 1 F_AC_00_G E_2_9 6 0 0 0
454_RIF_1592 A PF7 61_Rl F_AC_00_G E_2_97 0 0 0
454_RIF_1618 A PF761_RIF_AC_12_MR_11 4 0 0
454_RIF_1657 A P F761_R 1 F_AC_00_G E_2_105 0 0 0
454_RIF_1680 A PF761_RI F_AC_00_G E_2_107 0 0 0
454_RIF_1682 A PF761_R 1 F_AC_12_M R_16 10 0 0
454_RIF_1734 A PF761_RIF_AC_00_GE_2_112 0 0 0
454_RIF_1757 A PF761_R 1 F_A C_00_G E_2_l 14 0 0 0
454_RIF_1772 A PF761_RIF_AC_00_GE_2_116 0 0 0
454_RIF_1821 A P F761_R 1 F_AC_34_SZ_2_119 0 0 8
454_RIF_1890 A PF761_RIF_AC_34_SZ_2_123 0 0 18
454_RIF_0820 AX PF761_RIF_AC_16_MR_21 11 0 42
454_RIF_1015 AX PF761_RI F_AC_34_SZ_2_81 0 0 9
454_RIF_1029 AX P F7 61_R 1 F_AC_00_G E_2_7 5 0 0 0
454_RIF_1037 AX P F 7 6 1_R 1 F_AC_34_SZ_2_8 7 0 0 6
454_RIF_1060 AX P F761_R 1 F_AC_12_M R_10 4 0 0
454_RIF_1521 AX PF761_RIF_AC_00_GE_2_88 0 0 0
454_RIF_1560 AX PF761_RI F_AC_34_SZ_2_100 0 0 3
454_RIF_1569 AX PF761_RIF_AC_16_MR_25 9 0 0
454_RIF_1609 AX P F7 61_R 1 F_AC_34_SZ_2_10 6 0 0 6
454_RIF_1629 AX P F761_R 1 F_AC_00_G E_2_102 0 0 0
454_RIF_1651 AX PF761_RI F_AC_00_G E_2_104 0 0 0
454_RIF_1674 AX PF761_RI F_AC_00_G E_2_106 0 0 0
454_RIF_1761 AX PF761_RIF_AC_16_MR_27 7 0 0
454_RIF_1834 AX PF761_R 1 F_AC_60_E R_7 0 0 5
454_RIF_1850 AX P F761_RI F_AC_00_G E_2_125 0 0 0
454_RIF_1895 AX P F761_R 1 F_AC_00_G E_2_132 0 0 0
G
0
4
9
0
0
15
10
14
6
15
8
3
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0
0
0
10
0
0
9
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0
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0
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0
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0
4
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0
4
0
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6
0
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0
3
4
0
3
9
5
0
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0
3
0
0
0
3
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0
3
8
425
Isolate Cluster A/B Gene ID R LT S-ER2
10761 454_RIF_1926 AX PF761_RI F_AC_12_M R_24_ 7 0 0
10761 454_RIF_1935 AX PF761_RIF_AC_00_GE_2_134 0 0 0
10761 454_RIF_0006 B PF761 RIF AC 34 SZ 2 82 0 0 11
10761 454_RIF_0007 B PF761 RIF AC 34 SZ 2 68 0 0 4
10761 454_RIF_0034 B PF761 RIF AC 34 SZ 2 56 0 0 15
10761 454_RIF_0043 B PF761_RIF_AC_16_MR_11 17 9 25
10761 454_RIF_0054 B PF761 RIF AC 34 SZ 2 120 0 0 19
10761 454_RIF_0060 B PF761 RIF AC 34 SZ 2 59 0 0 71
10761 454_RIF_0069 B PF761 RIF AC 34 SZ 2 33 0 0 10
10761 454_RIF_0263 B PF761 RIF AC 34 SZ 2 16 0 0 7
10761 454_RIF_0277 B PF761 RIF AC 34 SZ 2 38 0 0 15
10761 454_RIF_0280 B PF761 RIF AC 34 SZ 2 32 6 0 42
10761 454_RIF_0314 B PF761 RIF AC 00 GE 2 30 0 0 6
10761 454_RIF_0315 B PF761 RIF AC 34 SZ 2 96 0 0 11
10761 454_RIF_0342 B P F7 6 1_R 1 F_AC_00_G E_2_67 0 0 0
10761 454_RIF_0419 B PF761 RIF AC 00 GE 2 65 0 0 10
10761 454_RIF_0449 B PF761_RIF_AC_12_MR_1 7 0 13
10761 454_RIF_0519 B PF761 RIF AC 34 SZ 2 85 0 0 6
10761 454_RIF_0614 B PF761 RIF AC 34 SZ 2 128 0 0 56
10761 454_RIF_0673 B PF761 RIF AC 34 SZ 2 60 8 4 26
10761 454_RIF_0676 B PF761 RIF AC 34 SZ 2 61 0 0 7
10761 454_RIF_0680 B PF761_RI F_AC_00_GE_2_81 0 0 37
10761 454_RIF_0726 B PF761 RIF AC 00 GE 2 14 0 0 4
10761 454_RIF_0727 B P F7 61_R 1 F_AC_00_G E_2_15 0 0 0
10761 454_RIF_0753 B PF761_RI F_AC_34_SZ_2_29 0 0 5
10761 454_RIF_0761 B PF761_RI F_AC_34_SZ_2_89 0 0 6
10761 454_RIF_0793 B P F7 61_R 1 F_AC_34_SZ_2_7 5 0 0 7
10761 454_RIF_0800 B PF761 RIF AC 34 SZ 2 114 0 0 15
10761 454_RIF_0804 B P F7 6 1_R 1 F_AC_00_G E_2_87 0 0 4
10761 454_RIF_0805 B P F7 6 1_R 1 F_AC_00_G E_2_56 0 0 16
10761 454_RIF_0807 B PF761 RIF AC 00 GE 2 53 0 0 8
10761 454_RIF_0825 B PF761_RIF_AC_34_SZ_2_124 0 0 12
10761 454_RIF_0890 B P F761_R 1 F_AC_00_G E_2_33 0 0 0
10761 454_RIF_0918 B PF761_RIF_AC_00_GE_2_25 0 0 0
10761 454_RIF_0930 B P F761_RI F_AC_00_G E_2_27 0 0 6
10761 454_RIF_0941 B P F761_RIF_AC_34_SZ_2_116 0 0 3
10761 454_RIF_0970 B P F761_R 1 F_AC_34_SZ_2_7 6 0 0 16
10761 454_RIF_0976 B PF761 RIF AC 00 GE 2 45 0 0 12
10761 454_RIF_0986 B P F7 61_R 1 F_AC_00_G E_2_50 0 0 0
10761 454_RIF_0989 B P F761_RI F_AC_12_M R_6 8 0 0
10761 454_RIF_0994 B PF761 RIF AC 34 SZ 2 57 0 0 14
10761"■~454_RIF_0999 B P F7 61_R 1 F_AC_00_GE_2_58 0 3 0
10761 454_RIF_1007 B P F7 61_R 1 F_AC_00_G E_2_62 0 0 0
10761 454_RIF_1018 B P F761_R 1 F_AC_00_G E_2_7 0 0 0 8
10761 454_RIF_1019 B P F761_RI F_AC_34_SZ_2_77 0 0 4
10761 454_RIF_1030 B P F761_R 1 F_AC_2 6_LT_6 0 7 7
10761 454_RIF_1039 B P F761_RI F_AC_00_GE_2_74 0 0 0
10761 454_RIF_1219 B P F761_R 1 F_AC_34_SZ_2_27 0 0 6
10761 454_RIF_1233 B P F7 6 1_R 1 F_AC_00_G E_2_26 0 0 0
10761 454_RIF_1303 B P F7 6 1_R 1 F_AC_00_G E_2_40 0 0 0
10761 454_RIF_1305 B P F761_RI F_AC_34_SZ_2_48 0 0 13
10761 454_RIF_1331 B P F761_RI F_AC_00_G E_2_47 0 0 0
10761 454_RIF_1353 B PF761_RI F_AC_34_SZ_2_58 0 0 8
10761 454_RIF_1386 B P F7 61_R 1 F_AC_0 0_G E_2_51 0 0 0
10761 454_RIF_1410 B P F7 61_R 1 F_AC_00_G E_2_64 0 0 0
10761 454_RIF_1417 B PF7 61_RI F_AC_34_SZ_2_66 0 0 5
10761 454_RIF_1464 B P F761_R 1 F_AC_00_G E_2_7 6 0 0 0
10761 454_RIF_1477 B P F761_RI F_AC_34_SZ_2_83 4 0 15
10761 454_RIF_1522 B P F761_R 1 F_AC_34_SZ_2_95 0 0 40
10761 454_RIF_1720 B PF761_RI F_AC_00_G E_2_123_ 0 0 0
10761 454_RIF_1732 B PF761_RI F_AC_00_G E _ 2 _ lll 0 0 0
10761 454_RIF_1800 B PF761_RIF_AC_00_GE_2_115 0 0 0
10761 454_RIF_1816 B P F761_R 1 F_AC_34_SZ_2_117 0 0 10
10761 454_RIF_1889 B P F761_RI F_AC_00_G E_2_130 0 0 0
10761 454_RIF_1900 B P F7 61_R 1 F_AC_34_SZ_2_125 0 0 8
10761 454_RIF_1541 BX P F761_R 1 F_AC_34_SZ_2_98 0 0 14
10761 454_RIF_1949 BX PF761_RIF_AC_00_GE_2_133 0 0 0
G
0
5
0
0
0
5
0
48
22
0
0
79
10
0
7
9
33
0
0
37
0
6
21
15
0
0
0
0
12
12
29
0
16
11
6
0
0
23
26
0
19
14
8
19
0
0
15
0
21
25
0
31
0
5
7
0
20
7
0
2
4
3
0
5
0
0
8
426
Isolate
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
Cluster A/B G ene ID
454_.RIF..0001 A PF814..RIF..AC..00..GE._2_43
454 ..RIF..0002 A PF814..RIF. AC. 00. GE._2_32
454 ..RIF..0005 A PF814..RIF..AC.-00. GE._2_38
454 ..RIF..0013 A PF814..RIF..AC..00. GE._2_36
454 ..RIF..0033 A PF814 RIF AC 10 ER 42
454 ..RIF..0038 A PF814 RIF AC 00 GE 2 141
454 ..RIF..0041 A PF814..RIF. AC..26..LR_9
454 ..RIF..0071 A PF814..RIF. AC..12..RN..2 0
454 ..RIF..0090 A PF814..RIF..AC..00. GE._2_33
454 ..RIF..0123 A PF814. RIF. AC..00. GE._2_56
454 ..RIF..0142 A PF814..RIF._AC_00_ GE._2_19
454 ..RIF..0148 A PF814..RIF. AC. 20..PR._2_49
454 ..RIF..0193 A PF814. RIF..AC..00. GE.-2_174
454 ..RIF..0197 A PF814. RIF._AC_00_ GE._2_108
454 . RIF..0218 A PF814. RIF._AC_00_ GE._2_162
454 . RIF..0232 A PF814. RIF. AC..12..RN..23
454 . RIF..0261 A PF814. RIF. AC..00. GE._2_114
454 . RIF..0266 A PF814..RIF. AC..00. GE._2_110
454 . RIF..0272 A PF814. RIF._AC_00_ GE._2_142
454 . RIF..0280 A PF814. RIF. AC..10..ER..45
454 . RIF..0352 A PF814. RIF. AC..10..ER..1
454 . RIF..0355 A PF814..RIF. AC..12..RN._22
454 . RIF..0387 A PF814..RIF..AC..16..MR_5
454 . RIF..0397 A PF814..RIF._AC_00_ GE._2_57
454 ..RIF..0401 A PF814..RIF. AC..00. GE._2_66
454 ..RIF..0447 A PF814..RIF..AC..16..MR_3
454 ..RIF..0461 A PF814..RIF._AC_46__ET_.37
454 ..RIF..0502 A PF814..RIF._AC_46__ET_43
454 ..RIF..0536 A PF814..RIF._AC_00_ GE..2_149
454 ..RIF..0548 A PF814..RIF. AC..10..ER..17
454 ..RIF..0580 A PF814..RIF..AC..10..ER..2
454 ..RIF..0598 A PF814..RIF..AC..20..PR..2_34
454 ..RIF..0603 A PF814..RIF..AC..00. GE._2_116
454 ..RIF..0624 A PF814.-RIF..AC..10..ER..14
454 ..RIF..0629 A PF814..RIF..AC..00. GE._2_37
454..RIF..0642 A PF814..RIF..AC..00. GE.,2_53
454 ..RIF..0646 A PF814..RIF..AC..20..PR. 2_26
454..RIF..0656 A PF814..RIF..AC..46._ET_7
454..RIF..0663 A PF814..RIF..AC..20..PR. 2_16
454..RIF..0710 A PF814..RIF..AC..10..ER..9
454..RIF..0711 A PF814..RIF..AC..10..ER..8
454.-RIF..0715 A PF814..RIF..AC..20..PR._2_30
454..RIF..0729 A PF814..RIF..AC..20..PR. 2_3
454..RIF..0769 A PF814..RIF..AC..00..GE._2_61
454..RIF..0843 A PF814..RIF._AC_00_ GE._2_11
454..RIF..0844 A PF814..RIF..AC..10..ER..4
454.-RIF..0847 A PF814..RIF..AC..10..ER..12
454..RIF..0849 A PF814..RIF..AC..00..GE._2_134
454..RIF..0853 A PF814..RIF..AC..00..GE..2_180
454.-RIF..0856 A PF814..RIF..AC..00..GE._2_7
454..RIF..0860 A PF814..RIF..AC..00. GE.-2_14
454..RIF..0870 A PF814..RIF..AC..00. GE._2_26
454..RIF..0878 A PF814..RIF._AC_00. GE._2_12
454.-RIF..0879 A PF814.-RIF..AC..10..ER..10
454..RIF..0884 A PF814..RIF._AC_00_.GE._2_13
454..RIF..0889 A PF814..RIF..AC..00..GE._2_17
454..RIF..0905 A PF814..RIF.-AC .00..GE..2_35
454..RIF..0907 A PF814..RIF -AC -00..GE._2_27
454..RIF..0928 A PF814..RIF.-AC -00..GE..2_44
RN! MR! LR! LRET ET! G
0 0 0 10 0 42
9 7 0 10 5 24
0 0 0 0 0 26
0 0 0 0 0 23
0 0 0 0 0 0
0 0 0 0 0 16
0 0 4 0 0 0
4 0 0 0 0 0
8 6 0 0 0 35
0 0 0 0 0 14
0 0 0 4 0 21
0 0 0 4 0 0
0 0 0 0 0 7
0 0 0 0 0 6
0 0 0 0 0 7
5 0 0 0 0 0
0 0 0 0 0 10
0 0 0 0 0 32
0 0 0 0 0 6
0 0 0 0 0 0
12 22 0 8 13 20
14 0 0 0 0 0
17 32 18 596 15 56
24 22 10 379 12 21
0 0 0 0 0 21
0 25 0 346 25 13
0 0 0 0 1 0
0 0 0 0 2 0
0 0 0 0 0 5
21 0 0 7 0 40
0 13 0 8 9 30
0 0 0 2 0 0
0 0 0 0 0 14
2 0 0 3 0 26
0 0 0 0 0 11
7 0 0 13 0 31
0 0 0 4 0 0
0 11 0 0 17 12
0 0 0 8 0 44
6 0 0 0 0 5
0 0 0 0 3 7
0 0 0 4 0 0
0 0 0 5 0 26
0 7 0 42 0 23
0 0 0 0 0 8
0 0 0 0 0 8
0 0 0 0 2 0
0 0 0 0 0 8
0 0 0 0 0 29
0 0 0 0 0 10
0 0 0 2 0 5
0 0 0 0 0 19
0 0 0 4 0 9
0 0 0 0 0 0
0 0 0 0 0 20
0 0 0 0 0 12
0 0 0 0 0 27
0 0 0 0 5 39
0 0 0 0 0 55
ER
0
191
0
0
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
340
0
29
25
0
10
0
0
0
29
479
0
0
31
0
13
0
119
9
11
99
0
0
0
12
88
100
0
0
3
0
119
0
26
44
0
15
0
10
427
Isolate Cluster A/B Gene ID ER RN! MR! LR! LRET ET! G
10814 454_RIF_0943 A PF814_RI F_AC_00_G E_2_42 0 0 0 0 0 0 55
10814 454_RIF_0947 A PF814_RIF_AC_00_GE_2_50 0 0 0 0 9 0 19
10814 454_RIF_0952 A PF814_RI F_AC_46_ET_34 0 0 0 0 0 8 0
10814 454_RIF_0958 A P F814_R 1 F_AC_00_G E_2_5 8 0 0 0 0 30 0 48
10814 454_RIF_0965 A PF814_RIF_AC_00_GE_2_55 0 0 0 0 2 0 18
10814 454_RIF_0968 A PF814_RIF_AC_00_G E_2_60 0 0 0 0 0 3 17
10814 454_RIF_0984 A PF814_RIF_AC_00_GE_2_79 0 0 0 0 3 0 28
10814 454_RIF_1016 A PF814_R 1 F_AC_00_G E_2_l 00 33 0 0 0 0 0 26
10814 454_RIF_1021 A PF814_Rl F_AC_00_G E_2_106 0 0 0 0 7 0 25
10814 454_RIF_1026 A PF814_RIF_AC_00_GE_2_111 0 0 0 0 0 6 31
10814 454_RIF_1032 A PF814_RI F_AC_00_G E_2_l 12 0 0 0 0 0 10 21
10814 454_RIF_1043 A PF814_RIF_AC_00_GE_2_120 0 0 0 0 0 2 13
10814 454_RIF_1057 A PF814_RIF_AC_10_ER_29 11 0 0 0 0 15 0
10814 454_RIF_1071 A PF814_RIF_AC_46_ET_19 0 2 0 0 0 2 0
10814 454_RIF_1090 A P F814_R 1 F_AC_00_G E_2_l 0 0 0 0 0 0 10
10814 454_RIF_1099 A PF814_Rl F_AC_00_G E_2_8 0 0 0 0 0 0 7
10814 454_RIF_1106 A PF814_RIF_AC_00_GE_2_10 0 0 0 0 0 0 7
10814 454_RIF_1120 A PF814_RIF_AC_00_GE_2_4 0 0 0 0 0 0 5
10814 454_RIF_1125 A PF814_RIF_AC_00_GE_2_3 0 0 0 0 0 0 6
10814 454_RIF_1126 A PF814_RIF_AC_00_GE_2_9 0 0 0 0 0 0 12
10814 454_RIF_1138 A PF814_RI F_AC_00_G E_2_5 0 0 0 0 0 0 17
10814 454_RIF_1146 A P F814_R 1 F_AC_00_G E_2_l 6 0 0 0 0 0 0 8
10814 454_RIF_1166 A PF814_RI F_AC_00_G E_2_18 0 0 0 0 0 0 12
10814 454_RIF_1167 A PF814_RI F_AC_00_GE_2_20 0 0 0 0 0 0 7
10814 454_RIF_1168 A PF814_Rl F_AC_00_G E_2_21 0 0 0 0 0 0 8
10814 454_RIF_1175 A PF814_RI F_AC_00_G E_2_25 0 0 0 0 0 0 16
10814 454_RIF_1179 A PF814_RI F_AC_12_RN_3 0 7 0 0 0 0 0
10814 454_RIF_1180 A P F814_RIF_AC_00_G E_2_3 0 0 0 0 0 0 0 7
10814 454_RIF_1191 A PF814_RIF_AC_20_PR_2_7 0 0 0 0 140 0 0
10814 454_RIF_1193 A PF814_RIF_AC_00_GE_2_24 0 0 0 0 0 0 6
10814 454_RIF_1202 A P F814_RI F_AC_00_G E_2_2 9 39 0 0 0 0 0 14
10814 454_RIF_1235 A P F814_R 1 F_AC_00_G E_2_46 0 0 0 0 0 0 21
10814 454_RIF_1238 A P F814_RIF_AC_00_G E_2_5 2 0 0 0 0 0 0 15
10814 454_RIF_1252 A PF814_RI F_AC_00_G E_2_48 0 0 0 0 0 0 48
10814 454_RIF_1256 A PF814_RI F_AC_00_G E_2_47 0 0 0 0 0 4 6
10814 454_RIF_1267 A PF814_RI F_AC_00_G E_2_54 0 0 0 0 0 0 5
10814 454_RIF_1279 A PF814_RI F_AC_00_G E_2_63 0 0 0 0 0 0 9
10814 454_RIF_1289 A PF814_RI F_AC_00_G E_2_59 0 0 0 0 0 0 6
10814 454_RIF_1301 A PF814_RI F_AC_00_G E_2_62 0 0 0 0 0 0 5
10814 454_RIF_1314 A PF814_RI F_AC_00_G E_2_64 0 0 0 0 0 0 17
10814 454_RIF_1333 A PF814_RI F_AC_00_G E_2_65 0 0 0 0 0 0 31
10814 454_RIF_1337 A PF814_RIF_AC_10_ER_21 35 0 0 0 0 0 0
10814 454_RIF_1341 A P F814_RI F_AC_00_G E_2_7 0 0 0 0 0 0 0 12
10814 454_RIF_1344 A P F814_R 1 F_AC_00_G E_2_68 0 0 0 0 0 0 37
10814 454_RIF_1354 A PF814_RIF_AC_00_GE_2_82 0 0 0 0 0 0 4
10814 454_RIF_1355 A P F814_RI F_AC_00_G E_2_8 6 0 0 0 0 0 0 5
10814 454_RIF_1377 A PF814_RIF_AC_00_GE_2_88 0 0 0 0 0 0 7
10814 454_RIF_1378 A PF814_RIF_AC_00_GE_2_92 0 0 0 0 0 0 24
10814 454_RIF_1384 A P F814_R 1 F_AC_00_G E_2_81 0 0 0 0 0 0 8
10814 454_RIF_1387 A PF814_RIF_AC_00_GE_2_94 0 0 0 0 0 0 11
10814 454_RIF_1404 A PF814_RIF_AC_20_PR_2_21 0 0 0 0 8 0 0
10814 454_RIF_1445 A PF814_RIF_AC_00_GE_2_109 0 0 0 0 0 0 5
10814 454_RIF_1455 A PF814_RIF_AC_00_GE_2_105 0 0 0 0 0 0 14
10814 454_RIF_1456 A PF814_RIF_AC_00_GE_2_103 0 0 0 0 0 0 6
10814 454_RIF_1479 A PF814_RIF_AC_00_GE_2_115 0 0 0 0 0 0 33
10814 454_RIF_1481 A PF814_RI F_AC_00_G E_2_l 13 0 0 0 0 0 0 10
10814 454_RIF_1492 A PF814_RI F_AC_00_G E_2_l 17 0 0 0 0 0 0 11
10814 454_RIF_1504 A PF814_RI F_AC_00_G E_2_l 19 0 0 0 0 0 0 12
10814 454_RIF_1518 A PF814_RIF_AC_10_ER_28 9 0 0 0 0 0 0
428
Isolate
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
Cluster A/B Gene ID
454..RIF..1537 A PF814..RIF. AC..00..GE._2_127
454..RIF..1570 A PF814..RIF. AC..46..ET..16
454..RIF..1600 A PF814..RIF. AC..00..GE._2_136
454..RIF..1605 A PF814 RIF AC 10 ER 31
454..RIF..1606 A PF814..RIF. AC .12..RN _io
454..RIF..1619 A PF814..RIF..AC..10..ER..30
454..RIF..1620 A PF814..RIF. AC..00..GE._2_135
454..RIF..1633 A PF814..RIF. AC..12.-RN..1 2
454..RIF..1642 A PF814..RIF..AC..12..RN._11
454..RIF..1661 A PF814..RIF. AC..00..GE._2_143
454..RIF..1670 A PF814 RIF AC 20 PR 2 39
454..RIF..1681 A PF814..RIF. AC..10._ER_.33
454..RIF..1683 A PF814..RIF. AC..10..ER..34
454..RIF..1690 A PF814..RIF._AC_00_.GE._2_144
454..RIF..1691 A PF814..RIF. AC..00..GE._2_148
454..RIF..1703 A PF814..RIF. AC_46_.ET. 25
454..RIF..1708 A PF814..RIF. AC..00..GE._2_151
454..RIF..1712 A PF814..RIF. AC..00..GE..2_153
454..RIF..1728 A PF814..RIF. AC..12..RN..1 7
454..RIF..1751 A PF814..RIF. AC..10..ER..36
454..RIF..1756 A PF814..RIF. AC..00..GE._2_158
454..RIF..1762 A PF814..RIF. AC..00..GE._2_157
454..RIF..1764 A PF814.-RIF. AC..00..GE._2_160
454..RIF..1769 A PF814..RIF. AC..00..GE._2_155
454..RIF..1775 A PF814..RIF. AC..20.-PR-.2_44
454..RIF..1788 A PF814..RIF. AC..00. GE._2_161
454..RIF..1789 A PF814..RIF. AC..00..GE._2_163
454..RIF..1805 A PF814..RIF. AC..26._LR_.10
454..RIF..1820 A PF814..RIF. AC..00..GE.-2_164
454..RIF..1824 A PF814..RIF. AC..10.-ER..38
454..RIF..1825 A PF814..RIF. AC..00..GE__2_168
454..RIF..1842 A PF814..RIF. AC..00..GE.-2_166
454..RIF..1854 A PF814..RIF. AC..10.-ER..40
454..RIF..1875 A PF814..RIF. AC..46._ET_.38
454..RIF..1882 A PF814.-RIF. AC_00_.GE._2_176
454.-RIF..1911 A PF814..RIF..AC..10._ER_.44
454..RIF..1049 AX PF814..RIF._AC_00..GE._2_123
454..RIF..1458 AX PF814..RIF..AC..00..GE._2_102
454..RIF..1485 AX PF814._RIF_AC_.10..ER..25
454..RIF..1498 AX PF814..RIF._AC_46_.ET..12
454..RIF..1523 AX PF814..RIF..AC..00..GE._2_126
454..RIF..1539 AX PF814._RIF_AC_.00..GE._2_128
454..RIF..1548 AX PF814..RIF..AC..20..PR._2_28
454..RIF..1549 AX PF814._RIF_AC .00..GE.-2-125
454..RIF..1591 AX PF814._RIF_AC_.00..GE.-2_133
454..RIF..1603 AX PF814..RIF..AC..00..GE..2 -1 3 7
454..RIF..1621 AX PF814..RIF..AC..10._ER_.32
454..RIF..1622 AX PF814..RIF..AC..20..PR..2 -35
454..RIF..1675 AX PF814..RIF..AC..00..GE.-2_145
454..RIF..1677 AX PF814..RIF..AC..00..GE..2 -1 4 6
454.-RIF..1715 AX PF814..RIF._AC_46_.ET..28
454..RIF..1773 AX PF814..RIF._AC_00_.GE.-2_159
454..RIF..1840 AX PF814..RIF.-ACOO..GE.-2 -171
454..RIF..1851 AX PF814..RIF..AC .10.-ER..41
454..RIF..1906 AX PF814.-RIF_AC .00..GE.-2 -178
454..RIF..1938 AX PF814..RIF.-AC..00..GE..2 -1 8 1
454..RIF..0006 B PF814..RIF..AC .00..GE.-2_69
454..RIF..0025 B PF814..RIF..AC.-00.-GE.-2 -140
454.-RIF..0060 B PF814.-RIF..AC -00..GE.-2_98
RN! MR! LR! LRET ET! G
0 0 0 0 0 25
0 0 0 0 7 0
0 0 0 0 0 20
0 0 0 0 0 0
5 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 12
3 0 0 0 0 0
8 0 0 0 0 0
0 0 0 0 0 5
0 0 0 6 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 8
0 0 0 0 0 12
0 0 0 0 2 0
0 0 0 0 0 4
0 0 0 0 0 13
2 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 10
0 0 0 0 0 6
0 0 0 0 0 7
0 0 0 0 0 6
0 0 0 7 0 0
0 0 0 0 0 8
0 0 0 0 0 9
0 0 0 0 0 0
0 0 0 0 0 10
0 0 0 0 0 0
0 0 0 0 0 3
0 0 0 0 0 6
0 0 0 0 0 0
0 0 0 0 11 0
0 0 0 0 0 14
0 0 0 0 0 0
0 0 0 0 0 11
0 0 0 0 0 9
0 0 0 0 0 0
0 0 0 0 9 0
0 0 0 0 0 18
0 0 0 0 0 6
0 0 0 2 0 0
0 0 0 0 0 10
0 0 0 0 0 8
0 0 0 0 0 11
0 0 0 0 0 0
0 0 0 6 0 0
0 0 0 0 0 6
0 0 0 0 0 9
0 0 0 0 5 0
0 0 0 0 0 3
0 0 0 0 0 3
0 0 0 0 0 0
0 0 0 0 0 10
0 0 0 0 0 2
0 0 0 0 0 24
0 0 0 0 15 24
0 0 0 0 0 13
ER
0
0
0
9
0
12
0
0
0
0
0
15
11
0
0
0
0
0
0
7
0
0
0
0
0
0
0
0
0
8
0
0
5
0
0
6
0
0
11
0
0
0
0
0
0
0
6
0
0
0
0
0
0
7
0
0
0
0
0
429
Isolate Cluster A/B Gene ID
10814 454..RIF .0094 B PF814.-RIF _AC .20 _PR._2_48
10814 454 .RIF..0101 B PF814..RIF _AC..00 _GE _2_90
10814 454..RIF..0116 B PF814.-RIF .AC..00 -GE _2_39
10814 454..RIF..0203 B PF814.-RIF -AC.-00 _GE _2_80
10814 454..RIF..0237 B PF814..RIF..AC..00 _GE -2_132
10814 454..RIF..0239 B PF814..RIF..AC..00..GE _2_83
10814 454..RIF..0240 B PF814.-RIF .AC..00 -GE _2_124
10814 454..RIF..0241 B PF814..RIF.-AC.46 _ET_.10
10814 454.-RIF..0287 B PF814..RIF..AC..00 -GE._2_172
10814 454..RIF..0289 B PF814.,RIF_AC_.20._PR-_2_25
10814 454.-RIF..0314 B PF814..RIF..AC..00.-GE._2_121
10814 454.-RIF..0317 B PF814..RIF..AC..10.-ER..22
10814 454.-RIF..0380 B PF814..RIF..AC..00.-GE._2_173
10814 454.-RIF..0561 B PF814..RIF..AC..00.-GE._2_77
10814 454..RIF..0562 B PF814..RIF.-AC..16..MR_8
10814 454.-RIF..0648 B PF814..RIF..AC..20.-PR..2_27
10814 454.-RIF..0671 B PF814.,RIF_AC_.00._GE._2_93
10814 454..RIF. 0673 B PF814..RIF.-AC. 00..GE._2_78
10814 454.-RIF-.0677 B PF814..RIF..AC..00..GE._2_85
10814 454.-RIF..0727 B PF814..RIF..AC..20.-PR-_2_4
10814 454.-RIF..0728 B PF814..RIF._AC_00_-GE._2_51
10814 454..RIF..0742 B PF814..RIF._AC_00_.GE..2_118
10814 454._RIF..0751 B PF814..RIF..AC. 00..GE._2_175
10814 454..RIF..0796 B PF814..RIF..AC. oo..GE._2_73
10814 454.-RIF..0809 B PF814. RIF.-AC..20.-PR. 2_24
10814 454.-RIF..0825 B PF814..RIF..AC_46__ET_ 18
10814 454..RIF..0891 B PF814..RIF..AC..46._ET_ 3
10814 454..RIF..0895 B PF814.-RIF._AC_46__ET_ 31
10814 454..RIF..0897 B PF814. Rl F_AC_ oo..GE._2_23
10814 454..RIF..0898 B PF814..RIF. AC. 20.-PR-_2_2
10814 454..RIF..0950 B PF814..RIF._AC_00__GE_.2_49
10814 454..RIF..0957 B PF814.-RIF..AC..12..RN..13
10814 454..RIF..0996 B PF814._RIF_AC_ oo..GE..2_97
10814 454..RIF..1008 B PF814..RIF_AC_00_.GE._2_95
10814 454..RIF..1020 B PF814..RIF_AC_00_.GE..2_104
10814 454. RIF..1067 B PF814._RIF_AC_00_.GE..2_138
10814 454..RIF..1081 B PF814. RIF._AC_46__ET_35
10814 454..RIF..1194 B PF814..RIF..AC. oo..GE._2_28
10814 454..RIF..1199 B PF814._RIF_AC_ 00..GE..2_31
10814 454..RIF..1242 B PF814..RIF_AC_ oo.-GE._2_41
10814 454..RIF..1346 B PF814. RIF_AC_00_.GE..2_72
10814 454..RIF..1360 B PF814.,RIF_AC. oo. GE..2_75
10814 454 ..RIF..1361 B PF814. RIF. AC..00. GE._2_87
10814 454..RIF..1373 B PF814._RIF_AC_00_.GE..2_71
10814 454..RIF..1379 B PF814..RIF_AC_00_ GE..2_89
10814 454 ..RIF..1381 B PF814. RIF. AC..00. GE. 2_74
10814 454 ..RIF..1390 B PF814. RIF_AC_.00. GE._2_84
10814 454 ..RIF..1433 B PF814. RIF. AC..00. GE._2_99
10814 454 . RIF..1477 B PF814. RIF_AC_00_ GE. 2_130
10814 454..RIF..1538 B PF814._RIF_AC_46__ET_ 15
10814 454..RIF..1565 B PF814..RIF. AC..20.-PR_ 2_32
10814 454 ..RIF..1599 B PF814. RIF. AC..16..MR_15
10814 454 ..RIF..1720 B PF814..RIF. AC..00. GE. 2_154
10814 454 ..RIF..1929 B PF814. RIF._AC_46__ET_44
10814 454 ..RIF..1530 BX PF814. RIF_AC_46__ET_14
10814 454..RIF..1588 BX PF814.,RIF_AC_00..GE..2_131
10814 454..RIF..1625 BX PF814. RIF_AC_00_ GE..2_139
10814 454..RIF..1628 BX PF814._RIF_AC_.20..PR. 2_37
10814 454 ..RIF..1947 X PF814..RIF. AC..00. GE._2_179
RN! MR! LR! LRET ET! G
0 0 0 4 0 128
0 0 0 0 0 24
0 0 0 0 0 6
0 0 0 0 0 55
0 0 0 0 0 9
0 0 0 0 0 9
0 0 0 0 0 7
17 24 0 8 10 62
0 0 0 0 0 10
0 0 0 3 0 0
0 0 0 0 0 16
0 0 0 0 0 0
0 0 0 0 0 44
0 2 0 0 0 56
0 18 20 209 3 37
0 0 0 2 0 0
0 6 0 8 0 32
0 0 0 8 0 29
8 6 0 0 5 22
0 0 0 7 0 ' 32
0 0 0 0 91 37
0 0 0 0 0 5
0 0 0 0 0 13
0 4 0 12 0 31
0 0 0 8 0 0
0 0 0 0 34 44
0 0 0 0 24 0
0 0 0 0 51 0
0 0 0 19 0 8
0 0 0 6 0 23
0 3 0 0 0 8
4 0 0 0 0 0
0 0 0 0 0 33
0 0 0 0 0 10
0 0 0 0 3 21
0 0 0 0 9 12
0 0 0 0 5 16
0 0 0 0 0 12
0 0 0 0 0 15
0 0 0 0 0 23
0 0 0 0 0 30
0 0 0 0 0 22
0 0 0 0 0 9
0 0 0 0 0 13
0 0 0 0 0 16
0 0 0 0 0 5
0 0 0 0 0 11
0 0 0 0 0 8
0 0 0 0 16 14
0 0 0 0 17 0
0 0 0 4 0 0
0 3 0 0 0 0
0 0 0 0 0 4
0 0 0 0 18 0
0 0 0 0 6 0
0 0 0 0 13 42
0 0 0 2 0 77
0 0 0 4 0 0
0 0 0 0 0 8
ER
0
0
0
0
0
0
0
0
0
0
0
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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Appendix Table 9.12. Raw stevor read counts from 454 amplicon sequencing o f  cDNA 
and gDNA from patient iolates that were put under differential selection pressure. AC  
(acute), CU (culture-adapted) HB (HBEC-slelected) R+ (rosetting clone), R- (non- 
rosetting fraction). The data in the table was generated by mapping 454 reads onto 
homologous genomes and computing read counts using Artemis. An average read count 
was taken when samples were sequenced in duplicates or triplicates. Genes in the table 
had greater than 5X  read coverage.
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Isolate G ene ID AC_R AC_T AC_G CU_R CU_LRET CU_T CU_S CU_G
9215 P F8443_8_4_U 533600 431 138 62 264 510 3324 5283 61
9215 PF8443_8_4_U026200 1063 1870 116 2116 905 801 444 338
9215 PF8443_8_4_U516100 2147 213 825 265 371 492 285 1065
9215 PF8443_8_4_U265000 2278 288 582 662 342 341 178 969
9215 PF8443_8_4_U546300 2152 173 374 725 772 426 251 585
9215 PF8443_8_4_U511100 709 298 916 390 555 631 448 1477
9215 PF8443_8_4_U523400 1126 250 715 609 320 225 153 1198
9215 PF8443_8_4_U503400 1937 597 225 657 347 283 126 416
9215 PF8443_8_4_U559100 1552 160 194 545 174 167 497 350
9215 PF8443_8_4_U537000 882 294 382 260 194 387 325 580
9215 PF8443_8_4_U560500 724 117 958 110 79 148 98 •900
9215 PF8443_8_4_U550600 786 79 379 212 227 265 139 821
9215 PF8443_8_4_U505800 876 175 296 425 285 271 171 369
9215 PF8443_8_4_U542800 389 52 457 55 63 159 446 874
9215 PF8443_8_4_U503300 625 108 283 385 111 256 271 266
9215 PF8443_8_4_U559700 995 50 148 197 102 97 64 249
9215 PF8443_8_4_U556500 709 81 254 65 45 82 116 235
9215 PF8443_8_4_U530700 166 50 116 191 54 66 57 160
9215 P F8443_8_4_U540400 568 36 72 3 5 1 7 1
9215 PF8443_8_4_U518800 133 18 61 30 15 60 66 103
9215 PF8443_8_4_U546700 56 55 12 21 19 12 7 35
Isolate G ene ID AC_R AC_G CU_R CUJ.RET CU_T cu_s CU_G HB_R HB_LRET HB_T HB_S HB_G
9106 PF8443_8_7_U557100 343 987 572 121 249 132 1894 702 3319 3733 3033 1867
9106 PF8443_8_7_U563400 353 117 3807 3825 5099 3785 123 471 1134 1429 2240 169
9106 PF8443_8_7_U503200 525 1224 1296 1223 777 523 2220 133 343 198 191 1567
9106 PF8443_8_7_U449600 146 616 266 314 409 257 1024 34 63 285 406 964
9106 PF8443_8_7_U447100 73 410 276 187 546 485 791 9 39 532 184 844
9106 PF8443_8_7_U449500 103 447 184 270 312 212 672 30 45 247 353 673
9106 PF8443_8_7_U486000 64 242 1191 924 246 32 451 22 43 26 75 435
9106 PF8443_8_7_U543200 80 291 201 215 202 147 528 19 64 110 111 447
9106 PF8443_8_7_U561200 66 343 122 94 67 71 583 21 20 34 46 571
9106 P F8443_8_7_U112400 21 187 60 8 6 4 598 21 22 11 99 621
9106 PF8443_8_7_U541900 120 366 169 25 37 22 564 . 2 9 5 11 306
9106 PF8443_8_7_U554300 106 202 264 33 10 12 442 43 66 14 75 406
9106 PF8443_8_7_U472600 95 275 83 61 50 27 325 80 128 65 83 366
9106 PF8443_8_7_U436400 24 206 41 60 105 77 449 16 27 32 78 455
9106 PF8443_8_7_U520800 49 252 85 56 89 49 338 9 35 30 51 337
9106 PF8443_8_7_U561400 116 300 222 89 73 39 380 6 16 14 10 37
9106 PF8443_8_7_U468200 27 109 130 27 37 16 107 20 57 10 188 99
9106 PF8443_8_7_U547700 38 132 68 39 67 42 87 16 32 32 41 146
9106 PF8443_8_7_U560500 72 47 0 0 0 0 19 388 31 0 0 48
9106 PF8443_8_7_U557900 20 53 137 20 11 10 137 49 56 2 51 89
9106 PF8443_8_7_U527100 16 43 64 44 15 8 65 19 42 3 54 73
9106 P F8443_8_7_U538400 43 73 27 7 16 7 67 5 4 2 2 84
9106 PF8443_8_7_U555100 8 28 5 8 3 4 42 6 3 4 2 46
9106 PF8443_8_7_U542600 7 16 3 0 2 4 10 0 1 0 2 11
9106 PF8443_8_7_U542500 6 4 7 0 3 2 10 0 0 0 0 4
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Isolate Gene ID AC_R ACT AC_G CU_R
10668 PF8443_8_8_U497600 6 50 74.5 4
10668 PF8443_8_8_U549200 7 0 30 9
10668 PF8443_8_8_U492900 68 3 113 28
10668 PF8443_8_8_U537300 49 27 104 37
10668 PF8443_8_8_U543100 305 3 147.5 78
10668 PF8443_8_8_U550500 69 10 235.5 50
10668 PF8443_8_8_U538400 169 44 240.5 57
10668 PF8443_8_8_U560900 319 25 144.5 71
10668 PF8443_8_8_U097100 225 17 171.5 97
10668 PF8443_8_8_U540800 258 7 98 62
10668 PF8443_8_8_U514700 195 8 244 60
10668 PF8443_8_8_U498500 109 14 158 182
10668 PF8443_8_8_U537100 255 4 383.5 115
10668 PF8443_8_8_U553100 63 19 220 33
10668 PF8443_8_8_U561500 153 4 90.5 43
10668 PF8443_8_8_U566600 126 22 619 131
10668 PF8443_8_8_U563300 1158 57 771 20
10668 PF8443_8_8_U501200 1014 9 481 2260
10668 PF8443_8_8_U553300 2802 13 543 545
10668 PF8443_8_8_U542300 204 1 546 142
10668 PF8443_8_8_U488800 968 34 744 497
10668 PF8443_8_8_U535700 791 43 441.5 486
Isolate Gene ID R+R R+LRET R+T R+S
SA075 PFSA075_493100 47 10 12 25
SA075 PFSA075_128400 372 2012 2337 510
SA075 PFSA075_051700 55 23 19 418
SA075 PF5AO75_154400 726 35 34 633
SA075 PFSA075_001200 237 13 32 654
SA075 PFSAO75_258600 279 21 19 146
SA075 PFSAO75_347800 264 24 34 88
SA075 PFSA075_072200 258 201 89 87
SA075 PFSAO75_348400 215 13 20 92
SA075 PFSA075_073100 202 17 21 88
SA075 PFSA075_PN67 173 10 18 27
SA075 PFSAO75_492500 94 80 51 54
SA075 PFSA075_PN64 88 9 36 144
SA075 PFSA075_493000 168 4 20 39
SA075 PFSA075_011100 49 195 101 138
SA075 PFSA075_071200 84 38 18 38
SA075 PFSA075_PN66 52 18 3 90
SA075 PFSA075_PN61 49 2 1 9
SA075 PFSA075_051200 35 1 2 38
SA075 PFSA075_PN62 12 33 19 10
SA075 PFSA075_PN65 27 3 4 78
SA075 PFSAO75_PN60 36 0 4 4
SA075 PFSA075_PN63 39 23 15 5
SA075 PFSA075_011900 6 0 1 12
SA075 PFSA075_492100 2 0 0 0
CU_T CU_S CU_G HB_R HBJ.RET HB_T HB_S HB_G
2 128 40 18 1 4 8 13
44 409 54 38 21 18 30 41
64 279 133 240 38 53 19 88
115 1001 57 12 8 14 98 73
277 773 87 119 15 32 82 78
97 729 218 376 25 41 80 202
142 577 118 302 110 13S 66 180
326 728 120 287 16 26 82 126
221 908 149 550 49 50 91 127
141 1581 95 235 21 23 172 73
159 1806 261 422 87 95 206 185
99 1435 128 723 293 308 157 120
360 845 343 602 237 253 79 308
152 1199 194 416 663 799 110 159
1567 1835 118 110 78 144 207 101
429 2570 507 1011 296 471 290 612
1 2976 0 385 646 620 348 670
412 3123 442 2084 282 373 319 600
1275 5859 505 1045 1219 1225 621 474
251 3822 391 9665 1334 1267 418 433
882 8400 659 1419 2372 3609 896 711
1247 14102 446 2063 722 1979 1460 548
:-r R-LRET R-T R-S R-G
742 4683 5061 7484 118
282 191 197 527 408
138 1678 642 1413 100
202 24 83 147 269
245 60 29 136 438
247 164 43 195 503
213 174 79 268 441
156 35 16 85 430
65 72 43 151 496
83 34 17 42 338
45 37 18 32 385
69 52 42 139 213
66 40 40 254 115
14 17 7 44 296
25 60 33 41 75
16 17 20 58 166
55 23 11 35 160
3 16 8 29 198
27 14 18 33 107
28 27 52 63 64
25 2 6 27 74
37 16 11 31 86
2 3 2 14 128
49 30 4 40 14
0 3 0 6 34
CUJ.RET
17
23
51
76
101
69
100
222
64
135
78
85
178
53
166
166
14
604
1242
200
687
587
R+G
95
393
85
308
318
438
389
387
358
353
390
172
95
269
54
125
115
126
107
42
59
66
7
79
26
433
Appendix Table 9.13. Raw stevor read counts from 454 amplicon sequencing ofcDNA  
and gDNA from a patient isolate, 8383 put under differential selection pressure. AC  
(acute rings and ex vivo trophozoites) and CU (culture-adapted) and fresh-from-the-arm  
patient samples that were matured in culture fo r  a single IDC, (acute rings, and ex vivo 
late rings to schizonts). These isolates lacked whole genome sequence data. Therefore the 
data in the table was generated by de novo assembly o f454 reads. The numbers o f  reads 
that went into contig assembly were computed per sample and these numbers were used 
at the read count data. !: samples that had limited sequencing depths (less than 100 
reads).
Isolate Cluster ID Sequence ID AC_R AC_T AC_G CU_P CU_T cu_s CU_G
8383 STE_454_001 PF383_STE_CU_06_P1_4 563 9287 233 8 2314 95 47
8383 STE_454_002 PF383_STE_AC_00_R1_3_1 94 175 190 16 24 778 24
8383 STE_454_005 PF383_STE_AC_00_G2_3_8 58 170 206 159 0 169 0
8383 STE_454_012 P F383_STE_CU_30_SZ_4 0 0 0 0 0 6 0
8383 STE_454_019 PF383_STE_AC_00_R1_3_18 43 240 1284 5 49 8 0
8383 STE_454_033 PF383_STE_CU_00_GE_3_2 609 886 879 460 504 20 204
8383 STE_454_050 PF383_STE_CU_18_TR_1 725 1117 754 1328 287 179 157
8383 STE_454_051 PF383_STE_CU_30_SZ_7 198 767 768 609 1667 75 149
8383 STE_454_052 PF383_STE_CU_06_P1_2 26 483 185 57 0 15 22
8383 STE_454_057 PF383_STE_AC_00_R1_3_9 81 1077 382 1257 137 261 99
8383 STE_454_078 PF383_STE_AC_00_G2_3_6 513 176 286 192 7 53 43
8383 STE_454_089 PF383_STE_AC_24_T1_10 89 706 539 763 18 215 119
8383 STE_454_095 PF383_STE_CU_00_GE_3_14 217 666 605 130 14 30 83
8383 STE_454_103 PF383_STE_CU_00_GE_3_9 832 387 1204 0 0 77 343
8383 STE_454_108 PF383_STE_AC_00_G 1_3_10 39 469 562 300 33 320 136
8383 STE_454_115 PF383_STE_AC_00_R1_3_10 9 131 103 184 0 848 29
8383 STE_454_148 PF383_STE_CU_06_P1_12 170 881 517 111 75 8 126
8383 STE_454_153 PF383_STE_CU_30_SZ_10 38 113 155 319 12 757 52
8383 STE_454_180 PF383_STE_AC_00_G1_3_4 0 26 28 0 0 0 13
8383 STE_454_200 PF383_STE_AC_00_G2_3_18 0 94 353 0 0 0 40
8383 STE_454 300 PF383_STE_AC_24_T1_22 0 6 0 0 0 0 0
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I s o la te
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
10727
Cluster ID Gene ID ER! MR T S G
STE_454_001 PF727_STE_AC_32_S1_3_9 35 300 3904 1177 107
STE_454_002 PF727 STE AC 12 Rl 3 2 0 68 8 45 15
STE_454_005 PF727 STE AC 00 ER 3 6 5 0 0 0 0
STE_454_008 PF727_STE_AC_12_R1_3_18 0 158 97 109 194
STE_454_026 PF727 STE AC 00 GE 3 7 0 198 19 75 83
STE_454_030 PF727_STE_AC_00_ER_3_3 28 0 0 0 0
STE_454_033 PF727 STE AC 00 ER 3 2 17 0 0 0 0
STE_454_034 PF727_STE_AC_12_R1_3_11 0 382 22 108 254
STE_454_037 PF727_STE_AC_00_G E_3_29 0 131 37 89 79
STE_454_044 PF727_STE_AC_00_ER_3_9 30 0 0 0 0
STE_454_047 PF727_STE_AC_00_E R _3_l1 43 0 0 0 0
STE_454_050 PF727_STE_AC_00_ER_3_10 44 0 0 0 0
STE_454_051 P F727_STE_AC_00_E R_3_4 34 0 0 0 0
STE_454_052 P F727_STE_AC_12_R 1_3_4 0 60 166 83 63
STE_454_061 PF727_STE_AC_12_R2_3_1 0 22 0 0 0
STE_454_064 PF727_STE_AC_32_S1_3_4 0 43 26 28 234
STE_454_066 PF727 STE AC 00 ER 3 7 26 0 0 0 0
STE_454_073 P F727_STE_AC_22_T1_3_23 0 677 74 414 383
STE_454_089 PF727_STE_AC_00_ER_3_12 17 0 0 0 0
STE_454_091 P F727_STE_AC_12_R1_3_7 0 273 82 266 10
STE_454_099 PF727_STE_AC_00_ER_3_14 15 0 0 0 0
STE_454_100 PF727 STE AC 12 Rl 3 3 0 128 0 49 15
STE_454_101 PF727_STE_AC_12_R1_3_1 0 111 56 156 369
STE_454_103 P F727_STE_AC_00_ER_3_5 111 0 0 0 0
STE_454_107 PF727_STE_AC_22_T2_3_25 0 26 25 8 19
STE_454_109 PF727_STE_AC_22_T1_3_16 0 815 20 273 108
STE_454_121 P F727_STE_AC_3 2_S 1_3_28 0 288 164 170 322
STE_454_122 PF727_STE_AC_12_R1_3_12 53 46 26 79 139
STE_454_150 PF727_STE_AC_12_R1_3_6 0 318 22 246 286
STE_454_155 PF727_STE_AC_22_T1_3_14 0 46 28 93 235
STE_454_156 PF727_STE_AC_22_T1_3_8 0 104 1509 737 174
STE_454_161 P F727_STE_AC_22_T1_3_17 0 319 189 139 318
STE_454_164 P F727_STE_AC_3 2_S 1_3_15 0 611 195 280 195
STE_454_166 PF727_STE_AC_22_T1_3_18 0 635 251 356 212
STE_454_169 P F727_STE_AC_2 2_T1_3_21 0 445 67 190 191
STE_454_171 P F727_STE_AC_00_G E_3_28 0 153 45 79 243
STE_454_173 P F727_STE_AC_00_G E_3_14 0 0 96 30 559
STE_454_176 PF727_STE_AC_32_S1_3_5 0 116 22 15 24
STE_454_178 PF727_STE_AC_00_ER_3_8 7 0 0 0 0
STE_454_182 P F727_STE_AC_22_T1_3_15 0 110 18 53 0
STE_454_183 PF727_STE_AC_22_T1_3_13 0 54 18 0 233
STE_454_190 P F727_STE_AC_3 2_S 1_3_14 0 0 52 42 143
STE_454_197 P F727_STE_AC_00_G E_3_17 0 253 168 136 461
STE_454_301 P F727_STE_AC_3 2_S 1_3_2 7 0 0 0 37 0
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Isolate Cluster ID Gene ID R T S G
10747 STE_454_001 PF747 STE AC 00 GE 3 1 281 893 1080 63
10747 STE_454_002 PF747 STE AC 00 GE 3 2 139 75 102 53
10747 STE_454_005 PF747 STE AC 60 ND 3 6 486 126 225 82
10747 STE_454_007 PF747 STE AC 40 T1 3 28 0 18 19 26
10747 STE_454_012 PF747 STE AC 40 T1 3 12 0 8 0 10
10747 STE_454_014 PF747 STE AC 40 T1 3 10 41 21 39 0
10747 STE_454_016 PF747 STE AC 60 ND 3 3 163 79 114 175
10747 STE_454_023 PF747 STE AC 00 GE 3 50 193 78 85 104
10747 STE_454_027 PF747 STE AC 00 GE 3 42 65 16 5 88
10747 STE_454_028 PF747 STE AC 00 GE 3 28 105 115 89 396
10747 STE_454_031 PF747 STE AC 00 GE 3 9 118 88 141 609
10747 STE_454_036 PF747 STE AC 00 GE 3 5 170 176 164 1309
10747 STE_454_040 PF747 STE AC 00 GE 3 15 0 6 0 6
10747 STE_454_042 PF747 STE AC 40 T1 3 18 16 21 20 19
10747 STE_454_048 PF747 STE AC 00 GE 3 51 80 130 282 226
10747 STE_454_054 PF747 STE AC 00 GE 3 45 12 60 14 47
10747 STE_454_058 PF747 STE AC 40 T1 3 27 29 44 32 33
10747 STE_454_063 PF747 STE AC 00 GE 3 12 124 72 80 24
10747 STE_454_076 PF747 STE AC 20 Rl 3 48 72 0 0 0
10747 STE_454_077 PF747 STE AC 60 ND 3 10 7 0 39 31
10747 STE_454_079 PF747 STE AC 60 ND 3 17 32 18 30 15
10747 STE_454_083 PF747 STE AC 60 ND 3 29 201 40 63 92
10747 STE_454_125 PF747 STE AC 40 T1 3 5 94 23 18 14
10747 STE_454_136 PF747 STE AC 20 Rl 3 20 47 12 16 28
10747 STE_454_146 PF747 STE AC 40 T1 3 20 124 68 55 124
10747 STE_454_154 PF747..STE. AC..40._T1_3_ 7 180 116 136 171
10747 STE_454_158 PF747..STE. AC..00._GE_3_.21 152 70 180 126
10747 STE_454_162 PF747..STE..AC..00._GE_3_.19 225 318 126 267
10747 STE_454_163 PF747..STE. AC_40_T1_3_ 17 367 231 262 571
10747 STE_454_172 PF747 STE AC 40 T1 3 4 15 20 11 35
10747 STE_454_174 PF747 STE AC 20 Rl 3 2 62 106 58 49
10747 STE_454_175 PF747..STE..AC..00._GE_3._6 69 51 62 105
10747 STE_454_177 PF747..STE..AC..20. Rl_3..7 6 31 74 85
10747 STE_454_184 PF747._STE .AC..20..R l_3..4 200 211 114 134
10747 STE_454_186 PF747..STE..AC..00._GE_3..17 44 39 57 62
10747 STE_454_187 PF747..STE..AC..20..R l_3..10 206 83 149 155
10747 STE_454_189 PF747. STE .AC..00._GE_3_.33 186 96 106 108
10747 STE_454_191 PF747._STE .AC..60._ND_3._23 15 20 18 12
10747 STE_454_192 PF747._STE .AC .20..R l_3..16 22 26 40 42
10747 STE_454_194 PF747._STE _AC_40__T1_3_ 25 132 73 127 50
10747 STE_454_196 PF747._STE_.AC..00._GE_3..37 55 45 55 54
10747 STE_454_198 PF747._STE_.AC._oo._GE_3..32 77 86 136 165
10747 STE_454_201 PF747._STE__AC_00._GE_3..38 115 49 74 99
10747 STE_454_202 PF747._STE._AC_.60. N D_3 _26 0 31 34 66
10747 STE_454_203 PF747._STE.AC .00._GE_3..18 704 399 611 502
10747 STE_454_204 PF747_STE_.AC._oo._GE_3..48 23 17 26 56
10747 STE_454_206 PF747 _STE..AC _oo._GE_3..4 21 10 16 6
10747 STE_454_217 PF747._STE..AC _40_T1_3_.16 17 8 0 12
10747 STE_454_221 PF747 STE AC 00 GE 3 46 0 20 86 60
10747 STE_454_232 PF747._STE.AC .60._ND_3_12 0 0 8 9
10747 STE_454_264 PF747._STE_AC_00__GE_3..23 0 0 0 14
10747 STE_454_290 PF747._STE_AC .20._R1_3..29 9 0 0 0
10747 STE 454_312 PF747 STE AC 20 Rl 3 50 8 0 0 0
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Isolate
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814-
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
10814
Cluster ID Gene ID R LRET
STE_454_001 PF814 STE AC 12 RN 3 1 137 618
STE_454_002 PF814_STE_AC_00_GE_3_31 0 0
STE_454_005 PF814 STE AC 12 RN 3 13 6 0
STE_454_006 PF814 STE AC 00 GE 3 14 0 0
STE_454_007 PF814_STE_AC_12_RN_3_19 94 7
STE_454_008 PF814_STE_AC_00_G E_3_35 0 0
STE_454_016 PF814 STE AC 12 RN 3 6 14 42
STE_454_017 PF814 STE AC 00 GE 3 41 0 0
STE_454_020 PF814 STE AC 12 RN 3 21 23 10
STE_454_025 PF814 STE AC 12 RN 3 11 30 13
STE_454_035 PF814 STE AC 00 GE 3 23 47 11
STE_454_042 PF814 STE AC 00 GE 3 18 0 0
STE_454_053 PF814_STE_AC_00_GE_3_1 121 0
STE_454_057 PF814 STE AC 12 RN 3 12 185 681
STE_454_059 PF814_STE_AC_12_RN_3_10 12 0
STE_454_062 PF814_STE_AC_12_RN_3_23 6 0
STE_454_063 PF814_STE_AC_00_GE_3_15 5 0
STE_454_066 PF814_STE_AC_00_GE_3_12 0 0
STE_454_067 PF814_STE_AC_12_RN_3_5 13 7
STE_454_073 PF814_STE_AC_12_RN_3_40 38 0
STE_454_086 PF814_STE_AC_12_RN_3_4 38 6
STE_454_087 PF814_STE_AC_20_PR_3_19 0 5
STE_454_088 PF814_STE_AC_00_G E _3_l 1 0 0
STE_454_091 P F814_STE_AC_00_G E _3_l 3 6 0
STE_454_095 PF814_STE_AC_00_G E_3_26 0 0
STE_454_102 PF814_STE_AC_00_G E_3_21 0 0
STE_454_109 PF814_STE_AC_12_R N_3_24 36 0
STE_454_123 PF814_STE_AC_00_G E_3_32 45 0
STE_454_125 PF814_STE_AC_00_G E_3_2 22 0
STE_454_127 PF814_STE_AC_12_RN_3_2 8 0
STE_454_145 PF814_STE_AC_12_RN_3_18 10 0
STE_454_193 PF814_STE_AC_12_RN_3_17 32 0
STE_454_199 PF814_STE_AC_20_PR_3_14 25 26
STE_454_210 PF814_STE_AC_20_PR_3_3 31 9
STE_454_211 PF814_STE_AC_00_G E_3_24 23 7
STE_454_213 PF814_STE_AC_20_PR_3_5 22 13
STE_454_215 PF814_STE_AC_12_RN_3_14 24 24
STE_454_216 PF814_STE_AC_00_GE_3_29 0 0
STE_454_218 PF814_STE_AC_20_PR_3_10 92 15
STE_454_219 PF814_STE_AC_20_PR_3_12 30 17
STE_454_220 PF814_STE_AC_12_RN_3_20 71 8
STE_454_224 PF814_STE_AC_12_RN_3_37 11 11
STE_454_225 PF814_STE_AC_20_PR_3_18 120 0
STE_454_229 PF814_STE_AC_12_RN_3_7 25 0
STE_454_230 PF814_STE_AC_12_RN_3_9 27 0
STE_454_233 PF814_STE_AC_20_PR_3_22 0 7
STE_454_239 PF814_STE_AC_00_G E_3_50 0 0
STE_454_242 PF814_STE_AC_00_G E_3_30 8 0
STE_454_243 PF814_STE_AC_00_GE_3_33 0 11
STE_454_244 PF814_STE_AC_00_G E_3_37 9 0
STE_454_247 PF814_STE_AC_00_G E_3_3 0 0
STE_454_250 PF814_STE_AC_00_GE_3_8 0 0
STE_454_256 PF814_STE_AC_00_G E_3_7 0 0
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Appendix Figure 9.1. Agarose gel electrophoresis images ofRT-PCR products for 
PFL2585c (A) and HRP2 (B) from SA075 cDNA at 4 stages o f  the IDC, rings (1), late 
ring to early trophozoites (2), trophozoites (3) and schizonts (4), mixed trophozoites 
cDNA from IT cultured in albumax (IT1), in pooled serum ( I f ) ,  and in an unrelated IT  
sample (IT), and two different trophozoite samples from a Kilifi isolate 8383 (K l and 
K2). Gl: ItgDNA, G2: 8383 gDNA. G3: SA075 R+ gDNA. -ve: no template control. L: 1 
kb plus DNA ladder. (+) and (-) indicate samples with and without the reverse 
transcriptase enzyme. Arrowheads in (A) indicate samples with incomplete gDNA 
digestion by the reverse transcriptase enzyme. * HRP PGR on gDNA resulted in many 
non-specific bands due to suboptimal PGR conditions.
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The cDNA used was of good quality as confirmed by HRP PCR. HRP PCR on gDNA did 
not give a clear band but rather a laddering of bands. This was probably due to 
suboptimal PCR cobditions, although changing the PCR conditions in a gradient PCR did 
not result in clear bands from gDNA.
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Appendix Figure 9.2. PFL2585c expression in trophozoites in culture-adapted Kilifi 
isolates and in laboratory lines, and PCR positive control from 3D7 gDNA. A 400bp 
band corresponding to PFL2585c HVL was detected in 8383 and the two IT trophozoite 
fractions sampled at different cycles.
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Appendix Figure 9.3. PFL2585c, total r i f  and HRP expression in trophozoites from 
laboratory and culture-adapted Kilifi isolates. (A) PFL2585c amplicons from laboratory 
lines, IT, 3D7, HB3, and culture-adapted patient isolates AK249 and 10668from  mixed 
trophozoite stages. The 400pb band corresponding to PFL2585c HVL amplicon was 
detected faintly in IT. HB3 and in 10668 (*). (B) r if  and HRP amplicons fo r  the same 
samples above. R if amplicons ranging from 800-95Obp were detected in all isolates 
except in AK249. HRP amplicons were detected in all isolates but not in gDNA. The fa in t 
HRP band in AK249 may suggest that the RNA sample used fo r RT-PCR may have been 
o f  poor quality hence the reason why no r if  amplicons could be detected.
Non-specific
(750bp)
500bp 
rif (400bp) rif (400bp)
Appendix Figure 9.4. Cloning PFL2585c RT-PCR amplicons from 10594. (A) 
Amplification products from PFL2585c specific RT-PCR from  a patient isolate 10595 at 
7 time points ex vivo. Asterisks (*) indicate amplicons that were purified fo r cloning by 
either total PCR cleanup using OIAquick PCR Purification Kit (QIAgen), or gel 
extraction and purification using the OIAquick Gel Extraction Kit (QIAgen). Red boxes 
denote bands that were gel extracted. (B) Purified amplicons fo r  cloning. N: The non- 
PFL2585c upper band of'750bp. R: PFL2585c expected band of400bp. T: Total PCR 
purification. L: 1 kb plus DNA ladder.
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Appendix Figure 9.5. ClustcilW alignment o f  10 PFL2585c HVL/V2 sequences from 3D7, 
IT., and HB3 genomes, and 4 wild isolates, 2 from Brazil (Albrecht et al., 2006) and 2 
from Kilifi, K 10594 and K8383. The 3D7, IT, K8383 and K 10594 were obtained by 
cloning PFL2585c HVL amplicons and capillary sequencing. Mean pairwise identity =
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A
-2 J
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Appendix Figure 9.6. Plots o f  signal (log2ratio) across chromosome 12 infield  isolates 
10595 (A) and 10594 (B) compared to 3D7. Regions with the red line above or below 
zero are possible CNVs or highly variable regions (such as VSAs at chromosomal ends). 
The arrows point to position o f  the PFL2585c loci. In 10595 (A) the gene lies within a 
deletion (log2ratio=-2.523). Images courtesy ofMackinnon (Mackinnon et al., 
unpublished).
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Appendix Figure 9.7. Plots oflog2 ratios fo r PFL2585c expression from Kilifi isolates 
at 10 hourly time points o f  the ex vivo parasite I DC. Images courtesy ofMackinnon 
(Mackinnon et a l, unpublished).
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